Main publications by team


(click to expand or collapse)

QEM main publications

Tenaillon O, Barrick JE, Ribeck N, Deatherage DE, Blanchard JL, Dasgupta A, Wu GC, Wielgoss S, Cruveiller S, Médigue C, Schneider D, Lenski RE
Tempo and mode of genome evolution in a 50,000-generation experiment.
Nature 2016, 536, 165-170.

Figliuzzi M, Jacquier H, Schug A, Tenaillon O, Weigt M
Coevolutionary Landscape Inference and the Context-Dependence of Mutations in Beta-Lactamase TEM-1.
Molecular Biology and Evolution 2016, 33, 268-280.

Feugeas JP, Tourret J, Launay A, Bouvet O, Hoede C, Denamur E, Tenaillon O
Links between Transcription, Environmental Adaptation and Gene Variability in Escherichia coli: Correlations between Gene Expression and Gene Variability Reflect Growth Efficiencies.
Molecular Biology and Evolution 2016

Long A, Liti G, Luptak A, Tenaillon O
Elucidating the molecular architecture of adaptation via evolve and resequence experiments.
Nature Reviews. Genetics 2015, 16, 567-582.

Blanquart F, Achaz G, Bataillon T, Tenaillon O
Properties of selected mutations and genotypic landscapes under Fisher's geometric model.
Evolution; International Journal of Organic Evolution 2014, 68, 3537-3554.

Jacquier H, Birgy A, Le Nagard H, Mechulam Y, Schmitt E, Glodt J, Bercot B, Petit E, Poulain J, Barnaud G, Gros PA, Tenaillon O
Capturing the mutational landscape of the beta-lactamase TEM-1.
Proceedings of the National Academy of Sciences of the United States of America 2013, 110, 13067-13072.

Tenaillon O, Rodríguez-Verdugo A, Gaut RL, McDonald P, Bennett AF, Long AD, Gaut BS
The molecular diversity of adaptive convergence.
Science (New York, N.Y.) 2012, 335, 457-461.

Gros PA, Tenaillon O
Selection for Chaperone-Like Mediated Genetic Robustness at Low Mutation Rate: Impact of Drift, Epistasis and Complexity.
Genetics 2009, 182, 555-564.

Silander OK, Tenaillon O, Chao L
Understanding the Evolutionary Fate of Finite Populations: The Dynamics of Mutational Effects.
PLoS Biol 2007, 5, e94.

Bjedov I, Tenaillon O, Gérard B, Souza V, Denamur E, Radman M, Taddei F, Matic I
Stress-induced mutagenesis in bacteria.
Science (New York, N.Y.) 2003, 300, 1404-1409.

EVRest main publications

Dufour N, Clermont O, La Combe B, Messika J, Dion S, Khanna V, Denamur E, Ricard J, Debarbieux L, ColoColi group
Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex..
Journal of Antimicrobial Chemotherapy 2016, 71, 3072.

Skurnik D, Clermont O, Guillard T, Launay A, Danilchanka O, Pons S, Diancourt L, Lebreton F, Kadlec K, Roux D, Jiang D, Dion S, Ashard H, Denamur M, Cywes-Bentley C, Schwarz S, Tenaillon O, Andremont A, Picard B, Mekalanos J, Brisse S, Denamur E
Emergence of Antimicrobial-Resistant Escherichia coli of Animal Origin Spreading in Humans.
Molecular Biology and Evolution 2016, 33, 898.

Soysal N, Mariani-Kurkdjian P, Smail Y, Liguori S, Gouali M, Loukiadis E, Fach P, Bruyand M, Blanco J, Bidet P, Bonacorsi S
Enterohemorrhagic Escherichia coli Hybrid Pathotype O80:H2 as a New Therapeutic Challenge..
Emerging Infectious Diseases 2016, 22, 1604-1612.

Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S
High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 593-600.

Basmaci R, Bonacorsi S, Bidet P, Biran V, Aujard Y, Bingen E, Béchet S, Cohen R, Levy C
Escherichia coli Meningitis Features in 325 Children From 2001 to 2013 in France..
Clinical Infectious Diseases 2015, 61, 779.

Rodríguez-Beltrán J, Tourret J, Tenaillon O, López E, Bourdelier E, Costas C, Matic I, Denamur E, Blázquez J
High Recombinant Frequency in Extraintestinal Pathogenic Escherichia coli Strains.
Molecular Biology and Evolution 2015, 32, 1708.

Roux D, Danilchanka O, Guillard T, Cattoir V, Aschard H, Fu Y, Angoulvant Y, Messika J, Ricard J, Mekalanos J, Lory S, Pier G, Skurnik D
Fitness cost of antibiotic susceptibility during bacterial infection.
Science Translational Medecine 2015, 22, 297.

Rossi B, Soubirou J, Chau F, Massias L, Dion S, Lepeule R, Fantin B, Lefort A
Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
Antimicrobial Agents and Chemotherapy 2015, 32, 1708.

de Lastours V, Bleibtreu A, Chau F, Burdet C, Duval X, Denamur E, Fantin B
Quinolone-resistant Escherichia coli from the faecal microbiota of healthy volunteers after ciprofloxacin exposure are highly adapted to a commensal lifestyle..
Journal of Antimicrobial Chemotherapy 2014, 69, 761.

STAR main publications

Senard O, Burdet C, Visseaux B, Charpentier C, Le Gac S, Julia Z, Lariven S, Descamps D, Yazdanpanah Y, Yeni P, Joly V
Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study.
AIDS research and human retroviruses 2017, 33, 11-16.

Madelain V, Le MP, Champenois K, Charpentier C, Landman R, Joly V, Yeni P, Descamps D, Yazdanpanah Y, Peytavin G
Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1137-1146.

Perrier M, Charpentier C, Peytavin G, Lê M, Blondel L, Visseaux B, Joly V, Pinto A, Matheron S, Yazdanpanah Y, Descamps D, Landman R
Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort.
The Journal of Antimicrobial Chemotherapy 2017

Delory T, Papot E, Rioux C, Charpentier C, Auge-Courtoi C, Michard F, Peytavin G, Descamps D, Matheron S, Yazdanpanah Y
Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience.
Journal of Medical Virology 2016, 88, 1204-1210.

Visseaux B, Damond F, Matheron S, Descamps D, Charpentier C
Hiv-2 molecular epidemiology.
Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2016, 46, 233-240.

Frange P, Faye A, Avettand-Fenoël V, Bellaton E, Descamps D, Angin M, David A, Caillat-Zucman S, Peytavin G, Dollfus C, Le Chenadec J, Warszawski J, Rouzioux C, Sáez-Cirión A, AECPCatAEVsg
HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.
The lancet. HIV 2016, 3, e49-54.

De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D, CaCiE
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1352-1360.

Bocket L, Peytavin G, Alidjinou EK, Ajana F, Choisy P, Lê M, Charpentier C, Descamps D, Yazdanpanah Y, Katlama C, Simon A, Calvez V, Marcelin AG, Soulie C
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2651-2653.

Bertine M, Visseaux B, Storto A, Collin G, Matheron S, Descamps D, Charpentier C, ACH2C
HIV-2 Vif Diversity Among Defective and Nondefective Sequences.
Journal of Acquired Immune Deficiency Syndromes (1999) 2016, 72, e9-e11.

Brunetta J, Moreno Guillén S, Antinori A, Yeni P, Wade B, Johnson M, Shalit P, Ebrahimi R, Johnson B, Walker I, De-Oertel S
Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial.
The Patient 2015

Canlorbe G, Matheron S, Mandelbrot L, Oudet B, Luton D, Azria E
Vasculoplacental complications in pregnant women with HIV infection: a case-control study.
American Journal of Obstetrics and Gynecology 2015

Chéret A, Nembot G, Mélard A, Lascoux C, Slama L, Miailhes P, Yeni P, Abel S, Avettand-Fenoel V, Venet A, Chaix ML, Molina JM, Katlama C, Goujard C, Tamalet C, Raffi F, Lafeuillade A, Reynes J, Ravaux I, Hoën B, Delfraissy JF, Meyer L, Rouzioux C, OASG
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.
The Lancet. Infectious Diseases 2015, 15, 387-396.

Descamps D, Peytavin G, Visseaux B, Tubiana R, Damond F, Campa P, Charpentier C, Khuong-Josses MA, Duvivier C, Karmochkine M, Lukiana T, Matheron S
Dolutegravir in HIV-2 infected patients with resistant virus to first-line integrase inhibitors from the French Named Patient Program.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015

Carrieri MP, Serfaty L, Vilotitch A, Winnock M, Poizot-Martin I, Loko MA, Lions C, Lascoux-Combe C, Roux P, Salmon-Ceron D, Spire B, Dabis F, ACHSG
Cannabis use and reduced risk of insulin-resistance in HIV-HCV infected patients: a longitudinal analysis (ANRS HEPAVIH CO-13).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015

Raymond S, Maillard A, Amiel C, Peytavin G, Trabaud MA, Desbois D, Bellecave P, Delaugerre C, Soulie C, Marcelin AG, Descamps D, Izopet J, obtAARSG
Virological failure of patients on maraviroc-based antiretroviral therapy.
The Journal of Antimicrobial Chemotherapy 2015

Loubet P, Charpentier C, Visseaux B, Borbor A, Nuta C, Adu E, Chapplain JM, Baysah M, Tattevin P, Yazdanpanah Y, Descamps D
Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1881-1884.

Bastard JP, Fellahi S, Couffignal C, Raffi F, Gras G, Hardel L, Sobel A, Leport C, Fardet L, Capeau J, ACACCSG
Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1816-1824.

Charpentier C, Lee GQ, Rodriguez C, Visseaux B, Storto A, Fagard C, Molina JM, Katlama C, Yazdanpanah Y, Harrigan PR, Descamps D
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2090-2096.

Mandelbrot L, Duro D, Belissa E, Peytavin G
Placental Transfer of Rilpivirine in an Ex Vivo Human Cotyledon Perfusion Model.
Antimicrobial Agents and Chemotherapy 2015

Deuzing IP, Charpentier C, Wright DW, Matheron S, Paton J, Frentz D, van de Vijver DA, Coveney PV, Descamps D, ACH2C, Boucher CAB, Beerens N
Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses.
Journal of Virology 2015, 89, 833-843.

de Monteynard LA, Dray-Spira R, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Gilquin J, Rey D, Simon A, Pavie J, Mahamat A, Matheron S, Costagliola D, Abgrall S, FHDoH
Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France.
PloS One 2015, 10, e0118492.

Charpentier C, Camacho R, Ruelle J, Kaiser R, Eberle J, Gürtler L, Pironti A, Stürmer M, Brun-Vézinet F, Descamps D, Obermeier M
HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 56, 1654-1658.

Visseaux B, Hurtado-Nedelec M, Charpentier C, Collin G, Storto A, Matheron S, Larrouy L, Damond F, Brun-Vézinet F, Descamps D, AC0H2C
Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool.
The Journal of Infectious Diseases 2012, 205, 111-120.

Visseaux B, Charpentier C, Hurtado-Nedelec M, Storto A, Antoine R, Peytavin G, Damond F, Matheron S, Brun-Vézinet F, Descamps D, FAH2C(C0V2
In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors.
Antimicrobial Agents and Chemotherapy 2012, 56, 137-139.

Larrouy L, Charpentier C, Landman R, Capitant C, Chazallon C, Yeni P, Peytavin G, Damond F, Brun-Vezinet F, Descamps D, A1sg
Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen.
AIDS (London, England) 2011, 25, 2143-2148.

Yazdanpanah Y, Fagard C, Descamps D, Taburet AM, Colin C, Roquebert B, Katlama C, Pialoux G, Jacomet C, Piketty C, Bollens D, Molina JM, Chêne G, A1TTG
High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2009, 49, 1441-1449.

Delaunay C, Brun-Vézinet F, Landman R, Collin G, Peytavin G, Trylesinski A, Flandre P, Miller M, Descamps D
Comparative selection of the K65R and M184V/I mutations in human immunodeficiency virus type 1-infected patients enrolled in a trial of first-line triple-nucleoside analog therapy (Tonus IMEA 021).
Journal of Virology 2005, 79, 9572-9578.

Descamps D, Chaix ML, André P, Brodard V, Cottalorda J, Deveau C, Harzic M, Ingrand D, Izopet J, Kohli E, Masquelier B, Mouajjah S, Palmer P, Pellegrin I, Plantier JC, Poggi C, Rogez S, Ruffault A, Schneider V, Signori-Schmück A, Tamalet C, Wirden M, Rouzioux C, Brun-Vezinet F, Meyer L, Costagliola D
French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.
Journal of Acquired Immune Deficiency Syndromes (1999) 2005, 38, 545-552.

Descamps D, Calvez V, Izopet J, Buffet-Janvresse C, Schmuck A, Colson P, Ruffault A, Maillard A, Masquelier B, Cottalorda J, Harzic M, Brun-Vézinet F, Costagliola D, AARSG
Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study.
AIDS (London, England) 2001, 15, 1777-1782.

Descamps D, Flandre P, Calvez V, Peytavin G, Meiffredy V, Collin G, Delaugerre C, Robert-Delmas S, Bazin B, Aboulker JP, Pialoux G, Raffi F, Brun-Vézinet F
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).
JAMA 2000, 283, 205-211.

Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, Simon F, Saragosti S, Brun-Vézinet F
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.
Journal of Virology 1997, 71, 8893-8898.

BIPID main publications

Protopopescu C, Carrieri MP, Raffi F, Picard O, Hardel L, Piroth L, Jadand C, Pierret J, Spire B, Leport C, ACACSG
Brief Report: Prolonged Viral Suppression Over a 12-Year Follow-up of HIV-Infected Patients: The Persistent Impact of Adherence at 4 Months After Initiation of Combined Antiretroviral Therapy in the ANRS CO8 APROCO-COPILOTE Cohort.
Journal of Acquired Immune Deficiency Syndromes (1999) 2017, 74, 293-297.

Desmée S, Mentré F, Veyrat-Follet C, Sébastien B, Guedj J
Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients.
Biometrics 2017, 73, 305-312.

Riviere MK, Ueckert S, Mentré F
An MCMC method for the evaluation of the Fisher information matrix for non-linear mixed effect models.
Biostatistics (Oxford, England) 2016, 17, 737-750.

Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna n, Kighoma PM, Koundouno FR, Réné Lolamou n, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Dortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D, JSG
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
PLoS medicine 2016, 13, e1001967.

Bertrand J, De Iorio M, Balding DJ
Integrating dynamic mixed-effect modelling and penalized regression to explore genetic association with pharmacokinetics.
Pharmacogenetics and Genomics 2015, 25, 231-238.

Nyberg J, Bazzoli C, Ogungbenro K, Aliev A, Leonov S, Duffull S, Hooker AC, Mentré F
Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies.
British Journal of Clinical Pharmacology 2015, 79, 6-17.

Claessens YE, Debray MP, Tubach F, Brun AL, Rammaert B, Hausfater P, Naccache JM, Ray P, Choquet C, Carette MF, Mayaud C, Leport C, Duval X
Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia.
American Journal of Respiratory and Critical Care Medicine 2015, 192, 974-982.

Tessier A, Bertrand J, Chenel M, Comets E
Comparison of Nonlinear Mixed Effects Models and Noncompartmental Approaches in Detecting Pharmacogenetic Covariates.
The AAPS journal 2015, 17, 597-608.

Thai HT, Mentré F, Holford NHG, Veyrat-Follet C, Comets E
Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics.
Journal of Pharmacokinetics and Pharmacodynamics 2014, 41, 15-33.

Nguyen TT, Mentre F
Evaluation of the Fisher information matrix in nonlinear mixed effect models using adaptive Gaussian quadrature.
Computational Statistics & Data Analysis 2014, 80, 57-69.

Bertrand J, Verstuyft C, Chou M, Borand L, Chea P, Nay KH, Blanc FX, Mentré F, Taburet AM, C(1CKSG
Dependence of efavirenz- and rifampicin-isoniazid-based antituberculosis treatment drug-drug interaction on CYP2B6 and NAT2 genetic polymorphisms: ANRS 12154 study in Cambodia.
The Journal of Infectious Diseases 2014, 209, 399-408.

Laouénan C, Marcellin P, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Peytavin G, Mentré F, Guedj J
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
Antimicrobial Agents and Chemotherapy 2014, 58, 5332-5341.

Nguyen TT, Guedj J, Chachaty E, de Gunzburg J, Andremont A, Mentré F
Mathematical modeling of bacterial kinetics to predict the impact of antibiotic colonic exposure and treatment duration on the amount of resistant enterobacteria excreted.
PLoS computational biology 2014, 10, e1003840.

Guedj J, Dahari H, Rong L, Sansone ND, Nettles RE, Cotler SJ, Layden TJ, Uprichard SL, Perelson AS
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life.
Proceedings of the National Academy of Sciences of the United States of America 2013, 110, 3991-3996.

Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen B, ASG
Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys.
Journal of the American College of Cardiology 2012, 59, 1968-1976.

DeSCID main publications

Bailly S, Leroy O, Dupont H, Timsit JF
Secondarily documented invasive candidiasis is unpredictable using traditional risk factors in non transplant - non-neutropenic adult ICU patients.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2017, 54, 31-33.

Baldesi O, Bailly S, Ruckly S, Lepape A, L'Heriteau F, Aupee M, Boussat S, Bervas C, Machut A, Berger-Carbonne A, Savey A, Timsit JF, RRn
ICU-acquired candidaemia in France: Epidemiology and temporal trends, 2004-2013 - A study from the REA-RAISIN network.
The Journal of Infection 2017

Papot E, Landman R, Louni F, Charpentier C, Peytavin G, Certain A, Fradet C, Castro DR, Preau M, Goujard C, Yeni P, Yazdanpanah Y, AGSG
Budget impact of antiretroviral therapy in a French clinic cohort.
AIDS (London, England) 2017, 31, 1271-1279.

Calvino-Gunther S, Schwebel C, Hamidfar-Roy R, Bonadona A, Lugosi M, Ara-Somohano C, Minet C, Potton L, Cartier JC, Vésin A, Chautemps M, Styfalova L, Ruckly S, Timsit JF
Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).
Intensive Care Medicine 2016, 42, 1753-1765.

Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M, ETG
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
JAMA 2016, 316, 1555-1564.

Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y
Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs.
Hepatology (Baltimore, Md.) 2016, 63, 1090-1101.

Weiss E, Zahar JR, Garrouste-Orgeas M, Ruckly S, Essaied W, Schwebel C, Timsit JF, OSG
De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition.
Intensive Care Medicine 2016, 42, 2098-2100.

Bailly S, Garnaud C, Cornet M, Pavese P, Hamidfar-Roy R, Foroni L, Boisset S, Timsit JF, Maubon D
Impact of systemic antifungal therapy on the detection of Candida species in blood cultures in clinical cases of candidemia.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2016, 35, 1023-1032.

Birgand G, Moore LSP, Bourigault C, Vella V, Lepelletier D, Holmes AH, Lucet JC
Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22, 162.e1-9.

Pelat C, Kardaś-Słoma L, Birgand G, Ruppé E, Schwarzinger M, Andremont A, Lucet JC, Yazdanpanah Y
Hand Hygiene, Cohorting, or Antibiotic Restriction to Control Outbreaks of Multidrug-Resistant Enterobacteriaceae.
Infection Control and Hospital Epidemiology 2016, 37, 272-280.

Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, Tacey M, Timsit JF, Leone M, Zahar JR, De Waele JJ, WGfAUitI
A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 62, 1009-1017.

Barbier F, Pommier C, Essaied W, Garrouste-Orgeas M, Schwebel C, Ruckly S, Dumenil AS, Lemiale V, Mourvillier B, Clec'h C, Darmon M, Laurent V, Marcotte G, Lucet JC, Souweine B, Zahar JR, Timsit JF, OSG
Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1088-1097.

Deuffic-Burban S, Obach D, Canva V, Pol S, Roudot-Thoraval F, Dhumeaux D, Mathurin P, Yazdanpanah Y
Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case.
Journal of Viral Hepatitis 2016, 23, 767-779.

Obach D, Yazdanpanah Y, Esmat G, Avihingsanon A, Dewedar S, Durier N, Attia A, Anwar WA, Cousien A, Tangkijvanich P, Eholié SP, Doss W, Mostafa A, Fontanet A, Mohamed MK, Deuffic-Burban S
How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.
Hepatology (Baltimore, Md.) 2015, 62, 31-39.

Bailly S, Leroy O, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Azoulay E, Timsit JF
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.
Intensive Care Medicine 2015, 41, 1931-1940.

Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, Lucet JC, Paugam-Burtz C, Brun-Buisson C, Timsit JF, DeSG
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 649.e1-10.

Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S, Friggeri A, Wallet F, Allou N, Ruckly S, Balayn D, Lepape A, Timsit JF, Cti
Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
Lancet (London, England) 2015, 386, 2069-2077.

Souweine B, Lautrette A, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Cointault O, Lepape A, Guelon D, Darmon M, Vesin A, Caillot N, Schwebel C, Boyer A, Azoulay E, Bouadma L, Timsit JF
Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 1024-1032.

Bailly S, Bouadma L, Azoulay E, Orgeas MG, Adrie C, Souweine B, Schwebel C, Maubon D, Hamidfar-Roy R, Darmon M, Wolff M, Cornet M, Timsit JF
Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 1139-1146.

Mourad A, Deuffic-Burban S, Ganne-Carrié N, Renaut-Vantroys T, Rosa I, Bouvier AM, Launoy G, Cattan S, Louvet A, Dharancy S, Trinchet JC, Yazdanpanah Y, Mathurin P
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach.
Hepatology (Baltimore, Md.) 2014, 59, 1471-1481.

Deuffic-Burban S, Schwarzinger M, Obach D, Mallet V, Pol S, Pageaux GP, Canva V, Deltenre P, Roudot-Thoraval F, Larrey D, Dhumeaux D, Mathurin P, Yazdanpanah Y
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).
Journal of Hepatology 2014, 61, 7-14.

Birgand G, Schwarzinger M, Perozziello A, Lolom I, Pelat C, Armand-Lefevre L, Buzzi JC, Andremont A, Yazdanpanah Y, Lucet JC
Prolonged hospital stay, an adverse effect of strict national policy for controlling the spread of highly resistant microorganisms.
Infection Control and Hospital Epidemiology 2014, 35, 1427-1429.

Obach D, Deuffic-Burban S, Esmat G, Anwar WA, Dewedar S, Canva V, Cousien A, Doss W, Mostafa A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed MK, Yazdanpanah Y
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1064-1071.

Deuffic-Burban S, Yazdanpanah Y
Mathematical modeling: a tool for selecting agents with complementary modes of action?.
Journal of Hepatology 2013, 59, 1346-1348.

Champenois K, Cousien A, Cuzin L, Le Vu S, Deuffic-Burban S, Lanoy E, Lacombe K, Patey O, Béchu P, Calvez M, Semaille C, Yazdanpanah Y
Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study.
BMC infectious diseases 2013, 13, 200.

Yazdanpanah Y, Perelman J, DiLorenzo MA, Alves J, Barros H, Mateus C, Pereira J, Mansinho K, Robine M, Park JE, Ross EL, Losina E, Walensky RP, Noubary F, Freedberg KA, Paltiel AD
Routine HIV screening in Portugal: clinical impact and cost-effectiveness.
PloS One 2013, 8, e84173.

Deuffic-Burban S, Deltenre P, Buti M, Stroffolini T, Parkes J, Mühlberger N, Siebert U, Moreno C, Hatzakis A, Rosenberg W, Zeuzem S, Mathurin P
Predicted effects of treatment for HCV infection vary among European countries.
Gastroenterology 2012, 143, 974-985.e14.

Deuffic-Burban S, Yazdanpanah Y
It is time to change the paradigm for hepatitis C virus testing.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1272-1274.

Deuffic-Burban S, Mathurin P, Pol S, Larsen C, Roudot-Thoraval F, Desenclos JC, Dhumeaux D, Yazdanpanah Y
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis.
Gut 2012, 61, 290-296.

Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Lepape A, Vesin A, Arrault X, Schwebel C, Adrie C, Zahar JR, Ruckly S, Tournegros C, Lucet JC
Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults.
American Journal of Respiratory and Critical Care Medicine 2012, 186, 1272-1278.


IAME exhaustive list of publications


(click to expand or collapse)

 2017                                                                            

Lascarrou JB, Boisrame-Helms J, Bailly A, Le Thuaut A, Kamel T, Mercier E, Ricard JD, Lemiale V, Colin G, Mira JP, Meziani F, Messika J, Dequin PF, Boulain T, Azoulay E, Champigneulle B, Reignier J, CRiICaS(G
Video Laryngoscopy vs Direct Laryngoscopy on Successful First-Pass Orotracheal Intubation Among ICU Patients: A Randomized Clinical Trial.
JAMA 2017, 317, 483-493.

Sachs A, Guglielminotti J, Miller R, Landau R, Smiley R, Li G
Risk Factors and Risk Stratification for Adverse Obstetrical Outcomes After Appendectomy or Cholecystectomy During Pregnancy.
JAMA surgery 2017, 152, 436-441.

Ursino M, Zohar S, Lentz F, Alberti C, Friede T, Stallard N, Comets E
Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populations.
Biometrical Journal. Biometrische Zeitschrift 2017, 59, 804-825.

Reeves S, Eggleston K, Cort E, McLachlan E, Brownings S, Nair A, Greaves S, Smith A, Dunn J, Marsden P, Kessler R, Taylor D, Bertrand J, Howard R
Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP).
International Journal of Geriatric Psychiatry 2017

Gantner P, Mélard A, Damond F, Delaugerre C, Dina J, Gueudin M, Maillard A, Sauné K, Rodallec A, Tuaillon E, Plantier JC, Rouzioux C, Avettand-Fenoel V, AAQWG
Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies.
Journal of Medical Virology 2017

Nguyen THT, Mouksassi MS, Holford N, Al-Huniti N, Freedman I, Hooker AC, John J, Karlsson MO, Mould DR, Pérez Ruixo JJ, Plan EL, Savic R, van Hasselt JGC, Weber B, Zhou C, Comets E, Mentré F, MEGotISoP(BPC
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics.
CPT: pharmacometrics & systems pharmacology 2017, 6, 87-109.

Bizzotto R, Comets E, Smith G, Yvon F, Kristensen NR, Swat M
PharmML in Action - An interoperable language for modelling and simulation.
CPT: pharmacometrics & systems pharmacology 2017

Smith MK, Moodie SL, Bizzotto R, Blaudez E, Borella E, Carrara L, Chan P, Chenel M, Comets E, Gieschke R, Harling K, Harnisch L, Hartung N, Hooker AC, Karlsson MO, Kaye R, Kloft C, Kokash N, Lavielle M, Lestini G, Magni P, Mari A, Mentré F, Muselle C, Nordgren R, Nyberg HB, Parra-Guillén ZP, Pasotti L, Rode-Kristensen N, Sardu ML, Smith GR, Swat MJ, Terranova N, Yngman G, Yvon F, Holford N, Dc
Model Description Language (MDL): A Standard for Modeling and Simulation.
CPT: pharmacometrics & systems pharmacology 2017

Sonneville R, Gimenez L, Labreuche J, Smonig R, Magalhaes E, Bouadma L, Timsit JF, Mazighi M
What is the prognosis of acute stroke patients requiring ICU admission?.
Intensive Care Medicine 2017, 43, 271-272.

Capuzzo M, Garrouste-Orgeas M, Martin-Loeches I
What were you able to do in your daily life? Performance status for the critically ill patient.
Intensive Care Medicine 2017, 43, 104-106.

Kentish-Barnes N, Chevret S, Champigneulle B, Thirion M, Souppart V, Gilbert M, Lesieur O, Renault A, Garrouste-Orgeas M, Argaud L, Venot M, Demoule A, Guisset O, Vinatier I, Troché G, Massot J, Jaber S, Bornstain C, Gaday V, Robert R, Rigaud JP, Cinotti R, Adda M, Thomas F, Calvet L, Galon M, Cohen-Solal Z, Cariou A, Azoulay E, FSG
Effect of a condolence letter on grief symptoms among relatives of patients who died in the ICU: a randomized clinical trial.
Intensive Care Medicine 2017, 43, 473-484.

Hadjaj Y, Roux D, Justet A, Berquier G
Intra-alveolar hemorrhages due to left heart dysfunction and calcified constrictive pericarditis.
Intensive Care Medicine 2017, 43, 929.

Dreyfuss D, Gaudry S, Madotto F, Laffey JG
Some remaining important questions after LUNG SAFE : Discussion of "Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study".
Intensive Care Medicine 2017, 43, 598-599.

Bassetti M, Garnacho-Montero J, Calandra T, Kullberg B, Dimopoulos G, Azoulay E, Chakrabarti A, Kett D, Leon C, Ostrosky-Zeichner L, Sanguinetti M, Timsit JF, Richardson MD, Shorr A, Cornely OA
Intensive care medicine research agenda on invasive fungal infection in critically ill patients.
Intensive Care Medicine 2017

Cambau E, Durand-Zaleski I, Bretagne S, Buisson CB, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S, Est
Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial.
Intensive Care Med 2017

Cambau E, Durand-Zaleski I, Bretagne S, Buisson CB, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S, Est
Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial.
Intensive Care Medicine 2017

Poulakou G, Matthaiou DK, Bassetti M, Erdem H, Dimopoulos G, Curcio DJ, Carlet J, Lipman J, Timsit JF, Giamarellou H, Arfaras-Melainis A, Rello J, EI
"Salvage treatment" for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal.
Intensive Care Medicine 2017

Timsit JF, de Kraker MEA, Sommer H, Weiss E, Bettiol E, Wolkewitz M, Nikolakopoulos S, Wilson D, Harbarth S, CNc
Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net.
Intensive Care Medicine 2017

Sonneville R, de Montmollin E, Poujade J, Garrouste-Orgeas M, Souweine B, Darmon M, Mariotte E, Argaud L, Barbier F, Goldgran-Toledano D, Marcotte G, Dumenil AS, Jamali S, Lacave G, Ruckly S, Mourvillier B, Timsit JF
Potentially modifiable factors contributing to sepsis-associated encephalopathy.
Intensive Care Medicine 2017

Perner A, Gordon AC, Angus DC, Lamontagne F, Machado F, Russell JA, Timsit JF, Marshall JC, Myburgh J, Shankar-Hari M, Singer M
The intensive care medicine research agenda on septic shock.
Intensive Care Medicine 2017

Laupland KB, Paiva JA, Timsit JF
Focus on severe infections.
Intensive Care Medicine 2017

Gaudry S, Hajage D, Dreyfuss D, Joannidis M, Perner A
Optimal timing of renal replacement therapy in patients with acute kidney injury in the context of sepsis : Discussion on "Sepsis: frontiers in supportive care, organisation and research".
Intensive Care Medicine 2017

Yamaga S, Shime N, Sonneville R, de Montmollin E, Timsit JF
Risk factors for sepsis-associated encephalopathy.
Intensive Care Medicine 2017

Bassetti M, Poulakou G, Ruppe E, Bouza E, Van Hal SJ, Brink A
Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.
Intensive Care Medicine 2017

Rasoanandrasana S, Decousser JW, Cattoir V, Berçot B, Domrane C, Fihman V, Grillon A, Lesenne A, Raskine L, Cambau E, Jacquier H
Use of ESwab in the Xpert® vanA/vanB PCR assay.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2017, 36, 755-756.

Righi L, Amarsy R, Picat MQ, Thuillier M, Cambau E, Raskine L, Chevret S, Flicoteaux R
Monitoring antimicrobial resistance (AMR) using CUSUM control charts.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2017, 36, 1519-1525.

Saba G, Andrade LF, Gaillat J, Bonnin P, Chidiac C, Illes HG, Laurichesse H, Messika J, Ricard JD, Detournay B, Petitpretz P, de Pouvourville G
Costs associated with community acquired pneumonia in France.
The European journal of health economics: HEPAC: health economics in prevention and care 2017

Préau M, Laguette V, March L, Rabaud C, Hardel L, Protopopescu C, Granier P, Pierret J, Leport C, Raffi F, ACACSG
Discussing HIV Status: Is It Easier After 10 Years of Antiretroviral Treatment? The ANRS CO8 APROCO-COPILOTE Cohort.
AIDS and behavior 2017, 21, 118-128.

Buatois S, Retout S, Frey N, Ueckert S
Item Response Theory as an Efficient Tool to Describe a Heterogeneous Clinical Rating Scale in De Novo Idiopathic Parkinson's Disease Patients.
Pharmaceutical Research 2017

Nguyen THT, Nguyen TT, Mentré F
Individual Bayesian Information Matrix for Predicting Estimation Error and Shrinkage of Individual Parameters Accounting for Data Below the Limit of Quantification.
Pharmaceutical Research 2017

Iung B, Rouzet F, Brochet E, Duval X
Cardiac Imaging of Infective Endocarditis, Echo and Beyond.
Current Infectious Disease Reports 2017, 19, 8.

Duval X, Iung B
Extracardiac Imaging of Infective Endocarditis.
Current Infectious Disease Reports 2017, 19, 24.

Alexandre K, Fantin B
Pharmacokinetics and Pharmacodynamics of Temocillin.
Clinical Pharmacokinetics 2017

Roquet F, Guezoulialail L, Wachowska B, Balcan I, Montravers P, Longrois D, Guglielminotti J
Comparison of three stimulation Sites on the pupillary dilation reflex amplitude evoked by a standardized noxious test.
Anaesthesia, Critical Care & Pain Medicine 2017

Millot S, Lesclous P, Colombier ML, Radoi L, Messeca C, Ballanger M, Charrier JL, Tramba P, Simon S, Berrebi A, Doguet F, Lansac E, Tribouilloy C, Habib G, Duval X, Iung B
Position paper for the evaluation and management of oral status in patients with valvular disease: Groupe de Travail Valvulopathies de la Société Française de Cardiologie, Société Française de Chirurgie Orale, Société Française de Parodontologie et d'Implantologie Orale, Société Française d'Endodontie et Société de Pathologie Infectieuse de Langue Française.
Archives of Cardiovascular Diseases 2017, 110, 482-494.

Lefebvre A, Lucet JC, Bertrand X, Chavanet P, Astruc K, Quantin C, Vanhems P, Aho-Glélé LS
Detection of temporal clusters of health care-associated infections or colonizations with Pseudomonas aeruginosa.
American Journal of Infection Control 2017, 45, 72-74.

Pilmis B, Thepot-Seegers V, Angebault C, Weiss E, Alaabouche I, Bougnoux ME, Zahar JR
Could we predict airborne Aspergillus contamination during construction work?.
American Journal of Infection Control 2017, 45, 39-41.

Piorkowski G, Jacquot F, Quérat G, Carbonnelle C, Pannetier D, Mentré F, Raoul H, de Lamballerie X
Implementation of a non-human primate model of Ebola disease: Infection of Mauritian cynomolgus macaques and analysis of virus populations.
Antiviral Research 2017, 140, 95-105.

Kollef MH, Ricard JD, Roux D, Francois B, Ischaki E, Rozgonyi Z, Boulain T, Ivanyi Z, János G, Garot D, Koura F, Zakynthinos E, Dimopoulos G, Torres A, Danker W, Montgomery AB
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS Trial.
Chest 2017, 151, 1239-1246.

Andre E, Goeminne L, Cabibbe A, Beckert P, Kabamba Mukadi B, Mathys V, Gagneux S, Niemann S, Van Ingen J, Cambau E
Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 167-172.

Montravers P, Perrigault PF, Timsit JF, Mira JP, Lortholary O, Leroy O, Gangneux JP, Guillemot D, Bensoussan C, Bailly S, Azoulay E, Constantin JM, Dupont H, ASG
Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 117.e1-117.e8.

Argy N, Bertin GI, Milet J, Hubert V, Clain J, Cojean S, Houzé P, Tuikue-Ndam N, Kendjo E, Deloron P, Houzé S, CSG
Preferential expression of domain cassettes 4, 8 and 13 of Plasmodium falciparum erythrocyte membrane protein 1 in severe malaria imported in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 211.e1-211.e4.

Pereyre S, Laurier Nadalié C, Bébéar C, ig
Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 122.e1-122.e7.

Loubet P, Lenzi N, Valette M, Foulongne V, Krivine A, Houhou N, Lagathu G, Rogez S, Alain S, Duval X, Galtier F, Postil D, Tattevin P, Vanhems P, Carrat F, Lina B, Launay O, FSG
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 253-259.

Ruppé E, Olearo F, Pires D, Baud D, Renzi G, Cherkaoui A, Goldenberger D, Huttner A, François P, Harbarth S, Schrenzel J
Clonal or not clonal? Investigating hospital outbreaks of KPC-producing Klebsiella pneumoniae with whole-genome sequencing.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 470-475.

Micaëlo M, Goubard A, La Ruche G, Denamur E, Tenaillon O, Cambau E, Jacquier H, Bercot B
Molecular epidemiology of penicillinase-producing Neisseria gonorrhoeae isolates in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017

Loubet P, Burdet C, Vindrios W, Grall N, Wolff M, Yazdanpanah Y, Andremont A, Duval X, Lescure FX
Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017

Jolivet S, Lescure FX, Armand-Lefevre L, Raffoul R, Dilly MP, Ghodbane W, Nataf P, Lucet JC
Surgical Site Infection with Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae after Cardiac Surgery: Incidence and Risk Factors.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017

Lecorche E, Haenn S, Mougari F, Kumanski S, Veziris N, Benmansour H, Raskine L, Moulin L, Cambau E, CM
Comparison of methods available for the identification of Mycobacterium chimaera.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017

Lachâtre M, Méchain M, Etienne M, Gautret P, Matheron S, Nahon M, Coignard-Biehler H, Malvy D, Duval X, Tattevin P
No evidence for major adverse events related to suspicion of Ebola in France, 2014-2015.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017

Ueckert S, Mentre F
A new method for evaluation of the Fisher information matrix for discrete mixed effect models using Monte Carlo sampling and adaptive Gaussian quadrature.
Computational Statistics & Data Analysis 2017, 111, 203-219.

Hakima N, Bidet P, Lopez M, Rioualen S, Carol A, Bonacorsi S
First case of neonatal bacteremia due to Dyella genus.
Diagnostic Microbiology and Infectious Disease 2017, 87, 199-201.

Rhee SY, Varghese V, Holmes SP, Van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MAA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW
Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: An international collaboration.
EBioMedicine 2017

Guet-Revillet H, Tomini E, Emirian A, Join-Lambert O, Lécuyer H, Zahar JR, Jullien V
Piperacillin/tazobactam as an alternative antibiotic therapy to carbapenems in the treatment of urinary tract infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: an in silico pharmacokinetic study.
International Journal of Antimicrobial Agents 2017, 49, 62-66.

Zahar JR, Lesprit P, Ruckly S, Eden A, Hikombo H, Bernard L, Harbarth S, Timsit JF, Brun-Buisson C, BSG
Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
International Journal of Antimicrobial Agents 2017, 49, 67-73.

Morel F, Decousser JW, Kumanski S, Cambau E, Denamur E, Berçot B
Association of the 16S rRNA methylase gene rmtB with a novel insertion sequence element belonging to the ISL3 family.
International Journal of Antimicrobial Agents 2017, 49, 117-118.

Pulcini C, Tebano G, Mutters NT, Tacconelli E, Cambau E, Kahlmeter G, Jarlier V, EEESRWG
Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey.
International Journal of Antimicrobial Agents 2017, 49, 162-166.

Grall N, Lazarevic V, Gaïa N, Couffignal C, Laouénan C, Ilic-Habensus E, Wieder I, Plesiat P, Angebault C, Bougnoux ME, Armand-Lefevre L, Andremont A, Duval X, Schrenzel J
Unexpected persistence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the faecal microbiota of hospitalised patients treated with imipenem.
International Journal of Antimicrobial Agents 2017, 50, 81-87.

Nguyen V, Cimadevilla C, Arangalage D, Dehoux M, Codogno I, Duval X, Tubiana S, Vahanian A, Messika-Zeitoun D
Determinants and prognostic value of B-type natriuretic peptide in patients with aortic valve stenosis.
International Journal of Cardiology 2017, 230, 371-377.

Testuz A, Nguyen V, Mathieu T, Kerneis C, Arangalage D, Kubota N, Codogno I, Tubiana S, Estellat C, Cimadevilla C, Vahanian A, Messika-Zeitoun D
Influence of metabolic syndrome and diabetes on progression of calcific aortic valve stenosis.
International Journal of Cardiology 2017

Bailly S, Leroy O, Dupont H, Timsit JF
Secondarily documented invasive candidiasis is unpredictable using traditional risk factors in non transplant - non-neutropenic adult ICU patients.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2017, 54, 31-33.

Loubet P, Voiriot G, Houhou-Fidouh N, Neuville M, Bouadma L, Lescure FX, Descamps D, Timsit JF, Yazdanpanah Y, Visseaux B
Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2017, 91, 52–57.

Loubet P, Voiriot G, Houhou-Fidouh N, Neuville M, Bouadma L, Lescure FX, Descamps D, Timsit JF, Yazdanpanah Y, Visseaux B
Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2017, 91, 52-57.

Deuffic-Burban S, Boursier J, Leroy V, Yazdanpanah Y, Castera L, Mathurin P
Are targeted treatment recommendations in chronic hepatitis C tailored to diagnostic methods of fibrosis?.
Journal of Hepatology 2017, 66, 304-312.

Mallet V, Hamed K, Schwarzinger M
Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based study.
Journal of Hepatology 2017, 66, 514-520.

Schwarzinger M, Baillot S, Yazdanpanah PY, Rehm PJ, Mallet V
Contribution of Alcohol Use Disorders on the Burden of Chronic Hepatitis C in France, 2008-2013: A Nationwide Retrospective Cohort Study.
Journal of Hepatology 2017

Corlouer C, Lamy B, Desroches M, Ramos-Vivas J, Mehiri-Zghal E, Lemenand O, Delarbre JM, Decousser JW, CdBVHdHdF
Stenotrophomonas maltophilia healthcare-associated infections: identification of two main pathogenic genetic backgrounds.
The Journal of Hospital Infection 2017, 96, 183-188.

Loison G, Troughton R, Raymond F, Lepelletier D, Lucet JC, Avril C, Birgand G, Awg
Compliance with clothing regulations and traffic flow in the operating room: a multi-centre study of staff discipline during surgical procedures.
The Journal of Hospital Infection 2017

Geraud de Galassus A, Cizeau F, Agathine A, Domrane C, Ducellier D, Fihman V, Decousser JW
Contribution and limits of clinical specimens for the screening of intestinal multi-drug-resistant bacteria in view of laboratory automation.
The Journal of Hospital Infection 2017, 97, 59-63.

Adrie C, Garrouste-Orgeas M, Ibn Essaied W, Schwebel C, Darmon M, Mourvillier B, Ruckly S, Dumenil AS, Kallel H, Argaud L, Marcotte G, Barbier F, Laurent V, Goldgran-Toledano D, Clec'h C, Azoulay E, Souweine B, Timsit JF, OSG
Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy.
The Journal of Infection 2017, 74, 131-141.

Wyplosz B, Mougari F, Al Rawi M, Baillon C, Marigot-Outtandy D, Le Dû D, Jachym M, Hervé V, Raskine L, Cambau E
Visualizing viable Mycobacterium tuberculosis in sputum to monitor isolation measures.
The Journal of Infection 2017, 74, 207-210.

Bailly S, Leroy O, Azoulay E, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Timsit JF, ASG
Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.
The Journal of Infection 2017, 74, 408-417.

Baldesi O, Bailly S, Ruckly S, Lepape A, L'Heriteau F, Aupee M, Boussat S, Bervas C, Machut A, Berger-Carbonne A, Savey A, Timsit JF, RRn
ICU-acquired candidaemia in France: Epidemiology and temporal trends, 2004-2013 - A study from the REA-RAISIN network.
The Journal of Infection 2017

Maitre T, Aubry A, Jarlier V, Robert J, Veziris N, CM
Multidrug and extensively drug-resistant tuberculosis.
Medecine Et Maladies Infectieuses 2017, 47, 3-10.

Stahl JP, Azouvi P, Bruneel F, De Broucker T, Duval X, Fantin B, Girard N, Herrmann JL, Honnorat J, Lecuit M, Mailles A, Martinez-Almoyna L, Morand P, Piroth L, Tattevin P, rg
Guidelines on the management of infectious encephalitis in adults.
Medecine Et Maladies Infectieuses 2017, 47, 179-194.

Goulenok T, Buzelé R, Duval X, Bruneel F, Stahl JP, Fantin B
Management of adult infectious encephalitis in metropolitan France.
Medecine Et Maladies Infectieuses 2017, 47, 206-220.

Brossier F, Sougakoff W, FNRCfM
Molecular detection methods of resistance to antituberculosis drugs in Mycobacterium tuberculosis.
Medecine Et Maladies Infectieuses 2017, 47, 340-348.

Perrineau S, Cazals-Hatem D, Zarrouk V, Fantin B, de Lastours V
Cytomegalovirus-associated protein-losing enteropathy in a healthy man.
Medecine Et Maladies Infectieuses 2017

Ruppé E, Greub G, Schrenzel J
Messages from the first International Conference on Clinical Metagenomics (ICCMg).
Microbes and Infection 2017, 19, 223-228.

Charfi K, Grami R, Ben Jeddou A, Messaoudi A, Mani Y, Bouallegue O, Boujaafar N, Aouni M, Mammeri H, Mansour W
Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates from neonates in Tunisia.
Microbial Pathogenesis 2017, 110, 184-188.

Welfringer A, Vuong V, Argy N, Chochillon C, Deschamps L, Rollin G, Harent S, Joly V, Vindrios W, Descamps V
A rare fungal infection: Phaehyphomycosis due to Veronaea botryosa and review of literature.
Medical Mycology Case Reports 2017, 15, 21-24.

Lequilliec N, Raymond R, Vanjak D, Baghdadi N, Boulestreau H, Zahar JR, Gangneux JP
Practices of infectious control management during neutropenia: A survey from 149 French hospitals.
Journal De Mycologie Medicale 2017

Simon-Tillaux N, Rouvier P, Deray G, Isnard-Bagnis C, Tourret J
[Lack of energy in a patient living with HIV].
Nephrologie & Therapeutique 2017

Tashk P, Lecronier M, Clermont O, Renvoisé A, Aubry A, Barrou B, Hertig A, Lescat M, Tenaillon O, Denamur E, Tourret J
[Molecular epidemiology and kinetics of early Escherichia coli urinary tract infections in kidney transplant recipients].
Nephrologie & Therapeutique 2017, 13, 236-244.

Gaudry S, Chaïbi K, Bénichou N, Verney C, Hajage D, Dreyfuss D
[Renal replacement therapy for acute kidney injury in the intensive care unit].
Nephrologie & Therapeutique 2017, 13 Suppl 1, S13-S21.

Tammaro P, Richard N, Andre B, Andremont A, Mammeri H
First report of human infection due to Streptococcus devriesei.
New Microbes and New Infections 2017, 15, 72-73.

Kortbaoui R, Allyn J, Guglielminotti J, Bussienne F, Montravers P, Martinet O, Vandroux D, Desmard M, Augustin P, Allou N
Pattern and consequences of cardiologic medications management for patients with elevated troponin I upon admission into an intensive care unit not linked to type 1 acute myocardial infarction: A prospective observational cohort study.
Annales Pharmaceutiques Francaises 2017

Messika J, Nahmani Y, Aouad P, Berquier G, Roux D, Delahousse M
[Renal abnormalities].
La Revue De Medecine Interne 2017

de Lastours V
[Should doses of antibiotics be adjusted?].
La Revue De Medecine Interne 2017

Abbara S, Georgin-Lavialle S, Bachmeyer C, Hermine O, Launay JM, de Lastours V
[Chronic asthenia and abdominal pain in a 26-year-old woman].
La Revue De Medecine Interne 2017

Doré J, Multon MC, Béhier JM, poGXRTN
The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?.
Therapie 2017, 72, 21-38.

Peiffer-Smadja N, Ouedraogo R, D'Ortenzio E, Cissé PN, Zeggani Z, Beavogui AH, Faye SL, Le Marcis F, Yazdanpanah Y, Nguyen VK
Vaccination and blood sampling acceptability during Ramadan fasting month: A cross-sectional study in Conakry, Guinea.
Vaccine 2017, 35, 2569-2574.

Armand-Lefevre L, Ruppé E, Andremont A
ESBL-producing Enterobacteriaceae in travellers: doctors beware.
The Lancet. Infectious Diseases 2017, 17, 8-9.

Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M, Msg
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.
The Lancet. Infectious Diseases 2017

Decousser JW
Prevention of paediatric nosocomial infections: adapting before acting.
The Lancet. Infectious Diseases 2017, 17, 350-351.

Asfar P, Schortgen F, Boisramé-Helms J, Charpentier J, Guérot E, Megarbane B, Grimaldi D, Grelon F, Anguel N, Lasocki S, Henry-Lagarrigue M, Gonzalez F, Legay F, Guitton C, Schenck M, Doise JM, Devaquet J, Van Der Linden T, Chatellier D, Rigaud JP, Dellamonica J, Tamion F, Meziani F, Mercat A, Dreyfuss D, Seegers V, Radermacher P, HI, Rrn
Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial.
The Lancet. Respiratory Medicine 2017, 5, 180-190.

Sissoko D, Duraffour S, Kerber R, Kolie JS, Beavogui AH, Camara AM, Colin G, Rieger T, Oestereich L, Pályi B, Wurr S, Guedj J, Nguyen THT, Eggo RM, Watson CH, Edmunds WJ, Bore JA, Koundouno FR, Cabeza-Cabrerizo M, Carter LL, Kafetzopoulou LE, Kuisma E, Michel J, Patrono LV, Rickett NY, Singethan K, Rudolf M, Lander A, Pallasch E, Bockholt S, Rodríguez E, Di Caro A, Wölfel R, Gabriel M, Gurry C, Formenty P, Keïta S, Malvy D, Carroll MW, Anglaret X, Günther S
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study.
The Lancet. Global Health 2017, 5, e80-e88.

Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Doré V, Meyer L, AISG
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
The lancet. HIV 2017

Leblanc S, Blein C, Andremont A, Bandinelli PA, Galvain T
Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.
Infection Control and Hospital Epidemiology 2017, 38, 906-911.

Clermont O, Couffignal C, Blanco J, Mentré F, Picard B, Denamur E, CaCg
Two levels of specialization in bacteraemic Escherichia coli strains revealed by their comparison with commensal strains.
Epidemiology and Infection 2017, 145, 872-882.

Bialek-Davenet S, Mayer N, Vergalli J, Duprilot M, Brisse S, Pagès JM, Nicolas-Chanoine MH
In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.
Scientific Reports 2017, 7, 6722.

Ruppé E, Lazarevic V, Girard M, Mouton W, Ferry T, Laurent F, Schrenzel J
Clinical metagenomics of bone and joint infections: a proof of concept study.
Scientific Reports 2017, 7, 7718.

Nguyen THT, Guedj J, Uprichard SL, Kohli A, Kottilil S, Perelson AS
The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?.
Scientific Reports 2017, 7, 10233.

Carrillo-Bustamante P, Nguyen THT, Oestereich L, Günther S, Guedj J, Graw F
Determining Ribavirin's mechanism of action against Lassa virus infection.
Scientific Reports 2017, 7, 11693.

Mamede JI, Damond F, Bernardo Ad, Matheron S, Descamps D, Battini JL, Sitbon M, Courgnaud V
Cyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates.
Scientific Reports 2017, 7, 45214.

Delafont V, Samba-Louaka A, Cambau E, Bouchon D, Moulin L, Héchard Y
Mycobacterium llatzerense, a waterborne Mycobacterium, that resists phagocytosis by Acanthamoeba castellanii.
Scientific Reports 2017, 7, 46270.

Dreyfuss D, Hajage D, Gaudry S
Why ELAIN and AKIKI Should Not Be Compared: Resolving Discordant Studies.
American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation 2017, 69, 864.

Timsit JF, Pilmis B, Zahar JR
How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?.
Seminars in Respiratory and Critical Care Medicine 2017, 38, 287-300.

Best K, Guedj J, Madelain V, de Lamballerie X, Lim SY, Osuna CE, Whitney JB, Perelson AS
Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral strategies.
Proceedings of the National Academy of Sciences of the United States of America 2017, 114, 8847-8852.

N'Guyen Y, Duval X, Revest M, Saada M, Erpelding ML, Selton-Suty C, Bouchiat C, Delahaye F, Chirouze C, Alla F, Strady C, Hoen B, Asg
Time interval between infective endocarditis first symptoms and diagnosis: relationship to infective endocarditis characteristics, microorganisms and prognosis.
Annals of Medicine 2017, 49, 117-125.

Bertrand J
Bioequivalence and Statistics in Clinical Pharmacology.
Journal of Biopharmaceutical Statistics 2017

Decousser JW, Poirel L, Nordmann P
Recent advances in biochemical and molecular diagnostics for the rapid detection of antibiotic-resistant Enterobacteriaceae: a focus on ß-lactam resistance.
Expert Review of Molecular Diagnostics 2017, 17, 327-350.

Post FA, Yazdanpanah Y, Schembri G, Lazzarin A, Reynes J, Maggiolo F, Yan M, Abram ME, Tran-Muchowski C, Cheng A, Rhee MS
Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial().
HIV clinical trials 2017, 1-6.

Pichon M, Mikail N, Ben Ali K, Rouzet F, Burdet C, Yazdanpanah Y, Joly V, Lepage L, Sarda-Mantel L
18FDG-PET/CT: a useful tool for the management of patients in infectious diseases.
Infectious Diseases (London, England) 2017, 49, 155-157.

Senard O, Burdet C, Visseaux B, Charpentier C, Le Gac S, Julia Z, Lariven S, Descamps D, Yazdanpanah Y, Yeni P, Joly V
Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study.
AIDS research and human retroviruses 2017, 33, 11-16.

Pourcher V, Desnoyer A, Assoumou L, Lebbe C, Curjol A, Marcelin AG, Cardon F, Gibowski S, Salmon D, Chennebault JM, Poizot-Martin I, Peytavin G, Boué F, Costagliola D
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.
AIDS research and human retroviruses 2017, 33, 1–10.

Reeves S, McLachlan E, Bertrand J, Antonio FD, Brownings S, Nair A, Greaves S, Smith A, Taylor D, Dunn J, Marsden P, Kessler R, Howard R
Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.
Brain: A Journal of Neurology 2017, 140, 1117-1127.

Lebeaux D, Freund R, van Delden C, Guillot H, Marbus SD, Matignon M, Van Wijngaerden E, Douvry B, De Greef J, Vuotto F, Tricot L, Fernández-Ruiz M, Dantal J, Hirzel C, Jais JP, Rodriguez-Nava V, Jacobs F, Lortholary O, Coussement J, ESGfNiSOT, ESGfNiSOT
Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017, 64, 1396-1405.

Dufour N, Delattre R, Ricard JD, Debarbieux L
The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-Lactams.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017, 64, 1582-1588.

Duval X, Millot S, Chirouze C, Selton-Suty C, Moby V, Tattevin P, Strady C, Euvrard E, Agrinier N, Thomas D, Hoen B, Alla F, EdAplelPdlI(SG
Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017, 64, 1678-1685.

Tschudin-Sutter S, Lucet JC, Mutters NT, Tacconelli E, Zahar JR, Harbarth S
Contact precautions for preventing nosocomial transmission of ESBL-producing Escherichia coli - a point/counterpoint review.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017

Vindrios W, Argy N, Le Gal S, Lescure FX, Massias L, Le MP, Wolff M, Yazdanpanah Y, Nevez G, Houze S, Dorent R, Lucet JC
Outbreak of Pneumocystis jirovecii Infection among Heart Transplant Recipients: Molecular Investigation and Management of an Inter-human Transmission.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017

Jullien V, Azoulay E, Schwebel C, Le Saux T, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Cour M, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Wolff M, Timsit JF, ETSG
Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation.
The Journal of Antimicrobial Chemotherapy 2017, 72, 181-189.

Calvez V, Hocqueloux L, Meynard JL, Muret P, Castan B, Tardy JC, Peytavin G, Landman R
Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why?.
The Journal of Antimicrobial Chemotherapy 2017, 72, 19-28.

Raffi F, Le Moing V, Assuied A, Habak S, Spire B, Cazanave C, Billaud E, Dellamonica P, Ferry T, Fagard C, Leport C, atACCSG
Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course.
The Journal of Antimicrobial Chemotherapy 2017, 72, 240-245.

Fonsart J, Saragosti S, Taouk M, Peytavin G, Bushman L, Charreau I, Hance A, Goldwirt L, Morel S, Mammano F, Loze B, Capitant C, Clavel F, Mahjoub N, Meyer L, Anderson PL, Delaugerre C, Molina JM
Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial.
The Journal of Antimicrobial Chemotherapy 2017, 72, 478–485.

Briand C, Dollfus C, Faye A, Kantor E, Avettand-Fenoel V, Caseris M, Descamps D, Schneider V, Tabone MD, Vaudre G, Veber F, Blanche S, Frange P
Efficacy and tolerance of dolutegravir-based combined ART in perinatally HIV-1-infected adolescents: a French multicentre retrospective study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 837–843.

Wirden M, Charpentier C, Tubiana R, Le MP, Desire N, Dionou S, Pichon F, Valantin MA, Yasdanpanah Y, Descamps D, Peytavin G, Katlama C, Calvez V, Marcelin AG
HIV-1 diagnosis with unquantifiable viraemia: don't be naive, look for antiretroviral drugs.
The Journal of Antimicrobial Chemotherapy 2017, 72, 630–632.

Wirden M, Charpentier C, Tubiana R, Le MP, Desire N, Dionou S, Pichon F, Valantin MA, Yasdanpanah Y, Descamps D, Peytavin G, Katlama C, Calvez V, Marcelin AG
HIV-1 diagnosis with unquantifiable viraemia: don't be naive, look for antiretroviral drugs.
The Journal of Antimicrobial Chemotherapy 2017, 72, 630-632.

Madelain V, Le MP, Champenois K, Charpentier C, Landman R, Joly V, Yeni P, Descamps D, Yazdanpanah Y, Peytavin G
Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
The Journal of Antimicrobial Chemotherapy 2017

Madelain V, Le MP, Champenois K, Charpentier C, Landman R, Joly V, Yeni P, Descamps D, Yazdanpanah Y, Peytavin G
Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1137-1146.

Duprilot M, Decre D, Genel N, Drieux L, Sougakoff W, Arlet G
Diversity and functionality of plasmid-borne VagCD toxin-antitoxin systems of Klebsiella pneumoniae.
The Journal of Antimicrobial Chemotherapy 2017

Cecchini J, Tuffet S, Sonneville R, Fartoukh M, Mayaux J, Roux D, Kouatchet A, Boissier F, Tchir M, Thyrault M, Maury E, Jochmans S, Mekontso Dessap A, Brun-Buisson C, de Prost N
Antimicrobial strategy for severe community-acquired legionnaires' disease: a multicentre retrospective observational study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1502-1509.

Perrier M, Charpentier C, Peytavin G, Lê M, Blondel L, Visseaux B, Joly V, Pinto A, Matheron S, Yazdanpanah Y, Descamps D, Landman R
Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort.
The Journal of Antimicrobial Chemotherapy 2017

Mougari F, Loiseau J, Veziris N, Bernard C, Bercot B, Sougakoff W, Jarlier V, Raskine L, Cambau E, FNRCfM
Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1669-1677.

Assoumou L, Charpentier C, Recordon-Pinson P, Grudé M, Pallier C, Morand-Joubert L, Fafi-Kremer S, Krivine A, Montes B, Ferré V, Bouvier-Alias M, Plantier JC, Izopet J, Trabaud MA, Yerly S, Dufayard J, Alloui C, Courdavault L, Le Guillou-Guillemette H, Maillard A, Amiel C, Vabret A, Roussel C, Vallet S, Guinard J, Mirand A, Beby-Defaux A, Barin F, Allardet-Servent A, Ait-Namane R, Wirden M, Delaugerre C, Calvez V, Chaix ML, Descamps D, Reigadas S, AA1RSG
Prevalence of HIV-1 drug resistance in treated patients with viral load \textgreater50 copies/mL: a 2014 French nationwide study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1769–1773.

de Lastours V, Maugy E, Mathy V, Chau F, Rossi B, Guérin F, Cattoir V, Fantin B, CSG
Ecological impact of ciprofloxacin on commensal enterococci in healthy volunteers.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1574-1580.

Birgy A, Delecourt M, Geslain G, Desselas E, Caseris M, Magnan M, Mariani-Kurkdjian P, Bidet P, Bonacorsi S
A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam.
The Journal of Antimicrobial Chemotherapy 2017

Mani Y, Mansour W, Mammeri H, Denamur E, Saras E, Boujâafar N, Bouallègue O, Madec JY, Haenni M
KPC-3-producing ST167 Escherichia coli from mussels bought at a retail market in Tunisia.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2403-2404.

Soulie C, Grudé M, Descamps D, Amiel C, Morand-Joubert L, Raymond S, Pallier C, Bellecave P, Reigadas S, Trabaud MA, Delaugerre C, Montes B, Barin F, Ferré V, Jeulin H, Alloui C, Yerly S, Signori-Schmuck A, Guigon A, Fafi-Kremer S, Haïm-Boukobza S, Mirand A, Maillard A, Vallet S, Roussel C, Assoumou L, Calvez V, Flandre P, Marcelin AG, AARSG
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
The Journal of Antimicrobial Chemotherapy 2017

Ruppé E, Chappuis F
What and how should we tell travellers about antimicrobial resistance?.
Journal of Travel Medicine 2017, 24,

Woerther PL, Andremont A, Kantele A
Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level.
Journal of Travel Medicine 2017, 24, S29-S34.

Ragonnet R, Deuffic-Burban S, Boesecke C, Guiguet M, Lacombe K, Guedj J, Rockstroh JK, Yazdanpanah Y
Estimating the Time to Diagnosis and the Chance of Spontaneous Clearance During Acute Hepatitis C in Human Immunodeficiency Virus-Infected Individuals.
Open Forum Infectious Diseases 2017, 4, ofw235.

Billard-Pomares T, Rouyer C, Walewski V, Badell-Ocando E, Dumas M, Zumelzu C, Jaureguy F, Brisse S, Caux F, Bouchaud O, Carbonnelle E
Diagnosis in France of a Non-Toxigenic tox Gene-Bearing Strain of Corynebacterium diphtheriae in a Young Male Back From Senegal.
Open Forum Infectious Diseases 2017, 4, ofw271.

Dres M, Roux D, Pham T, Beurton A, Ricard JD, Fartoukh M, Demoule A
Prevalence and Impact on Weaning of Pleural Effusion at the Time of Liberation from Mechanical Ventilation: A Multicenter Prospective Observational Study.
Anesthesiology 2017, 126, 1107-1115.

Roca O, García-de-Acilu M, Ricard JD
High-Flow Nasal Cannula Meta-Analysis: Do Not Mix Apples and Oranges!.
Critical Care Medicine 2017, 45, e244.

Prat D, Messika J, Ricard JD, Sztrymf B
Meta-Analysis of Bowel Protocols in Critical Care Patients: A Word of Caution.
Critical Care Medicine 2017, 45, e990.

Crowell CS, Maiga AI, Sylla M, Taiwo B, Kone N, Oron AP, Murphy RL, Marcelin AG, Traore B, Fofana DB, Peytavin G, Chadwick EG
High Rates of Baseline Drug Resistance and Virologic Failure Among ART Naïve HIV-Infected Children in Mali.
The Pediatric Infectious Disease Journal 2017

Richaud C, De Lastours V, Panhard X, Petrover D, Bruno F, Lefort A
Candida vertebral osteomyelitis (CVO) 28 cases from a 10-year retrospective study in France.
Medicine 2017, 96, e7525.

Masson-Behar V, Jacquier H, Richette P, Ziza JM, Zeller V, Rioux C, Coustet B, Dieudé P, Ottaviani S
Arthritis secondary to meningococcal disease: A case series of 7 patients.
Medicine 2017, 96, e7573.

Sellier PO, Maylin S, Berçot B, Chopin D, Lopes A, Simoneau G, Evans J, Delcey V, Bénifla JL, Simon F, Bergmann JF
Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
European Journal of Gastroenterology & Hepatology 2017, 29, 259-263.

Messika J, Goutorbe P, Hajage D, Ricard JD
Severe pulmonary embolism managed with high-flow nasal cannula oxygen therapy.
European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 2017, 24, 230-232.

Papot E, Landman R, Louni F, Charpentier C, Peytavin G, Certain A, Fradet C, Castro DR, Preau M, Goujard C, Yeni P, Yazdanpanah Y, AGSG
Budget impact of antiretroviral therapy in a French clinic cohort.
AIDS (London, England) 2017, 31, 1271–1279.

Papot E, Landman R, Louni F, Charpentier C, Peytavin G, Certain A, Fradet C, Castro DR, Preau M, Goujard C, Yeni P, Yazdanpanah Y, AGSG
Budget impact of antiretroviral therapy in a French clinic cohort.
AIDS (London, England) 2017, 31, 1271-1279.

Todesco E, Demeret S, Calin R, Roque-Afonso AM, Thibault V, Mallet V, Akhavan S, Jaspard M, Peytavin G, Poynard T, Katlama C, Pourcher V
Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.
AIDS (London, England) 2017, 31, 1346-1348.

Seng R, Ghislain M, Girard PM, Cotte L, Meybeck A, Raffi F, Abgrall S, Yazdanpanah Y, Goujard C, Dray-Spira R, Meyer L
Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives.
AIDS (London, England) 2017, 31, 1323-1332.

Lebrun D, Hentzien M, Cuzin L, Rey D, Joly V, Cotte L, Allavena C, Dellamonica P, Servettaz A, Bani-Sadr F, atDsg
Epidemiology of autoimmune and inflammatory diseases in a French Nationwide HIV cohort.
AIDS (London, England) 2017

Protopopescu C, Carrieri MP, Raffi F, Picard O, Hardel L, Piroth L, Jadand C, Pierret J, Spire B, Leport C, ACACSG
Brief Report: Prolonged Viral Suppression Over a 12-Year Follow-up of HIV-Infected Patients: The Persistent Impact of Adherence at 4 Months After Initiation of Combined Antiretroviral Therapy in the ANRS CO8 APROCO-COPILOTE Cohort.
Journal of Acquired Immune Deficiency Syndromes (1999) 2017, 74, 293-297.

Dutertre M, Cuzin L, Demonchy E, Puglièse P, Joly V, Valantin MA, Cotte L, Huleux T, Delobel P, Martin-Blondel G, dsg
Initiation of antiretroviral therapy containing integrase inhibitors increases the risk of IRIS requiring hospitalization.
Journal of Acquired Immune Deficiency Syndromes (1999) 2017

Tourret J, Willing BP, Dion S, MacPherson J, Denamur E, Finlay BB
Immunosuppressive Treatment Alters Secretion of Ileal Antimicrobial Peptides and Gut Microbiota, and Favors Subsequent Colonization by Uropathogenic Escherichia coli.
Transplantation 2017, 101, 74-82.

Messika J, Clermont O, Landraud L, Schmidt M, Aubry A, Sougakoff W, Fernandes R, Combes A, Denamur E, Ricard JD
Extra-corporeal membrane oxygenation-associated infections: implication of extra-intestinal pathogenic Escherichia coli clones.
Journal of Medical Microbiology 2017, 66, 1189-1195.

Bouvet O, Bourdelier E, Glodt J, Clermont O, Denamur E
Diversity of the auxotrophic requirements in natural isolates of Escherichia coli.
Microbiology (Reading, England) 2017, 163, 891-899.

Arfi A, Cohen R, Varon E, Béchet S, Bonacorsi S, Levy C
Case-control study shows that neonatal pneumococcal meningitis cannot be distinguished from group B Streptococcus cases.
Acta Paediatrica (Oslo, Norway: 1992) 2017

Rodrigues C, Chiron C, Rey E, Dulac O, Comets E, Pons G, Jullien V
Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children.
British Journal of Clinical Pharmacology 2017

Desmée S, Mentré F, Veyrat-Follet C, Sébastien B, Guedj J
Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients.
Biometrics 2017, 73, 305-312.

de Risi-Pugliese T, Servy A, Decousser JW, Nebbad B, Desroches M, Wolkenstein P, de Prost N, Chosidow O
Skin biopsy PCR for rapid microbiological diagnosis in patients with purpura fulminans.
The British Journal of Dermatology 2017

Audureau E, Hua C, de Prost Nicolas N, Hemery F, Decousser JW, Bosc R, Lepeule R, Chosidow O, Sbidian E, HMHNFg
Mortality of Necrotising Fasciitis: relative influence of individual and hospital-level factors, a Nationwide Multi-Level Study, France, 2007-2012.
The British Journal of Dermatology 2017

Desvignes C, Becquart C, Launay D, Terriou L, Patenotre P, Deheul S, Peytavin G, Dupin N, Delaporte E, Staumont-Sallé D
Extensive levamisole-induced vasculitis.
Clinical and Experimental Dermatology 2017

Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d'Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R, SRDoCRtHPTftCoOHERE(iE
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.
HIV medicine 2017, 18, 33–44.

Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, Sabin C, van Sighem A, Ledergerber B, Torti C, Mocroft A, Podzamczer D, Dorrucci M, De Wit S, Obel N, Dabis F, Cozzi-Lepri A, García F, Brockmeyer NH, Warszawski J, Gonzalez-Tome MI, Mussini C, Touloumi G, Zangerle R, Ghosn J, Castagna A, Fätkenheuer G, Stephan C, Meyer L, Campbell MA, Chene G, Phillips A, PLTOI(IPTftCoOHERE(iE
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
HIV medicine 2017, 18, 171–180.

Feuillet P, Lert F, Tron L, Aubriere C, Spire B, Dray-Spira R, ANdRslSelHV(VEslpa(SG
Prevalence of and factors associated with depression among people living with HIV in France.
HIV Med. 2017, 18, 383–394.

Feuillet P, Lert F, Tron L, Aubriere C, Spire B, Dray-Spira R, ANdRslSelHV(VEslpa(SG
Prevalence of and factors associated with depression among people living with HIV in France.
HIV medicine 2017, 18, 383-394.

Cuzin L, Katlama C, Cotte L, Pugliese P, Cheret A, Bernaud C, Rey D, Poizot-Martin I, Chirouze C, Bani-Sadr F, Cabié A, DSG
Ageing with HIV: do comorbidities and polymedication drive treatment optimization?.
HIV medicine 2017, 18, 395-401.

Gantner P, Cuzin L, Allavena C, Cabie A, Pugliese P, Valantin MA, Bani-Sadr F, Joly V, Ferry T, Poizot-Martin I, Garraffo R, Peytavin G, Fafi-Kremer S, Rey D, Dsg
Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.
HIV medicine 2017

Todesco E, Charpentier C, Bertine M, Wirden M, Storto A, Desire N, Grude M, Nguyen T, Sayon S, Yazdanpanah Y, Katlama C, Descamps D, Calvez V, Marcelin AG
Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations.
HIV medicine 2017

MHWGftCoOHERiE(iE
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?.
HIV medicine 2017

Cuzin L, Yazdanpanah Y, Huleux T, Cotte L, Pugliese P, Allavena C, Reynes J, Poizot-Martin I, Bani-Sadr F, Delpierre C, DSG
No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France.
HIV medicine 2017

Ploton MC, Gaschignard J, Lemaitre C, Cadennes A, Germanaud D, Poncelet G, Bidet P, Faye A, Basmaci R
Salmonella Typhimurium bacteraemia complicated by meningitis and brain abscess in a 3-month-old boy.
Journal of Paediatrics and Child Health 2017, 53, 204-205.

Isnard Bagnis C, Couchoud C, Bowens M, Sarraj A, Deray G, Tourret J, Cacoub P, Tezenas du Montcel S
Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in France.
Liver International: Official Journal of the International Association for the Study of the Liver 2017

Lescat M, Launay A, Ghalayini M, Magnan M, Glodt J, Pintard C, Dion S, Denamur E, Tenaillon O
Using long-term experimental evolution to uncover the patterns and determinants of molecular evolution of an Escherichia coli natural isolate in the streptomycin-treated mouse gut.
Molecular Ecology 2017, 26, 1802-1817.

Dupont H, Choinier P, Roche D, Adiba S, Sookdeb M, Branger C, Denamur E, Mammeri H
Structural Alteration of OmpR as a Source of Ertapenem Resistance in a CTX-M-15-Producing Escherichia coli O25b:H4 Sequence Type 131 Clinical Isolate.
Antimicrobial Agents and Chemotherapy 2017, 61,

Burdet C, Sayah-Jeanne S, Nguyen TT, Miossec C, Saint-Lu N, Pulse M, Weiss W, Andremont A, Mentré F, de Gunzburg J
Protection of hamsters from mortality by reducing fecal moxifloxacin concentration with DAV131A in a model of moxifloxacin-induced Clostridium difficile colitis.
Antimicrobial Agents and Chemotherapy 2017

Mougari F, Bouziane F, Crockett F, Nessar R, Chau F, Veziris N, Sapriel G, Raskine L, Cambau E
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
Antimicrobial Agents and Chemotherapy 2017, 61,

Madelain V, Guedj J, Mentré F, Nguyen THT, Jacquot F, Oestereich L, Kadota T, Yamada K, Taburet AM, de Lamballerie X, Raoul H
Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses.
Antimicrobial Agents and Chemotherapy 2017, 61,

Robin F, Beyrouthy R, Bonacorsi S, Aissa N, Bret L, Brieu N, Cattoir V, Chapuis A, Chardon H, Degand N, Doucet-Populaire F, Dubois V, Fortineau N, Grillon A, Lanotte P, Leyssene D, Patry I, Podglajen I, Recule C, Ros A, Colomb-Cotinat M, Ponties V, Ploy MC, Bonnet R
Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study.
Antimicrobial Agents and Chemotherapy 2017, 61,

Massot M, Couffignal C, Clermont O, D'Humières C, Chatel J, Plault N, Andremont A, Caron A, Mentré F, Denamur E
Day-to-Day Dynamics of Commensal Escherichia coli in Zimbabwean Cows Evidence Temporal Fluctuations within a Host-Specific Population Structure.
Applied and Environmental Microbiology 2017, 83,

Roux D, Weatherholt M, Clark B, Gadjeva M, Renaud D, Scott D, Skurnik D, Priebe GP, Pier G, Gerard C, Yoder-Himes DR
Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.
Infection and Immunity 2017, 85,

Leyer C, Gregorowicz G, Mougari F, Raskine L, Cambau E, de Briel D
Comparison of Saramis 4.12 and IVD 3.0 Vitek MS Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Mycobacteria from Solid and Liquid Culture Media.
Journal of Clinical Microbiology 2017, 55, 2045-2054.

Dupieux C, Bouchiat C, Larsen AR, Pichon B, Holmes M, Teale C, Edwards G, Hill R, Decousser JW, Trouillet-Assant S, Petersen A, Skov R, Kearns A, Laurent F
Detection of mecC-Positive Staphylococcus aureus: What To Expect from Immunological Tests Targeting PBP2a?.
Journal of Clinical Microbiology 2017, 55, 1961-1963.

Bidet P, Tran Quang V, Yagusky P, Birgy A, Bonacorsi S, Basmaci R
Investigation of Kingella kingae Invasive Infection Outbreaks in Day Care Facilities: Assessment of a Rapid Genotyping Tool Targeting the DNA Uptake Sequence.
Journal of Clinical Microbiology 2017, 55, 2422-2430.

El Houmami N, Bzdrenga J, Durand GA, Minodier P, Seligmann H, Prudent E, Bakour S, Bonacorsi S, Raoult D, Yagupsky P, Fournier PE
Molecular tests that target the RTX locus do not distinguish between Kingella kingae and the recently described Kingella negevensis species.
Journal of Clinical Microbiology 2017

Bertine M, Gueudin M, Mélard A, Damond F, Descamps D, Matheron S, Collin F, Rouzioux C, Plantier JC, Avettand-Fenoel V, ACH2atAAqwg
New Highly Sensitive Real-Time PCR assay for HIV-2 Group A and Group B DNA quantification.
Journal of Clinical Microbiology 2017

Aubry A, Mougari F, Reibel F, Cambau E
Mycobacterium marinum.
Microbiology Spectrum 2017

Gordon DM, Geyik S, Clermont O, O'Brien CL, Huang S, Abayasekara C, Rajesh A, Kennedy K, Collignon P, Pavli P, Rodriguez C, Johnston BD, Johnson JR, Decousser JW, Denamur E
Fine-Scale Structure Analysis Shows Epidemic Patterns of Clonal Complex 95, a Cosmopolitan Escherichia coli Lineage Responsible for Extraintestinal Infection.
mSphere 2017

Aupiais C, Basmaci R, Ilharreborde B, Blachier A, Desmarest M, Job-Deslandre C, Faye A, Bonacorsi S, Alberti C, Lorrot M
Arthritis in children: comparison of clinical and biological characteristics of septic arthritis and juvenile idiopathic arthritis.
Archives of Disease in Childhood 2017, 102, 316-322.

Flicoteaux R, Protopopescu C, Tibi A, Blanchon T, Werf SVD, Duval X, Mosnier A, Charlois-Ou C, Lina B, Leport C, Chevret S
Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial.
BMJ open 2017, 7, e014546.

Sugarman J, Revill P, Zoulim F, Yazdanpanah Y, Janssen HLA, Lim SG, Lewin SR
Ethics and hepatitis B cure research.
Gut 2017, 66, 389-392.

Kirchgesner J, Beaugerie L, Carrat F, Andersen NN, Jess T, Schwarzinger M, Bsg
Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study.
Gut 2017

Mathieu C, Mikaïl N, Benali K, Iung B, Duval X, Nataf P, Jondeau G, Hyafil F, Le Guludec D, Rouzet F
Characterization of (18)F-Fluorodeoxyglucose Uptake Pattern in Noninfected Prosthetic Heart Valves.
Circulation. Cardiovascular Imaging 2017, 10, e005585.

Gatti G, Perrotti A, Obadia JF, Duval X, Iung B, Alla F, Chirouze C, Selton-Suty C, Hoen B, Sinagra G, Delahaye F, Tattevin P, Le Moing V, Pappalardo A, Chocron S, AftSaPoIESGplelPdlI(
Simple Scoring System to Predict In-Hospital Mortality After Surgery for Infective Endocarditis.
Journal of the American Heart Association 2017

de Montmollin E, Demeret S, Brulé N, Conrad M, Dailler F, Lerolle N, Navellou JC, Schwebel C, Alves M, Cour M, Engrand N, Tonnelier JM, Maury E, Ruckly S, Picard G, Rogemond V, Magalhaes É, Sharshar T, Timsit JF, Honnorat J, Sonneville R, ESG‡
Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.
American Journal of Respiratory and Critical Care Medicine 2017, 195, 491-499.

Bellani G, Laffey JG, Pham T, Madotto F, Fan E, Brochard L, Esteban A, Gattinoni L, Bumbasirevic V, Piquilloud L, van Haren F, Larsson A, McAuley DF, Bauer PR, Arabi YM, Ranieri M, Antonelli M, Rubenfeld GD, Thompson BT, Wrigge H, Slutsky AS, Pesenti A, LSI, ETG
Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study.
American Journal of Respiratory and Critical Care Medicine 2017, 195, 67-77.

Messika J, Gaudry S, Tubach F, Guillo S, Dreyfuss D, Hajage D, Ricard JD
Under-reporting of End-of-life Decisions in Critical Care Trials: A Call to Modify CONSORT Statement.
American Journal of Respiratory and Critical Care Medicine 2017

Emonet S, Lazarevic V, Pugin J, Schrenzel J, Ruppé E
Clinical Metagenomics for the Diagnostic of Hospital-acquired Infections: Promises and Hurdles.
American Journal of Respiratory and Critical Care Medicine 2017

Vieillard-Baron A, Dreyfuss D
Ventilator-induced Lung Injury: Follow the Right Direction! Another Piece of the Puzzle in the VILI Epic.
American Journal of Respiratory and Critical Care Medicine 2017

Vernet MA, Reynard S, Fizet A, Schaeffer J, Pannetier D, Guedj J, Rives M, Georges N, Garcia-Bonnet N, Sylla AI, Grovogui P, Kerherve JY, Savio C, Savio-Coste S, de Séverac ML, Zloczewski P, Linares S, Harouna S, Abdoul BM, Petitjean F, Samake N, Shepherd S, Kinda M, Koundouno FR, Joxe L, Mateo M, Lecine P, Page A, Tchamdja TM, Schoenhals M, Barbe S, Simon B, Tran-Minh T, Longuet C, L'Hériteau F, Baize S
Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea.
JCI insight 2017, 2, e88864.

Ailioaie O, Arzouk N, Valantin MA, Tourret J, Calin RO, Turinici M, Mircescu G, Barrou B
Infectious complications in HIV-infected kidney transplant recipients.
International journal of STD & AIDS 2017, 956462417726213.

Veziris N, Bernard C, Guglielmetti L, Le Du D, Marigot-Outtandy D, Jaspard M, Caumes E, Lerat I, Rioux C, Yazdanpanah Y, Tiotiu A, Lemaitre N, Brossier F, Jarlier V, Robert J, Sougakoff W, Aubry A, CMatTCotCM, CMaTCotCM
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors.
The European Respiratory Journal 2017, 49,

Guglielmetti L, Jaspard M, Le Dû D, Lachâtre M, Marigot-Outtandy D, Bernard C, Veziris N, Robert J, Yazdanpanah Y, Caumes E, Fréchet-Jachym M, FMTMG
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis.
The European Respiratory Journal 2017, 49,

Nicolas-Chanoine MH, Petitjean M, Mora A, Mayer N, Lavigne JP, Boulet O, Leflon-Guibout V, Blanco J, Hocquet D
The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone.
BMC microbiology 2017, 17, 71.

Desmée S, Mentré F, Veyrat-Follet C, Sébastien B, Guedj J
Nonlinear joint models for individual dynamic prediction of risk of death using Hamiltonian Monte Carlo: application to metastatic prostate cancer.
BMC medical research methodology 2017, 17, 105.

Tournu G, Abramowitz L, Couffignal C, Juguet F, Sénéjoux A, Berger S, Wiart AL, Bernard M, Provost F, Pillant-Le Moult H, Bouchard D, Aubert JP, Gsg, MPsg
Prevalence of anal symptoms in general practice: a prospective study.
BMC family practice 2017, 18, 78.

Robert J, Pantel A, Merens A, Meiller E, Lavigne JP, Nicolas-Chanoine MH, Ocrsg
Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
BMC infectious diseases 2017, 17, 78.

Cousien A, Leclerc P, Morissette C, Bruneau J, Roy É, Tran VC, Yazdanpanah Y, Cox J
The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study.
BMC infectious diseases 2017, 17, 162.

Tourret J, Benabdellah N, Drouin S, Charlotte F, Rottembourg J, Arzouk N, Fekkar A, Barrou B
Unique case report of a chromomycosis and Listeria in soft tissue and cerebellar abscesses after kidney transplantation.
BMC infectious diseases 2017, 17, 288.

Gaschignard J, Geslain G, Mallet C, Lorrot M, Blot N, Alison M, Bonacorsi S
Spondylodiscitis in a healthy 12-year-old girl with Extraintestinal pathogenic Escherichia coli (ExPEC) bacteraemia.
BMC infectious diseases 2017, 17, 380.

Douine M, Mosnier E, Le Hingrat Q, Charpentier C, Corlin F, Hureau L, Adenis A, Lazrek Y, Niemetsky F, Aucouturier AL, Demar M, Musset L, Nacher M
Illegal gold miners in French Guiana: a neglected population with poor health.
BMC public health 2017, 18, 23.

Weiss E, Essaied W, Adrie C, Zahar JR, Timsit JF
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials.
Critical Care (London, England) 2017, 21, 162.

Dupuis C, Sonneville R, Adrie C, Gros A, Darmon M, Bouadma L, Timsit JF
Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis.
Annals of Intensive Care 2017, 7, 5.

Gaudry S, Tuffet S, Lukaszewicz AC, Laplace C, Zucman N, Pocard M, Costaglioli B, Msika S, Duranteau J, Payen D, Dreyfuss D, Hajage D, Ricard JD
Prone positioning in acute respiratory distress syndrome after abdominal surgery: a multicenter retrospective study : SAPRONADONF (Study of Ards and PRONe position After abDOmiNal surgery in France).
Annals of Intensive Care 2017, 7, 21.

Carbonne H, Le Dorze M, Bourrel AS, Poupet H, Poyart C, Cambau E, Mira JP, Charpentier J, Amarsy R
Relation between presence of extended-spectrum β-lactamase-producing Enterobacteriaceae in systematic rectal swabs and respiratory tract specimens in ICU patients.
Annals of Intensive Care 2017, 7, 13.

Adrie C, Lugosi M, Sonneville R, Souweine B, Ruckly S, Cartier JC, Garrouste-Orgeas M, Schwebel C, Timsit JF, Osg
Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission.
Annals of Intensive Care 2017, 7, 30.

Gaudry S, Messika J, Ricard JD, Guillo S, Pasquet B, Dubief E, Boukertouta T, Dreyfuss D, Tubach F
Patient-important outcomes in randomized controlled trials in critically ill patients: a systematic review.
Annals of Intensive Care 2017, 7, 28.

Neuville M, El-Helali N, Magalhaes E, Radjou A, Smonig R, Soubirou JF, Voiriot G, Le Monnier A, Ruckly S, Bouadma L, Sonneville R, Timsit JF, Mourvillier B
Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects.
Annals of Intensive Care 2017, 7, 34.

Razazi K, Mekontso Dessap A, Carteaux G, Jansen C, Decousser JW, de Prost N, Brun-Buisson C
Frequency, associated factors and outcome of multi-drug-resistant intensive care unit-acquired pneumonia among patients colonized with extended-spectrum β-lactamase-producing Enterobacteriaceae.
Annals of Intensive Care 2017, 7, 61.

Hamitouche N, Comets E, Ribot M, Alvarez JC, Bellissant E, Laviolle B
Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers.
The AAPS journal 2017, 19, 727-735.

Kantor E, Guglielminotti J, Azria E, Luton D, Laurent M, Jean-François O, Mahieu-Caputo D, Ravaud P, Estellat C, PSG
Socioeconomic Deprivation and Utilization of Anesthetic Care During Pregnancy and Delivery: A French Retrospective, Multicenter, Cohort Study.
Anesthesia and Analgesia 2017

Delerue T, de Pontual L, Carbonnelle E, Zahar JR
The potential role of microbiota for controlling the spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) in neonatal population.
F1000Research 2017, 6, 1217.

Nguyen THT, Guedj J, Anglaret X, Laouénan C, Madelain V, Taburet AM, Baize S, Sissoko D, Pastorino B, Rodallec A, Piorkowski G, Carazo S, Conde MN, Gala JL, Bore JA, Carbonnelle C, Jacquot F, Raoul H, Malvy D, de Lamballerie X, Mentré F, Jsg
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.
PLoS neglected tropical diseases 2017, 11, e0005389.

Sangare SA, Rondinaud E, Maataoui N, Maiga AI, Guindo I, Maiga A, Camara N, Dicko OA, Dao S, Diallo S, Bougoudogo F, Andremont A, Maiga II, Armand-Lefevre L
Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali.
PloS One 2017, 12, e0172652.

Visseaux B, Collin G, Ichou H, Charpentier C, Bendhafer S, Dumitrescu M, Allal L, Cojocaru B, Desfrère L, Descamps D, Mandelbrot L, Houhou-Fidouh N
Usefulness of multiplex PCR methods and respiratory viruses' distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study.
PloS One 2017, 12, e0172809.

Cohen JF, Cohen R, Bidet P, Elbez A, Levy C, Bossuyt PM, Chalumeau M
Efficiency of a clinical prediction model for selective rapid testing in children with pharyngitis: A prospective, multicenter study.
PloS One 2017, 12, e0172871.

Cento V, Nguyen THT, Di Carlo D, Biliotti E, Gianserra L, Lenci I, Di Paolo D, Calvaruso V, Teti E, Cerrone M, Romagnoli D, Melis M, Danieli E, Menzaghi B, Polilli E, Siciliano M, Nicolini LA, Di Biagio A, Magni CF, Bolis M, Antonucci FP, Di Maio VC, Alfieri R, Sarmati L, Casalino P, Bernardini S, Micheli V, Rizzardini G, Parruti G, Quirino T, Puoti M, Babudieri S, D'Arminio Monforte A, Andreoni M, Craxì A, Angelico M, Pasquazzi C, Taliani G, Guedj J, Perno CF, Ceccherini-Silberstein F
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens.
PloS One 2017, 12, e0177352.

Visseaux B, Burdet C, Voiriot G, Lescure FX, Chougar T, Brugière O, Crestani B, Casalino E, Charpentier C, Descamps D, Timsit JF, Yazdanpanah Y, Houhou-Fidouh N
Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016.
PloS One 2017, 12, e0180888.

Casalino E, Antoniol S, Fidouh N, Choquet C, Lucet JC, Duval X, Visseaux B, Pereira L
Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: A 3-year prospective observational study during seasonal epidemic periods.
PloS One 2017, 12, e0182191.

Schaefers MM, Liao TL, Boisvert NM, Roux D, Yoder-Himes D, Priebe GP
An Oxygen-Sensing Two-Component System in the Burkholderia cepacia Complex Regulates Biofilm, Intracellular Invasion, and Pathogenicity.
PLoS pathogens 2017, 13, e1006116.

Basmaci R, Bonacorsi S
Kingella kingae: From carriage to infection.
CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne 2017, 189, E1105-E1106.

Bosshard L, Dupanloup I, Tenaillon O, Bruggmann R, Ackermann M, Peischl S, Excoffier L
Accumulation of Deleterious Mutations During Bacterial Range Expansions.
Genetics 2017

Sangaré SA, Maïga AI, Maïga A, Diallo S, Camara N, Savadogo S, Guindo I, Bougoudogo F, Armand-Lefèvre L, Andremont A, Maïga II
Prevalence of extended-spectrum beta-lactamase phenotypes in enterobacteria isolated from blood cultures of patients at admission to the University Hospital of Bamako.
Medecine Et Sante Tropicales 2017, 27, 170-175.

Bousquet G, El Bouchtaoui M, Sophie T, Leboeuf C, de Bazelaire C, Ratajczak P, Giacchetti S, de Roquancourt A, Bertheau P, Verneuil L, Feugeas JP, Espié M, Janin A
Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer.
Oncotarget 2017

Furet E, El Bouchtaoui M, Feugeas JP, Miquel C, Leboeuf C, Beytout C, Bertheau P, Le Rhun E, Bonneterre J, Janin A, Bousquet G
Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes.
Oncotarget 2017

Neuville M, Mourvillier B, Bouadma L, Timsit JF
Bundle of care decreased ventilator-associated events-implications for ventilator-associated pneumonia prevention.
Journal of Thoracic Disease 2017, 9, 430-433.

Wuijts S, van den Berg HHJL, Miller J, Abebe L, Sobsey M, Andremont A, Medlicott KO, van Passel MWJ, de Roda Husman AM
Towards a research agenda for water, sanitation and antimicrobial resistance.
Journal of Water and Health 2017, 15, 175-184.

Boukobza M, Smaali I, Duval X, Laissy JP
Convexity Subarachnoid Hemorrhage, Pseudomonas Aeruginosa (PA) Infective Endocarditis and Left Atrial Appendage Occluder (LAAO) Device Infection. A Case Report.
The Open Neuroimaging Journal 2017, 11, 26-31.

Ara-Somohano C, Bonadona A, Carpentier F, Pavese P, Vesin A, Hamidfar-Roy R, Minet C, Vanzetto G, Schwebel C, Timsit JF
Evaluation of eight biomarkers to predict short term mortality in patients with acute severe dyspnea.
Minerva Anestesiologica 2017

Sanna A, Le Strat Y, Roudot-Thoraval F, Deuffic Burban S, Carrieri P, Delarocque-Astagneau E, Larsen C
Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2017, 22,

Lotte R, Hérissé AL, Berrouane Y, Lotte L, Casagrande F, Landraud L, Herbin S, Ramarao N, Boyer L, Ruimy R
Virulence Analysis of Bacillus cereus Isolated after Death of Preterm Neonates, Nice, France, 2013.
Emerging Infectious Diseases 2017, 23, 845-848.

Birgy A, Bidet P, Levy C, Sobral E, Cohen R, Bonacorsi S
CTX-M-27-Producing Escherichia coli of Sequence Type 131 and Clade C1-M27, France.
Emerging Infectious Diseases 2017, 23, 885.

Nguyen Y, Rossi B, Argy N, Baker C, Nickel B, Marti H, Zarrouk V, Houzé S, Fantin B, Lefort A
Autochthonous Case of Eosinophilic Meningitis Caused by Angiostrongylus cantonensis, France, 2016.
Emerging Infectious Diseases 2017, 23, 1045-1046.

Delannoy S, Beutin L, Mariani-Kurkdjian P, Fleiss A, Bonacorsi S, Fach P
The Escherichia coli Serogroup O1 and O2 Lipopolysaccharides Are Encoded by Multiple O-antigen Gene Clusters.
Frontiers in Cellular and Infection Microbiology 2017, 7, 30.

Petit F, Clermont O, Delannoy S, Servais P, Gourmelon M, Fach P, Oberlé K, Fournier M, Denamur E, Berthe T
Change in the Structure of Escherichia coli Population and the Pattern of Virulence Genes along a Rural Aquatic Continuum.
Frontiers in Microbiology 2017, 8, 609.

Reeves S, Bertrand J, McLachlan E, D'Antonio F, Brownings S, Nair A, Greaves S, Smith A, Dunn JT, Marsden P, Kessler R, Uchida H, Taylor D, Howard R
A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease.
The Journal of Clinical Psychiatry 2017, 78, e844-e851.

Guerrier G, Lefèvre P, Chouvin C, D'Ortenzio E
Jarisch-Herxheimer Reaction Among Patients with Leptospirosis: Incidence and Risk Factors.
The American Journal of Tropical Medicine and Hygiene 2017

Haddad E, Lescure FX, Ghodhbane W, Lepage L, D'humieres C, Vindrios W, Yazdanpanah Y, Nataf P, Kirsch M
Left ventricular assist pump pocket infection: conservative treatment strategy for destination therapy candidates.
The International Journal of Artificial Organs 2017

Comets E, Lavenu A, Lavielle M
Parameter estimation in nonlinear mixed effect models using saemix, an R implementation of the SAEM algorithm.
Journal of Statistical Software 2017

Sommer H, Timsit JF, Wolkewitz M
Bezlotoxumab and Recurrent Clostridium difficile Infection.
The New England Journal of Medicine 2017, 376, 1594.

Tubiana S, Blotière PO, Hoen B, Lesclous P, Millot S, Rudant J, Weill A, Coste J, Alla F, Duval X
Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study.
BMJ (Clinical research ed.) 2017, 358, j3776.

 2016                                                                            

Calvino-Gunther S, Schwebel C, Hamidfar-Roy R, Bonadona A, Lugosi M, Ara-Somohano C, Minet C, Potton L, Cartier JC, Vésin A, Chautemps M, Styfalova L, Ruckly S, Timsit JF
Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).
Intensive Care Medicine 2016, 42, 1753-1765.

Faisy C, Meziani F, Planquette B, Clavel M, Gacouin A, Bornstain C, Schneider F, Duguet A, Gibot S, Lerolle N, Ricard JD, Sanchez O, Djibre M, Ricome JL, Rabbat A, Heming N, Urien S, Esvan M, Katsahian S, DI
Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.
JAMA 2016, 315, 480-488.

Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A, LSI, ETG
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.
JAMA 2016, 315, 788-800.

Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M, ETG
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
JAMA 2016, 316, 1555-1564.

Guillard T, Pons S, Roux D, Pier GB, Skurnik D
Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy.
BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology 2016, 38, 682-693.

Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y
Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs.
Hepatology (Baltimore, Md.) 2016, 63, 1090-1101.

Boyd A, Peytavin G, Lacombe K
Reply to: Novel Quantification of TDF adherence in HIV-hepatitis B co-infected patients with incomplete HBV viral suppression.
Hepatology (Baltimore, Md.) 2016

Delory T, Papot E, Rioux C, Charpentier C, Auge-Courtoi C, Michard F, Peytavin G, Descamps D, Matheron S, Yazdanpanah Y
Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience.
Journal of Medical Virology 2016, 88, 1204–1210.

Delory T, Papot E, Rioux C, Charpentier C, Auge-Courtoi C, Michard F, Peytavin G, Descamps D, Matheron S, Yazdanpanah Y
Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience.
Journal of Medical Virology 2016, 88, 1204-1210.

Tessier A, Bertrand J, Chenel M, Comets E
Combined Analysis of Phase I and Phase II Data to Enhance the Power of Pharmacogenetic Tests.
CPT: pharmacometrics & systems pharmacology 2016, 5, 123-131.

Bailly S, Pirracchio R, Timsit JF
What's new in the quantification of causal effects from longitudinal cohort studies: a brief introduction to marginal structural models for intensivists.
Intensive Care Medicine 2016, 42, 576-579.

Garrouste-Orgeas M, Flaatten H, Moreno R
Understanding medical errors and adverse events in ICU patients.
Intensive Care Medicine 2016, 42, 107-109.

Do Vale J, Mezhari I, Oker N, Roux D
Keep an ear to the ground, the answer's behind.
Intensive Care Medicine 2016, 42, 440-442.

Mekontso Dessap A, Ware LB, Bouadma L
What's new with biomarker-driven clinical strategy in sepsis and circulatory failure?.
Intensive Care Medicine 2016, 42, 418-421.

Poulakou G, Bassetti M, Timsit JF
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe.
Intensive Care Medicine 2016, 42, 245-248.

Sakr Y, Ferrer R, Reinhart K, Beale R, Rhodes A, Moreno R, Timsit JF, Brochard L, Thompson BT, Rezende E, Chiche JD, IGI, ETG
The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study.
Intensive Care Medicine 2016, 42, 817-828.

Deniau B, Ricard JD, Messika J, Dreyfuss D, Gaudry S
Use of extracorporeal carbon dioxide removal (ECCO2R) in 239 intensive care units: results from a French national survey.
Intensive Care Medicine 2016, 42, 624-625.

Mimoz O, Chopra V, Timsit JF
What's new in catheter-related infection: skin cleansing and skin antisepsis.
Intensive Care Medicine 2016, 42, 1784-1786.

Gélisse E, Neuville M, de Montmollin E, Bouadma L, Mourvillier B, Timsit JF, Sonneville R
Extracorporeal membrane oxygenation (ECMO) does not impact on amikacin pharmacokinetics: a case-control study.
Intensive Care Medicine 2016, 42, 946-948.

Papazian L, Corley A, Hess D, Fraser JF, Frat JP, Guitton C, Jaber S, Maggiore SM, Nava S, Rello J, Ricard JD, Stephan F, Trisolini R, Azoulay E
Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review.
Intensive Care Medicine 2016, 42, 1336-1349.

Bassetti M, Poulakou G, Timsit JF
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU.
Intensive Care Medicine 2016, 42, 955-958.

Laupland KB, Ruppé E, Harbarth S
In 2035, will all bacteria be multidrug resistant? We are not sure.
Intensive Care Medicine 2016, 42, 2021-2023.

Bruneel F, Tubach F, Mira JP, Houze S, Gibot S, Huisse MG, Megarbane B, Choquet C, Corne P, Peytel E, Villers D, Camus C, Bouchaud O, Caumes E, Girard PM, Simon F, Kalloumeh A, Roy C, Durand R, Le Bras J, Matheron S, Wolff M, PSG
Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.
Intensive Care Medicine 2016

Truche AS, Darmon M, Bailly S, Clec'h C, Dupuis C, Misset B, Azoulay E, Schwebel C, Bouadma L, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Zaoui P, Laurent V, Goldgran-Toledano D, Sonneville R, Souweine B, Timsit JF, OSG
Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery.
Intensive Care Medicine 2016, 42, 1408-1417.

Weiss E, Zahar JR, Garrouste-Orgeas M, Ruckly S, Essaied W, Schwebel C, Timsit JF, OSG
De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition.
Intensive Care Medicine 2016, 42, 2098-2100.

Citerio G, Perner A, Timsit JF
The ten wishes and hopes of the deputy editors of Intensive Care Medicine.
Intensive Care Medicine 2016, 42, 1316-1318.

Timsit JF, Paiva JA, Bassetti M
Focus on optimization of early antimicrobial therapy in ICU-acquired infections.
Intensive Care Medicine 2016, 42, 1658-1660.

Jensen JU, Bouadma L
Why biomarkers failed in sepsis.
Intensive Care Medicine 2016, 42, 2049-2051.

Benoit DD, Doig G, Timsit JF
Focus on adequate antimicrobial treatment and de-escalation in the ICU.
Intensive Care Medicine 2016, 42, 1856-1858.

Timsit JF, Perner A
Sepsis: find me, manage me, and stop me!.
Intensive Care Medicine 2016, 42, 1851-1853.

Reeves S, Bertrand J, D'Antonio F, McLachlan E, Nair A, Brownings S, Greaves S, Smith A, Taylor D, Howard R
A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's disease.
Psychopharmacology 2016, 233, 3371-3381.

Castañeda-Sanabria J, Hajage D, Le Jouan M, Perozziello A, Tubach F
Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.
European Journal of Clinical Pharmacology 2016, 72, 737-746.

Debray MP, Dauriat G, Khalil A, Leygnac S, Tubiana S, Grandjean A, Schouman-Claeys E, Laissy JP, Ou P
Diagnostic accuracy of low-mA chest CT reconstructed with Model Based Iterative Reconstruction in the detection of early pleuro-pulmonary complications following a lung transplantation.
European Radiology 2016, 26, 3138-3146.

Mahé I, Puget H, Buzzi JC, Lamuraglia M, Chidiac J, Strukov A, Helfer H, Perozziello A
Adherence to treatment guidelines for cancer-associated thrombosis: a French hospital-based cohort study.
Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2016, 24, 3369-3377.

Lepelletier D, Pinaud V, Le Conte P, Bourigault C, Asseray N, Ballereau F, Caillon J, Ferron C, Righini C, Batard E, Potel G, FPSG
Peritonsillar abscess (PTA): clinical characteristics, microbiology, drug exposures and outcomes of a large multicenter cohort survey of 412 patients hospitalized in 13 French university hospitals.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2016, 35, 867-873.

Verriere B, Sabatier B, Carbonnelle E, Mainardi JL, Prognon P, Whitaker I, Lantieri L, Hivelin M
Medicinal leech therapy and Aeromonas spp. infection.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2016, 35, 1001-1006.

Bailly S, Garnaud C, Cornet M, Pavese P, Hamidfar-Roy R, Foroni L, Boisset S, Timsit JF, Maubon D
Impact of systemic antifungal therapy on the detection of Candida species in blood cultures in clinical cases of candidemia.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2016, 35, 1023-1032.

Lepelletier D, Pinaud V, Le Conte P, Bourigault C, Asseray N, Ballereau F, Caillon J, Ferron C, Righini C, Batard E, Potel G, FPSG
Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case-control study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2016

Rouzaud D, Alexandra JF, Chauchard M, Delon M, Dossier A, Goulenok T, Perozziello A, Papo T, Sacre K
Frequency of malignancy is high in patients admitted for a first venous thromboembolism episode: an observational study.
Journal of Thrombosis and Thrombolysis 2016, 42, 329-335.

Lenuzza N, Duval X, Nicolas G, Thevenot E, Job S, Videau O, Narjoz C, Loriot MA, Beaune P, Becquemont L, Mentre F, Funck-Brentano C, Alavoine L, Arnaud P, Delaforge M, Benech H
Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers.
European Journal of Drug Metabolism and Pharmacokinetics 2016, 41, 125-138.

Madelain V, Nguyen THT, Olivo A, de Lamballerie X, Guedj J, Taburet AM, Mentré F
Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.
Clinical Pharmacokinetics 2016, 55, 907-923.

Lepere V, Messika J, La Combe B, Ricard JD
High-flow nasal cannula oxygen supply as treatment in hypercapnic respiratory failure.
The American Journal of Emergency Medicine 2016, 34, 1914.e1-2.

Salmona M, Jolivet S, Duprilot M, Akpabie AC, Fourati S, Decousser JW
Laboratory-based strategy using a new marketed polymerase chain reaction assay to manage diarrheic episodes among patients from rehabilitation and long-term care facilities.
American Journal of Infection Control 2016, 44, 716-718.

Marinosci A, Doit C, Koehl B, Belhacel K, Mariani Kurkdjian P, Melki I, Renaud A, Lemaitre C, Ammar Khodja N, Blachier A, Bonacorsi S, Faye A, Lorrot M
[Nosocomial rotavirus gastroenteritis].
Archives De Pediatrie: Organe Officiel De La Societe Francaise De Pediatrie 2016, 23, 1118-1123.

Birgand G, Moore LSP, Bourigault C, Vella V, Lepelletier D, Holmes AH, Lucet JC
Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22, 162.e1-9.

Couce A, Alonso-Rodriguez N, Costas C, Oliver A, Blázquez J
Intrapopulation variability in mutator prevalence among urinary tract infection isolates of Escherichia coli.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22, 566.e1-7.

Bernard J, Armand-Lefèvre L, Luce E, El Mniai A, Chau F, Casalino E, Andremont A, Ruppé E
Impact of a short exposure to levofloxacin on faecal densities and relative abundance of total and quinolone-resistant Enterobacteriaceae.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22, 646.e1-4.

de Rougemont A, Kaplon J, Fremy C, Legrand-Guillien MC, Minoui-Tran A, Payan C, Vabret A, Mendes-Martins L, Chouchane M, Maudinas R, Huet F, Dubos F, Hober D, Lazrek M, Bouquignaud C, Decoster A, Alain S, Languepin J, Gillet Y, Lina B, Mekki Y, Morfin-Sherpa F, Guigon A, Guinard J, Foulongne V, Rodiere M, Avettand-Fenoel V, Bonacorsi S, Garbarg-Chenon A, Gendrel D, Lebon P, Lorrot M, Mariani P, Meritet JF, Schnuriger A, Agius G, Beby-Defaux A, Oriot D, Colimon R, Lagathu G, Mory O, Pillet S, Pozzetto B, Stephan JL, Aho S, Pothier P, FNRN
Clinical severity and molecular characteristics of circulating and emerging rotaviruses in young children attending hospital emergency departments in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22, 737.e9-737.e15.

Braquet P, Alla F, Cornu C, Goehringer F, Piroth L, Chirouze C, Revest M, Lechiche C, Duval X, Le Moing V, VAsg
Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22, 948.e1-948.e7.

Allerberger F, Cambau E, Lange C
Joint efforts urgently needed at times of emerging tuberculosis drug resistance.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016

Bleibtreu A, Arias P, Vallois D, Debit A, Lermuzeaux M, Rioux C, Cabras O, Lucet JC, Choquet C, Timsit JF, Yazdanpanah Y, Lescure FX
Delayed management of Staphyloccocus aureus infective endocarditis in a Middle East respiratory syndrome coronavirus possible case hospitalized in 2015 in Paris, France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016

Plainvert C, Doloy A, Joubrel C, Maataoui N, Dmytruk N, Touak G, Collobert G, Fouet A, Poyart C, Loubinoux J
Characterization of Streptococcus pyogenes isolates responsible for adult meningitis in France from 2003 to 2013.
Diagnostic Microbiology and Infectious Disease 2016, 84, 350-352.

Moustarhfir M, Bresson B, Koch P, Perozziello A, Barreau G, Schouman-Claeys E, Henry-Feugeas MC, Ou P, Dallaudière B
MR imaging of Schmorl's nodes: Imaging characteristics and epidemio-clinical relationships.
Diagnostic and Interventional Imaging 2016, 97, 411-417.

Roupie AL, Dossier A, Goulenok T, Perozziello A, Papo T, Sacre K
First venous thromboembolism in admitted patients younger than 50years old.
European Journal of Internal Medicine 2016, 34, e18-e20.

Stora C, Epelboin S, Devouche E, Matheron S, Epelboin L, Yazbeck C, Damond F, Longuet P, Dzineku F, Rajguru M, Delaroche L, Mandelbrot L, Luton D, Patrat C
Women infected with human immunodeficiency virus type 1 have poorer assisted reproduction outcomes: a case-control study.
Fertility and Sterility 2016, 105, 1193–1201.

Jauréguy F, Chariot P, Vessières A, Picard B
Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections detected by real-time PCR among individuals reporting sexual assaults in the Paris, France area.
Forensic Science International 2016, 266, 130-133.

Sauget M, Cholley P, Vannier A, Thouverez M, Nicolas-Chanoine MH, Hocquet D, Bertrand X
Trends of extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 and its H30 subclone in a French hospital over a 15-year period.
International Journal of Antimicrobial Agents 2016, 48, 744-747.

Nguyen V, Mathieu T, Melissopoulou M, Cimadevilla C, Codogno I, Huart V, Duval X, Vahanian A, Messika-Zeitoun D
Sex Differences in the Progression of Aortic Stenosis and Prognostic Implication: The COFRASA-GENERAC Study.
JACC. Cardiovascular imaging 2016, 9, 499-501.

Messika J, Ricard JD
Evaluation of risk factors for high flow nasal oxygen failure: a means to avoid disillusion.
Journal of Critical Care 2016, 32, 222-223.

Roca O, Messika J, Caralt B, García-de-Acilu M, Sztrymf B, Ricard JD, Masclans JR
Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index.
Journal of Critical Care 2016, 35, 200-205.

Loubet P, Samih-Lenzi N, Galtier F, Vanhems P, Loulergue P, Duval X, Jouneau S, Postil D, Rogez S, Valette M, Merle C, Régis C, Costa Y, Lesieur Z, Tattevin P, Lina B, Carrat F, Launay O, FSG
Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2016, 79, 68-73.

Picone O, Vauloup-Fellous C, D'Ortenzio E, Huissoud C, Carles G, Benachi A, Faye A, Luton D, Paty MC, Ayoubi JM, Yazdanpanah Y, Mandelbrot L, Matheron S
[Zika virus infection during pregnancy].
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2016, 45, 415–423.

Desnoyer A, Pospai D, Lê MP, Gervais A, Heurgué-Berlot A, Laradi A, Harent S, Pinto A, Salmon D, Hillaire S, Fontaine H, Zucman D, Simonpoli AM, Muret P, Larrouy L, Bernard Chabert B, Descamps D, Yazdanpanah Y, Peytavin G
Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.
Journal of Hepatology 2016, 65, 40–47.

Desnoyer A, Pospai D, Lê MP, Gervais A, Heurgué-Berlot A, Laradi A, Harent S, Pinto A, Salmon D, Hillaire S, Fontaine H, Zucman D, Simonpoli AM, Muret P, Larrouy L, Bernard Chabert B, Descamps D, Yazdanpanah Y, Peytavin G
Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.
Journal of Hepatology 2016, 65, 40-47.

Desnoyer A, Lê MP, Yazdanpanah Y, Peytavin G, ca
Reply to: "Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease".
Journal of Hepatology 2016, 65, 1065-1066.

Fernández J, Bert F, Nicolas-Chanoine MH
The challenges of multi-drug-resistance in hepatology.
Journal of Hepatology 2016, 65, 1043-1054.

Jolivet S, Fines-Guyon M, Nebbad B, Merle JC, Le Pluart D, Brun-Buisson C, Decousser JW, Cattoir V
First nosocomial outbreak of vanA-type vancomycin-resistant Enterococcus raffinosus in France.
The Journal of Hospital Infection 2016, 94, 346-350.

Lefebvre A, Bertrand X, Quantin C, Vanhems P, Lucet JC, Nuemi G, Astruc K, Chavanet P, Aho-Glélé LS
Association between Pseudomonas aeruginosa positive water samples and healthcare-associated cases: nine-year study at one university hospital.
The Journal of Hospital Infection 2016

Lepelletier C, Salmona M, Berçot B, Maylin S, Sellier PO
First description of past Hepatitis B Virus infection acute reactivation occurring in a Human Immunodeficiency Virus infected patient as manifestation of immune reconstitution inflammatory syndrome.
Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy 2016

Tubiana S, Duval X, Alla F, Selton-Suty C, Tattevin P, Delahaye F, Piroth L, Chirouze C, Lavigne JP, Erpelding ML, Hoen B, Vandenesch F, Iung B, Le Moing V, VSG
The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia.
The Journal of Infection 2016, 72, 544-553.

Le Bourgeois F, Germanaud D, Bendavid M, Bonnefoy R, Desnous B, Beyler C, Blauwblomme T, Elmaleh M, Pierron C, Lorrot M, Bonacorsi S, Basmaci R
Kingella kingae Sequence Type 25 Causing Endocarditis with Multiple and Severe Cerebral Complications.
The Journal of Pediatrics 2016, 169, 326-326.e1.

Perrier M, Désiré N, Deback C, Agut H, Boutolleau D, Burrel S
Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals.
Journal of Virological Methods 2016, 233, 10–14.

Buzelé R, Barbier L, Sauvanet A, Fantin B
Medical complications following splenectomy.
Journal of Visceral Surgery 2016, 153, 277-286.

Jolly D, Ambrosi P, Chaffanjon P, Dreyfuss D, Le Jeunne C, Lorette G, Obert L, Palombi O, Romanet JP
[Results of the 2015 national ranking in France].
Presse Medicale (Paris, France: 1983) 2016, 45, 133-142.

Yazdanpanah Y, Schwarzinger M
Generic antiretroviral drugs and HIV care: An economic review.
Medecine Et Maladies Infectieuses 2016, 46, 67-71.

Briand C, Levy C, Baumie F, Joao L, Béchet S, Carbonnelle E, Grimprel E, Cohen R, Gaudelus J, de Pontual L
Outcomes of bacterial meningitis in children.
Médecine Et Maladies Infectieuses 2016, 46, 177-187.

Poirier C, Dinh A, Salomon J, Grall N, Andremont A, Bernard L
Prevention of urinary tract infections by antibiotic cycling in spinal cord injury patients and low emergence of multidrug resistant bacteria.
Médecine Et Maladies Infectieuses 2016, 46, 294-299.

Lemaire X, Bonnet E, Castan B, Forestier E, Lescure FX, Roblot F, Pulcini C
Management of non-necrotizing cellulitis in France.
Medecine Et Maladies Infectieuses 2016, 46, 355-359.

Guégan JF, Zylberman P, Le Tyrant M, Che D, Bergeron H, Meynard JB, Leport C, scot4VdGsoeid
Proceedings of the 4th School of Val-de-Grâce's seminar on emerging infectious diseases. Current trends and proposals, March 2015, 25th.
Medecine Et Maladies Infectieuses 2016, 46, 333-341.

Visseaux B, Damond F, Matheron S, Descamps D, Charpentier C
Hiv-2 molecular epidemiology.
Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2016, 46, 233–240.

Mohammedi K, Patente TA, Bellili-Muñoz N, Driss F, Le Nagard H, Fumeron F, Roussel R, Hadjadj S, Corrêa-Giannella ML, Marre M, Velho G
Glutathione peroxidase-1 gene (GPX1) variants, oxidative stress and risk of kidney complications in people with type 1 diabetes.
Metabolism: Clinical and Experimental 2016, 65, 12-19.

Isnard-Bagnis C, Aloy B, Deray G, Tourret J
[Tenofovir nephrotoxicity].
Néphrologie & Thérapeutique 2016, 12, 179-189.

Tourret J, Hertig A
[The inner life of Lactobacillus].
Néphrologie & Thérapeutique 2016, 12, 190-192.

Walewski V, Méchaï F, Billard-Pomares T, Juguet W, Jauréguy F, Picard B, Tandjaoui-Lambiotte Y, Carbonnelle E, Bouchaud O
MALDI-TOF MS contribution to diagnosis of melioidosis in a nonendemic country in three French travellers.
New Microbes and New Infections 2016, 12, 31-34.

Collarino R, Vergeylen U, Emeraud C, Latournèrie G, Grall N, Mammeri H, Messika-Zeitoun D, Vallois D, Yazdanpanah Y, Lescure FX, Bleibtreu A
Mitral endocarditis due to Rothia aeria with cerebral haemorrhage and femoral mycotic aneurysms, first French description.
New Microbes and New Infections 2016, 13, 40-42.

Larbi A, Pesquer L, Reboul G, Omoumi P, Perozziello A, Abadie P, Loriaut P, Copin P, Ducouret E, Dallaudière B
MRI in patients with chronic pubalgia: Is precise useful information provided to the surgeon? A case-control study.
Orthopaedics & traumatology, surgery & research: OTSR 2016, 102, 747-754.

de Lastours V, Fantin B
[Pyogenic brain abscesses in adults].
La Revue De Medecine Interne / Fondee ... Par La Societe Nationale Francaise De Medecine Interne 2016

Roux D, Meyer G, Cymbalista F, Bouaziz JD, Falgarone G, Tesniere A, Gervais J, Cariou A, Peffault de Latour R, Marat M, Moenaert E, Guebli T, Rodriguez O, Lefort A, Dreyfuss D, Hajage D, Ricard JD
[Computerized ranking test in three French universities: Staff experience and students' feedback].
La Revue De Médecine Interne / Fondée ... Par La Société Nationale Francaise De Médecine Interne 2016, 37, 166-172.

Rossi G, Lafont E, Gasperini L, Dokmak S, Ronot M, Rossi B, Zarrouk V, Fantin B, Lefort A
[Liver abscess].
La Revue De Medecine Interne 2016, 37, 827-833.

Florea AM, Iordache TV, Branger C, Ghiurea M, Avramescu S, Hubca G, Sârbu A
An innovative approach to prepare hypericin molecularly imprinted pearls using a "phyto-template".
Talanta 2016, 148, 37-45.

Rouzaud D, Alexandra JF, Chauchard M, Delon M, Dossier A, Chauveheid MP, Perozziello A, Papo T, Sacre K
Incidental venous thromboembolism diagnosed in patients admitted with a first venous thromboembolism: Frequency and clinical significance (an observational study).
Thrombosis Research 2016, 144, 116-118.

Gazal S, Génin E, Leutenegger AL
Relationship inference from the genetic data on parents or offspring: A comparative study.
Theoretical Population Biology 2016, 107, 31-38.

Brossier F, Cambau E, Tessier E, Jarlier V, Sougakoff W
The in vitro mechanisms of isoniazid and ethionamide resistance poorly reflect those in vivo in Mycobacterium tuberculosis.
Tuberculosis (Edinburgh, Scotland) 2016, 101, 144-145.

Cohen R, Varon E, Béchet S, Bonacorsi S, Levy C
Comparative impact of pneumococcal conjugate vaccines on pneumococcal meningitis according to underlying conditions.
Vaccine 2016

Delfraissy JF, Yazdanpanah Y, Levy Y
REACTing: the French response to infectious disease crises.
Lancet (London, England) 2016, 387, 2183-2185.

Chas J, Lebrette MG, Amiel C, Lassel L, Adda A, Guessant S, Chevaliez S, Peytavin G, Pialoux G
COL 4-02 - Efficience d'une prise en charge intégrée des nouveaux traitements du VHC..
Médecine Et Maladies Infectieuses 2016, 46, 8.

D'Ortenzio E, Brichler S, Dorchies J, Matra R, Eme AL, Houhou N, Vallois D, Leparc-Goffart I, Yazdanpanah Y, Matheron S
TROP-03 - Arboviroses et voyageurs : l'expérience d'une consultation de pathologies tropicales..
Médecine Et Maladies Infectieuses 2016, 46, 104.

Benmoussa N, Charpentier C, Mariaggi AA, Collin G, Descamps D, Hourseau M, Barry B, Albert S, Picard A, Conan P, Charlier P
HPV 16 in squamous cell carcinoma of 19th century tonsils.
The Lancet. Oncology 2016, 17, e477–e478.

TSG
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study.
The Lancet. Infectious Diseases 2016, 16, 565-575.

Lachâtre M, Rioux C, Dû DL, Fréchet-Jachym M, Veziris N, Bouvet E, Yazdanpanah Y
Bedaquiline plus delamanid for XDR tuberculosis.
The Lancet. Infectious Diseases 2016, 16, 294.

Ruppé E, Chatelier EL, Pons N, Andremont A, Ehrlich SD
Dissemination of the mcr-1 colistin resistance gene.
The Lancet. Infectious Diseases 2016, 16, 290-291.

Visseaux B, Mortier E, Houhou-Fidouh N, Brichler S, Collin G, Larrouy L, Charpentier C, Descamps D
Zika virus in the female genital tract.
The Lancet. Infectious Diseases 2016, 16, 1220.

Pépin JL, Timsit JF, Tamisier R, Borel JC, Lévy P, Jaber S
Prevention and care of respiratory failure in obese patients.
The Lancet. Respiratory Medicine 2016, 4, 407-418.

Frat JP, Ragot S, Girault C, Perbet S, Prat G, Boulain T, Demoule A, Ricard JD, Coudroy R, Robert R, Mercat A, Brochard L, Thille AW, Rn
Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial.
The Lancet. Respiratory Medicine 2016, 4, 646-652.

Frange P, Faye A, Avettand-Fenoël V, Bellaton E, Descamps D, Angin M, David A, Caillat-Zucman S, Peytavin G, Dollfus C, Le Chenadec J, Warszawski J, Rouzioux C, Sáez-Cirión A, AECPCatAEVsg
HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.
The lancet. HIV 2016, 3, e49–54.

Pelat C, Kardaś-Słoma L, Birgand G, Ruppé E, Schwarzinger M, Andremont A, Lucet JC, Yazdanpanah Y
Hand Hygiene, Cohorting, or Antibiotic Restriction to Control Outbreaks of Multidrug-Resistant Enterobacteriaceae.
Infection Control and Hospital Epidemiology 2016, 37, 272-280.

Cuzin L, Dellamonica P, Yazdanpanah Y, Bouchez S, Rey D, Hoen B, Cabié A, DSG
Characteristics and consequences of medical care interruptions in HIV-infected patients in France.
Epidemiology and Infection 2016, 144, 2363-2370.

DE Lastours V, Malosh R, Ramadugu K, Srinivasan U, Dawid S, Ohmit S, Foxman B
Co-colonization by Streptococcus pneumoniae and Staphylococcus aureus in the throat during acute respiratory illnesses.
Epidemiology and Infection 2016, 1-13.

Gazal S, Gosset S, Verdura E, Bergametti F, Guey S, Babron MC, Tournier-Lasserve E
Can whole-exome sequencing data be used for linkage analysis?.
European journal of human genetics: EJHG 2016, 24, 581-586.

Tenaillon O, Barrick JE, Ribeck N, Deatherage DE, Blanchard JL, Dasgupta A, Wu GC, Wielgoss S, Cruveiller S, Médigue C, Schneider D, Lenski RE
Tempo and mode of genome evolution in a 50,000-generation experiment.
Nature 2016, 536, 165-170.

Njamkepo E, Fawal N, Tran-Dien A, Hawkey J, Strockbine N, Jenkins C, Talukder KA, Bercion R, Kuleshov K, Kolínská R, Russell JE, Kaftyreva L, Accou-Demartin M, Karas A, Vandenberg O, Mather AE, Mason CJ, Page AJ, Ramamurthy T, Bizet C, Gamian A, Carle I, Sow AG, Bouchier C, Wester AL, Lejay-Collin M, Fonkoua MC, Hello SL, Blaser MJ, Jernberg C, Ruckly C, Mérens A, Page AL, Aslett M, Roggentin P, Fruth A, Denamur E, Venkatesan M, Bercovier H, Bodhidatta L, Chiou CS, Clermont D, Colonna B, Egorova S, Pazhani GP, Ezernitchi AV, Guigon G, Harris SR, Izumiya H, Korzeniowska-Kowal A, Lutyńska A, Gouali M, Grimont F, Langendorf C, Marejková M, Peterson LAM, Perez-Perez G, Ngandjio A, Podkolzin A, Souche E, Makarova M, Shipulin GA, Ye C, Žemličková H, Herpay M, Grimont PAD, Parkhill J, Sansonetti P, Holt KE, Brisse S, Thomson NR, Weill FX
Global phylogeography and evolutionary history of Shigella dysenteriae type 1.
Nature Microbiology 2016, 1, 16027.

D'Ortenzio E, Matheron S, Yazdanpanah Y, de Lamballerie X, Hubert B, Piorkowski G, Maquart M, Descamps D, Damond F, Leparc-Goffart I
Evidence of Sexual Transmission of Zika Virus.
The New England Journal of Medicine 2016, 374, 2195–2198.

D'Ortenzio E, Matheron S, Yazdanpanah Y, de Lamballerie X, Hubert B, Piorkowski G, Maquart M, Descamps D, Damond F, Leparc-Goffart I
Evidence of Sexual Transmission of Zika Virus.
The New England Journal of Medicine 2016, 374, 2195-2198.

Gaudry S, Hajage D, Dreyfuss D
Initiation of Renal-Replacement Therapy in the Intensive Care Unit.
The New England Journal of Medicine 2016, 375, 1901-1902.

Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D, de Prost N, Lautrette A, Bretagnol A, Mayaux J, Nseir S, Megarbane B, Thirion M, Forel JM, Maizel J, Yonis H, Markowicz P, Thiery G, Tubach F, Ricard JD, Dreyfuss D, ASG
Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit.
The New England Journal of Medicine 2016, 375, 122-133.

Dumont C, Chenel M, Mentre F
Two-stage Adaptive Designs in Nonlinear Mixed Effects Models: Application to Pharmacokinetics in Children.
Communications in Statistics-Simulation and Computation 2016, 45, 1511-1525.

Sagaon-Teyssier L, Suzan-Monti M, Demoulin B, Capitant C, Lorente N, Préau M, Mora M, Rojas Castro D, Chidiac C, Chas J, Meyer L, Molina JM, Spire B, AISG
Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
AIDS care 2016, 28 Suppl 1, 48–55.

Préau M, Lorente N, Sagaon-Teyssier L, Champenois K, Gall JML, Mabire X, Spire B, Mora M, Yazdanpanah Y, Suzan M, ADgaACG
Factors associated with satisfaction with community-based non-medicalized counseling and testing using HIV rapid tests among MSM in France.
AIDS care 2016, 28, 1240-1248.

Mougari F, Guglielmetti L, Raskine L, Sermet-Gaudelus I, Veziris N, Cambau E
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment.
Expert Review of Anti-Infective Therapy 2016, 14, 1139-1154.

Ruiz-Palacios GM, Leroux-Roels G, Beran J, Devaster JM, Esen M, Launay O, McElhaney JE, van Essen GA, Benoit A, Claeys C, Dewé W, Durand C, Duval X, Falsey AR, Feldman G, Galtier F, Gervais P, Hwang SJ, McNeil S, Richardus JH, Trofa A, Oostvogels L, Isg
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis.
Human Vaccines & Immunotherapeutics 2016, 12, 3043-3055.

Galy A, Decousser JW, El-Anbassi S, Nebbad B, Belzunce C, Cochennec F, Deforges L, Lepeule R
Psoas abscess and chronic Q fever: a contiguous or hematogenous complication? A case report and literature review.
Infectious Diseases (London, England) 2016, 48, 626-631.

Riviere MK, Ueckert S, Mentré F
An MCMC method for the evaluation of the Fisher information matrix for non-linear mixed effect models.
Biostatistics (Oxford, England) 2016, 17, 737-750.

Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, Tacey M, Timsit JF, Leone M, Zahar JR, De Waele JJ, WGfAUitI
A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 62, 1009-1017.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ, SP
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 62, 655–663.

Coussement J, Lebeaux D, van Delden C, Guillot H, Freund R, Marbus S, Melica G, Van Wijngaerden E, Douvry B, Van Laecke S, Vuotto F, Tricot L, Fernández-Ruiz M, Dantal J, Hirzel C, Jais JP, Rodriguez-Nava V, Lortholary O, Jacobs F, ESGfNiSOT
Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 63, 338-345.

Collignon PC, Conly JM, Andremont A, McEwen SA, Aidara-Kane A, WHOAGBMoISoAR(A, Agerso Y, Andremont A, Collignon P, Conly J, Dang Ninh T, Donado-Godoy P, Fedorka-Cray P, Fernandez H, Galas M, Irwin R, Karp B, Matar G, McDermott P, McEwen S, Mitema E, Reid-Smith R, Scott HM, Singh R, DeWaal CS, Stelling J, Toleman M, Watanabe H, Woo GJ
World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal Production.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 63, 1087-1093.

Matheron S, d'Ortenzio E, Leparc-Goffart I, Hubert B, de Lamballerie X, Yazdanpanah Y
Long-Lasting Persistence of Zika Virus in Semen.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 63, 1264.

PADCPWGfISATaCiE
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 63, 1245–1253.

Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V, Poyart C, Alla F, Cambau E, Tattevin P, Chirouze C, Obadia JF, Duval X, Hoen B, ASG
Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices.
European Heart Journal 2016, 37, 840-848.

Puthanakit T, Huang LM, Chiu CH, Tang RB, Schwarz TF, Esposito S, Frenette L, Giaquinto C, McNeil S, Rheault P, Durando P, Horn M, Klar M, Poncelet S, De Simoni S, Friel D, De Muynck B, Suryakiran PV, Hezareh M, Descamps D, Thomas F, Struyf F
Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9-14 Years Versus a 3-Dose Regimen in Women Aged 15-25 Years.
The Journal of Infectious Diseases 2016

Piroth L, Moinot L, Yeni P, Avettand-Fénoel V, Reynes J, Girard PM, Marchou B, Georget A, Rouzioux C, Autran B, Duvillard L, Chêne G, Fagard C, A1TTSG
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).
The Journal of Antimicrobial Chemotherapy 2016, 71, 490–496.

Lortholary O, Roussillon C, Boucherie C, Padoin C, Chaix ML, Breton G, Rami A, Veziris N, Patey O, Caumes E, May T, Molina JM, Robert J, Tod M, Fagard C, Chêne G, A1BTG
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.
The Journal of Antimicrobial Chemotherapy 2016, 71, 783–793.

Barbier F, Pommier C, Essaied W, Garrouste-Orgeas M, Schwebel C, Ruckly S, Dumenil AS, Lemiale V, Mourvillier B, Clec'h C, Darmon M, Laurent V, Marcotte G, Lucet JC, Souweine B, Zahar JR, Timsit JF, OSG
Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1088-1097.

Lambert-Niclot S, George EC, Pozniak A, White E, Schwimmer C, Jessen H, Johnson M, Dunn D, Perno CF, Clotet B, Plettenberg A, Blaxhult A, Palmisano L, Wittkop L, Calvez V, Marcelin AG, Raffi F, N01SG
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1056–1062.

Jayol A, Janvier F, Guillard T, Chau F, Mérens A, Robert J, Fantin B, Berçot B, Cambau E
qnrA6 genetic environment and quinolone resistance conferred on Proteus mirabilis.
The Journal of Antimicrobial Chemotherapy 2016, 71, 903-908.

Skurnik D, Roux D, Pons S, Guillard T, Lu X, Cywes-Bentley C, Pier GB
Extended-spectrum antibodies protective against carbapenemase-producing Enterobacteriaceae.
The Journal of Antimicrobial Chemotherapy 2016

De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D, CaCiE
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1352–1360.

Jost C, Bidet P, Carrère T, Mariani-Kurkdjian P, Bonacorsi S
Susceptibility of enterohaemorrhagic Escherichia coli to azithromycin in France and analysis of resistance mechanisms.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1183-1187.

Alexandre K, Chau F, Guérin F, Massias L, Lefort A, Cattoir V, Fantin B
Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.
The Journal of Antimicrobial Chemotherapy 2016

Slama L, Landman R, Assoumou L, Benalycherif A, Samri A, Joly V, Pialoux G, Valin N, Cabié A, Duvivier C, Lambert-Niclot S, Marcelin AG, Peytavin G, Costagliola D, Girard PM, I0DSG
Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial).
The Journal of Antimicrobial Chemotherapy 2016, 71, 2252–2261.

Mougari F, Amarsy R, Veziris N, Bastian S, Brossier F, Berçot B, Raskine L, Cambau E
Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2208-2212.

Bocket L, Peytavin G, Alidjinou EK, Ajana F, Choisy P, Lê M, Charpentier C, Descamps D, Yazdanpanah Y, Katlama C, Simon A, Calvez V, Marcelin AG, Soulie C
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2651–2653.

Bocket L, Peytavin G, Alidjinou EK, Ajana F, Choisy P, Lê M, Charpentier C, Descamps D, Yazdanpanah Y, Katlama C, Simon A, Calvez V, Marcelin AG, Soulie C
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2651-2653.

Belkacem A, Jacquier H, Goubard A, Mougari F, La Ruche G, Patey O, Micaëlo M, Semaille C, Cambau E, Bercot B
Molecular epidemiology and mechanisms of resistance of azithromycin-resistant Neisseria gonorrhoeae isolated in France during 2013-14.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2471-2478.

Katlama C, Soulié C, Caby F, Denis A, Blanc C, Schneider L, Valantin MA, Tubiana R, Kirstetter M, Valdenassi E, Nguyen T, Peytavin G, Calvez V, Marcelin AG
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2646–2650.

Birgy A, Levy C, Bidet P, Thollot F, Derkx V, Béchet S, Mariani-Kurkdjian P, Cohen R, Bonacorsi S
ESBL-producing Escherichia coli ST131 versus non-ST131: evolution and risk factors of carriage among French children in the community between 2010 and 2015.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2949-2956.

Dufour N, Clermont O, La Combe B, Messika J, Dion S, Khanna V, Denamur E, Ricard J, Debarbieux L, ColoColi group
Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex..
Journal of Antimicrobial Chemotherapy 2016, 71, 3072.

Gantner P, Assoumou L, Leruez-Ville M, David L, Suzan-Monti M, Costagliola D, Rouzioux C, Ghosn J, EAE4SG
HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens.
The Journal of Antimicrobial Chemotherapy 2016, 71, 3202–3205.

de Truchis P, Lê MP, Daou M, Madougou B, Nouhou Y, Moussa Saley S, Sani A, Adehossi E, Rouveix E, Saidou M, Peytavin G, Delaugerre C
High efficacy of first-line ART in a West African cohort, assessed by dried blood spot virological and pharmacological measurements.
The Journal of Antimicrobial Chemotherapy 2016, 71, 3222–3227.

Diallo YL, Ollivier V, Joly V, Faille D, Catalano G, Jandrot-Perrus M, Rauch A, Yeni P, Ajzenberg N
Abacavir has no prothrombotic effect on platelets in vitro.
The Journal of Antimicrobial Chemotherapy 2016, 71, 3506–3509.

Bassetti M, Peghin M, Timsit JF
The current treatment landscape: candidiasis.
The Journal of Antimicrobial Chemotherapy 2016, 71, ii13-ii22.

Sokal A, D'Ortenzio E, Houhou-Fidouh N, Brichler S, Dorchies J, Cabras O, Leparc-Goffart I, Yazdanpanah Y, Matheron S
Zika virus infection: report of the first imported cases in a Paris travel centre.
Journal of Travel Medicine 2016, 24,

Figliuzzi M, Jacquier H, Schug A, Tenaillon O, Weigt M
Coevolutionary Landscape Inference and the Context-Dependence of Mutations in Beta-Lactamase TEM-1.
Molecular Biology and Evolution 2016, 33, 268-280.

Rodríguez-Verdugo A, Tenaillon O, Gaut BS
First-Step Mutations during Adaptation Restore the Expression of Hundreds of Genes.
Molecular Biology and Evolution 2016, 33, 25-39.

Skurnik D, Clermont O, Guillard T, Launay A, Danilchanka O, Pons S, Diancourt L, Lebreton F, Kadlec K, Roux D, Jiang D, Dion S, Ashard H, Denamur M, Cywes-Bentley C, Schwarz S, Tenaillon O, Andremont A, Picard B, Mekalanos J, Brisse S, Denamur E
Emergence of Antimicrobial-Resistant Escherichia coli of Animal Origin Spreading in Humans.
Molecular Biology and Evolution 2016, 33, 898.

Feugeas JP, Tourret J, Launay A, Bouvet O, Hoede C, Denamur E, Tenaillon O
Links between Transcription, Environmental Adaptation and Gene Variability in Escherichia coli: Correlations between Gene Expression and Gene Variability Reflect Growth Efficiencies.
Molecular Biology and Evolution 2016

Guégan S, Garcia-Hermoso D, Sitbon K, Ahmed S, Moguelet P, Dromer F, Lortholary O, FMSG
Ten-Year Experience of Cutaneous and/or Subcutaneous Infections Due to Coelomycetes in France.
Open Forum Infectious Diseases 2016, 3, ofw106.

Roux D, Pons S, Guillard T, Ricard JD, Pier GB, Skurnik D
Impact of Drug Resistance on Virulence and Fitness of Bacterial Pathogens.
Critical Care Medicine 2016, 44, e50.

Lasocki S, Piednoir P, Couffignal C, Rineau E, Dufour G, Lefebvre T, Puy H, Duval X, Driss F, Schilte C
Does IV Iron Induce Plasma Oxidative Stress in Critically Ill Patients? A Comparison With Healthy Volunteers.
Critical Care Medicine 2016, 44, 521-530.

Garrouste-Orgeas M, Max A, Lerin T, Grégoire C, Ruckly S, Kloeckner M, Brochon S, Pichot E, Simons C, El-Mhadri M, Bruel C, Philippart F, Fournier J, Tiercelet K, Timsit JF, Misset B
Impact of Proactive Nurse Participation in ICU Family Conferences: A Mixed-Method Study.
Critical Care Medicine 2016, 44, 1116-1128.

El Houmami N, Minodier P, Dubourg G, Mirand A, Jouve JL, Basmaci R, Charrel R, Bonacorsi S, Yagupsky P, Raoult D, Fournier PE
Patterns of Kingella kingae Disease Outbreaks.
The Pediatric Infectious Disease Journal 2016, 35, 340-346.

Toubiana J, Timsit S, Ferroni A, Grasseau M, Nassif X, Lortholary O, Zahar JR, Chalumeau M
Community-Onset Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France.
Medicine 2016, 95, e3163.

Audemard-Verger A, Descloux E, Ponard D, Deroux A, Fantin B, Fieschi C, John M, Bouldouyre A, Karkowsi L, Moulis G, Auvinet H, Valla F, Lechiche C, Davido B, Martinot M, Biron C, Lucht F, Asseray N, Froissart A, Buzelé R, Perlat A, Boutboul D, Fremeaux-Bacchi V, Isnard S, Bienvenu B
Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 Patients.
Medicine 2016, 95, e3548.

Sonneville R, Mariotte E, Neuville M, Minaud S, Magalhaes E, Ruckly S, Cantier M, Voiriot G, Radjou A, Smonig R, Soubirou JF, Mourvillier B, Bouadma L, Wolff M, Timsit JF
Early-onset status epilepticus in patients with acute encephalitis.
Medicine 2016, 95, e4092.

Sellier PO, Schnepf N, Amarsy R, Maylin S, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Simoneau G, Evans J, Souak S, Matheron S, Benifla JL, Simon F, Bergmann JF
Short article: Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.
European Journal of Gastroenterology & Hepatology 2016, 28, 328–332.

Desgrees-du-Lou A, Pannetier J, Ravalihasy A, Le Guen M, Gosselin A, Panjo H, Bajos N, Lydie N, Lert F, Dray-Spira R, PSG
Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-Saharan African migrants in France.
AIDS 2016, 30, 645–656.

Desgrees-du-Lou A, Pannetier J, Ravalihasy A, Le Guen M, Gosselin A, Panjo H, Bajos N, Lydie N, Lert F, Dray-Spira R, PSG
Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-Saharan African migrants in France.
AIDS (London, England) 2016, 30, 645-656.

Ananworanich J, Melvin D, Amador JTR, Childs T, Medin G, Boscolo V, Compagnucci A, Kanjanavanit S, Montero S, Gibb DM, P1SG
Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption.
AIDS (London, England) 2016, 30, 1075–1081.

Jean K, Puren A, Cutler E, Singh B, Bouscaillou J, Rain-Taljaard R, Taljaard D, Gouws E, Lissouba P, Lewis DA, Peytavin G, Auvert B
Level of viral suppression and the cascade of HIV care in a South African semi-urban setting in 2012.
AIDS (London, England) 2016, 30, 2107-2116.

de Monteynard LA, Matheron S, Gilquin J, Pavie J, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Simon A, Mahamat A, Dray-Spira R, Costagliola D, Abgrall S, FAC
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France.
AIDS (London, England) 2016, 30, 2235–2246.

Bertine M, Visseaux B, Storto A, Collin G, Matheron S, Descamps D, Charpentier C, ACH2C
HIV-2 Vif Diversity Among Defective and Nondefective Sequences.
Journal of Acquired Immune Deficiency Syndromes (1999) 2016, 72, e9–e11.

Banerjee S, Guedj J, Ribeiro RM, Moses M, Perelson AS
Estimating biologically relevant parameters under uncertainty for experimental within-host murine West Nile virus infection.
Journal of the Royal Society, Interface 2016, 13,

Cabaret O, Bonnal C, Canoui-Poitrine F, Emirian A, Bizouard G, Levesque E, Maitre B, Fihman V, Decousser JW, Botterel F
Concomitant presence of Aspergillus fumigatus and Stenotrophomonas maltophilia in the respiratory tract: a new risk for patients with liver disease?.
Journal of Medical Microbiology 2016

Massot M, Daubié AS, Clermont O, Jauréguy F, Couffignal C, Dahbi G, Mora A, Blanco J, Branger C, Mentré F, Eddi A, Picard B, Denamur E, The Coliville Group n
Phylogenetic, virulence and antibiotic resistance characteristics of commensal strain populations of Escherichia coli from community subjects in the Paris area in 2010 and evolution over 30 years.
Microbiology (Reading, England) 2016, 162, 642-650.

Sabarly V, Aubron C, Glodt J, Balliau T, Langella O, Chevret D, Rigal O, Bourgais A, Picard B, de Vienne D, Denamur E, Bouvet O, Dillmann C
Interactions between genotype and environment drive the metabolic phenotype within Escherichia coli isolates.
Environmental Microbiology 2016, 18, 100-117.

De Sousa Mendes M, Hirt D, Vinot C, Valade E, Lui G, Pressiat C, Bouazza N, Foissac F, Blanche S, Lê MP, Peytavin G, Treluyer JM, Urien S, Benaboud S
Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.
British Journal of Clinical Pharmacology 2016, 81, 646–657.

Desnoyer A, Dupin N, Assoumou L, Carlotti A, Gaudin F, Deback C, Peytavin G, Marcelin AG, Boué F, Balabanian K, Pourcher-Martinez V, A1Ltg
Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi's sarcoma skin lesions.
The British Journal of Dermatology 2016

Lainé F, Angeli A, Ropert M, Jezequel C, Bardou-Jacquet E, Deugnier Y, Gissot V, Lacut K, Sacher-Huvelin S, Lavenu A, Laviolle B, Comets E
Variations of hepcidin and iron-status parameters during the menstrual cycle in healthy women.
British Journal of Haematology 2016, 175, 980-982.

Abramowitz L, Benabderrahmane D, Walker F, Yazdapanah Y, Yéni P, Rioux C, Bouscarat F, Lafferre E, Mentré F, Duval X
Determinants of macroscopic anal cancer and precancerous lesions in 1206 HIV-infected screened patients.
Colorectal Disease: The Official Journal of the Association of Coloproctology of Great Britain and Ireland 2016, 18, 997-1004.

Aubin-Auger I, Laouénan C, Le Bel J, Mercier A, Baruch D, Lebeau JP, Youssefian A, Le Trung T, Peremans L, Van Royen P
Efficacy of communication skills training on colorectal cancer screening by GPs: a cluster randomised controlled trial.
European Journal of Cancer Care 2016, 25, 18-26.

Caudron A, Battistella M, Feugeas JP, Pages C, Basset-Seguin N, Mazouz Dorval S, Funck Brentano E, Sadoux A, Podgorniak MP, Menashi S, Janin A, Lebbé C, Mourah S
EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
Experimental Dermatology 2016

Flandre P, Pugliese P, Allavena C, Katlama C, Cotte L, Cheret A, Cabié A, Rey D, Chirouze C, Bani-Sadr F, Cuzin L, DSg
Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load.
HIV medicine 2016, 17, 380–384.

Deuffic-Burban S, Obach D, Canva V, Pol S, Roudot-Thoraval F, Dhumeaux D, Mathurin P, Yazdanpanah Y
Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case.
Journal of Viral Hepatitis 2016, 23, 767-779.

Bottero J, Brouard C, Roudot-Thoraval F, Deuffic-Burban S, Hofliger P, Abergel A, Volant J, Dhumeaux D, Yazdanpanah Y, VHTEg
2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.
Liver International: Official Journal of the International Association for the Study of the Liver 2016, 36, 1442-1449.

Hauser L, Menasie S, Bonacorsi S, Raoult L, AitOubelli N, Belloy M, Avran D, Beyloune A, Simonet M, Billard-Pomares T, Pangon B, Bierling P
Fatal transfusion-transmitted infection due to Citrobacter koseri.
Transfusion 2016, 56, 1311-1313.

Val ME, Marbouty M, de Lemos Martins F, Kennedy SP, Kemble H, Bland MJ, Possoz C, Koszul R, Skovgaard O, Mazel D
A checkpoint control orchestrates the replication of the two chromosomes of Vibrio cholerae.
Science Advances 2016, 2, e1501914.

Vinot C, Tréluyer JM, Giraud C, Gavard L, Peytavin G, Mandelbrot L
Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.
Antimicrobial Agents and Chemotherapy 2016, 60, 3112–3114.

Jayol A, Nordmann P, Desroches M, Decousser JW, Poirel L
Acquisition of Broad-Spectrum Cephalosporin Resistance Leading to Colistin Resistance in Klebsiella pneumoniae.
Antimicrobial Agents and Chemotherapy 2016, 60, 3199-3201.

Mourand G, Touzain F, Jouy E, Fleury MA, Denamur E, Kempf I
Rare spontaneous loss of multi-resistance gene carrying IncI/ST12 plasmid in Escherichia coli in pig microbiota.
Antimicrobial Agents and Chemotherapy 2016

de Lastours V, Chopin D, Jacquier H, d'Humières C, Burdet C, Chau F, Denamur E, Fantin B
Prospective Cohort Study of the Relative Abundance of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli in the Gut of Patients Admitted to Hospitals.
Antimicrobial Agents and Chemotherapy 2016, 60, 6941-6944.

de Curraize C, Kumanski S, Micaëlo M, Fournet N, La Ruche G, Meunier F, Amarsy R, Jacquier H, Cambau E, Goubard A, Bercot B
Ceftriaxone-Resistant Neisseria gonorrhoeae Isolates (2010 to 2014) in France Characterized by Using Whole-Genome Sequencing.
Antimicrobial Agents and Chemotherapy 2016, 60, 6962-6964.

Mercat M, Clermont O, Massot M, Ruppe E, de Garine-Wichatitsky M, Miguel E, Valls Fox H, Cornelis D, Andremont A, Denamur E, Caron A
Escherichia coli Population Structure and Antibiotic Resistance at a Buffalo/Cattle Interface in Southern Africa.
Applied and Environmental Microbiology 2016, 82, 1459-1467.

Tourret J, Denamur E
Population Phylogenomics of Extraintestinal Pathogenic Escherichia coli.
Microbiology Spectrum 2016

Bellulo S, Sommet J, Lévy C, Gillet Y, Hees L, Lorrot M, Gras-Le-Guen C, Craiu I, Dubos F, Minodier P, Biscardi S, Dommergues MA, Béchet S, Bidet P, Alberti C, Cohen R, Faye A, FPIDSG(
When should clinicians suspect group A streptococcus empyema in children? A multicentre case-control study in French tertiary care centres.
Archives of Disease in Childhood 2016

Birgand G, Leroy C, Nerome S, Luong Nguyen LB, Lolom I, Armand-Lefevre L, Ciotti C, Lecorre B, Marcade G, Fihman V, Nicolas-Chanoine MH, Pelat C, Perozziello A, Fantin B, Yazdanpanah Y, Ricard JD, Lucet JC
Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.
BMJ open 2016, 6, e009029.

Mourvillier B, Radjou A, Timsit JF
Subclavian site should be preferred for central venous access.
Evidence-Based Nursing 2016, 19, 126.

Ichou L, Carbonell N, Rautou PE, Laurans L, Bourcier S, Pichereau C, Baudel JL, Nousbaum JB, Renou C, Anty R, Tankovic J, Maury E, Guidet B, Landraud L, Ait-Oufella H
Ascitic fluid TREM-1 for the diagnosis of spontaneous bacterial peritonitis.
Gut 2016, 65, 536-538.

Arangalage D, Nguyen V, Robert T, Melissopoulou M, Mathieu T, Estellat C, Codogno I, Huart V, Duval X, Cimadevilla C, Vahanian A, Dehoux M, Messika-Zeitoun D
Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis.
Heart (British Cardiac Society) 2016, 102, 862-868.

Pépin JL, Tamisier R, Baguet JP, Lepaulle B, Arbib F, Arnol N, Timsit JF, Lévy P
Fixed-pressure CPAP versus auto-adjusting CPAP: comparison of efficacy on blood pressure in obstructive sleep apnoea, a randomised clinical trial.
Thorax 2016, 71, 726-733.

Raharolahy O, Ramarozatovo LS, Ranaivo IM, Sendrasoa FA, Andrianarison M, Andrianarivelo MR, Cambau E, Rabenja FR
A Case of Fluoroquinolone-Resistant Leprosy Discovered after 9 Years of Misdiagnosis.
Case Reports in Infectious Diseases 2016, 2016, 4632369.

Carrara J, N'Diaye DS, Azria E, Launay O, Rozenberg F, Yazpandanah Y, Tsatsaris V, Ayoubi JM, Picone O
Management of Cytomegalovirus Seroconversion during Pregnancy in France.
Fetal Diagnosis and Therapy 2016, 39, 4-12.

Petit C, Samson A, Morita S, Ursino M, Guedj J, Jullien V, Comets E, Zohar S
Unified approach for extrapolation and bridging of adult information in early-phase dose-finding paediatric studies.
Statistical Methods in Medical Research 2016, 962280216671348.

Guglielmetti L, Le Dû D, Veziris N, Caumes E, Marigot-Outtandy D, Yazdanpanah Y, Robert J, Fréchet-Jachym M, MTMGotFNRCfMatPotFMTC
Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?.
The European Respiratory Journal 2016, 48, 582-585.

La Combe B, Messika J, Fartoukh M, Ricard JD
Increased use of high-flow nasal oxygen during bronchoscopy.
The European Respiratory Journal 2016, 48, 590-592.

Casalino E, Etienne A, Mentré F, Houzé S, IMHSG
Hospitalization and ambulatory care in imported-malaria: evaluation of trends and impact on mortality. A prospective multicentric 14-year observational study.
Malaria Journal 2016, 15, 312.

Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, Abu-Zidan FM, Coimbra R, Moore EE, Moore FA, Maier RV, De Waele JJ, Kirkpatrick AW, Griffiths EA, Eckmann C, Brink AJ, Mazuski JE, May AK, Sawyer RG, Mertz D, Montravers P, Kumar A, Roberts JA, Vincent JL, Watkins RR, Lowman W, Spellberg B, Abbott IJ, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Agresta F, Althani AA, Ansari S, Ansumana R, Augustin G, Bala M, Balogh ZJ, Baraket O, Bhangu A, Beltrán MA, Bernhard M, Biffl WL, Boermeester MA, Brecher SM, Cherry-Bukowiec JR, Buyne OR, Cainzos MA, Cairns KA, Camacho-Ortiz A, Chandy SJ, Che Jusoh A, Chichom-Mefire A, Colijn C, Corcione F, Cui Y, Curcio D, Delibegovic S, Demetrashvili Z, De Simone B, Dhingra S, Diaz JJ, Di Carlo I, Dillip A, Di Saverio S, Doyle MP, Dorj G, Dogjani A, Dupont H, Eachempati SR, Enani MA, Egiev VN, Elmangory MM, Ferrada P, Fitchett JR, Fraga GP, Guessennd N, Giamarellou H, Ghnnam W, Gkiokas G, Goldberg SR, Gomes CA, Gomi H, Guzmán-Blanco M, Haque M, Hansen S, Hecker A, Heizmann WR, Herzog T, Hodonou AM, Hong SK, Kafka-Ritsch R, Kaplan LJ, Kapoor G, Karamarkovic A, Kees MG, Kenig J, Kiguba R, Kim PK, Kluger Y, Khokha V, Koike K, Kok KYY, Kong V, Knox MC, Inaba K, Isik A, Iskandar K, Ivatury RR, Labbate M, Labricciosa FM, Laterre PF, Latifi R, Lee JG, Lee YR, Leone M, Leppaniemi A, Li Y, Liang SY, Loho T, Maegele M, Malama S, Marei HE, Martin-Loeches I, Marwah S, Massele A, McFarlane M, Melo RB, Negoi I, Nicolau DP, Nord CE, Ofori-Asenso R, Omari AH, Ordonez CA, Ouadii M, Pereira Júnior GA, Piazza D, Pupelis G, Rawson TM, Rems M, Rizoli S, Rocha C, Sakakhushev B, Sanchez-Garcia M, Sato N, Segovia Lohse HA, Sganga G, Siribumrungwong B, Shelat VG, Soreide K, Soto R, Talving P, Tilsed JV, Timsit JF, Trueba G, Trung NT, Ulrych J, van Goor H, Vereczkei A, Vohra RS, Wani I, Uhl W, Xiao Y, Yuan KC, Zachariah SK, Zahar JR, Zakrison TL, Corcione A, Melotti RM, Viscoli C, Viale P
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).
World journal of emergency surgery: WJES 2016, 11, 33.

Hilgers RD, Roes K, Stallard N, IAaIpg
Directions for new developments on statistical design and analysis of small population group trials.
Orphanet Journal of Rare Diseases 2016, 11, 78.

Paiva JA, Pereira JM, Tabah A, Mikstacki A, de Carvalho FB, Koulenti D, Ruckly S, Çakar N, Misset B, Dimopoulos G, Antonelli M, Rello J, Ma X, Tamowicz B, Timsit JF
Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study.
Critical Care (London, England) 2016, 20, 53.

Montravers P, Augustin P, Grall N, Desmard M, Allou N, Marmuse JP, Guglielminotti J
Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections.
Critical Care (London, England) 2016, 20, 83.

May F, El-Helali N, Timsit JF, Misset B
Absence of obvious link between supra-therapeutic serum levels of β lactams and clinical toxicity in ICU patients with acute renal failure treated with intermittent hemodialysis.
Critical Care (London, England) 2016, 20, 220.

Coupez E, Timsit JF, Ruckly S, Schwebel C, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Cointault O, Lepape A, Darmon M, Boyer A, Azoulay E, Bouadma L, Lautrette A, Souweine B
Guidewire exchange vs new site placement for temporary dialysis catheter insertion in ICU patients: is there a greater risk of colonization or dysfunction?.
Critical Care (London, England) 2016, 20, 230.

Voiriot G, Visseaux B, Cohen J, Nguyen LBL, Neuville M, Morbieu C, Burdet C, Radjou A, Lescure FX, Smonig R, Armand-Lefèvre L, Mourvillier B, Yazdanpanah Y, Soubirou JF, Ruckly S, Houhou-Fidouh N, Timsit JF
Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia.
Critical Care (London, England) 2016, 20, 375.

Contou D, Roux D, Jochmans S, Coudroy R, Guérot E, Grimaldi D, Ricome S, Maury E, Plantefève G, Mayaux J, Mekontso Dessap A, Brun-Buisson C, de Prost N
Septic shock with no diagnosis at 24 hours: a pragmatic multicenter prospective cohort study.
Critical Care (London, England) 2016, 20, 360.

Kalfon P, Mimoz O, Loundou A, Geantot MA, Revel N, Villard I, Amour J, Azoulay E, Garrouste-Orgeas M, Martin C, Sharshar T, Baumstarck K, Auquier P
Reduction of self-perceived discomforts in critically ill patients in French intensive care units: study protocol for a cluster-randomized controlled trial.
Trials 2016, 17, 87.

Messika J, Hajage D, Panneckoucke N, Villard S, Martin Y, Renard E, Blivet A, Reignier J, Maquigneau N, Stoclin A, Puechberty C, Guétin S, Dechanet A, Fauquembergue A, Gaudry S, Dreyfuss D, Ricard JD
Effect of a musical intervention on tolerance and efficacy of non-invasive ventilation in the ICU: study protocol for a randomized controlled trial (MUSique pour l'Insuffisance Respiratoire Aigue - Mus-IRA).
Trials 2016, 17, 450.

Leroy O, Bailly S, Gangneux JP, Mira JP, Devos P, Dupont H, Montravers P, Perrigault PF, Constantin JM, Guillemot D, Azoulay E, Lortholary O, Bensoussan C, Timsit JF, Asg
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.
Annals of Intensive Care 2016, 6, 2.

Garrouste-Orgeas M, Ruckly S, Grégoire C, Dumesnil AS, Pommier C, Jamali S, Golgran-Toledano D, Schwebel C, Clec'h C, Soufir L, Fartoukh M, Marcotte G, Argaud L, Verdière B, Darmon M, Azoulay E, Timsit JF
Treatment intensity and outcome of nonagenarians selected for admission in ICUs: a multicenter study of the Outcomerea Research Group.
Annals of Intensive Care 2016, 6, 31.

Labbé V, Ederhy S, Pasquet B, Miguel-Montanes R, Rafat C, Hajage D, Gaudry S, Dreyfuss D, Cohen A, Fartoukh M, Ricard JD
Can we improve transthoracic echocardiography training in non-cardiologist residents? Experience of two training programs in the intensive care unit.
Annals of Intensive Care 2016, 6, 44.

Boumendil A, Woimant M, Quenot JP, Rooryck FX, Makhlouf F, Yordanov Y, Delerme S, Takun K, Ray P, Kouka MC, Poly C, Garrouste-Orgeas M, Thomas C, Simon T, Azerad S, Leblanc G, Pateron D, Guidet B, IC2sn
Designing and conducting a cluster-randomized trial of ICU admission for the elderly patients: the ICE-CUB 2 study.
Annals of Intensive Care 2016, 6, 74.

Garrouste-Orgeas M, Vinatier I, Tabah A, Misset B, Timsit JF
Reappraisal of visiting policies and procedures of patient's family information in 188 French ICUs: a report of the Outcomerea Research Group.
Annals of Intensive Care 2016, 6, 82.

Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M
Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).
Annals of Intensive Care 2016, 6, 90.

Mieras L, Anthony R, van Brakel W, Bratschi MW, van den Broek J, Cambau E, Cavaliero A, Kasang C, Perera G, Reichman L, Richardus JH, Saunderson P, Steinmann P, Yew WW
Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.
Infectious Diseases of Poverty 2016, 5, 46.

Angeli A, Lainé F, Lavenu A, Ropert M, Lacut K, Gissot V, Sacher-Huvelin S, Jezequel C, Moignet A, Laviolle B, Comets E
Joint Model of Iron and Hepcidin During the Menstrual Cycle in Healthy Women.
The AAPS journal 2016, 18, 490-504.

Lestini G, Mentré F, Magni P
Optimal Design for Informative Protocols in Xenograft Tumor Growth Inhibition Experiments in Mice.
The AAPS journal 2016, 18, 1233-1243.

Prin M, Guglielminotti J, Moitra V, Li G
Prophylactic Ondansetron for the Prevention of Intrathecal Fentanyl- or Sufentanil-Mediated Pruritus: A Meta-Analysis of Randomized Trials.
Anesthesia and Analgesia 2016, 122, 402-409.

Hunt TD, Guglielminotti J, Li G
Costs Associated with Anesthesia-Related Adverse Events During Labor and Delivery in New York State, 2010.
Anesthesia and Analgesia 2016, 122, 2007-2016.

Guglielminotti J, Deneux-Tharaux C, Wong CA, Li G
Hospital-Level Factors Associated with Anesthesia-Related Adverse Events in Cesarean Deliveries, New York State, 2009-2011.
Anesthesia and Analgesia 2016, 122, 1947-1956.

Guglielminotti J
A Practical Approach to Obstetric Anesthesia, 2nd Edition.
Anesthesia and Analgesia 2016

Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna n, Kighoma PM, Koundouno FR, Réné Lolamou n, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Dortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D, JSG
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
PLoS medicine 2016, 13, e1001967.

Elanga Ndille E, Doucoure S, Poinsignon A, Mouchet F, Cornelie S, D'Ortenzio E, DeHecq JS, Remoue F
Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area.
PLoS neglected tropical diseases 2016, 10, e0005109.

Morel V, Joly D, Villatte C, Dubray C, Durando X, Daulhac L, Coudert C, Roux D, Pereira B, Pickering G
Memantine before Mastectomy Prevents Post-Surgery Pain: A Randomized, Blinded Clinical Trial in Surgical Patients.
PloS One 2016, 11, e0152741.

Nikolayevskyy V, Hillemann D, Richter E, Ahmed N, van der Werf MJ, Kodmon C, Drobniewski F, Ruesch-Gerdes S, ENN
External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study.
PloS One 2016, 11, e0152926.

Tourret J, Willing BP, Croxen MA, Dufour N, Dion S, Wachtel S, Denamur E, Finlay BB
Small Intestine Early Innate Immunity Response during Intestinal Colonization by Escherichia coli Depends on Its Extra-Intestinal Virulence Status.
PloS One 2016, 11, e0153034.

Kirchgesner J, Beaugerie L, Carrat F, Sokol H, Cosnes J, Schwarzinger M, BSG
Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis.
PloS One 2016, 11, e0157191.

Bailly S, Destors M, Grillet Y, Richard P, Stach B, Vivodtzev I, Timsit JF, Lévy P, Tamisier R, Pépin JL, scaiotFnsar(
Obstructive Sleep Apnea: A Cluster Analysis at Time of Diagnosis.
PloS One 2016, 11, e0157318.

Selton-Suty C, Delahaye F, Tattevin P, Federspiel C, Le Moing V, Chirouze C, Nazeyrollas P, Vernet-Garnier V, Bernard Y, Chocron S, Obadia JF, Alla F, Hoen B, Duval X, A(plelPdlI
Symptomatic and Asymptomatic Neurological Complications of Infective Endocarditis: Impact on Surgical Management and Prognosis.
PloS One 2016, 11, e0158522.

Hema MN, Ferry T, Dupon M, Cuzin L, Verdon R, Thiébaut R, Protopopescu C, Leport C, Raffi F, Le Moing V, AC8(sg
Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study.
PloS One 2016, 11, e0161594.

Melloul E, Luiggi S, Anaïs L, Arné P, Costa JM, Fihman V, Briard B, Dannaoui E, Guillot J, Decousser JW, Beauvais A, Botterel F
Characteristics of Aspergillus fumigatus in Association with Stenotrophomonas maltophilia in an In Vitro Model of Mixed Biofilm.
PloS One 2016, 11, e0166325.

Couce A, Rodríguez-Rojas A, Blázquez J
Determinants of Genetic Diversity of Spontaneous Drug Resistance in Bacteria.
Genetics 2016, 203, 1369-1380.

Jagani M, Legay H, Ranmal SR, Bertrand J, Ooi K, Tuleu C
Can a Flavored Spray (Pill Glide) Help Children Swallow Their Medicines? A Pilot Study.
Pediatrics 2016, 138,

Houamel D, Ducrot N, Lefebvre T, Daher R, Moulouel B, Sari MA, Letteron P, Lyoumi S, Millot S, Tourret J, Bouvet O, Vaulont S, Vandewalle A, Denamur E, Puy H, Beaumont C, Gouya L, Karim Z
Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli.
Journal of the American Society of Nephrology: JASN 2016, 27, 835-846.

Romero M, Gapihan G, Castro-Vega LJ, Acevedo A, Wang L, Li ZW, El Bouchtaoui M, Di Benedetto M, Ratajczak P, Feugeas JP, Thieblemont C, Saavedra C, Janin A
Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
Oncotarget 2016

Delyon J, Varna M, Feugeas JP, Sadoux A, Yahiaoui S, Podgorniak MP, Leclert G, Dorval SM, Dumaz N, Janin A, Mourah S, Lebbé C
Validation of a preclinical model for assessment of drug efficacy in melanoma.
Oncotarget 2016, 7, 13069-13081.

Galy A, Lepeule R, Goulenok T, Buzele R, de Lastours V, Fantin B
Presentation and impact of catheter-associated thrombosis in patients with infected long-term central venous catheters: a prospective bicentric observational study.
Annals of Medicine 2016, 48, 182-189.

Soysal N, Mariani-Kurkdjian P, Smail Y, Liguori S, Gouali M, Loukiadis E, Fach P, Bruyand M, Blanco J, Bidet P, Bonacorsi S
Enterohemorrhagic Escherichia coli Hybrid Pathotype O80:H2 as a New Therapeutic Challenge.
Emerging Infectious Diseases 2016, 22, 1604-1612.

Dufour N, Henry M, Ricard JD, Debarbieux L
Commentary: Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro.
Frontiers in Microbiology 2016, 7, 1029.

Canini L, Guedj J, Chatterjee A, Lemenuel-Diot A, Smith PF, Perelson AS
Modelling the interaction between danoprevir and mericitabine in the treatment of chronic HCV infection.
Antiviral Therapy 2016, 21, 297-306.

Angin M, Wong G, Papagno L, Versmisse P, David A, Bayard C, Charmeteau-De Muylder B, Besseghir A, Thiébaut R, Boufassa F, Pancino G, Sauce D, Lambotte O, Brun-Vézinet F, Matheron S, Rowland-Jones SL, Cheynier R, Sáez-Cirión A, Appay V, ACI2SG
Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers.
Journal of Immunology (Baltimore, Md.: 1950) 2016, 197, 2787–2795.

Messika J, Stoclin A, Bouvard E, Fulgencio JP, Ridel C, Muresan IP, Boffa JJ, Bachmeyer C, Denis M, Gounant V, Esteso A, Loi V, Verdet C, Prigent H, Parrot A, Fartoukh M
The Challenging Diagnosis of Non-Community-Acquired Pneumonia in Non-Mechanically Ventilated Subjects: Value of Microbiological Investigation.
Respiratory Care 2016, 61, 225-234.

Loubet P, Palich R, Kojan R, Peyrouset O, Danel C, Nicholas S, Conde M, Porten K, Augier A, Yazdanpanah Y
Development of a Prediction Model for Ebola Virus Disease: A Retrospective Study in Nzérékoré Ebola Treatment Center, Guinea.
The American Journal of Tropical Medicine and Hygiene 2016, 95, 1362-1367.

Andre E, Isaacs C, Affolabi D, Alagna R, Brockmann D, de Jong BC, Cambau E, Churchyard G, Cohen T, Delmee M, Delvenne JC, Farhat M, Habib A, Holme P, Keshavjee S, Khan A, Lightfoot P, Moore D, Moreno Y, Mundade Y, Pai M, Patel S, Nyaruhirira AU, Rocha LEC, Takle J, Trébucq A, Creswell J, Boehme C
Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease 2016, 20, 999-1003.

Hugonnet JE, Mengin-Lecreulx D, Monton A, den Blaauwen T, Carbonnelle E, Veckerlé C, Brun YV, van Nieuwenhze M, Bouchier C, Tu K, Rice LB, Arthur M
Factors essential for L,D-transpeptidase-mediated peptidoglycan cross-linking and β-lactam resistance in Escherichia coli.
eLife 2016

Suzan-Monti M, Lorente N, Demoulin B, Marcellin F, Préau M, Dray-Spira R, Lert F, Spire B, AVSG
Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey.
Journal of the International AIDS Society 2016, 19, 20095.

Ricard JD
Hazards of intubation in the ICU: role of nasal high flow oxygen therapy for preoxygenation and apneic oxygenation to prevent desaturation.
Minerva Anestesiologica 2016, 82, 1098-1106.

Aloy B, Tazi I, Bagnis CI, Gauthier M, Janus N, Launay-Vacher V, De Scheerder MA, Tourret J
Tenofovir: Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?.
AIDS reviews 2016, 18,

Ghalayini M, Brun PY, Augustin P, Guivarch E, Dilly MP, Provenchere S, Mordant P, Castier Y, Montravers P, Longrois D
Esmolol Corrects Severe Hypoxemia in Patients with Femoro-Femoral Venoarterial Extracorporeal Life Support for Lung Transplantation.
The Journal of Extra-Corporeal Technology 2016, 48, 113-121.

Sangare SA, Maiga AI, Guindo I, Maiga A, Camara N, Dicko OA, Diallo S, Bougoudogo F, Armand-Lefevre L, Andremont A, Maiga II
Prevalence of ESBL-producing Enterobacteriaceae isolated from blood cultures in Mali.
Journal of Infection in Developing Countries 2016, 10, 1059-1064.

Djuikoue IC, Woerther PL, Toukam M, Burdet C, Ruppé E, Gonsu KH, Fokunang C, El Mniai A, Larissa K, Pieme AC, Mboupaing MG, Kakam CM, Fogang HK, Andremont A, Ngogang J
Intestinal carriage of Extended Spectrum Beta-Lactamase producing E. coli in women with urinary tract infections, Cameroon.
Journal of Infection in Developing Countries 2016, 10, 1135-1139.

Dreyer C, Couvelard A, Walter T, Bohas CL, Niccoli P, Seitz JF, Hentic O, Pellat A, Andre T, Couffignal C, Lobbe N, Mentre F, Bedossa P, Hammel P, Faivre SJ, Zappa M, Ruszniewski PB, Raymond E
Clinical and biomarker evaluations of sunitinib in patients (pts) with advanced well-differentiated grade 3 (G3) and poorly differentiated neuroendocrine neoplasms (PD-NEN)..
Journal of Clinical Oncology 2016, 34,

 2015                                                                            

Lemiale V, Mokart D, Resche-Rigon M, Pène F, Mayaux J, Faucher E, Nyunga M, Girault C, Perez P, Guitton C, Ekpe K, Kouatchet A, Théodose I, Benoit D, Canet E, Barbier F, Rabbat A, Bruneel F, Vincent F, Klouche K, Loay K, Mariotte E, Bouadma L, Moreau AS, Seguin A, Meert AP, Reignier J, Papazian L, Mehzari I, Cohen Y, Schenck M, Hamidfar R, Darmon M, Demoule A, Chevret S, Azoulay E, GdReRRdpdH(O
Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial.
JAMA 2015, 314, 1711-1719.

Silverman HJ, Dreyfuss D
Were There "Additional Foreseeable Risks" in the SUPPORT Study? Lessons Not Learned from the ARDSnet Clinical Trials.
The Hastings Center Report 2015, 45, 21-29.

Silverman HJ, Dreyfuss D
What counts as equipoise?.
The Hastings Center Report 2015, 45, 3-4.

Obach D, Yazdanpanah Y, Esmat G, Avihingsanon A, Dewedar S, Durier N, Attia A, Anwar WA, Cousien A, Tangkijvanich P, Eholié SP, Doss W, Mostafa A, Fontanet A, Mohamed MK, Deuffic-Burban S
How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.
Hepatology (Baltimore, Md.) 2015, 62, 31-39.

Ibarrola-Villava M, Kumar R, Nagore E, Benfodda M, Guedj M, Gazal S, Hu HH, Guan J, Rachkonda PS, Descamps V, Basset-Seguin N, Bensussan A, Bagot M, Saiag P, Schadendorf D, Martin-Gonzalez M, Mayor M, Grandchamp B, Ribas G, Soufir N
Genes involved in the WNT and vesicular trafficking pathways are associated with melanoma predisposition.
International Journal of Cancer. Journal International Du Cancer 2015, 136, 2109-2119.

Gautheret-Dejean A, Bocobza J, Brunet S, Damond F, Plantier JC, Barin F
Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections.
Journal of Medical Virology 2015, 87, 2061–2066.

Gautheret-Dejean A, Bocobza J, Brunet S, Damond F, Plantier JC, Barin F
Response to comments by Hønge et al. on our paper titled, "Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections".
Journal of Medical Virology 2015

Smati M, Clermont O, Bleibtreu A, Fourreau F, David A, Daubié AS, Hignard C, Loison O, Picard B, Denamur E
Quantitative analysis of commensal Escherichia coli populations reveals host-specific enterotypes at the intra-species level.
MicrobiologyOpen 2015, 4, 604-615.

Nguyen T, Guedj J
HCV Kinetic Models and Their Implications in Drug Development.
CPT: pharmacometrics & systems pharmacology 2015, 4, 231-242.

Swat MJ, Moodie S, Wimalaratne SM, Kristensen NR, Lavielle M, Mari A, Magni P, Smith MK, Bizzotto R, Pasotti L, Mezzalana E, Comets E, Sarr C, Terranova N, Blaudez E, Chan P, Chard J, Chatel K, Chenel M, Edwards D, Franklin C, Giorgino T, Glont M, Girard P, Grenon P, Harling K, Hooker AC, Kaye R, Keizer R, Kloft C, Kok JN, Kokash N, Laibe C, Laveille C, Lestini G, Mentré F, Munafo A, Nordgren R, Nyberg HB, Parra-Guillen ZP, Plan E, Ribba B, Smith G, Trocóniz IF, Yvon F, Milligan PA, Harnisch L, Karlsson M, Hermjakob H, Le Novère N
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development.
CPT: pharmacometrics & systems pharmacology 2015, 4, 316-319.

Laouénan C, Guedj J, Peytavin G, Nguyen TT, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Marcellin P, Mentré F
A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy.
CPT: pharmacometrics & systems pharmacology 2015, 4, e00008.

Clémençon S, Cousien A, Felipe MD, Tran VC
On computer-intensive simulation and estimation methods for rare-event analysis in epidemic models.
Statistics in Medicine 2015, 34, 3696-3713.

Zwaans W, Verhagen T, Roumen R, Scheltinga M, Dieleman J, Vad M, Frost P, Rosenberg J, Svendsen SW, Tabbara M, Carandina S, Bossi M, Polliand C, Barrat C, Soler M, Chander J, Sharma R, Lal R, Pradhan G, Mol F, Mitura K, Romanczuk M, Lundstrom K, Nordin P, Holmberg H, Sahin A, Kulacoglu H, Olcucuoglu E, Guadalaxara A, Rampinelli LA, Mariani P, Ubezio D, Felici A, Santagati G, Novellino L, Gitelis M, DeAsis F, Chao S, Lapin B, Denham W, Linn J, Haggerty S, Carbray J, Ujiki M, Evans L, Canciani GN, Gordon EM, Wei P, Tam K, Chen C, Kao C, Protasov A, Bogdanov D, Meshkov M, Kurganov I, Misra MC, Bansal VK, Subodh K, Krishna A, Bansal D, Ray S, Rajeshwari S, Marzo F, Forni S, Massi M, Gia L, Dabrowski A
Topic: Inguinal Hernia - Post op chronic pain: incidence, evaluation, legal consequences, therapy, follow up.
Hernia: The Journal of Hernias and Abdominal Wall Surgery 2015, 19 Suppl 1, S267-274.

Bakker J, Perner A, Timsit JF
Evaluation of 7.5 years of Surviving Sepsis Campaign Guidelines.
Intensive Care Medicine 2015, 41, 151-153.

Yazdanpanah Y, Arribas JR, Malvy D
Treatment of Ebola virus disease.
Intensive Care Medicine 2015, 41, 115-117.

Toffart AC, Dhalluin X, Girard N, Chouaid C, Audigier-Valette C, Duruisseaux M, Mennecier B, Parrot A, Fournel P, Moro-Sibilot D, Timsit JF
Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units.
Intensive Care Medicine [Letter] 2015, 41, 164-165.

Garrouste-Orgeas M, Perrin M, Soufir L, Vesin A, Blot F, Maxime V, Beuret P, Troché G, Klouche K, Argaud L, Azoulay E, Timsit JF
The Iatroref study: medical errors are associated with symptoms of depression in ICU staff but not burnout or safety culture.
Intensive Care Medicine 2015, 41, 273-284.

Cambau E, Bauer M
Multi-pathogen real-time PCR system adds benefit for my patients: yes.
Intensive Care Medicine 2015, 41, 528-530.

Reignier J, Darmon M, Sonneville R, Borel AL, Garrouste-Orgeas M, Ruckly S, Souweine B, Dumenil AS, Haouache H, Adrie C, Argaud L, Soufir L, Marcotte G, Laurent V, Goldgran-Toledano D, Clec'h C, Schwebel C, Azoulay E, Timsit JF
Impact of early nutrition and feeding route on outcomes of mechanically ventilated patients with shock: a post hoc marginal structural model study.
Intensive Care Medicine 2015, 41, 875-886.

Timsit JF, Perner A, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Doig GS, Herridge M, Jaber S, Joannidis M, Papazian L, Peters MJ, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Citerio G, Azoulay E
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics.
Intensive Care Medicine [YEAR IN REVIEW 2014] 2015, 41, 575-588.

Ricard JD, Messika J, Sztrymf B, Gaudry S
Impact on outcome of delayed intubation with high-flow nasal cannula oxygen: is the device solely responsible?.
Intensive Care Medicine 2015

Bretonnière C, Leone M, Milési C, Allaouchiche B, Armand-Lefevre L, Baldesi O, Bouadma L, Decré D, Figueiredo S, Gauzit R, Guery B, Joram N, Jung B, Lasocki S, Lepape A, Lesage F, Pajot O, Philippart F, Souweine B, Tattevin P, Timsit JF, Vialet R, Zahar JR, Misset B, Bedos JP
Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).
Intensive Care Medicine 2015, 41, 1181-1196.

Bassetti M, Leon C, Timsit JF
Are prophylactic antifungals in highly colonized patients safe and effective?.
Intensive Care Medicine 2015, 41, 1336-1339.

de Prost N, Sbidian E, Chosidow O, Brun-Buisson C, Amathieu R, HMHNFG
Management of necrotizing soft tissue infections in the intensive care unit: results of an international survey.
Intensive Care Medicine 2015, 41, 1506-1508.

Lautrette A, Garrouste-Orgeas M, Bertrand PM, Goldgran-Toledano D, Jamali S, Laurent V, Argaud L, Schwebel C, Mourvillier B, Darmon M, Ruckly S, Dumenil AS, Lemiale V, Souweine B, Timsit JF, OSG
Respective impact of no escalation of treatment, withholding and withdrawal of life-sustaining treatment on ICU patients' prognosis: a multicenter study of the Outcomerea Research Group.
Intensive Care Medicine 2015, 41, 1763-1772.

Schortgen F, Charles-Nelson A, Bouadma L, Bizouard G, Brochard L, Katsahian S
Respective impact of lowering body temperature and heart rate on mortality in septic shock: mediation analysis of a randomized trial.
Intensive Care Medicine 2015, 41, 1800-1808.

Bailly S, Leroy O, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Azoulay E, Timsit JF
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.
Intensive Care Medicine 2015, 41, 1931-1940.

Dreyfuss D, Ricard JD, Gaudry S
Did studies on HFOV fail to improve ARDS survival because they did not decrease VILI? On the potential validity of a physiological concept enounced several decades ago.
Intensive Care Medicine 2015, 41, 2076-2086.

Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, De Waele J, Petrosillo N, Seifert H, Timsit JF, Vila J, Zahar JR, Bassetti M, ESoICM
Task force on management and prevention of Acinetobacter baumannii infections in the ICU.
Intensive Care Medicine 2015, 41, 2057-2075.

Burdet C, Pajot O, Couffignal C, Armand-Lefèvre L, Foucrier A, Laouénan C, Wolff M, Massias L, Mentré F
Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia.
European Journal of Clinical Pharmacology 2015, 71, 75-83.

Amarsy-Guerle R, Mougari F, Jacquier H, Oliary J, Benmansour H, Riahi J, Berçot B, Raskine L, Cambau E
High medical impact of implementing the new polymeric bead-based BacT/ALERT® FAPlus and FNPlus blood culture bottles in standard care.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2015, 34, 1031-1037.

Lepelletier D, Lucet JC, Astagneau P, Coignard B, Vaux S, Rabaud C, Grandbastien B, Berthelot P
Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2015, 34, 1615-1620.

Lestini G, Dumont C, Mentré F
Influence of the Size of Cohorts in Adaptive Design for Nonlinear Mixed Effects Models: An Evaluation by Simulation for a Pharmacokinetic and Pharmacodynamic Model for a Biomarker in Oncology.
Pharmaceutical Research 2015, 32, 3159-3169.

Pichon M, Savatovsky J, Lamirel C, Joly V, Moulignier A
Isolated blepharoptosis may point to HIV-associated Burkitt's lymphoma.
Acta Neurologica Belgica 2015, 115, 833–835.

Jacquier H, Benmansour H, Zadegan F, Hannouche D, Micaelo M, Mongiat-Artus P, Salomon E, Cambau E, Berçot B
Actinobaculum schaalii, a new cause of knee prosthetic joint infection in elderly.
Infection 2015

Brunetta J, Moreno Guillén S, Antinori A, Yeni P, Wade B, Johnson M, Shalit P, Ebrahimi R, Johnson B, Walker I, De-Oertel S
Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial.
The Patient 2015

Carosella ED, Rouas-Freiss N, Roux DTL, Moreau P, LeMaoult J
HLA-G: An Immune Checkpoint Molecule.
Advances in Immunology 2015, 127, 33-144.

Dupont H, Marciniak S, Zogheib E, Mammeri H, Friggeri A, Ammenouche N, Levrard M, Airapetian N, Tinturier F, Mahjoub Y
Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
Anaesthesia, Critical Care & Pain Medicine 2015, 34, 141-144.

Jaubert J, Mougari F, Picot S, Boukerrou M, Barau G, Ali Ahmed SA, Raskine L, Camuset G, Michault A, Simac C, Cambau E
A case of postoperative breast infection by Mycobacterium fortuitum associated with the hospital water supply.
American Journal of Infection Control 2015, 43, 406-408.

Birgand G, Toupet G, Rukly S, Antoniotti G, Deschamps MN, Lepelletier D, Pornet C, Stern JB, Vandamme YM, van der Mee-Marquet N, Timsit JF, Lucet JC
Air contamination for predicting wound contamination in clean surgery: A large multicenter study.
American Journal of Infection Control 2015, 43, 516-521.

Parienti JJ, Lucet JC, Lefort A, Armand-Lefèvre L, Wolff M, Caron F, Cattoir V, Yazdanpanah Y
Empirical therapies among adults hospitalized for community-acquired upper urinary tract infections: A decision-tree analysis of mortality, costs, and resistance.
American Journal of Infection Control 2015

Canlorbe G, Matheron S, Mandelbrot L, Oudet B, Luton D, Azria E
Vasculoplacental complications in pregnant women with HIV infection: a case-control study.
American Journal of Obstetrics and Gynecology 2015

Mabileau G, Schwarzinger M, Flores J, Patrat C, Luton D, Epelboin S, Mandelbrot L, Matheron S, Yazdanpanah Y
HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?.
American Journal of Obstetrics and Gynecology 2015, 213, 341.e1–341.e12.

Mabileau G, Schwarzinger M, Flores J, Patrat C, Luton D, Epelboin S, Mandelbrot L, Matheron S, Yazdanpanah Y
HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?.
American Journal of Obstetrics and Gynecology 2015, 213, 341.e1-341.e12.

Madelain V, Oestereich L, Graw F, Nguyen THT, de Lamballerie X, Mentré F, Günther S, Guedj J
Ebola virus dynamics in mice treated with favipiravir.
Antiviral Research 2015, 123, 70-77.

Tarbé de Saint Hardouin AL, Mariani P, Esteve V, Msélati JC, Lorrot M, Blachier A, Aujard Y, Bonacorsi S, Faye A
[Dermo-hypodermitis caused by group B Streptococcus in infants under 3 months of age: A retrospective study in two hospitals].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2015, 22, 693-698.

Mallet V, Schwarzinger M, Vallet-Pichard A, Fontaine H, Corouge M, Sogni P, Pol S
Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.
Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2015, 13, 1181-1188.e1.

Ladjeroud S, Touraine S, Laouénan C, Parlier-Cuau C, Bousson V, Laredo JD
Impact of osteoid osteomas of the hip on the size and fatty infiltration of the thigh muscles.
Clinical Imaging 2015, 39, 128-132.

Lesprit P, de Pontfarcy A, Esposito-Farese M, Ferrand H, Mainardi JL, Lafaurie M, Parize P, Rioux C, Tubach F, Lucet JC
Postprescription review improves in-hospital antibiotic use: a multicenter randomized controlled trial.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 180.e1-7.

Decousser JW, Poirel L, Desroches M, Jayol A, Denamur E, Nordmann P
Failure to detect carbapenem-resistant Escherichia coli producing OXA-48-like using the Xpert Carba-R assay®.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, e9-10.

Le Dorze M, Gault N, Foucrier A, Ruppé E, Mourvillier B, Woerther PL, Birgand G, Montravers P, Dilly MP, Tubach F, Andremont A, Timsit JF, Wolff M, Armand-Lefèvre L
Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 468.e1-6.

Buzelé R, Zarrouk V, Francoz C, Durand F, Fantin B
Characteristics of vertebral osteomyelitis after liver transplantation.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015

Das D, Le Floch H, Houhou N, Epelboin L, Hausfater P, Khalil A, Ray P, Duval X, Claessens YE, Leport C, ESG
Viruses detected by systematic multiplex polymerase chain reaction in adults with suspected community-acquired pneumonia attending emergency departments in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 608.e1-8.

Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, Lucet JC, Paugam-Burtz C, Brun-Buisson C, Timsit JF, DeSG
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 649.e1-10.

Lemaignen A, Birgand G, Ghodhbane W, Alkhoder S, Lolom I, Belorgey S, Lescure FX, Armand-Lefevre L, Raffoul R, Dilly MP, Nataf P, Lucet JC
Sternal wound infection after cardiac surgery: incidence and risk factors according to clinical presentation.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 674.e11-18.

LeGoff J, Roques P, Jenabian MA, Charpentier C, Brochier C, Bouhlal H, Gresenguet G, Frost E, Pepin J, Mayaud P, Belec L, A1SG
Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 873.e1-9.

Joubrel C, Tazi A, Six A, Dmytruk N, Touak G, Bidet P, Raymond J, Trieu Cuot P, Fouet A, Kernéis S, Poyart C
Group B streptococcus neonatal invasive infections, France 2007-2012.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 910-916.

Birgand G, Johansson A, Szilagyi E, Lucet JC
Overcoming the obstacles of implementing infection prevention and control guidelines.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 1067-1071.

Maraux B, Hamelin C, Bajos N, Dray-Spira R, Spire B, Lert F, Vsg
Women living with HIV still lack highly effective contraception: results from the ANRS VESPA2 study, France, 2011.
Contraception 2015, 92, 160–169.

Charfi K, Mansour W, Khalifa ABH, Mastouri M, Aouni M, Mammeri H
Emergence of OXA-204 β-lactamase in Tunisia.
Diagnostic Microbiology and Infectious Disease 2015, 82, 314-317.

Leprince C, Desroches M, Emirian A, Coutureau C, Anais L, Fihman V, Soussy CJ, Decousser JW, Psg
Distribution and antimicrobial susceptibility of bacteria from adults with community-acquired pneumonia or complicated skin and soft tissue infections in France: the nationwide French PREMIUM study.
Diagnostic Microbiology and Infectious Disease 2015

Walewski V, Podglajen I, Lefeuvre P, Dutasta F, Neuschwander A, Tilouche L, Carbonnelle E, Ferroni A
Early detection with the β-LACTA™ test of extended-spectrum β-lactamase-producing Enterobacteriaceae in blood cultures.
Diagnostic Microbiology and Infectious Disease 2015, 83, 216-218.

K-Kutala B, Bedossa P, Guedj J, Asselah T, Martinot-Peignoux M, Duval X, Marcellin P
Patients with chronic hepatitis C without advanced fibrosis and hepatocellular carcinoma: a retrospective clinical-pathological study.
Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2015, 47, 296-302.

Shadoud L, Almahmoud I, Jarraud S, Etienne J, Larrat S, Schwebel C, Timsit JF, Schneider D, Maurin M
Hidden Selection of Bacterial Resistance to Fluoroquinolones In Vivo: The Case of Legionella pneumophila and Humans.
EBioMedicine 2015, 2, 1179-1185.

Ferron G, Simon L, Guyon F, Glehen O, Goere D, Elias D, Pocard M, Gladieff L, Bereder JM, Brigand C, Classe JM, Guilloit JM, Quenet F, Abboud K, Arvieux C, Bibeau F, De Chaisemartin C, Delroeux D, Durand-Fontanier S, Goasguen N, Gouthi L, Heyd B, Kianmanesh R, Leblanc E, Loi V, Lorimier G, Marchal F, Mariani P, Mariette C, Meeus P, Msika S, Ortega-Deballon P, Paineau J, Pezet D, Piessen G, Pirro N, Pomel C, Porcheron J, Pourcher G, Rat P, Regimbeau JM, Sabbagh C, Thibaudeau E, Torrent JJ, Tougeron D, Tuech JJ, Zinzindohoue F, Lundberg P, Herin F, Villeneuve L, BRWG
Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey.
European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2015, 41, 1361-1367.

Costet N, Pelé F, Comets E, Rouget F, Monfort C, Bodeau-Livinec F, Linganiza EM, Bataille H, Kadhel P, Multigner L, Cordier S
Perinatal exposure to chlordecone and infant growth.
Environmental Research 2015, 142, 123-134.

Fihman V, Messika J, Hajage D, Tournier V, Gaudry S, Magdoud F, Barnaud G, Billard-Pomares T, Branger C, Dreyfuss D, Ricard JD
Five-year trends for ventilator-associated pneumonia: Correlation between microbiological findings and antimicrobial drug consumption.
International Journal of Antimicrobial Agents 2015, 46, 518-525.

Decousser JW, Desroches M, Bourgeois-Nicolaos N, Potier J, Jehl F, Lina G, Cattoir V, Vandenesh F, Doucet-Populaire F, MSG
Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.
International Journal of Antimicrobial Agents 2015, 46, 622-630.

Gauzit R, Pean Y, Alfandari S, Bru JP, Bedos JP, Rabaud C, Robert J, SdPIdLF(, ONdldlRBaA(, SdlPdA(G
Carbapenem use in French hospitals: A nationwide survey at the patient level.
International Journal of Antimicrobial Agents 2015, 46, 707-712.

Munier AL, de Lastours V, Barbier F, Chau F, Fantin B, Ruimy R
Comparative dynamics of the emergence of fluoroquinolone resistance in staphylococci from the nasal microbiota of patients treated with fluoroquinolones according to their environment.
International Journal of Antimicrobial Agents 2015

Hua C, Sbidian E, Hemery F, Decousser JW, Bosc R, Amathieu R, Rahmouni A, Wolkenstein P, Valeyrie-Allanore L, Brun-Buisson C, de Prost N, Chosidow O
Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study.
Journal of the American Academy of Dermatology 2015, 73, 1006-1012.e8.

Lefebvre A, Saliou P, Mimoz O, Lucet JC, Le Guyader A, Bruyère F, Roche PH, Astruc K, Tiv M, Lepelletier D, Aho-Glélé LS, FSGftPoPoSSI
Is surgical site scrubbing before painting of value? Review and meta-analysis of clinical studies.
The Journal of Hospital Infection 2015, 89, 28-37.

Lepelletier D, Berthelot P, Lucet JC, Fournier S, Jarlier V, Grandbastien B, NWG
French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission.
The Journal of Hospital Infection 2015, 90, 186-195.

Le Monnier A, Duburcq A, Zahar JR, Corvec S, Guillard T, Cattoir V, Woerther PL, Fihman V, Lalande V, Jacquier H, Mizrahi A, Farfour E, Morand P, Marcadé G, Coulomb S, Torreton E, Fagnani F, Barbut F, GSG
Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.
The Journal of Hospital Infection 2015, 91, 117-122.

Lefebvre A, Saliou P, Lucet JC, Mimoz O, Keita-Perse O, Grandbastien B, Bruyère F, Boisrenoult P, Lepelletier D, Aho-Glélé LS, FSGftPPoSSI
Preoperative hair removal and surgical site infections: network meta-analysis of randomized controlled trials.
The Journal of Hospital Infection 2015, 91, 100-108.

Lepainteur M, Nérome S, Bendjelloul G, Monteil C, Cottard-Boulle B, Nion-Huang M, Jarlier V, Fournier S, NoICToAP–HdP
Evaluation of excreta management in a large French multi-hospital institution.
The Journal of Hospital Infection 2015, 91, 346-350.

Charlier C, Hourrier S, Leruez-Ville M, Zahar JR, Floret D, Salomon LJ, Toubiana J, Lecuit M, Lapillonne A, Lortholary O, Kermorvant-Duchemin E
Polyvalent immunoglobulins in neonates after perinatal exposure to measles: Benefits and long-term tolerance of immunoglobulins.
The Journal of Infection 2015, 71, 131-134.

Poirier C, Dinh A, Salomon J, Grall N, Andremont A, Bernard L
Antibiotic cycling prevents urinary tract infections in spinal cord injury patients and limits the emergence of multidrug resistant organism.
The Journal of Infection 2015

Bailly S, Maubon D, Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF
Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.
The Journal of Infection 2015

Bataille J, Prot-Labarthe S, Melki I, de Lauzanne A, Doit C, Lorrot M
[Complications of BCG vaccine SSI(®) in a pediatric hospital: Two reported cases].
Presse Médicale (Paris, France: 1983) 2015, 44, 462-465.

Jolly D, Ambrosi P, Chaffanjon P, Dreyfuss D, Le Jeunne C, Lorette G, Obert L, Palombi O, Romanet JP
[Results of the 2014 National Ranking in France.].
Presse Medicale (Paris, France: 1983) 2015

Bonnal C, Birgand G, Lolom I, Diamantis S, Dumortier C, L'Heriteau F, Armand-Lefevre L, Lucet JC
Staphylococcus aureus healthcare associated bacteraemia: An indicator of catheter related infections.
Medecine Et Maladies Infectieuses 2015, 45, 84-88.

Leport C, Coignard H, Diehl JL
Organizing the French response to the Ebola virus infection in West Africa - ethical considerations on information given to patients, their relatives, and healthcare professionals.
Medecine Et Maladies Infectieuses 2015, 45, 109-110.

Lefébure A, Papy E, Rioux C, Diamantis S, Armand-Lefèvre L, Longuet P, Lescure FX, Wolff M, Arnaud P, Lucet JC
Audit of carbapenem prescriptions comparing 2 assessment periods.
Medecine Et Maladies Infectieuses 2015, 45, 273-278.

Sangare SA, Maiga AI, Guindo I, Maiga A, Camara N, Savadogo S, Diallo S, Bougoudogo F, Armand-Lefevre L, Andremont A, Maiga II
Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated from blood cultures in Africa.
Médecine Et Maladies Infectieuses 2015, 45, 374-382.

Reibel F, Cambau E, Aubry A
Update on the epidemiology, diagnosis, and treatment of leprosy.
Médecine Et Maladies Infectieuses 2015, 45, 383-393.

Alfandari S, Robert J, Péan Y, Rabaud C, Bedos JP, Varon E, Lepape A, Bru JP, Gauzit R, FIDS(aStFNOfEoBRtA(atSg
Antibiotic use and good practice in 314 French hospitals: The 2010 SPA2 prevalence study.
Medecine Et Maladies Infectieuses 2015, 45, 475–480.

Bouchiat C, Moreau K, Devillard S, Rasigade JP, Mosnier A, Geissmann T, Bes M, Tristan A, Lina G, Laurent F, Piroth L, Aissa N, Duval X, Le Moing V, Vandenesch F, FVSG
Staphylococcus aureus infective endocarditis versus bacteremia strains: Subtle genetic differences at stake.
Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2015, 36, 524-530.

Jost C, Breton B, Biran V, Khung S, Chekroune S, Bonacorsi S
First case of pregnant women bacteraemia and probable early-onset neonatal infection due to Aerococcus urinae.
New Microbes and New Infections 2015, 3, 1-3.

Wagner N, Wyler-Lazarevic CA, Yerly S, Samer C, Peytavin G, Posfay-Barbe KM, Calmy A, Ambrosioni J
Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review.
New Microbes and New Infections 2015, 6, 1–4.

Gallois C, Hauw-Berlemont C, Richaud C, Bonacorsi S, Diehl JL, Mainardi JL
Fatal necrotizing fasciitis due to necrotic toxin-producing Escherichia coli strain.
New Microbes and New Infections 2015, 8, 109-112.

Wagner N, Wyler-Lazarevic CA, Yerly S, Samer C, Peytavin G, Posfay-Barbe KM, Calmy A, Ambrosioni J
Corrigendum to "Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review" [New Microbes New Infect] 6 (2015) 1-4].
New Microbes and New Infections 2015, 8, 174.

Hutin A, Lidouren F, Kohlhauer M, Lotteau L, Seemann A, Mongardon N, Renaud B, Isabey D, Carli P, Vivien B, Ricard JD, Hauet T, Kerber RE, Berdeaux A, Ghaleh B, Tissier R
Total liquid ventilation offers ultra-fast and whole-body cooling in large animals in physiological conditions and during cardiac arrest.
Resuscitation 2015, 93, 69-73.

Caseris M, Burdet C, Lepeule R, Houhou N, Yeni P, Yazdanpanah Y, Joly V
[An update on measles].
La Revue De Médecine Interne / Fondée ... Par La Société Nationale Francaise De Médecine Interne 2015, 36, 339-345.

Caseris M, Burdet C, Lepeule R, Houhou N, Yeni P, Yazdanpanah Y, Joly V
[An update on measles].
La Revue De Medecine Interne 2015, 36, 339-345.

Monnier D, Goulenok T, Allary J, Zarrouk V, Fantin B
[Starvation ketosis in a breastfeeding woman].
La Revue De Medecine Interne / Fondee ... Par La Societe Nationale Francaise De Medecine Interne 2015

Ficko C, Bechara C, Gerin M, Carbonnelle E, Podglajen I, Mainardi JL
[Bloodstream infection due to Campylobacter fetus subspecies fetus and skin involvement: A case series of three patients].
La Revue De Medecine Interne / Fondee ... Par La Societe Nationale Francaise De Medecine Interne 2015

Couffignal C, Desgrandchamps F, Mongiat-Artus P, Ravery V, Ouzaid I, Roupret M, Phe V, Ciofu C, Tubach F, Mentre F, Cussenot O, Grandchamp B
The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study.
Urology 2015, 86, 1185-1190.

Lepoutre A, Varon E, Georges S, Dorléans F, Janoir C, Gutmann L, Lévy-Bruhl D, MoE, ON
Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
Vaccine 2015, 33, 359-366.

Ribadeau Dumas F, N’Diaye DS, Paireau J, Gautret P, Bourhy H, Le Pen C, Yazdanpanah Y
Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France.
Vaccine 2015, 33, 2367-2378.

Loubet P, Kernéis S, Groh M, Loulergue P, Blanche P, Verger P, Launay O
Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.
Vaccine 2015, 33, 3703-3708.

Mullaert J, Abgrall S, Lele N, Batteux F, Slama LB, Meritet JF, Lebon P, Bouchaud O, Grabar S, Launay O, AVSG
Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study.
Vaccine 2015, 33, 4938–4944.

Mullaert J, Abgrall S, Lele N, Batteux F, Slama LB, Meritet JF, Lebon P, Bouchaud O, Grabar S, Launay O, AVSG
Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study.
Vaccine 2015, 33, 4938-4944.

Cohen R, Varon E, Doit C, Schlemmer C, Romain O, Thollot F, Béchet S, Bonacorsi S, Levy C
A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation.
Vaccine 2015

Varon E, Cohen R, Béchet S, Doit C, Levy C
Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children.
Vaccine 2015, 33, 6178-6185.

Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, Le Moing V, Belmatoug N, Lesprit P, Bru JP, Therby A, Bouhour D, Dénes E, Debard A, Chirouze C, Fèvre K, Dupon M, Aegerter P, Mulleman D, DoTfS(sg
Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial.
Lancet 2015, 385, 875-882.

Duval X, Hoen B
Prophylaxis for infective endocarditis: let's end the debate.
Lancet (London, England) 2015, 385, 1164-1165.

Guerrier G, Sjögren L, Guerrier M, Bretonnière S, Letier T, Dancoisne A, Wirtz M, D'Ortenzio E
Scientific journalism in Africa to help fight global health emergencies.
Lancet (London, England) 2015, 386, 851.

Ricard JD, Messika J
Corticosteroid therapy for pneumonia.
Lancet (London, England) 2015, 386, 954.

Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S, Friggeri A, Wallet F, Allou N, Ruckly S, Balayn D, Lepape A, Timsit JF, Cti
Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
Lancet (London, England) 2015, 386, 2069-2077.

Guerrier G, D'Ortenzio E
Teaching anthropology to medical students.
Lancet (London, England) 2015, 385, 603.

Bouazza N, Treluyer JM, Foissac F, Mentré F, Taburet AM, Guedj J, Anglaret X, de Lamballerie X, Keïta S, Malvy D, Frange P
Favipiravir for children with Ebola.
Lancet (London, England) 2015, 385, 603-604.

Ndawinz JDA, Cissé M, Diallo MSK, Sidibé CT, D'Ortenzio E
Prevention of HIV spread during the Ebola outbreak in Guinea.
Lancet (London, England) 2015, 385, 1393.

Iung B, Tubiana S, Alla F, Lavielle M
Infective endocarditis and antibiotic prophylaxis.
Lancet (London, England) 2015, 386, 529-530.

Raymond J, Bonacorsi S
Quelles méthodes microbiologiques dans un schéma repensé de prise en charge des infections néonatales précoces?.
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2015, 22, 58.

Bonacorsi S
[Antibacterial resistance of community acquired infections: warnings and good news].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2015, 22, 69-70.

Mentré F, Taburet AM, Guedj J, Anglaret X, Keïta S, de Lamballerie X, Malvy D
Dose regimen of favipiravir for Ebola virus disease.
The Lancet. Infectious Diseases 2015, 15, 150-151.

Arribas JR, Girard PM, Landman R, Pich J, Mallolas J, Martínez-Rebollar M, Zamora FX, Estrada V, Crespo M, Podzamczer D, Portilla J, Dronda F, Iribarren JA, Domingo P, Pulido F, Montero M, Knobel H, Cabié A, Weiss L, Gatell JM, OESG
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial.
The Lancet. Infectious Diseases 2015, 15, 785–792.

Rey D, Piroth L, Wendling MJ, Miailhes P, Michel ML, Dufour C, Haour G, Sogni P, Rohel A, Ajana F, Billaud E, Molina JM, Launay O, Carrat F, AHBBsg
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
The Lancet. Infectious Diseases 2015, 15, 1283–1291.

Yazdanpanah Y, Horby P, van Griensven J, Mentre F, Nguyen VK, Malvy JMD, Dunning J, Sissoko D, Delfraissy JF, Levy Y
Drug assessment in the Ebola virus disease epidemic in west Africa.
The Lancet. Infectious Diseases 2015, 15, 1258.

Horby PW, Endzt H, Muyembe-Tamfum JJ, van Griensven J, Gevao S, Goossens H, Malvy JMD, Haba NY, Yazdanpanah Y, Olliaro P, Semple C, de Jong M, Delamou A, Lang T, Carson G, Kennedy S
Ebola: Europe-Africa research collaborations.
The Lancet. Infectious Diseases 2015, 15, 1258-1259.

Chéret A, Nembot G, Mélard A, Lascoux C, Slama L, Miailhes P, Yeni P, Abel S, Avettand-Fenoel V, Venet A, Chaix ML, Molina JM, Katlama C, Goujard C, Tamalet C, Raffi F, Lafeuillade A, Reynes J, Ravaux I, Hoën B, Delfraissy JF, Meyer L, Rouzioux C, OASG
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.
Lancet Infect Dis 2015, 15, 387–396.

Martin-Loeches I, Povoa P, Rodríguez A, Curcio D, Suarez D, Mira JP, Cordero ML, Lepecq R, Girault C, Candeias C, Seguin P, Paulino C, Messika J, Castro AG, Valles J, Coelho L, Rabello L, Lisboa T, Collins D, Torres A, Salluh J, Nseir S, Ts
Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study.
The Lancet. Respiratory Medicine 2015, 3, 859-868.

Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA, HCC
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
The lancet. HIV 2015, 2, e335–343.

Birgand G, Saliou P, Lucet JC
Influence of staff behavior on infectious risk in operating rooms: what is the evidence?.
Infection Control and Hospital Epidemiology 2015, 36, 93-106.

Lucet JC, Abiteboul D, Estellat C, Roy C, Chollet-Martin S, Tubach F, Carcelain G, QSG
Interferon-γ release assay vs. tuberculin skin test for tuberculosis screening in exposed healthcare workers: a longitudinal multicenter comparative study.
Infection Control and Hospital Epidemiology 2015, 36, 569-574.

Osio A, Battistella M, Feugeas JP, Cuccuini W, Noguera ME, Petrella T, Raffoux E, Janin A, Pennamen V
Myelodysplasia Cutis Versus Leukemia Cutis.
The Journal of Investigative Dermatology 2015, 135, 2321-2324.

Battistella M, Romero M, Castro-Vega LJ, Gapihan G, Bouhidel F, Bagot M, Feugeas JP, Janin A
The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression.
The Journal of Investigative Dermatology 2015, 135, 1659-1667.

Maubec E, Laouénan C, Deschamps L, Nguyen VT, Scheer-Senyarich I, Wackenheim-Jacobs AC, Steff M, Duhamel S, Tubiana S, Brahimi N, Leclerc-Mercier S, Crickx B, Perret C, Aractingi S, Escoubet B, Duval X, Arnaud P, Jaisser F, Mentré F, Farman N
Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.
The Journal of Investigative Dermatology 2015, 135, 1781-1789.

Caye A, Strullu M, Guidez F, Cassinat B, Gazal S, Fenneteau O, Lainey E, Nouri K, Nakhaei-Rad S, Dvorsky R, Lachenaud J, Pereira S, Vivent J, Verger E, Vidaud D, Galambrun C, Picard C, Petit A, Contet A, Poirée M, Sirvent N, Méchinaud F, Adjaoud D, Paillard C, Nelken B, Reguerre Y, Bertrand Y, Häussinger D, Dalle JH, Ahmadian MR, Baruchel A, Chomienne C, Cavé H
Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.
Nature Genetics 2015, 47, 1334-1340.

Long A, Liti G, Luptak A, Tenaillon O
Elucidating the molecular architecture of adaptation via evolve and resequence experiments.
Nature Reviews. Genetics 2015, 16, 567-582.

Perelson AS, Guedj J
Modelling hepatitis C therapy--predicting effects of treatment.
Nature Reviews. Gastroenterology & Hepatology 2015, 12, 437-445.

Gazal S, Sahbatou M, Babron MC, Génin E, Leutenegger AL
High level of inbreeding in final phase of 1000 Genomes Project.
Scientific Reports 2015, 5, 17453.

Nghe P, Hordijk W, Kauffman SA, Walker SI, Schmidt FJ, Kemble H, Yeates JAM, Lehman N
Prebiotic network evolution: six key parameters.
Molecular bioSystems 2015, 11, 3206-3217.

Parmentier B, Berrebi D, Peycelon M, Doit C, Ghoneimi AE, Bonnard A
Failure of First-Line Antibiotics in Nonoperative Management of Appendiceal Mass, toward a Second-Line Instead of Surgery?.
European Journal of Pediatric Surgery: Official Journal of Austrian Association of Pediatric Surgery ... [et Al] = Zeitschrift Fur Kinderchirurgie 2015

Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, Morawiec E, Cottereau A, Devaquet J, Nseir S, Razazi K, Mira JP, Argaud L, Chakarian JC, Ricard JD, Wittebole X, Chevalier S, Herbland A, Fartoukh M, Constantin JM, Tonnelier JM, Pierrot M, Mathonnet A, Béduneau G, Delétage-Métreau C, Richard JCM, Brochard L, Robert R, FSG, RN
High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.
The New England Journal of Medicine 2015, 372, 2185-2196.

Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Préau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Doré V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF, AISG
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
The New England Journal of Medicine 2015, 373, 2237–2246.

TA1SG, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni Td, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
The New England Journal of Medicine 2015, 373, 808–822.

Roux D, Cywes-Bentley C, Zhang YF, Pons S, Konkol M, Kearns DB, Little DJ, Howell PL, Skurnik D, Pier GB
Identification of Poly-N-acetylglucosamine as a Major Polysaccharide Component of the Bacillus subtilis Biofilm Matrix.
The Journal of Biological Chemistry 2015, 290, 19261-19272.

Soulie C, Peytavin G, Charpentier C, Lambert-Niclot S, Sayon S, Visseaux B, Simon A, Katlama C, Yazdanpanah Y, Descamps D, Calvez V, Marcelin AG
Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response.
AIDS research and human retroviruses 2015, 31, 475–478.

Soulie C, Peytavin G, Charpentier C, Lambert-Niclot S, Sayon S, Visseaux B, Simon A, Katlama C, Yazdanpanah Y, Descamps D, Calvez V, Marcelin AG
Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response.
AIDS research and human retroviruses 2015, 31, 475-478.

Verdura E, Hervé D, Scharrer E, Amador MDM, Guyant-Maréchal L, Philippi A, Corlobé A, Bergametti F, Gazal S, Prieto-Morin C, Beaufort N, Le Bail B, Viakhireva I, Dichgans M, Chabriat H, Haffner C, Tournier-Lasserve E
Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease.
Brain: A Journal of Neurology 2015, 138, 2347-2358.

Grabar S, Tattevin P, Selinger-Leneman H, de La Blanchardiere A, de Truchis P, Rabaud C, Rey D, Daneluzzi V, Ferret S, Lascaux AS, Hanslik T, Costagliola D, Launay O, FHDoH(ACC
Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 1269–1277.

HCC, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JAC, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 1262–1268.

Cohen R, Levy C, Bonacorsi S, Wollner A, Koskas M, Jung C, Béchet S, Chalumeau M, Cohen J, Bidet P
Diagnostic accuracy of clinical symptoms and rapid diagnostic test in group a streptococcal perianal infections in children.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 267-270.

Delaugerre C, Ghosn J, Lacombe JM, Pialoux G, Cuzin L, Launay O, Menard A, de Truchis P, Costagliola D, FAC
Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 463–472.

Descamps D, Peytavin G, Visseaux B, Tubiana R, Damond F, Campa P, Charpentier C, Khuong-Josses MA, Duvivier C, Karmochkine M, Lukiana T, Matheron S
Dolutegravir in HIV-2 infected patients with resistant virus to first-line integrase inhibitors from the French Named Patient Program.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015

Carrieri MP, Serfaty L, Vilotitch A, Winnock M, Poizot-Martin I, Loko MA, Lions C, Lascoux-Combe C, Roux P, Salmon-Ceron D, Spire B, Dabis F, ACHSG
Cannabis use and reduced risk of insulin-resistance in HIV-HCV infected patients: a longitudinal analysis (ANRS HEPAVIH CO-13).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015

Tubiana S, Le Moing V, Duval X
Echocardiography in Patients With Enterococcal Bacteremia.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 132.

Sibiude J, Le Chenadec J, Bonnet D, Tubiana R, Faye A, Dollfus C, Mandelbrot L, Delmas S, Lelong N, Khoshnood B, Warszawski J, Blanche S, FNAfRoAaVHFPCIMET
In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Clin. Infect. Dis. 2015, 61, 270–280.

Sibiude J, Le Chenadec J, Bonnet D, Tubiana R, Faye A, Dollfus C, Mandelbrot L, Delmas S, Lelong N, Khoshnood B, Warszawski J, Blanche S, FNAfRoAaVHFPCIMET
In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 270-280.

Abgrall S, Rachas A, Tourret J, Isnard-Bagnis C, Billaud E, Tattevin P, Costagliola D, Guiguet M, Durieux P, FHDoH
A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 375–384.

Abgrall S, Rachas A, Tourret J, Isnard-Bagnis C, Billaud E, Tattevin P, Costagliola D, Guiguet M, Durieux P, FHDoH
A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 375-384.

Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S
High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 593-600.

Basmaci R, Bonacorsi S, Bidet P, Biran V, Aujard Y, Bingen E, Béchet S, Cohen R, Levy C
Escherichia coli Meningitis Features in 325 Children From 2001 to 2013 in France..
Clinical Infectious Diseases 2015, 61, 779.

Charpentier C, Camacho R, Ruelle J, Eberle J, Gürtler L, Pironti A, Stürmer M, Brun-Vézinet F, Kaiser R, Descamps D, Obermeier M
HIV-2EU-Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 1346–1347.

Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, Matheron S, Khuong MA, Garrait V, Reliquet V, Devidas A, Berrebi A, Allisy C, Elleau C, Arvieux C, Rouzioux C, Warszawski J, Blanche S, AESG
No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
Clin. Infect. Dis. 2015, 61, 1715–1725.

Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, Matheron S, Khuong MA, Garrait V, Reliquet V, Devidas A, Berrebi A, Allisy C, Elleau C, Arvieux C, Rouzioux C, Warszawski J, Blanche S, AESG
No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 1715-1725.

Ruppé E, Armand-Lefèvre L, Estellat C, Coignard B, Lucet JC, Andremont A, Matheron S
Reply to Collignon and Kennedy.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 1767.

Frère J, Bidet P, Tapiéro B, Rallu F, Minodier P, Bonacorsi S, Bingen E, Ovetchkine P
Clinical and Microbiological Characteristics of Invasive Group A Streptococcal Infections Before and After Implementation of a Universal Varicella Vaccine Program.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015

Orenstein R, Dubberke E, Hardi R, Ray A, Mullane K, Pardi DS, Ramesh MS, PCI
Safety and Durability of RBX2660 (microbiota suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015

Fofana DB, Charpentier C, Maïga AI, Lambert-Niclot S, Sayon S, Désiré N, Simon A, Yazdanpanah Y, Katlama C, Descamps D, Calvez V, Marcelin AG, Soulié C
Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes.
The Journal of Antimicrobial Chemotherapy 2015, 70, 130-135.

Cambau E, Viveiros M, Machado D, Raskine L, Ritter C, Tortoli E, Matthys V, Hoffner S, Richter E, Perez Del Molino ML, Cirillo DM, van Soolingen D, Böttger EC
Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study.
The Journal of Antimicrobial Chemotherapy 2015, 70, 686-696.

Lê MP, Landman R, Koulla-Shiro S, Charpentier C, Sow PS, Diallo MB, Ngom Gueye NF, Ngolle M, Le Moing V, Eymard-Duvernay S, Benalycherif A, Delaporte E, Girard PM, Peytavin G, DSG
Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1517–1521.

Fourati S, Charpentier C, Amiel C, Morand-Joubert L, Reigadas S, Trabaud MA, Delaugerre C, Nicot F, Rodallec A, Maillard A, Mirand A, Jeulin H, Montès B, Barin F, Bettinger D, Le Guillou-Guillemette H, Vallet S, Signori-Schmuck A, Descamps D, Calvez V, Flandre P, Marcelin AG, AARSG
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1507–1512.

Soubirou JF, Rossi B, Couffignal C, Ruppé E, Chau F, Massias L, Lepeule R, Mentre F, Fantin B
Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1466-1472.

Pajot O, Burdet C, Couffignal C, Massias L, Armand-Lefevre L, Foucrier A, Da Silva D, Lasocki S, Laouénan C, Mentec H, Mentré F, Wolff M
Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1487-1494.

Danion F, Belissa E, Peytavin G, Thierry E, Lanternier F, Scemla A, Lortholary O, Delelis O, Avettand-Fenoel V, Duvivier C
Non-virological response to a dolutegravir-containing regimen in a patient harbouring a E157Q-mutated virus in the integrase region.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1921–1923.

Raymond S, Maillard A, Amiel C, Peytavin G, Trabaud MA, Desbois D, Bellecave P, Delaugerre C, Soulie C, Marcelin AG, Descamps D, Izopet J, obtAARSG
Virological failure of patients on maraviroc-based antiretroviral therapy.
The Journal of Antimicrobial Chemotherapy 2015

Loubet P, Charpentier C, Visseaux B, Borbor A, Nuta C, Adu E, Chapplain JM, Baysah M, Tattevin P, Yazdanpanah Y, Descamps D
Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1881–1884.

Loubet P, Charpentier C, Visseaux B, Borbor A, Nuta C, Adu E, Chapplain JM, Baysah M, Tattevin P, Yazdanpanah Y, Descamps D
Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1881-1884.

Bastard JP, Fellahi S, Couffignal C, Raffi F, Gras G, Hardel L, Sobel A, Leport C, Fardet L, Capeau J, ACACCSG
Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1816-1824.

Charpentier C, Lee GQ, Rodriguez C, Visseaux B, Storto A, Fagard C, Molina JM, Katlama C, Yazdanpanah Y, Harrigan PR, Descamps D
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2090–2096.

Charpentier C, Lee GQ, Rodriguez C, Visseaux B, Storto A, Fagard C, Molina JM, Katlama C, Yazdanpanah Y, Harrigan PR, Descamps D
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2090-2096.

Frange P, Assoumou L, Descamps D, Chéret A, Goujard C, Tran L, Gousset M, Avettand-Fenoël V, Bocket L, Fafi-Kremer S, Guinard J, Morand-Joubert L, Nicot F, Plantier JC, Rogez S, Wirden M, Rouzioux C, Meyer L, Chaix ML, FAC6PCtA1OCTatARSG, FAC6PCtA1OCTatARSG
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2084–2089.

Raffi F, Yazdanpanah Y, Fagnani F, Laurendeau C, Lafuma A, Gourmelen J
Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2121-2128.

Chéret A, Bacchus-Souffan C, Avettand-Fenoël V, Mélard A, Nembot G, Blanc C, Samri A, Sáez-Cirión A, Hocqueloux L, Lascoux-Combe C, Allavena C, Goujard C, Valantin MA, Leplatois A, Meyer L, Rouzioux C, Autran B, OA1SG
Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.
J. Antimicrob. Chemother. 2015, 70, 2108–2120.

Wirden M, Todesco E, Valantin MA, Lambert-Niclot S, Simon A, Calin R, Tubiana R, Peytavin G, Katlama C, Calvez V, Marcelin AG
Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice.
The Journal of Antimicrobial Chemotherapy 2015

Lê MP, Soulié C, Assoumou L, Valantin MA, Duvivier C, Chas J, Ponscarme D, Marcelin AG, Calvez V, Katlama C, Peytavin G, RA1SG
Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2418–2420.

Tabah A, De Waele J, Lipman J, Zahar JR, Cotta MO, Barton G, Timsit JF, Roberts JA, WGfAUitIwtISotESoICM(
The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2671-2677.

Ferrand H, Blanc-Gruyelle AL, Amsilli M, Lemaire X, Papot E, Papy E, Bervar J, Senneville E, Bouvet E, Yazdanpanah Y
Use of fluoroquinolones for the treatment of TB: 8 years of experience.
The Journal of Antimicrobial Chemotherapy 2015, 70, 3166-3167.

Lanternier F, Poiree S, Elie C, Garcia-Hermoso D, Bakouboula P, Sitbon K, Herbrecht R, Wolff M, Ribaud P, Lortholary O, FMSG
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.
The Journal of Antimicrobial Chemotherapy 2015, 70, 3116–3123.

Soulié C, Assoumou L, Darty M, Rodriguez C, Donati F, Sayon S, Peytavin G, Valantin MA, Caby F, Schneider L, Canestri A, Costagliola D, Katlama C, Calvez V, Marcelin AG, RA1SG
Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).
The Journal of Antimicrobial Chemotherapy 2015, 70, 3339–3344.

Rodríguez-Beltrán J, Tourret J, Tenaillon O, López E, Bourdelier E, Costas C, Matic I, Denamur E, Blázquez J
High Recombinant Frequency in Extraintestinal Pathogenic Escherichia coli Strains.
Molecular Biology and Evolution 2015, 32, 1708.

Cazanave C, Reigadas S, Mazubert C, Bellecave P, Hessamfar M, Le Marec F, Lazaro E, Peytavin G, Bruyand M, Fleury H, Dabis F, Neau D
Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012-2014.
Open Forum Infectious Diseases 2015, 2, ofv018.

Belkacem A, Caseris M, Yazdanpanah Y
A Case of Aggregatibacter aphrophilus Multiple Abscess.
Open Forum Infectious Diseases 2015, 2, ofv031.

Guglielminotti J, Li G
Monitoring Obstetric Anesthesia Safety across Hospitals through Multilevel Modeling.
Anesthesiology 2015, 122, 1268-1279.

Guglielminotti J, Grillot N, Paule M, Mentré F, Servin F, Montravers P, Longrois D
Prediction of movement to surgical stimulation by the pupillary dilatation reflex amplitude evoked by a standardized noxious test.
Anesthesiology 2015, 122, 985-993.

Guglielminotti J, Wong CA, Landau R, Li G
Temporal Trends in Anesthesia-related Adverse Events in Cesarean Deliveries, New York State, 2003-2012.
Anesthesiology 2015, 123, 1013-1023.

Miguel-Montanes R, Hajage D, Messika J, Bertrand F, Gaudry S, Rafat C, Labbé V, Dufour N, Jean-Baptiste S, Bedet A, Dreyfuss D, Ricard JD
Use of high-flow nasal cannula oxygen therapy to prevent desaturation during tracheal intubation of intensive care patients with mild-to-moderate hypoxemia.
Critical Care Medicine 2015, 43, 574-583.

Dufour N, Debarbieux L, Fromentin M, Ricard JD
Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages.
Critical Care Medicine 2015, 43, e190-e198.

Margetis D, Roux D, Gaudry S, Messika J, Bouvet O, Branger C, Ponnuswamy P, Oufella HA, Dreyfuss D, Denamur E, Ricard JD
Effects of Proanthocyanidins on Adhesion, Growth, and Virulence of Highly Virulent Extraintestinal Pathogenic Escherichia coli Argue for Its Use to Treat Oropharyngeal Colonization and Prevent Ventilator-Associated Pneumonia.
Critical Care Medicine 2015, 43, e170-e178.

Bouadma L, Sonneville R, Garrouste-Orgeas M, Darmon M, Souweine B, Voiriot G, Kallel H, Schwebel C, Goldgran-Toledano D, Dumenil AS, Argaud L, Ruckly S, Jamali S, Planquette B, Adrie C, Lucet JC, Azoulay E, Timsit JF, OSG
Ventilator-Associated Events: Prevalence, Outcome, and Relationship With Ventilator-Associated Pneumonia.
Critical Care Medicine 2015, 43, 1798-1806.

Kohlhauer M, Lidouren F, Remy-Jouet I, Mongardon N, Adam C, Bruneval P, Hocini H, Levy Y, Blengio F, Carli P, Vivien B, Ricard JD, Micheau P, Walti H, Nadeau M, Robert R, Richard V, Mulder P, Maresca D, Demené C, Pernot M, Tanter M, Ghaleh B, Berdeaux A, Tissier R
Hypothermic Total Liquid Ventilation Is Highly Protective Through Cerebral Hemodynamic Preservation and Sepsis-Like Mitigation After Asphyxial Cardiac Arrest.
Critical Care Medicine 2015

Feeney ER, Chung RT, Yazdanpanah Y
Current guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patients.
Current opinion in HIV and AIDS 2015, 10, 323-329.

Bertrand J, De Iorio M, Balding DJ
Integrating dynamic mixed-effect modelling and penalized regression to explore genetic association with pharmacokinetics.
Pharmacogenetics and Genomics 2015, 25, 231-238.

d'Humières C, Bidet P, Levy C, Béchet S, Bonacorsi S, Bingen E, Cohen R
Comparative Epidemiology of Streptococcus pyogenes emm-Types Causing Invasive and Noninvasive Infections in French Children by Use of High-Resolution Melting-Polymerase Chain Reaction.
The Pediatric Infectious Disease Journal 2015, 34, 557-561.

Tubiana S, Belchior E, Guillot S, Guiso N, Lévy-Bruhl D, RP
Monitoring the Impact of Vaccination on Pertussis in Infants Using an Active Hospital-based Pediatric Surveillance Network: Results from 17 Years' Experience, 1996-2012, France.
The Pediatric Infectious Disease Journal 2015, 34, 814-820.

Levy C, Bonacorsi S, Béchet S, Poyart C, Cohen R
Late-onset Group B Streptococcal Meningitis, Potential Effectiveness of a Vaccine by Maternal Immunization?.
The Pediatric Infectious Disease Journal 2015, 34, 1039.

Maesani M, Doit C, Lorrot M, Vitoux C, Hilly J, Michelet D, Vidal C, Julien-Marsollier F, Ilharreborde B, Mazda K, Bonacorsi S, Dahmani S
Surgical Site Infections in Pediatric Spine Surgery: Comparative Microbiology of Patients with Idiopathic and Non-Idiopathic Etiologies of Spine Deformity.
The Pediatric Infectious Disease Journal 2015

Prat D, Messika J, Avenel A, Jacobs F, Fichet J, Lemeur M, Ricard JD, Sztrymf B
Constipation incidence and impact in medical critical care patients: importance of the definition criterion.
European Journal of Gastroenterology & Hepatology 2015

Bourgeois-Nicolaos N, Jaureguy F, Pozzi-Gaudin S, Masson C, Guillet-Caruba C, Lavisse F, Larmignat P, Benachi A, Picard B, Doucet-Populaire F
Benefits of Rapid Molecular Diagnosis of Chlamydia Trachomatis and Neisseria Gonorrhoeae Infections in Women Attending Family Planning Clinics.
Sexually Transmitted Diseases 2015, 42, 652-653.

Bertine M, Charpentier C, Visseaux B, Storto A, Collin G, Larrouy L, Damond F, Matheron S, Brun-Vézinet F, Descamps D, ACH2C
High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients.
AIDS (London, England) 2015, 29, 779–784.

Alessandri-Gradt E, Morgand M, Delaugerre C, Peytavin G, Sellier P, Simon F, Plantier JC
HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M.
AIDS (London, England) 2015, 29, 1271–1273.

Péré H, Roques P, Talla F, Meillo H, Charpentier C, Bélec L
Sustained virological failure in Cameroonese patient infected by HIV-1 group N evidenced by sequence-based genotyping assay.
AIDS (London, England) 2015, 29, 1267–1269.

Annequin M, Lert F, Spire B, Dray-Spira R, VSG
Has the employment status of people living with HIV changed since the early 2000s?.
AIDS 2015, 29, 1537–1547.

Cuzin L, Pugliese P, Sauné K, Allavena C, Ghosn J, Cottalorda J, Rodallec A, Chaix ML, Fafi-Kremer S, Soulié C, Ouka M, Charpentier C, Bocket L, Mirand A, Guiguet M, Dsg
Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy.
AIDS (London, England) 2015, 29, 1665–1671.

Loubet P, Mabileau G, Baysah M, Nuta C, Taylor M, Jusu H, Weeks H, Ingels A, Perennec-Olivier M, Chapplain JM, Cartier N, Mendiharat P, Raguin G, Tattevin P, Yazdanpanah Y
Likely effect of the 2014 Ebola epidemic on HIV care in Liberia.
AIDS (London, England) 2015, 29, 2347-2351.

Visseaux B, Charpentier C, Ozanne A, Nizard A, Drumard S, Fagard C, Glohi D, Damond F, Brun-Vézinet F, Matheron S, Descamps D, ACH2C
Tropism distribution among antiretroviral-naive HIV-2-infected patients.
AIDS (London, England) 2015, 29, 2209–2212.

Zucman D, Sené T, Hillaire S, Kahn JE, Farfour E, Peytavin G
Antihepatitis C virus treatments for HIV-hepatitis C virus coinfected cirrhotic patients: a need to look beyond the sustained viral response.
AIDS (London, England) 2015, 29, 1903–1904.

Andrade A, Guedj J, Rosenkranz SL, Lu D, Mellors J, Kuritzkes DR, Perelson AS, Ribeiro RM, AApt
Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b).
AIDS (London, England) 2015, 29, 2419-2426.

Chirouze C, Journot V, Le Moing V, Raffi F, Piroth L, Reigadas S, Cassuto JP, Chêne G, Leport C, Hoen B, AC0ACSG
Viremia copy-years as a predictive marker of all-cause mortality in HIV-1-infected patients initiating a protease inhibitor-containing antiretroviral treatment.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 68, 204-208.

Boullé C, Kouanfack C, Laborde-Balen G, Boyer S, Aghokeng AF, Carrieri MP, Kazé S, Dontsop M, Mben JM, Koulla-Shiro S, Peytavin G, Spire B, Delaporte E, Laurent C, SA1SG
Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 69, 355–364.

Harrison L, Melvin A, Fiscus S, Saidi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, McKinney R, Gibb D, Tudor-Williams G, P1(93ST
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 70, 42–53.

Moulignier A, Gueguen A, Lescure FX, Ziegler M, Girard PM, Cardon B, Pialoux G, Molina JM, Brandel JP, Lamirel C
Does HIV Infection Alter Parkinson Disease?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 70, 129-136.

Marcellin F, Demoulin B, Suzan-Monti M, Maradan G, Carrieri MP, Dray-Spira R, Spire B, AVSG
Risk Factors for HCV Reinfection or Transmission in HIV-HCV Coinfected MSM (ANRS-VESPA2 French National Survey).
J. Acquir. Immune Defic. Syndr. 2015, 70, e179–182.

Marcellin F, Demoulin B, Suzan-Monti M, Maradan G, Carrieri MP, Dray-Spira R, Spire B, AVSG
Risk Factors for HCV Reinfection or Transmission in HIV-HCV Coinfected MSM (ANRS-VESPA2 French National Survey).
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 70, e179-182.

Piessen G, Lefèvre JH, Cabau M, Duhamel A, Behal H, Perniceni T, Mabrut JY, Regimbeau JM, Bonvalot S, Tiberio GAM, Mathonnet M, Regenet N, Guillaud A, Glehen O, Mariani P, Denost Q, Maggiori L, Benhaim L, Manceau G, Mutter D, Bail JP, Meunier B, Porcheron J, Mariette C, Brigand C, AatFwg
Laparoscopic Versus Open Surgery for Gastric Gastrointestinal Stromal Tumors: What Is the Impact on Postoperative Outcome and Oncologic Results?.
Annals of Surgery 2015, 262, 831-840.

Couce A, Rodríguez-Rojas A, Blázquez J
Bypass of genetic constraints during mutator evolution to antibiotic resistance.
Proc. R. Soc. B 2015, 282, 20142698.

Clermont O, Gordon D, Denamur E
A guide to the various phylogenetic classification schemes for Escherichia coli and the correspondence among schemes.
Microbiology (Reading, England) 2015

Grall N, Barraud O, Wieder I, Hua A, Perrier M, Babosan A, Gaschet M, Clermont O, Denamur E, Catzeflis F, Decré D, Ploy MC, Andremont A
Lack of dissemination of acquired resistance to β-lactam in small wild mammals around an isolated village in the Amazonian forest.
Environmental Microbiology Reports 2015

Hogan J, Mahjoub F, Larakeb AS, Vu Thien H, Hosany A, Bensman A, Grimprel E, Bingen E, Bonacorsi S, Ulinski T
Escherichia coli virulence patterns may help to predict vesicoureteral reflux in paediatric urinary tract infections.
Acta Paediatrica (Oslo, Norway: 1992) 2015

Nyberg J, Bazzoli C, Ogungbenro K, Aliev A, Leonov S, Duffull S, Hooker AC, Mentré F
Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies.
British Journal of Clinical Pharmacology 2015, 79, 6-17.

Sonneville R, Gault N, de Montmollin E, Klein IF, Mariotte E, Chemam S, Tubach F, Mourvillier B, Timsit JF, Wolff M, Bouadma L
Clinical spectrum and outcomes of patients with encephalitis requiring intensive care.
European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies 2015, 22, 6-16, e1.

Deconinck L, Yazdanpanah Y, Gilson RJ, Melliez H, Viget N, Joly V, Sabin CA
Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study.
HIV medicine 2015, 16, 219–229.

Deconinck L, Yazdanpanah Y, Gilson RJ, Melliez H, Viget N, Joly V, Sabin CA
Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study.
HIV medicine 2015, 16, 219-229.

Winston A, Stöhr W, Antinori A, Arenas-Pinto A, Llibre JM, Amieva H, Cabié A, Williams I, Di Perri G, Tellez MJ, Rockstroh J, Babiker A, Pozniak A, Raffi F, Richert L, N0NdRslS(1SG, N0NdRslSA1SG
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy.
HIV medicine 2015

Lecefel C, Eloy P, Chauvin B, Wyplosz B, Amilien V, Massias L, Taburet AM, Francois H, Furlan V
Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.
Journal of Clinical Pharmacy and Therapeutics 2015, 40, 119-120.

Polivka L, Peytavin G, Franck N, Mouthon L, Dupin N
Testing for levamisole and cocaine in hair samples for the diagnosis of levamisole-related panniculitis.
Journal of the European Academy of Dermatology and Venereology: JEADV 2015, 29, 2487–2489.

Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y
Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.
Journal of Viral Hepatitis 2015, 22, 213-229.

Sellier P, Maylin S, Amarsy R, Mazeron MC, Larrouy L, Haïm-Boukobza S, Lopes A, Moreno MD, Ricbourg A, Simoneau G, Magnier JD, Mercier-Delarue S, Delcey V, Evans J, Cambau E, Barranger E, Simon F, Bergmann JF
Untreated highly viraemic pregnant women from Asia or sub-Saharan Africa often transmit hepatitis B virus despite serovaccination to newborns.
Liver Int. 2015, 35, 409–416.

Sellier P, Maylin S, Amarsy R, Mazeron MC, Larrouy L, Haïm-Boukobza S, Lopes A, Moreno MD, Ricbourg A, Simoneau G, Magnier JD, Mercier-Delarue S, Delcey V, Evans J, Cambau E, Barranger E, Simon F, Bergmann JF
Untreated highly viraemic pregnant women from Asia or sub-Saharan Africa often transmit hepatitis B virus despite serovaccination to newborns.
Liver International: Official Journal of the International Association for the Study of the Liver 2015, 35, 409-416.

Guedj J, Nguyen THT
Can we use viral kinetic models to individualize treatment?.
Liver International: Official Journal of the International Association for the Study of the Liver 2015, 35, 297-298.

Lapalus M, Laouenan C, Cardoso AC, Estrabaud E, Carvalho-Filho RJ, Zhang Q, Lada O, Appourchaux K, Mouri F, Boyer N, Bedossa P, Asselah T, Martinot-Peignoux M, Marcellin P
Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.
Liver International: Official Journal of the International Association for the Study of the Liver 2015, 35, 2082-2089.

Welsch C, Augustin P, Allyn J, Massias L, Montravers P, Allou N
Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation.
Transplant Infectious Disease: An Official Journal of the Transplantation Society 2015, 17, 103-105.

Tebano G, Geneve C, Tanaka S, Grall N, Atchade E, Augustin P, Thabut G, Castier Y, Montravers P, Desmard M
Epidemiology and risk factors of multidrug-resistant bacteria in respiratory samples after lung transplantation.
Transplant Infectious Disease: An Official Journal of the Transplantation Society 2015

Bridier-Nahmias A, Tchalikian-Cosson A, Baller JA, Menouni R, Fayol H, Flores A, Saïb A, Werner M, Voytas DF, Lesage P
Retrotransposons. An RNA polymerase III subunit determines sites of retrotransposon integration.
Science (New York, N.Y.) 2015, 348, 585-588.

Roux D, Danilchanka O, Guillard T, Cattoir V, Aschard H, Fu Y, Angoulvant Y, Messika J, Ricard J, Mekalanos J, Lory S, Pier G, Skurnik D
Fitness cost of antibiotic susceptibility during bacterial infection.
Science Translational Medecine 2015, 22, 297.

Mandelbrot L, Duro D, Belissa E, Peytavin G
Placental Transfer of Rilpivirine in an Ex Vivo Human Cotyledon Perfusion Model.
Antimicrobial Agents and Chemotherapy 2015

Pain JB, Lê MP, Caseris M, Amiel C, Lassel L, Charpentier C, Desnoyer A, Farnoux C, Pialoux G, Descamps D, Peytavin G
Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy.
Antimicrobial Agents and Chemotherapy 2015, 59, 3660–3662.

Renvoisé A, Brossier F, Galati E, Veziris N, Sougakoff W, Aubry A, Robert J, Cambau E, Jarlier V, Bernard C
Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex.
Antimicrobial Agents and Chemotherapy 2015

Petit C, Jullien V, Samson A, Guedj J, Kiechel JR, Zohar S, Comets E
Designing a Pediatric Study for an Antimalarial Drug by Using Information from Adults.
Antimicrobial Agents and Chemotherapy 2015, 60, 1481-1491.

Mandelbrot L, Duro D, Belissa E, Peytavin G
Erratum for Mandelbrot et al., Placental Transfer of Rilpivirine in an Ex Vivo Human Cotyledon Perfusion Model.
Antimicrobial Agents and Chemotherapy 2015, 59, 5869.

Gosalbes MJ, Vázquez-Castellanos JF, Angebault C, Woerther PL, Ruppé E, Ferrús ML, Latorre A, Andremont A, Moya A
Carriage of enterobacteria producing extended spectrum beta-lactamases and composition of the gut microbiota in an Amerindian community.
Antimicrobial Agents and Chemotherapy 2015

Dupont H, Gaillot O, Goetgheluck AS, Plassart C, Emond JP, Lecuru M, Gaillard N, Derdouri S, Lemaire B, Girard de Courtilles M, Cattoir V, Mammeri H
Molecular Characterization of Carbapenem-Non-Susceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.
Antimicrobial Agents and Chemotherapy 2015

Rossi B, Soubirou J, Chau F, Massias L, Dion S, Lepeule R, Fantin B, Lefort A
Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
Antimicrobial Agents and Chemotherapy 2015, 32, 1708.

Bidet P, Basmaci R, Guglielmini J, Doit C, Jost C, Birgy A, Bonacorsi S
Genome Analysis of Kingella kingae Strain KWG1 Reveals How a β-Lactamase Gene Inserted in the Chromosome of This Species.
Antimicrobial Agents and Chemotherapy 2015, 60, 703-708.

Kutala BK, Guedj J, Asselah T, Boyer N, Mouri F, Martinot-Peignoux M, Valla D, Marcellin P, Duval X
Impact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver disease.
Antimicrobial Agents and Chemotherapy 2015, 59, 803-810.

Basmaci R, Bidet P, Jost C, Yagupsky P, Bonacorsi S
Penicillinase-encoding gene blaTEM-1 may be plasmid borne or chromosomally located in Kingella kingae species.
Antimicrobial Agents and Chemotherapy 2015, 59, 1377-1378.

Delannoy S, Mariani-Kurkdjian P, Bonacorsi S, Liguori S, Ison SA, Fach P
Draft Genome Sequences of Human-Pathogenic Escherichia coli O26:H11 Strains Carrying the stx2 Gene Only and Circulating in France.
Genome Announcements 2015

Solis M, Meddeb M, Sueur C, Domingo-Calap P, Soulier E, Chabaud A, Perrin P, Moulin B, Bahram S, Stoll-Keller F, Caillard S, Barth H, Fafi-Kremer S, FBSG
Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement.
Journal of Clinical Microbiology 2015, 53, 3842–3852.

Delannoy S, Mariani-Kurkdjian P, Bonacorsi S, Liguori S, Fach P
Characteristics of emerging human-pathogenic Escherichia coli O26:H11 strains isolated in France between 2010 and 2013 and carrying the stx2d gene only.
Journal of Clinical Microbiology 2015, 53, 486-492.

Berçot B, Amarsy R, Goubard A, Aparicio C, Loeung HU, Segouin C, Gueret D, Jacquier H, Meunier F, Mougari F, Cambau E
Assessment of coinfection of sexually transmitted pathogen microbes by use of the anyplex II STI-7 molecular kit.
Journal of Clinical Microbiology 2015, 53, 991-993.

Deuzing IP, Charpentier C, Wright DW, Matheron S, Paton J, Frentz D, van de Vijver DA, Coveney PV, Descamps D, ACH2C, Boucher CAB, Beerens N
Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses.
J. Virol. 2015, 89, 833–843.

Deuzing IP, Charpentier C, Wright DW, Matheron S, Paton J, Frentz D, van de Vijver DA, Coveney PV, Descamps D, ACH2C, Boucher CAB, Beerens N
Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses.
Journal of Virology 2015, 89, 833-843.

Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F, FCSG
Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation.
mBio 2015, 6, e00311.

Gazal S, Sacre K, Allanore Y, Teruel M, Goodall AH, (Cc, Tohma S, Alfredsson L, Okada Y, Xie G, Constantin A, Balsa A, Kawasaki A, Nicaise P, Amos C, Rodriguez-Rodriguez L, Chiocchia G, Boileau C, Zhang J, Vittecoq O, Barnetche T, Gonzalez Gay MA, Furukawa H, Cantagrel A, Le Loët X, Sumida T, Hurtado-Nedelec M, Richez C, Chollet-Martin S, Schaeverbeke T, Combe B, Khoryati L, Coustet B, El-Benna J, Siminovitch K, Plenge R, Padyukov L, Martin J, Tsuchiya N, Dieudé P
Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene.
Annals of the Rheumatic Diseases 2015, 74, e19.

Aupiais C, Ilharreborde B, Doit C, Blachier A, Desmarest M, Job-Deslandre C, Mazda K, Faye A, Bonacorsi S, Alberti C, Lorrot M
Aetiology of arthritis in hospitalised children: an observational study.
Archives of Disease in Childhood 2015

Deuffic-Burban S, Yazdanpanah Y
Fair prices for new direct-acting antiviral agents (DAAs) to make treatment for all affordable.
Gut 2015, 64, 1190-1191.

Nahon P, Lescat M, Layese R, Bourcier V, Talmat N, Allam S, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Goria O, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Hillaire S, Di Martino V, Trinchet JC, Moreau R, Roudot-Thoraval F, ACCaMG
Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort).
Gut 2015

Zoulim F, Liang TJ, Gerbes AL, Aghemo A, Deuffic-Burban S, Dusheiko G, Fried MW, Pol S, Rockstroh JK, Terrault NA, Wiktor S
Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.
Gut 2015, 64, 1824-1833.

Nguyen V, Cimadevilla C, Estellat C, Codogno I, Huart V, Benessiano J, Duval X, Pibarot P, Clavel MA, Enriquez-Sarano M, Vahanian A, Messika-Zeitoun D
Haemodynamic and anatomic progression of aortic stenosis.
Heart (British Cardiac Society) 2015, 101, 943-947.

Mansiaux Y, Salez N, Lapidus N, Setbon M, Andreoletti L, Leruez-Ville M, Cauchemez S, Gougeon ML, Vely F, Schwarzinger M, Abel L, Delabre RM, Flahault A, de Lamballerie X, Carrat F
Causal analysis of H1N1pdm09 influenza infection risk in a household cohort.
Journal of Epidemiology and Community Health 2015, 69, 272-277.

Borel JC, Pelletier J, Taleux N, Briault A, Arnol N, Pison C, Tamisier R, Timsit JF, Pepin JL
Parameters recorded by software of non-invasive ventilators predict COPD exacerbation: a proof-of-concept study.
Thorax 2015, 70, 284-285.

El Maaroufi H, Goubard A, Redjoul R, Legrand P, Pautas C, Mikdame M, Doghmi K, Toma A, Maury S, Schwarzinger M, Cordonnier C
Risk factors and scoring system for predicting bacterial resistance to cefepime as used empirically in haematology wards.
BioMed Research International 2015, 2015, 945769.

Varna M, Gapihan G, Feugeas JP, Ratajczak P, Tan S, Ferreira I, Leboeuf C, Setterblad N, Duval A, Verine J, Germain S, Mongiat-Artus P, Janin A, Bousquet G
Stem cells increase in numbers in perinecrotic areas in human renal cancer.
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2015, 21, 916-924.

Philippart F, Gaudry S, Quinquis L, Lau N, Ouanes I, Touati S, Nguyen JC, Branger C, Faibis F, Mastouri M, Forceville X, Abroug F, Ricard JD, Grabar S, Misset B, TCSG
Randomized intubation with polyurethane or conical cuffs to prevent pneumonia in ventilated patients.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 637-645.

Souweine B, Lautrette A, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Cointault O, Lepape A, Guelon D, Darmon M, Vesin A, Caillot N, Schwebel C, Boyer A, Azoulay E, Bouadma L, Timsit JF
Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 1024-1032.

Bailly S, Bouadma L, Azoulay E, Orgeas MG, Adrie C, Souweine B, Schwebel C, Maubon D, Hamidfar-Roy R, Darmon M, Wolff M, Cornet M, Timsit JF
Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 1139-1146.

van Mourik MSM, Bouadma L, Bonten MJM
An old world's view on a new world's solution.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 243-245.

Claessens YE, Debray MP, Tubach F, Brun AL, Rammaert B, Hausfater P, Naccache JM, Ray P, Choquet C, Carette MF, Mayaud C, Leport C, Duval X
Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia.
American Journal of Respiratory and Critical Care Medicine 2015, 192, 974-982.

Pahlavan G, Burdet C, Laouénan C, Guiroy F, Bouscarat F, Tosini W, Yazdanpanah Y, Bouvet E
Predictors of return rate for an HIV-positive result in a French Voluntary Counseling and Testing centre.
International journal of STD & AIDS 2015, 26, 33-36.

Dallaudière B, Larbi A, Lefere M, Perozziello A, Hauger O, Pommerie F, Fraboulet B, Jacob D
Musculoskeletal injuries in a resource-constrained environment: comparing diagnostic accuracy of on-the-spot ultrasonography and conventional radiography for bone fracture screening during the Paris-Dakar rally raid.
Acta Radiologica Open 2015, 4, 2058460115577566.

Kannengiesser C, Borie R, Ménard C, Réocreux M, Nitschké P, Gazal S, Mal H, Taillé C, Cadranel J, Nunes H, Valeyre D, Cordier JF, Callebaut I, Boileau C, Cottin V, Grandchamp B, Revy P, Crestani B
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis.
The European Respiratory Journal 2015, 46, 474-485.

Ricard JD, Messika J
Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia.
The European Respiratory Journal 2015, 46, 876-877.

Toffart AC, Pizarro CA, Schwebel C, Sakhri L, Minet C, Duruisseaux M, Azoulay E, Moro-Sibilot D, Timsit JF
Selection criteria for intensive care unit referral of lung cancer patients: a pilot study.
European Respiratory Journal 2015, 45, 491-500.

Ricard JD, Messika J
Low-dose corticosteroids during severe community-acquired pneumonia: end of the story.
The European Respiratory Journal 2015, 45, 305-307.

Chauveau L, Puigdomenech I, Ayinde D, Roesch F, Porrot F, Bruni D, Visseaux B, Descamps D, Schwartz O
HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells.
Retrovirology 2015, 12, 2.

Angoulvant F, Cohen R, Doit C, Elbez A, Werner A, Béchet S, Bonacorsi S, Varon E, Levy C
Trends in antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction.
BMC infectious diseases 2015, 15, 236.

Garinet S, Tourret J, Barete S, Arzouk N, Meyer I, Frances C, Datry A, Mazier D, Barrou B, Fekkar A
Invasive cutaneous Neoscytalidium infections in renal transplant recipients: a series of five cases.
BMC infectious diseases 2015, 15, 535.

Orne-Gliemann J, Larmarange J, Boyer S, Iwuji C, McGrath N, Bärnighausen T, Zuma T, Dray-Spira R, Spire B, Rochat T, Lert F, Imrie J, A1TG
Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal.
BMC public health 2015, 15, 209.

Mohammedi K, Bellili-Muñoz N, Marklund SL, Driss F, Le Nagard H, Patente TA, Fumeron F, Roussel R, Hadjadj S, Marre M, Velho G
Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.
Cardiovascular Diabetology 2015, 14, 845.

Gaillard T, Wurtz N, Houzé S, Sriprawat K, Wangsing C, Hubert V, Lebras J, Nosten F, Briolant S, Pradines B, FNRCfIMSG
Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline.
Malar. J. 2015, 14, 348.

Gaillard T, Wurtz N, Houzé S, Sriprawat K, Wangsing C, Hubert V, Lebras J, Nosten F, Briolant S, Pradines B, FNRCfIMSG
Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline.
Malaria Journal 2015, 14, 348.

Sartelli M, Malangoni MA, Abu-Zidan FM, Griffiths EA, Di Bella S, McFarland LV, Eltringham I, Shelat VG, Velmahos GC, Kelly CP, Khanna S, Abdelsattar ZM, Alrahmani L, Ansaloni L, Augustin G, Bala M, Barbut F, Ben-Ishay O, Bhangu A, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Canterbury LA, Catena F, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cook CH, Cui Y, Czepiel J, Das K, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckert C, Eckmann C, Eiland EH, Enani MA, Faro M, Ferrada P, Forrester JD, Fraga GP, Frossard JL, Galeiras R, Ghnnam W, Gomes CA, Gorrepati V, Ahmed MH, Herzog T, Humphrey F, Kim JI, Isik A, Ivatury R, Lee YY, Juang P, Furuya-Kanamori L, Karamarkovic A, Kim PK, Kluger Y, Ko WC, LaBarbera FD, Lee JG, Leppaniemi A, Lohsiriwat V, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Nord CE, Ordoñez CA, Júnior GAP, Petrosillo N, Portela F, Puri BK, Ray A, Raza M, Rems M, Sakakushev BE, Sganga G, Spigaglia P, Stewart DB, Tattevin P, Timsit JF, To KB, Tranà C, Uhl W, Urbánek L, van Goor H, Vassallo A, Zahar JR, Caproli E, Viale P
WSES guidelines for management of Clostridium difficile infection in surgical patients.
World journal of emergency surgery: WJES 2015, 10, 38.

Montravers P, Dufour G, Guglielminotti J, Desmard M, Muller C, Houissa H, Allou N, Marmuse JP, Augustin P
Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis.
Critical Care (London, England) 2015, 19, 70.

Kutz A, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Schuetz P
Prognostic value of procalcitonin in respiratory tract infections across clinical settings.
Critical Care (London, England) 2015, 19, 74.

Allou N, Allyn J, Snauwaert A, Welsch C, Lucet JC, Kortbaoui R, Desmard M, Augustin P, Montravers P
Postoperative pneumonia following cardiac surgery in non-ventilated patients versus mechanically ventilated patients: is there any difference?.
Critical Care (London, England) 2015, 19, 845.

Minet C, Potton L, Bonadona A, Hamidfar-Roy R, Somohano CA, Lugosi M, Cartier JC, Ferretti G, Schwebel C, Timsit JF
Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis.
Critical Care (London, England) 2015, 19, 287.

Le Bel J, Hausfater P, Chenevier-Gobeaux C, Blanc FX, Benjoar M, Ficko C, Ray P, Choquet C, Duval X, Claessens YE, Esg
Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan.
Critical Care (London, England) 2015, 19, 366.

Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Tubach F, Pons B, Boulet E, Boyer A, Lerolle N, Chevrel G, Carpentier D, Lautrette A, Bretagnol A, Mayaux J, Thirion M, Markowicz P, Thomas G, Dellamonica J, Richecoeur J, Darmon M, de Prost N, Yonis H, Megarbane B, Loubières Y, Blayau C, Maizel J, Zuber B, Nseir S, Bigé N, Hoffmann I, Ricard JD, Dreyfuss D
Comparison of two strategies for initiating renal replacement therapy in the intensive care unit: study protocol for a randomized controlled trial (AKIKI).
Trials 2015, 16, 170.

Rafat C, Flamant M, Gaudry S, Vidal-Petiot E, Ricard JD, Dreyfuss D
Hyponatremia in the intensive care unit: How to avoid a Zugzwang situation?.
Annals of Intensive Care 2015, 5, 39.

Arabi Y, Balkhy H, Hajeer AH, Bouchama A, Hayden FG, Al-Omari A, Al-Hameed FM, Taha Y, Shindo N, Whitehead J, Merson L, AlJohani S, Al-Khairy K, Carson G, Luke TC, Hensley L, Al-Dawood A, Al-Qahtani S, Modjarrad K, Sadat M, Rohde G, Leport C, Fowler R
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol.
SpringerPlus 2015, 4, 709.

Fourreau F, Méchaï F, Brossier J, Bouchaud O, Picard B
Vascular graft infection due to Pasteurella multocida.
SpringerPlus 2015, 4, 824.

El Khoury P, Ghislain M, Villard EF, Le Goff W, Lascoux-Combe C, Yeni P, Meyer L, Vigouroux C, Goujard C, Guerin M
Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART.
Journal of Lipid Research 2015, 56, 692–702.

Tessier A, Bertrand J, Chenel M, Comets E
Comparison of Nonlinear Mixed Effects Models and Noncompartmental Approaches in Detecting Pharmacogenetic Covariates.
The AAPS journal 2015, 17, 597-608.

Desmée S, Mentré F, Veyrat-Follet C, Guedj J
Nonlinear Mixed-effect Models for Prostate-specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: A Comparison by Simulation of Two-stage and Joint Approaches.
The AAPS journal 2015, 17, 691-699.

Guglielminotti J, Dechartres A, Mentré F, Montravers P, Longrois D, Laouénan C
Reporting and Methodology of Multivariable Analyses in Prognostic Observational Studies Published in 4 Anesthesiology Journals: A Methodological Descriptive Review.
Anesthesia and Analgesia 2015, 121, 1011-1029.

Timsit JF, Chemam S, Bailly S
Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients.
F1000prime Reports 2015, 7, 21.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L, Dsg, RFHCC, Isg, Ssg, Esg
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
PLoS medicine 2015, 12,

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TFR, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CAB, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HHM, van de Vijver DAMC, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JPA, Vandamme AM, Shafer RW
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.
PLoS medicine 2015, 12,

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TFR, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CAB, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Kee PN, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HHM, van de Vijver DAMC, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JPA, Vandamme AM, Shafer RW
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.
PLoS medicine 2015, 12, e1001845.

Reibel F, Chauffour A, Brossier F, Jarlier V, Cambau E, Aubry A
New Insights into the Geographic Distribution of Mycobacterium leprae SNP Genotypes Determined for Isolates from Leprosy Cases Diagnosed in Metropolitan France and French Territories.
PLoS neglected tropical diseases 2015, 9, e0004141.

de Monteynard LA, Dray-Spira R, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Gilquin J, Rey D, Simon A, Pavie J, Mahamat A, Matheron S, Costagliola D, Abgrall S, FHDoH
Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France.
PloS One 2015, 10, e0118492.

Pereira L, Choquet C, Perozziello A, Wargon M, Juillien G, Colosi L, Hellmann R, Ranaivoson M, Casalino E
Unscheduled-return-visits after an emergency department (ED) attendance and clinical link between both visits in patients aged 75 years and over: a prospective observational study.
PloS One 2015, 10, e0123803.

Chas J, Hema A, Slama L, Kabore NF, Lescure FX, Fontaine C, Pialoux G, Sawadogo A
The Day-Hospital of the University Hospital, Bobo Dioulasso: An Example of Optimized HIV Management in Southern Burkina Faso.
PloS One 2015, 10, e0125588.

Le Moing V, Alla F, Doco-Lecompte T, Delahaye F, Piroth L, Chirouze C, Tattevin P, Lavigne JP, Erpelding ML, Hoen B, Vandenesch F, Duval X, Vsg
Staphylococcus aureus Bloodstream Infection and Endocarditis--A Prospective Cohort Study.
PloS One 2015, 10, e0127385.

Venot M, Weis L, Clec'h C, Darmon M, Allaouchiche B, Goldgran-Tolédano D, Garrouste-Orgeas M, Adrie C, Timsit JF, Azoulay E
Acute Kidney Injury in Severe Sepsis and Septic Shock in Patients with and without Diabetes Mellitus: A Multicenter Study.
PloS One 2015, 10, e0127411.

Rodriguez C, Soulié C, Marcelin AG, Calvez V, Descamps D, Charpentier C, Flandre P, Recordon-Pinson P, Bellecave P, Pawlotsky JM, Masquelier B, AASG
HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc.
PloS One 2015, 10, e0127816.

Ekouévi DK, Avettand-Fènoël V, Tchounga BK, Coffie PA, Sawadogo A, Minta D, Minga A, Eholie SP, Plantier JC, Damond F, Dabis F, Rouzioux C, IWAc
Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.
PloS One 2015, 10, e0129886.

Maunoury F, Motrunich A, Palka-Santini M, Bernatchez SF, Ruckly S, Timsit JF
Cost-Effectiveness Analysis of a Transparent Antimicrobial Dressing for Managing Central Venous and Arterial Catheters in Intensive Care Units.
PloS One 2015, 10, e0130439.

Béraud G, Kazmercziak S, Beutels P, Levy-Bruhl D, Lenne X, Mielcarek N, Yazdanpanah Y, Boëlle PY, Hens N, Dervaux B
The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases.
PloS One 2015, 10, e0133203.

Charpentier C, Lê MP, Joly V, Visseaux B, Lariven S, Phung B, Yéni P, Yazdanpanah Y, Descamps D, Peytavin G, Landman R
Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up.
PloS One 2015, 10, e0134430.

Visseaux B, Charpentier C, Collin G, Bertine M, Peytavin G, Damond F, Matheron S, Lefebvre E, Brun-Vézinet F, Descamps D, ACH2C
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates.
PloS One 2015, 10, e0134904.

Philippart F, Bouroche G, Timsit JF, Garrouste-Orgeas M, Azoulay E, Darmon M, Adrie C, Allaouchiche B, Ara-Somohano C, Ruckly S, Dumenil AS, Souweine B, Goldgran-Toledano D, Bouadma L, Misset B, Osg
Decreased Risk of Ventilator-Associated Pneumonia in Sepsis Due to Intra-Abdominal Infection.
PloS One 2015, 10, e0137262.

Bennabi M, Delorme R, Oliveira J, Fortier C, Lajnef M, Boukouaci W, Feugeas JP, Marzais F, Gaman A, Charron D, Ghaleh B, Krishnamoorthy R, Leboyer M, Tamouza R
Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders?.
PloS One 2015, 10, e0137339.

Dubert M, Pourbaix A, Alkhoder S, Mabileau G, Lescure FX, Ghodhbane W, Belorgey S, Rioux C, Armand-Lefèvre L, Wolff M, Raffoul R, Nataf P, Yazdanpanah Y, Lucet JC
Sternal Wound Infection after Cardiac Surgery: Management and Outcome.
PloS One 2015, 10, e0139122.

Lefebvre A, Bertrand X, Vanhems P, Lucet JC, Chavanet P, Astruc K, Thouverez M, Quantin C, Aho-Glélé LS
Detection of Temporal Clusters of Healthcare-Associated Infections or Colonizations with Pseudomonas aeruginosa in Two Hospitals: Comparison of SaTScan and WHONET Software Packages.
PloS One 2015, 10, e0139920.

Raben D, Mocroft A, Rayment M, Mitsura VM, Hadziosmanovic V, Sthoeger ZM, Palfreeman A, Morris S, Kutsyna G, Vassilenko A, Minton J, Necsoi C, Estrada VP, Grzeszczuk A, Johansson VS, Begovac J, Ong ELC, Cabié A, Ajana F, Celesia BM, Maltez F, Kitchen M, Comi L, Dragsted UB, Clumeck N, Gatell J, Gazzard B, d'Arminio Monforte A, Rockstroh J, Yazdanpanah Y, Champenois K, Jakobsen ML, Sullivan A, Lundgren JD, HASG
Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.
PloS One 2015, 10, e0140845.

Fung M, Kim J, Marty FM, Schwarzinger M, Koo S
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
PloS One 2015, 10, e0140930.

Bonnal C, Leleu C, Brugière O, Chochillon C, Porcher R, Boelle PY, Menotti J, Houze S, Lucet JC, Derouin F
Relationship between Fungal Colonisation of the Respiratory Tract in Lung Transplant Recipients and Fungal Contamination of the Hospital Environment.
PloS One 2015, 10, e0144044.

Potard V, Reynes J, Ferry T, Aubin C, Finkielsztejn L, Yazdanpanah Y, Costagliola D, FAC
Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice.
PloS One 2015, 10, e0144746.

Leoz M, Feyertag F, Kfutwah A, Mauclère P, Lachenal G, Damond F, De Oliveira F, Lemée V, Simon F, Robertson DL, Plantier JC
The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.
PLoS pathogens 2015, 11, e1005029.

Cohen JF, Cohen R, Levy C, Thollot F, Benani M, Bidet P, Chalumeau M
Selective testing strategies for diagnosing group A streptococcal infection in children with pharyngitis: a systematic review and prospective multicentre external validation study.
CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne 2015, 187, 23-32.

Schuetz P, Balk R, Briel M, Kutz A, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Lacey MJ, Ohsfeldt RL, Scheibling CM, Schneider JE
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.
Clinical Chemistry and Laboratory Medicine 2015, 53, 583-592.

Marcellin F, Demoulin B, Spire B, Suzan-Monti M, Roux P, Protopopescu C, Sagaon-Teyssier L, Duracinsky M, Dray-Spira R, Carrieri MP, AVSG
Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study).
Expert Rev Gastroenterol Hepatol 2015, 9, 701–713.

Bousquet G, El Bouchtaoui M, Leboeuf C, Battistella M, Varna M, Ferreira I, Plassa LF, Hamdan D, Bertheau P, Feugeas JP, Damotte D, Janin A
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma.
Oncotarget 2015, 6, 19279-19289.

Basmaci R, Bonacorsi S, Ilharreborde B, Doit C, Lorrot M, Kahil M, Visseaux B, Houhou N, Bidet P
High respiratory virus oropharyngeal carriage rate during Kingella kingae osteoarticular infections in children.
Future Microbiol 2015, 10, 9–14.

Basmaci R, Bonacorsi S, Ilharreborde B, Doit C, Lorrot M, Kahil M, Visseaux B, Houhou N, Bidet P
High respiratory virus oropharyngeal carriage rate during Kingella kingae osteoarticular infections in children.
Future Microbiology 2015, 10, 9-14.

de Lastours V, Fantin B
Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.
Future Microbiology 2015, 10, 1241-1255.

Guglielmetti L, Mougari F, Lopes A, Raskine L, Cambau E
Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.
Future Microbiology 2015

Andremont A, Fiona Fleck n
What to do about resistant bacteria in the food-chain?.
Bulletin of the World Health Organization 2015, 93, 217-218.

Desgrées-du-Loû A, Pannetier J, Ravalihasy A, Gosselin A, Supervie V, Panjo H, Bajos N, Lert F, Lydié N, Dray-Spira R, PSG
Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013.
Euro Surveill. 2015, 20,

LpwgiCiE, Mocroft A, Lundgren J, Antinori A, Monforte Ad, Brännström J, Bonnet F, Brockmeyer N, Casabona J, Castagna A, Costagliola D, De Wit S, Fätkenheuer G, Furrer H, Jadand C, Johnson A, Lazanas M, Leport C, Moreno S, Mussini C, Obel N, Post F, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Loano I, Torti C, Warszawski J, Wittkop L, Zangerle R, Chene G, Raben D, Kirk O
Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2015, 20,

Maignan M, Richard A, Debaty G, Pommier P, Viglino D, Loizzo F, Timsit JF, Hanna J, Carpentier F, Danel V
Intentional Drug Poisoning Care in a Physician-manned Emergency Medical Service.
Prehospital emergency care: official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 2015, 19, 224-231.

Lopes AA, Champion V, Bonacorsi S, Mitanchez D
Livedo Reticularis: A Presenting Sign of Escherichia Coli Sepsis in a Newborn.
Fetal and Pediatric Pathology 2015, 1-5.

Pommier JD, Ben Lasfar N, Van Grunderbeeck N, Burdet C, Laouénan C, Rioux C, Pierre-Audigier C, Meybeck A, Choudat L, Benchikh A, Nguyen S, Bouvet E, Yeni P, Yazdanpanah Y, Joly V
Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
Infectious Diseases (London, England) 2015, 47, 725-731.

Kernéis S, Valade S, Geri G, Compain F, Lavollay M, Rostane H, Carbonnelle E, Mainardi JL
Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Infectious Diseases (London, England) 2015, 47, 793-799.

Jauréguiberry S, Thellier M, Ndour PA, Ader F, Roussel C, Sonneville R, Mayaux J, Matheron S, Angoulvant A, Wyplosz B, Rapp C, Pistone T, Lebrun-Vignes B, Kendjo E, Danis M, Houzé S, Bricaire F, Mazier D, Buffet P, Caumes E, FAWG
Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011-2013.
Emerging Infectious Diseases 2015, 21, 804–812.

Smati M, Palacios C, Cohen Y, Méchaï F, Tankovic J, Le Flèche-Mateos A, Picard B, Gonzalez F
Carnobacterium divergens Bacteremia in woman.
Emerging Infectious Diseases 2015, 21, 1081-1082.

Couce A, Tenaillon OA
The rule of declining adaptability in microbial evolution experiments.
Frontiers in Genetics 2015, 6, 99.

Canini L, Chatterjee A, Guedj J, Lemenuel-Diot A, Brennan B, Smith PF, Perelson AS
A pharmacokinetic/viral kinetic model to evaluate the treatment effectiveness of danoprevir against chronic HCV.
Antiviral Therapy 2015, 20, 469-477.

Lê MP, Mandelbrot L, Descamps D, Soulié C, Ichou H, Bourgeois-Moine A, Damond F, Lariven S, Valantin MA, Landman R, Faucher P, Tubiana R, Duro D, Meier F, Legac S, Bourse P, Mortier E, Dommergues M, Calvez V, Matheron S, Peytavin G
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women.
Antiviral Therapy 2015, 20, 507–513.

Blanchon T, Geffrier F, Turbelin C, Daviaud I, Laouénan C, Duval X, Lambert B, Hanslik T, Mosnier A, Leport C
Use of neuraminidase inhibitors in primary health care during pandemic and seasonal influenza between 2009 and 2013.
Antiviral Therapy 2015, 20, 753-761.

Protopopescu C, Raffi F, Spire B, Hardel L, Michelet C, Cheneau C, Le Moing V, Leport C, Carrieri MP, ACACSG
Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort.
Antiviral Therapy 2015, 20, 763-772.

Jenabian MA, Talla F, Talla P, Mbopi-Kéou FX, Charpentier C, Kane CT, Bélec L
Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays.
Nigerian Medical Journal: Journal of the Nigeria Medical Association 2015, 56, 420–424.

Messika J, Ben Ahmed K, Gaudry S, Miguel-Montanes R, Rafat C, Sztrymf B, Dreyfuss D, Ricard JD
Use of High-Flow Nasal Cannula Oxygen Therapy in Subjects With ARDS: A 1-Year Observational Study.
Respiratory Care 2015, 60, 162-169.

Dimopoulos G, Koulenti D, Tabah A, Poulakou G, Vesin A, Arvaniti K, Lathyris D, Matthaiou DK, Armaganidis A, Timsit JF
Bloodstream infections in ICU with increased resistance: epidemiology and outcomes.
Minerva Anestesiologica 2015, 81, 405-418.

Pelletier J, Roux D, Viollet B, Mazure NM, Pouysségur J
AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of Ras-transformed fibroblasts.
Oncotarget 2015, 6, 11833-11847.

Loubet P, Lescure FX, Lepage L, Kirsch M, Armand-Lefevre L, Bouadma L, Lariven S, Duval X, Yazdanpanah Y, Joly V
Endocarditis due to gram-negative bacilli at a French teaching hospital over a 6-year period: clinical characteristics and outcome.
Infectious Diseases (London, England) 2015, 47, 889-895.

La Ruche G, Le Strat Y, Fromage M, Berçot B, Goubard A, de Barbeyrac B, Sednaoui P, Cambau E, Lot F
Incidence of gonococcal and chlamydial infections and coverage of two laboratory surveillance networks, France, 2012.
Euro Surveillance: Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2015, 20, 6-15.

Nogueira E, Lager F, Le Roux D, Nogueira P, Freitas J, Charvet C, Renault G, Loureiro A, Almeida CR, Ohradanova-Repic A, Machacek C, Bernardes GJL, Moreira A, Stockinger H, Burnet M, Carmo AM, Gomes AC, Preto A, Bismuth G, Cavaco-Paulo A
Enhancing Methotrexate Tolerance with Folate Tagged Liposomes in Arthritic Mice.
Journal of Biomedical Nanotechnology 2015, 11, 2243-2252.

Freedberg KA, Possas C, Deeks S, Ross AL, Rosettie KL, Di Mascio M, Collins C, Walensky RP, Yazdanpanah Y
The HIV Cure Research Agenda: The Role of Mathematical Modelling and Cost-Effectiveness Analysis.
Journal of Virus Eradication 2015, 1, 245-249.

 2014                                                                            

Ruppe E, Armand-Lefevre L, Estellat C, El-Mniai A, Boussadia Y, Consigny P, Girard P, Vittecoq D, Bouchaud O, Pialoux G, Esposito-Farese M, Coignard B, Lucet J, Andremont A, Matheron S
Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013.
Euro Surveill. 2014, 19,

Tourret J, Bagnis CI, Denamur E
[Urinary tract infections in diabetic patients].
La Revue Du Praticien 2014, 64, 980-983.

van Zanten ARH, Sztark F, Kaisers UX, Zielmann S, Felbinger TW, Sablotzki AR, De Waele JJ, Timsit JF, Honing MLH, Keh D, Vincent JL, Zazzo JF, Fijn HBM, Petit L, Preiser JC, van Horssen PJ, Hofman Z
High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial.
JAMA: the journal of the American Medical Association 2014, 312, 514-524.

Servy A, Valeyrie-Allanore L, Alla F, Lechiche C, Nazeyrollas P, Chidiac C, Hoen B, Chosidow O, Duval X, APlelPdlISG
Prognostic value of skin manifestations of infective endocarditis.
JAMA dermatology 2014, 150, 494-500.

Mahr A, Batteux F, Tubiana S, Goulvestre C, Wolff M, Papo T, Vrtovsnik F, Klein I, Iung B, Duval X, ISG
Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis.
Arthritis & Rheumatology (Hoboken, N.J.) 2014, 66, 1672-1677.

Mourad A, Deuffic-Burban S, Ganne-Carrié N, Renaut-Vantroys T, Rosa I, Bouvier AM, Launoy G, Cattan S, Louvet A, Dharancy S, Trinchet JC, Yazdanpanah Y, Mathurin P
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach.
Hepatology (Baltimore, Md.) 2014, 59, 1471-1481.

Guedj J, Yu J, Levi M, Li B, Kern S, Naoumov NV, Perelson AS
Modeling viral kinetics and treatment outcome during alisporivir interferon-free treatment in hepatitis C virus genotype 2 and 3 patients.
Hepatology (Baltimore, Md.) 2014, 59, 1706-1714.

Boyd A, Gozlan J, Maylin S, Delaugerre C, Peytavin G, Girard PM, Zoulim F, Lacombe K
Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications.
Hepatology (Baltimore, Md.) 2014, 60, 497–507.

Guedj J, Rotman Y, Cotler SJ, Koh C, Schmid P, Albrecht J, Haynes-Williams V, Liang TJ, Hoofnagle JH, Heller T, Dahari H
Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling.
Hepatology (Baltimore, Md.) 2014, 60, 1902-1910.

de Gunzburg J, Ducher A, Modess C, Wegner D, Oswald S, Dressman J, Augustin V, Feger C, Andremont A, Weitschies W, Siegmund W
Targeted adsorption of molecules in the colon with the novel adsorbent-based medicinal product, DAV132: a proof of concept study in healthy subjects.
Journal of Clinical Pharmacology 2014

Burrell RC, Easter JA, Cassidy MP, Gillman KW, Olson RE, Bonacorsi SJ
Synthesis of carbon-14 and stable isotope labeled Avagacestat: a novel gamma secretase inhibitor for the treatment of Alzheimer's disease.
Journal of Labelled Compounds & Radiopharmaceuticals 2014, 57, 600-605.

Cao K, Maxwell BD, Bonacorsi SJ
The synthesis of 14C-labeled N-succinimidyl-3-maleimidopropionate, a linker molecule for PEGylated biologics.
Journal of Labelled Compounds & Radiopharmaceuticals 2014, 57, 667-669.

Mariani-Kurkdjian P, Lemaître C, Bidet P, Perez D, Boggini L, Kwon T, Bonacorsi S
Haemolytic-uraemic syndrome with bacteraemia caused by a new hybrid Escherichia coli pathotype.
New Microbes and New Infections 2014, 2, 127-131.

Achaz G, Rodriguez-Verdugo A, Gaut BS, Tenaillon O
The reproducibility of adaptation in the light of experimental evolution with whole genome sequencing.
Advances in Experimental Medicine and Biology 2014, 781, 211-231.

Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Timsit JF, Azoulay E
Year in review in Intensive Care Medicine 2013: I. Acute kidney injury, ultrasound, hemodynamics, cardiac arrest, transfusion, neurocritical care, and nutrition.
Intensive Care Medicine 2014, 40, 147-159.

Azoulay E, Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Timsit JF
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients.
Intensive care medicine [YEAR IN REVIEW 2013] 2014, 40, 305-319.

Schnell D, Timsit JF, Darmon M, Vesin A, Goldgran-Toledano D, Dumenil AS, Garrouste-Orgeas M, Adrie C, Bouadma L, Planquette B, Cohen Y, Schwebel C, Soufir L, Jamali S, Souweine B, Azoulay E
Noninvasive mechanical ventilation in acute respiratory failure: trends in use and outcomes.
Intensive Care Medicine 2014, 40, 582-591.

Timsit JF, Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Azoulay E
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics.
Intensive care medicine [YEAR IN REVIEW 2013] 2014, 40, 471-483.

Lucet JC, Koulenti D, Zahar JR
Persistence of colonisation with MDRO following discharge from the ICU.
Intensive Care Medicine 2014, 40, 603-605.

de Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R
Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.
Intensive Care Medicine 2014, 40, 998-1005.

Roux D, Ricard JD
Ask the wrong question, you'll the get the wrong answer.
Intensive Care Medicine 2014, 40, 1611-1612.

Timsit JF, Harbarth S, Carlet J
De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU.
Intensive Care Medicine 2014, 40, 1580-1582.

Wolff M, Mourvillier B, Sonneville R, Timsit JF
My paper 10 years later: infective endocarditis in the intensive care unit.
Intensive Care Medicine [MY PAPER 20 YEARS LATER] 2014, 40, 1843-1852.

Debaty G, Maignan M, Savary D, Koch FX, Ruckly S, Durand M, Picard J, Escallier C, Chouquer R, Santre C, Minet C, Guergour D, Hammer L, Bouvaist H, Belle L, Adrie C, Payen JF, Carpentier F, Gueugniaud PY, Danel V, Timsit JF
Impact of intra-arrest therapeutic hypothermia in outcomes of prehospital cardiac arrest: a randomized controlled trial.
Intensive Care Medicine 2014, 40, 1832-1842.

Hurmic O, Grall N, Al Nakib M, Poyart C, Grondin S, Ploy MC, Varon E, Raymond J, TOIdFON
Evidence of a clonal expansion of Streptococcus pneumoniae serotype 19A in adults as in children assessed by the DiversiLab® system.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2014

Thai HT, Mentré F, Holford NHG, Veyrat-Follet C, Comets E
Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics.
Journal of Pharmacokinetics and Pharmacodynamics 2014, 41, 15-33.

Chirouze C, Hoen B, Duval X
Infective endocarditis epidemiology and consequences of prophylaxis guidelines modifications: the dialectical evolution.
Current Infectious Disease Reports 2014, 16, 440.

Benenson JF, Kuhn MN, Ryan PJ, Ferranti AJ, Blondin R, Shea M, Charpentier C, Thompson ME, Wrangham RW
Human males appear more prepared than females to resolve conflicts with same-sex peers.
Human Nature (Hawthorne, N.Y.) 2014, 25, 251–268.

Traore P, Bourgeois-Nicolaos N, Ruimy R, Laurent F, Labrune P, Doucet-Populaire F, Decousser JW
First autochthonous familial cluster of invasive community-acquired leukocidin-positive methicillin-resistant USA300 Staphylococcus aureus in France.
Folia Microbiologica 2014

Carbonnelle E, Josserand V, Riou LM, Ormezzano O, Broisat A, Perret P, Barone-Rochette G, Fagret D, Ghezzi C
Preclinical characterization of a novel radiolabeled analog of practolol for the molecular imaging of myocardial β-adrenoceptor density.
Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 2014, 21, 984-992.

Camara S, Zucman D, Vasse M, Goudjo A, Guillard E, Peytavin G
[Lack of bioavailability of generic lopinavir/ritonavir not prequalified by WHO marketed in Africa (Congo Brazzaville).].
Bulletin De La Societe De Pathologie Exotique (1990) 2014

Caby F, Schneider L, Blanc C, Soulié C, Tindel M, Peytavin G, Agher R, Valantin MA, Tubiana R, Wirden M, Calvez V, Marcelin AG, Katlama C
Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score.
Infection 2014, 42, 295–301.

de Prost N, Bosc R, Brun-Buisson C, Chosidow O, Decousser JW, Dhonneur G, Lepeule R, Rahmouni A, Sbidian E, Amathieu R, GfndlHM
[Necrotizing fasciitis: results of a survey on management practices in French-speaking intensive care units].
Annales Françaises D'anesthèsie Et De Rèanimation 2014, 33, 638-642.

Houdouin V, Pouessel G, Angoulvant F, Brouard J, Derelle J, Fayon M, Ferroni A, Gangneux JP, Hau I, Le Bourgeois M, Lorrot M, Menotti J, Nathan N, Vabret A, Wallet F, Bonacorsi S, Cohen R, de Blic J, Deschildre A, Gandemer V, Pin I, Labbe A, Le Roux P, Martinot A, Rammaert S, Gdrslaepp(, Dubus JC, Delacourt C, Marguet C
[Recommendations for the use of diagnostic testing in low respiratory infection in children older than 3 months].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2014, 21, 418-423.

Lorrot M, Bourrat E, Doit C, Prot-Labarthe S, Dauger S, Faye A, Blondé R, Gillet Y, Grimprel E, Moulin F, Quinet B, Cohen R, Bonacorsi S
[Superficial skin infections and bacterial dermohypodermitis].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2014, 21, 906-912.

Levy C, Varon E, Taha MK, Béchet S, Bonacorsi S, Cohen R, Bingen E
[Change in French bacterial meningitis in children resulting from vaccination].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2014, 21, 736-744.

Basmaci R, Ilharreborde B, Bonacorsi S, Kahil M, Mallet C, Aupiais C, Doit C, Dugué S, Lorrot M
[Septic arthritis in children with normal initial C-reactive protein: clinical and biological features].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2014, 21, 1195-1199.

Lefèvre CT, Bennet M, Landau L, Vach P, Pignol D, Bazylinski DA, Frankel RB, Klumpp S, Faivre D
Diversity of magneto-aerotactic behaviors and oxygen sensing mechanisms in cultured magnetotactic bacteria.
Biophysical Journal 2014, 107, 527-538.

Elsen S, Huber P, Bouillot S, Couté Y, Fournier P, Dubois Y, Timsit JF, Maurin M, Attrée I
A type III secretion negative clinical strain of Pseudomonas aeruginosa employs a two-partner secreted exolysin to induce hemorrhagic pneumonia.
Cell Host & Microbe 2014, 15, 164-176.

Amsallem M, Iung B, Bouleti C, Armand-Lefevre L, Eme AL, Touati A, Kirsch M, Duval X, Vahanian A
First reported human case of native mitral infective endocarditis caused by Streptococcus canis.
The Canadian Journal of Cardiology 2014, 30, 1462.e1-2.

Bauer R, Mentré F, Kaddouri H, Le Bras J, Le Nagard H
Benefits of a new Metropolis-Hasting based algorithm, in non-linear regression for estimation of ex vivo antimalarial sensitivity in patients infected with two strains.
Computers in Biology and Medicine 2014, 55, 16-25.

Rahier J, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, Cottone M, de Ridder L, Doherty G, Ehehalt R, Esteve M, Katsanos K, Lees C, MacMahon E, Moreels T, Reinisch W, Tilg H, Tremblay L, Veereman-Wauters G, Viget N, Yazdanpanah Y, Eliakim R, Colombel J
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
Journal of Crohn's and Colitis 2014, 8, 443-468.

Nguyen TT, Mentre F
Evaluation of the Fisher information matrix in nonlinear mixed effect models using adaptive Gaussian quadrature.
Computational Statistics & Data Analysis 2014, 80, 57-69.

Porres-Osante N, de Champs C, Dupont H, Torres C, Mammeri H
Use of avibactam to detect Ambler class A carbapenemases and OXA-48 β-lactamases in Enterobacteriaceae.
Diagnostic Microbiology and Infectious Disease 2014, 79, 399-400.

Deuffic-Burban S, Mathurin P, Rosa I, Bouvier AM, Cannesson A, Mourad A, Canva V, Louvet A, Deltenre P, Boleslawski E, Truant S, Pruvot FR, Dharancy S
Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approach.
Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2014, 46, 157-163.

Dallaudière B, Dautry R, Preux PM, Perozziello A, Lincot J, Schouman-Claeys E, Serfaty JM
Comparison of apparent diffusion coefficient in spondylarthritis axial active inflammatory lesions and type 1 Modic changes.
European Journal of Radiology 2014, 83, 366-370.

Ezraty B, Henry C, Hérisse M, Denamur E, Barras F
Commercial Lysogeny Broth culture media and oxidative stress: A cautious tale.
Free Radical Biology & Medicine 2014, 74, 245-251.

Mandelbrot L, Berrebi A, Rouzioux C, Partisani M, Faucher P, Tubiana R, Matheron S, Bujan L, Morlat P, commission Prise en charge médicale des personnes vivant avec VIH cDdeg
[Reproductive options for people living with HIV: 2013 guidelines from the French expert working group].
Gynécologie, Obstétrique & Fertilité 2014, 42, 543–550.

Lefort A, Chau F, Lepeule R, Dubée V, Kitzis MD, Dion S, Fantin B
Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum β-lactamase.
International Journal of Antimicrobial Agents 2014, 43, 366-369.

Bonnin RA, Poirel L, van der Reijden TJK, Dijkshoorn L, Lescat M, Nordmann P
Carbapenem resistance in a human clinical isolate identified to be closely related to Acinetobacter indicus.
International Journal of Antimicrobial Agents 2014, 44, 345-350.

Bousquet A, Duprilot M, Moissenet D, Salauze B, Rambaud J, Genel N, Vu-Thien H, Arlet G, Decré D
First case of multidrug-resistant blaNDM-1- and blaOXA-232-carrying Klebsiella pneumoniae and its probable cross-transmission in a French hospital.
International Journal of Antimicrobial Agents 2014, 44, 469-470.

Tattevin P, Revest M, Lefort A, Michelet C, Lortholary O
Fungal endocarditis: current challenges.
International Journal of Antimicrobial Agents 2014, 44, 290-294.

Pierre I, Zarrouk V, Noussair L, Molina JM, Fantin B
Invasive actinomycosis: surrogate marker of a poor prognosis in immunocompromised patients.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2014, 29, 74-79.

Compain F, Poisson A, Le Hello S, Branger C, Weill FX, Arlet G, Decré D
Targeting relaxase genes for classification of the predominant plasmids in Enterobacteriaceae.
International journal of medical microbiology: IJMM 2014, 304, 236-242.

Dahbi G, Mora A, Mamani R, López C, Alonso MP, Marzoa J, Blanco M, Herrera A, Viso S, García-Garrote F, Tchesnokova V, Billig M, de la Cruz F, de Toro M, González-López JJ, Prats G, Chaves F, Martínez-Martínez L, López-Cerezo L, Denamur E, Blanco J
Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131.
International journal of medical microbiology: IJMM 2014, 304, 1247-1257.

Roux AL, Catherinot E, Soismier N, Heym B, Bellis G, Lemonnier L, Chiron R, Fauroux B, Le Bourgeois M, Munck A, Pin I, Sermet I, Gutierrez C, Véziris N, Jarlier V, Cambau E, Herrmann JL, Guillemot D, Gaillard JL, ftOg
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.
Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society 2014

Messika J, Sztrymf B, Bertrand F, Billard-Pomares T, Barnaud G, Branger C, Dreyfuss D, Ricard JD
Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: Younger and more severely affected patients.
Journal of Critical Care 2014, 29, 733-738.

Gaudry S, Ricard JD, Leclaire C, Rafat C, Messika J, Bedet A, Regard L, Hajage D, Dreyfuss D
Acute kidney injury in critical care: Experience of a conservative strategy.
Journal of Critical Care 2014

Leporrier J, Etienne M, Chapuzet C, Peytavin G, Bord S, Borsa-Lebas F, Caron F, Plantier JC, Mourez T
Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2014, 60, 428–430.

Mandelbrot L, Berrébi A, Matheron S, Blanche S, Tubiana R, Rouzioux C, Faucher P, Partisani M, Boyer V, Taeron C, Faye A, Bujan L, Dabis F, Warszawski J, Morlat P
[HIV and pregnancy: 2013 guidelines from the French expert working group].
Journal De Gynécologie, Obstétrique Et Biologie De La Reproduction 2014, 43, 534–548.

Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B, ACHSG
Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Journal of Hepatology 2014, 60, 46–53.

Durand F, Buyse S, Francoz C, Laouénan C, Bruno O, Belghiti J, Moreau R, Vilgrain V, Valla D
Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography.
Journal of Hepatology 2014, 60, 1151-1157.

Deuffic-Burban S, Schwarzinger M, Obach D, Mallet V, Pol S, Pageaux GP, Canva V, Deltenre P, Roudot-Thoraval F, Larrey D, Dhumeaux D, Mathurin P, Yazdanpanah Y
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).
Journal of Hepatology 2014, 61, 7-14.

Elliott T, Timsit JF
epic3: guidelines for preventing infections associated with the use of intravascular access devices.
The Journal of Hospital Infection 2014, 87, 182.

Contou D, d'Ythurbide G, Messika J, Ridel C, Parrot A, Djibré M, Hertig A, Rondeau E, Fartoukh M
Description and predictive factors of infection in patients with chronic kidney disease admitted to the critical care unit.
The Journal of Infection 2014, 68, 105-115.

Krastinova E, Bani-Sadr F, Fromentin D, Goujard C, Hessamfar M, Yazdanpanah Y, Pol S, Cacoub P, Perronne C, Carrat F
Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response.
The Journal of Infection 2014, 68, 462-466.

Pilmis B, Lefort A, Lecuit M, Join-Lambert O, Nassif X, Lortholary O, Charlier C
Endocarditis due to Neisseria mucosa: case report and review of 21 cases: a rare and severe cause of endocarditis.
The Journal of Infection 2014, 68, 601-604.

Lugosi M, Alberti C, Zahar JR, Garrouste M, Lemiale V, Descorps-Desclère A, Ricard JD, Goldgran-Tolédano D, Cohen Y, Schwebel C, Vésin A, Timsit JF, Azoulay E
Aspergillus in the lower respiratory tract of immunocompetent critically ill patients.
The Journal of Infection 2014, 69, 284-292.

Berthe-Aucejo A, Papon A, Doit C, Costa J, Bourdon O
[How to improve supervision of carbapenem's prescriptions? Development of a cross-disciplinary computerized system].
Presse Médicale (Paris, France: 1983) 2014, 43, 219-221.

Jolly D, Ambrosi P, Chaffanjon P, Dreyfuss D, Le Jeunne C, Lorette G, Obert L, Palombi O, Romanet JP
[Results of the 2013 national ranking in France].
Presse Médicale (Paris, France: 1983) 2014, 43, 865-867.

Marc F, Esquirol C, Papy E, Longuet P, Armand-Lefevre L, Rioux C, Diamantis S, Dumortier C, Bourgeois-Nicolaos N, Lucet JC, Wolff M, Arnaud P
A retrospective study of daptomycin use in a Paris teaching-hospital.
Médecine et maladies infectieuses 2014, 44, 25-31.

Neulier C, Birgand G, Ruppé E, Armand-Lefèvre L, Lolom I, Yazdanpanah Y, Lucet JC, Andremont A
Enterobacteriaceae bacteremia: Risk factors for ESBLPE.
Médecine et maladies infectieuses 2014, 44, 32-38.

Alioua MA, Labid A, Amoura K, Bertine M, Gacemi-Kirane D, Dekhil M
Emergence of the European ST80 clone of community-associated methicillin-resistant Staphylococcus aureus as a cause of healthcare-associated infections in Eastern Algeria.
Médecine Et Maladies Infectieuses 2014, 44, 180–183.

Shoai Tehrani M, Hajage D, Fihman V, Tankovic J, Cau S, Day N, Visseaux C, Carbonnelle E, Kouatchet A, Cattoir V, Nhan TX, Corvec S, Jacquier H, Jauréguy F, Le Monnier A, Morand P, Zahar JR, obtGdmc
Gram-negative bacteremia: which empirical antibiotic therapy?.
Médecine Et Maladies Infectieuses 2014, 44, 159-166.

Lepelletier D, Saliou P, Lefebvre A, Lucet JC, Grandbastien B, Bruyère F, Stahl JP, Keita-Perse O, Berthelot P, Aho S, wS
"Preoperative risk management: strategy for Staphylococcus aureus preoperative decolonization" (2013 update). French society of Hospital Hygiene.
Medecine Et Maladies Infectieuses 2014, 44, 261-267.

Lepeule R, Leflon-Guibout V, Vanjak D, Zahar JR, Lafaurie M, Besson C, Lefort A, GdReIddF(
Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use.
Medecine Et Maladies Infectieuses 2014, 44, 530-534.

Clermont O, Christenson JK, Daubié AS, Gordon DM, Denamur E
Development of an allele-specific PCR for Escherichia coli B2 sub-typing, a rapid and easy to perform substitute of multilocus sequence typing.
Journal of Microbiological Methods 2014, 101, 24-27.

Hamy AS, Porcher R, Cuvier C, Giacchetti S, Schlageter MH, Coussieu C, Gronier H, Feugeas JP, Adoui N, Lacorte JM, Poirot C, Mohamed H, Marc E
Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone.
Reproductive Biomedicine Online 2014

Macheras E, Konjek J, Roux AL, Thiberge JM, Bastian S, Leão SC, Palaci M, Sivadon-Tardy V, Gutierrez C, Richter E, Rüsch-Gerdes S, Pfyffer GE, Bodmer T, Jarlier V, Cambau E, Brisse S, Caro V, Rastogi N, Gaillard JL, Heym B
Multilocus sequence typing scheme for the Mycobacterium abscessus complex.
Research in Microbiology 2014, 165, 82-90.

Lemaignen A, Goulenok T, Kalamarides S, Plat A, Pfau G, Fantin B
[Agranulocytosis and vasculitis in a cocaine addict: Levamisole, the hidden culprit].
La Revue De Médecine Interne / Fondée ... Par La Société Nationale Francaise De Médecine Interne 2014, 35, 676-679.

de Lastours V, Fantin B
[Resistance to fluoroquinolones in 2013: what are the consequences in internal medicine?].
La Revue De Médecine Interne / Fondée ... Par La Société Nationale Francaise De Médecine Interne 2014, 35, 601-608.

Fillion A, Koutlidis N, Froissart A, Fantin B
[Investigation and management of genito-urinary tuberculosis.].
La Revue De Medecine Interne / Fondee ... Par La Societe Nationale Francaise De Medecine Interne 2014

Flicoteaux R, Pulcini C, Carrieri P, Schwarzinger M, Leport C, Verger P
Correlates of general practitioners' recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: implications for future vaccination campaigns.
Vaccine 2014, 32, 2281-2287.

Bidet P, Plainvert C, Bonacorsi S
Escherichia coli "O45:K1:H7-B2-ST95" harbor an O-antigen cross reacting with reference antigen O45 that should be designated O45S88.
Veterinary Microbiology 2014, 168, 459.

Clotet B, Feinberg J, van Lunzen J, Khuong-Josses MA, Antinori A, Dumitru I, Pokrovskiy V, Fehr J, Ortiz R, Saag M, Harris J, Brennan C, Fujiwara T, Min S, IST
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.
Lancet 2014, 383, 2222–2231.

Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chêne G, Pozniak A, NSG
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.
Lancet 2014, 384, 1942–1951.

Matheron S, Baize S, Lerat I, Houhou N, Yazdanpanah Y
Ebola: should we consider influenza vaccination?.
The Lancet [Correspondence] 2014, 384, 2023–2024.

Matheron S, Baize S, Lerat I, Houhou N, Yazdanpanah Y
Ebola: should we consider influenza vaccination?.
The Lancet [Correspondence] 2014, 384, 2023-2024.

Mabileau G, Schwarzinger M, Flores J, Patrat C, Matheron S, Yazdanpanah Y
Procréation chez les couples VIH séro-différents : TasP, PrEP ou AMP ? (ANRS 12008).
Médecine Et Maladies Infectieuses 2014, 44,

Hoen B, Dupon M, Girard PM, Yeni P, Pozniak A, Garner W, Nguyen T
Essai de switch de INNTI + FTC/TDF par E/C/F/TDF : maintien de l’efficacité virologique et bon profil de tolérance.
Médecine Et Maladies Infectieuses 2014, 44,

Molina JM, Yeni P, Girard PM, Cotte L, Ebrahimi R, Porter D, Scharen-Guivel V
Étude STaR : maintien à S96 de la non-infériorité entre les trithérapies à comprimé unique (STR) rilpivirine/emtricitabine/ténofovir DF (RPV/FTC/TDF) et éfavirenz/emtricitabine/ténofovir DF (EFV/FTC/TDF) chez des patients VIH-1 naïfs de traitement.
Médecine Et Maladies Infectieuses 2014, 44,

Delory T, Papot E, Rioux C, Auge-Courtois C, Peytavin G, Charpentier C, Matheron S
Association Foscarnet (PFA)/ Dolutegravir (DTG), dans le traitement des infections VIH avancées : une série de 5 cas.
Médecine Et Maladies Infectieuses 2014, 44,

Pichon M, Mikail N, Sarda L, Rioux C, Lerat I, Yazdanpanah Y, Joly V
Intérêt de la tomographie d’émission de positons en maladies infectieuses.
Médecine Et Maladies Infectieuses 2014, 44, 84-85.

Epelboin S, Stora C, Devouche E, Patrat C, Longuet P, Luton D, Matheron S
Résultats de l’assistance médicale à la procréation chez les femmes infectées par le VIH1 : étude cas-contrôle.
Médecine Et Maladies Infectieuses 2014, 44,

Wittkop L, Matheron S
Réponse CD4 à une première trithérapie de l’infection VIH-2 : comparaison à VIH-1.
Médecine Et Maladies Infectieuses 2014, 44,

Bidet P, Bonacorsi S
[Streptococcus pyogenes pathogenic factors].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2014, 21 Suppl 2, S54-61.

Wollner A, Levy C, Benani M, Thollot F, Béchet S, Cohen J, Bonacorsi S, Bidet P, Cohen R
[Use of group A streptococcal rapid diagnostic test in extra-pharyngeal infections].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2014, 21 Suppl 2, S84-86.

Faye A, Lorrot M, Bidet P, Bonacorsi S, Cohen R
[Management of severe invasive group A streptococcal infections].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2014, 21 Suppl 2, S87-92.

Cohen R, Levy C, Cohen J, Corrard F, Deberdt P, Béchet S, Bonacorsi S, Bidet P
[Diagnostic of group A streptococcal blistering distal dactylitis].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2014, 21 Suppl 2, S93-96.

Koskas M, Levy C, Romain O, Schlemmer C, Béchet S, Bonacorsi S, Bidet P, Cohen R
[Group A streptococcal perineal infection in children].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2014, 21 Suppl 2, S97-S100.

Levy C, Bidet P, Bonacorsi S, Béchet S, Cohen R
[Characteristics of group A streptococcal meningitis in children].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2014, 21 Suppl 2, S101-103.

Zahar JR, Lucet JC, Timsit JF
Antimicrobial resistance in intensive care units.
The Lancet. Infectious Diseases 2014, 14, 3-5.

La Ruche G, Sednaoui P, Berçot B, Cambau E, Semaille C
Decreased susceptibility to cephalosporins among gonococci?.
The Lancet. Infectious Diseases 2014, 14, 184-185.

Roubaud Baudron C, Panhard X, Clermont O, Mentré F, Fantin B, Denamur E, Lefort A, CG
Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome.
Epidemiology and Infection 2014, 142, 2672-2683.

Delafont V, Mougaris F, Cambau E, Joyeux M, Bouchon D, Hechard Y, Moulin L
First evidence of amoebae - mycobacteria association in drinking water network.
Environmental Science & Technology 2014

Guerrier G, D'Ortenzio E
Africa: Ebola virus control needs local buy-in.
Nature 2014, 513, 315.

Ribba B, Holford N, Mentré F
The use of model-based tumor-size metrics to predict survival.
Clinical Pharmacology and Therapeutics 2014, 96, 133-135.

Nguyen THT, Mentré F, Levi M, Yu J, Guedj J
A pharmacokinetic-viral kinetic model describes the effect of alisporivir as monotherapy or in combination with peg-IFN on hepatitis C virologic response.
Clinical Pharmacology and Therapeutics 2014, 96, 599-608.

Bruno R, Mentré F, Tannenbaum S, Wang Y, Corrigan B, Mager DE
The ISoP Standards and Best Practices Committee.
Clinical Pharmacology and Therapeutics 2014, 95, 581-582.

Rafat C, Haymann JP, Gaudry S, Labbé V, Miguel-Montanes R, Dufour N, Daudon M, Dreyfuss D, Ricard JD
The case: a crystal-clear diagnosis: acute kidney injury in a patient with suspected meningoencephalitis. Diagnosis: Amoxicillin-induced crystal nephropathy.
Kidney International 2014, 86, 1065-1066.

Combes FP, Retout S, Frey N, Mentré F
Powers of the likelihood ratio test and the correlation test using empirical bayes estimates for various shrinkages in population pharmacokinetics.
CPT: pharmacometrics & systems pharmacology 2014, 3, e109.

Mentré F
Lewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice Versa.
CPT: pharmacometrics & systems pharmacology 2014, 3, e154.

Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, Mira JP, Dequin PF, Gergaud S, Weiss N, Legay F, Le Tulzo Y, Conrad M, Robert R, Gonzalez F, Guitton C, Tamion F, Tonnelier JM, Guezennec P, Van Der Linden T, Vieillard-Baron A, Mariotte E, Pradel G, Lesieur O, Ricard JD, Hervé F, du Cheyron D, Guerin C, Mercat A, Teboul JL, Radermacher P, SI
High versus low blood-pressure target in patients with septic shock.
The New England Journal of Medicine 2014, 370, 1583-1593.

Landman R, Sharma J, Sur M, Desimone R
Effect of distracting faces on visual selective attention in the monkey.
Proceedings of the National Academy of Sciences of the United States of America 2014

Rosenthal E, Piroth L, Cua E, Joulié A, Ravaux I, Chauveau M, Lacombe K, Cotte L, Bonnard P, Weiss L, Longuet M, Pradier C, Cacoub P, GSG
Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study).
AIDS care 2014, 26, 176–185.

Douab T, Marcellin F, Vilotitch A, Protopopescu C, Préau M, Suzan-Monti M, Sagaon-Teyssier L, Lert F, Carrieri MP, Dray-Spira R, Spire B, AVSG
Health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys).
AIDS Care 2014, 26 Suppl 1, S29–40.

Dumont C, Chenel M, Mentré F
Influence of covariance between random effects in design for nonlinear mixed-effect models with an illustration in pediatric pharmacokinetics.
Journal of Biopharmaceutical Statistics 2014, 24, 471-492.

Chow SC, Endrenyi L, Lachenbruch PA, Mentré F
Scientific factors and current issues in biosimilar studies.
Journal of Biopharmaceutical Statistics 2014, 24, 1138-1153.

Birgand G, Schwarzinger M, Perozziello A, Lolom I, Pelat C, Armand-Lefevre L, Buzzi JC, Andremont A, Yazdanpanah Y, Lucet JC
Prolonged hospital stay, an adverse effect of strict national policy for controlling the spread of highly resistant microorganisms.
Infection Control and Hospital Epidemiology 2014, 35, 1427-1429.

Mekontso Dessap A, Jansen C, Boissier F, Razazi K, de Prost N, Michaud G, Cizeau F, Ducellier D, Abid S, Decousser JW, Brun-Buisson C
Risk of cross transmission with point-of-care ultrasound system: effect of a glass-sealed control panel on microbial contamination.
Infection Control and Hospital Epidemiology 2014, 35, 1539-1542.

Loubet P, Charpentier C, Visseaux B, Nuta C, Adu E, Chapplain JM, Baysah M, Walters-Doe S, Tattevin P, Peytavin G, Yazdanpanah Y, Descamps D
Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia.
AIDS research and human retroviruses 2014, 30, 863–866.

Loubet P, Charpentier C, Visseaux B, Nuta C, Adu E, Chapplain JM, Baysah M, Walters-Doe S, Tattevin P, Peytavin G, Yazdanpanah Y, Descamps D
Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia.
AIDS research and human retroviruses 2014, 30, 863-866.

Soares M, Toffart AC, Timsit JF, Burghi G, Irrazábal C, Pattison N, Tobar E, Almeida BFC, Silva UVA, Azevedo LCP, Rabbat A, Lamer C, Parrot A, Souza-Dantas VC, Wallet F, Blot F, Bourdin G, Piras C, Delemazure J, Durand M, Tejera D, Salluh JIF, Azoulay E, LCiCC(SI
Intensive care in patients with lung cancer: a multinational study.
Annals of Oncology: Official Journal of the European Society for Medical Oncology 2014, 25, 1829-1835.

Gazal S, Sahbatou M, Babron MC, Génin E, Leutenegger AL
FSuite: exploiting inbreeding in dense SNP chip and exome data.
Bioinformatics (Oxford, England) 2014, 30, 1940-1941.

Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Touré-Kane C, Truong LXT, Delaporte E, Chaix ML, Peeters M, Ayouba A, A1SG
Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 99–109.

Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, de Olalla PG, Guest J, Samji H, Castagna A, d'Arminio Monforte A, Skaletz-Rorowski A, Ramos J, Lapadula G, Mussini C, Force L, Meyer L, Lampe F, Boufassa F, Bucher HC, De Wit S, Burkholder GA, Teira R, Justice AC, Sterling TR, M Crane H, Gerstoft J, Grarup J, May M, Chêne G, Ingle SM, Sterne J, Obel N, ATCC(CatCoOHERE(iE
Long-term mortality in HIV-positive individuals virally suppressed for \textgreater3 years with incomplete CD4 recovery.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1312–1321.

Obach D, Deuffic-Burban S, Esmat G, Anwar WA, Dewedar S, Canva V, Cousien A, Doss W, Mostafa A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed MK, Yazdanpanah Y
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1064-1071.

Ghosn J, Leruez-Ville M, Blanche J, Delobelle A, Beaudoux C, Mascard L, Lecuyer H, Canestri A, Landman R, Zucman D, Ponscarme D, Rami A, Viard JP, Spire B, Rouzioux C, Costagliola D, Suzan-Monti M, EE4SG
HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1763–1770.

Marcellin F, Roux P, Loko MA, Lions C, Caumont-Prim A, Dabis F, Salmon-Ceron D, Spire B, Carrieri MP, H(CSG
High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 59, 1190–1192.

Taron-Brocard C, Le Chenadec J, Faye A, Dollfus C, Goetghebuer T, Gajdos V, Labaune JM, Perilhou A, Mandelbrot L, Blanche S, Warszawski J, FRNSHHEPFCSG
Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 59, 1332-1345.

Izzedine H, Lescure FX, Bonnet F
HIV medication-based urolithiasis.
Clinical Kidney Journal 2014, 7, 121-126.

Mirabel M, Sonneville R, Hajage D, Novy E, Tubach F, Vignon P, Perez P, Lavoue S, Kouatchet A, Pajot O, Mekontso-Dessap A, Tonnelier JM, Bollaert PE, Frat JP, Navellou JC, Hyvernat H, Hssain AA, Timsit JF, Megarbane B, Wolff M, Trouillet JL, ftESG
Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditis.
European Heart Journal 2014, 35, 1195-1204.

Gelly J, Le Bel J, Aubin-Auger I, Mercier A, Youssef E, Mentre F, Nougairede M, Letrilliart L, Duval X, Esg
Profile of French general practitioners providing opportunistic primary preventive care--an observational cross-sectional multicentre study.
Family Practice 2014, 31, 445-452.

Mary-Krause M, Grabar S, Lièvre L, Abgrall S, Billaud E, Boué F, Boyer L, Cabié A, Cotte L, De Truchis P, Duval X, Duvivier C, Enel P, Gasnault J, Gaud C, Gilquin J, Guiguet M, Katlama C, Khuong-Josses MA, Lacombe JM, Lang S, Lascaux AS, Launay O, Mahamat A, Matheron S, Meynard JL, Pavie J, Pilorgé F, Piroth L, Poizot-Martin I, Potard V, Pradier C, Reynes J, Rouveix E, Selinger-Leneman H, Simon A, Tattevin P, Tissot-Dupont H, Viard JP, Viget N, Costagliola D
Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4).
International Journal of Epidemiology 2014, 43, 1425-1436.

Bertrand J, Verstuyft C, Chou M, Borand L, Chea P, Nay KH, Blanc FX, Mentré F, Taburet AM, C(1CKSG
Dependence of efavirenz- and rifampicin-isoniazid-based antituberculosis treatment drug-drug interaction on CYP2B6 and NAT2 genetic polymorphisms: ANRS 12154 study in Cambodia.
The Journal of Infectious Diseases 2014, 209, 399-408.

Lerat I, Cambau E, Roth Dit Bettoni R, Gaillard JL, Jarlier V, Truffot C, Veziris N
In vivo evaluation of antibiotic activity against Mycobacterium abscessus.
The Journal of Infectious Diseases 2014, 209, 905-912.

Falsey AR, McElhaney JE, Beran J, van Essen GA, Duval X, Esen M, Galtier F, Gervais P, Hwang SJ, Kremsner P, Launay O, Leroux-Roels G, McNeil SA, Nowakowski A, Richardus JH, Ruiz-Palacios G, St Rose S, Devaster JM, Oostvogels L, Durviaux S, Taylor S
Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness.
The Journal of Infectious Diseases 2014, 209, 1873-1881.

Roux D, Ricard JD
Secondary bacterial infection following first viral or fungal hit: could granulocyte-macrophage colony-stimulating factor help?.
The Journal of Infectious Diseases 2014, 210, 1339-1340.

Marcadé G, Micol JB, Jacquier H, Raskine L, Donay JL, Nicolas-Viaud S, Rouveau M, Ribaud P, Dombret H, Leclercq R, Cambau E
Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes.
The Journal of Antimicrobial Chemotherapy 2014, 69, 500-505.

Grohs P, Kernéis S, Sabatier B, Lavollay M, Carbonnelle E, Rostane H, Souty C, Meyer G, Gutmann L, Mainardi JL
Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime.
The Journal of Antimicrobial Chemotherapy 2014, 69, 786-789.

de Lastours V, Bleibtreu A, Chau F, Burdet C, Duval X, Denamur E, Fantin B
Quinolone-resistant Escherichia coli from the faecal microbiota of healthy volunteers after ciprofloxacin exposure are highly adapted to a commensal lifestyle..
Journal of Antimicrobial Chemotherapy 2014, 69, 761.

Lambert-Niclot S, Charpentier C, Storto A, Fofana D, Soulie C, Fourati S, Wirden M, Morand-Joubert L, Masquelier B, Flandre P, Calvez V, Descamps D, Marcelin AG
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy.
The Journal of Antimicrobial Chemotherapy 2014, 69, 1086–1089.

Blanc V, Leflon-Guibout V, Blanco J, Haenni M, Madec JY, Rafignon G, Bruno P, Mora A, Lopez C, Dahbi G, Dunais B, Anastay M, Branger C, Moreau R, Pradier C, Nicolas-Chanoine MH
Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains.
The Journal of Antimicrobial Chemotherapy 2014, 69, 1231-1237.

Katlama C, Assoumou L, Valantin MA, Soulié C, Duvivier C, Chablais L, Kolta S, Pialoux G, Mercié P, Simon A, Costagliola D, Peytavin G, Marcelin AG, RA1SG
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study.
The Journal of Antimicrobial Chemotherapy 2014, 69, 1648–1652.

Porres-Osante N, Dupont H, Torres C, Ammenouche N, de Champs C, Mammeri H
Avibactam activity against extended-spectrum AmpC β-lactamases.
The Journal of Antimicrobial Chemotherapy 2014, 69, 1715-1716.

Charpentier C, Joly V, Ghosn J, Yeni P, Raffi F, Descamps D, Morand-Joubert L
Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimen.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2588–2590.

Burdet C, Lepeule R, Duval X, Caseris M, Rioux C, Lucet JC, Yazdanpanah Y
Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2354-2360.

Robert J, Pantel A, Mérens A, Lavigne JP, Nicolas-Chanoine MH, OCRSG
Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2706-2712.

Charpentier C, Choquet M, Joly V, Yeni P, Visseaux B, Caseris M, Brun-Vézinet F, Yazdanpanah Y, Peytavin G, Descamps D, Landman R
Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2819–2825.

Charpentier C, Choquet M, Joly V, Yeni P, Visseaux B, Caseris M, Brun-Vézinet F, Yazdanpanah Y, Peytavin G, Descamps D, Landman R
Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2819-2825.

de Lastours V, Chau F, Roy C, Larroque B, Fantin B
Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone.
The Journal of Antimicrobial Chemotherapy 2014

Soulie C, Descamps D, Grudé M, Schneider V, Trabaud MA, Morand-Joubert L, Delaugerre C, Montes B, Barin F, Ferre V, Raymond S, Jeulin H, Alloui C, Yerly S, Pallier C, Reigadas S, Signori-Schmuck A, Guigon A, Fafi-Kremer S, Haïm-Boukobza S, Mirand A, Maillard A, Vallet S, Roussel C, Assoumou L, Calvez V, Flandre P, Marcelin AG, obotARAG
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.
The Journal of Antimicrobial Chemotherapy 2014

Chumpitazi BFF, Lebeau B, Faure-Cognet O, Hamidfar-Roy R, Timsit JF, Pavese P, Thiebaut-Bertrand A, Quesada JL, Pelloux H, Pinel C
Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis.
Medical Mycology 2014, 52, 462-471.

Kantor E, Montravers P, Longrois D, Guglielminotti J
Pain assessment in the postanaesthesia care unit using pupillometry: A cross-sectional study after standard anaesthetic care.
European Journal of Anaesthesiology 2014, 31, 91-97.

Dreyfuss D, Eidelman M
Treatment of complex intercondylar humeral fractures in adolescents by open reduction and internal fixation through the transolecranon approach.
Journal of Pediatric Orthopedics. Part B 2014, 23, 364-368.

Roux D, Reignier J, Thiery G, Boyer A, Hayon J, Souweine B, Papazian L, Mercat A, Bernardin G, Combes A, Chiche JD, Diehl JL, du Cheyron D, L'her E, Perrotin D, Schneider F, Thuong M, Wolff M, Zeni F, Dreyfuss D, Ricard JD
Acquiring procedural skills in ICUs: a prospective multicenter study*.
Critical Care Medicine 2014, 42, 886-895.

Allou N, Bronchard R, Guglielminotti J, Dilly MP, Provenchere S, Lucet JC, Laouénan C, Montravers P
Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score*.
Critical Care Medicine 2014, 42, 1150-1156.

Garrouste-Orgeas M, Ben-Rehouma M, Darmon M, Ruckly S, Clec'h C, Adrie C, Tabah A, Vesin A, Schwebel C, Misset B, Timsit JF
ICU physician-based determinants of life-sustaining therapy during nights and weekends: French multicenter study from the Outcomerea Research Group.
Critical Care Medicine 2014, 42, 2393-2400.

Caeymaex L, Varon E, Levy C, Béchet S, Derkx V, Desvignes V, Doit C, Cohen R
Characteristics and outcomes of acute otitis media in children carrying streptococcus pneumoniae or haemophilus influenzae in their nasopharynx as a single otopathogen after introduction of the heptavalent pneumococcal conjugate vaccine.
The Pediatric Infectious Disease Journal 2014, 33, 533-536.

Madhi F, Godot C, Bidet P, Bahuaud M, Epaud R, Cohen R
Serotype 3 pneumococcal pleural empyema in an immunocompetent child after 13-valent pneumococcal conjugate vaccine.
The Pediatric Infectious Disease Journal 2014, 33, 545-546.

Burdet C, Clermont O, Bonacorsi S, Laouénan C, Bingen E, Aujard Y, Mentré F, Lefort A, Denamur E, CG
Escherichia coli bacteremia in children: age and portal of entry are the main predictors of severity.
The Pediatric Infectious Disease Journal 2014, 33, 872-879.

Aupiais C, Faye A, Le Chenadec J, Rouzioux C, Bouallag N, Laurent C, Blanche S, Dollfus C, Warszawski J, AECFPC
Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children.
The Pediatric Infectious Disease Journal 2014, 33, 1237–1245.

Levy C, Varon E, Picard C, Béchet S, Martinot A, Bonacorsi S, Cohen R
Trends of Pneumococcal Meningitis in Children after Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in France.
The Pediatric Infectious Disease Journal 2014

Grivea IN, Michoula AN, Basmaci R, Dailiana ZH, Tsimitselis G, Bonacorsi S, Syrogiannopoulos GA
Kingella kingae Sequence Type-complex 14 Arthritis in a 16-month Child in Greece.
The Pediatric Infectious Disease Journal 2014

Mallet C, Ceroni D, Litzelmann E, Dubois-Ferriere V, Lorrot M, Bonacorsi S, Mazda K, Ilharreborde B
Unusually severe cases of Kingella kingae osteoarticular infections in children.
The Pediatric Infectious Disease Journal 2014, 33, 1-4.

Zucman D, Camara S, Gravisse J, Dimi S, Vasse M, Goudjo A, Choquet M, Peytavin G
Generic antiretroviral drugs in developing countries: friends or foes?.
AIDS (London, England) 2014, 28, 607–609.

NHPWGftCoOHERE(iE
Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals.
AIDS (London, England) 2014, 28, 1351–1356.

Charpentier C, Eholié S, Anglaret X, Bertine M, Rouzioux C, Avettand-Fenoël V, Messou E, Minga A, Damond F, Plantier JC, Dabis F, Peytavin G, Brun-Vézinet F, Ekouevi DK, IWAC
Genotypic resistance profiles of HIV-2-treated patients in West Africa.
AIDS (London, England) 2014, 28, 1161–1169.

Yazdanpanah Y, Champenois K
Assessing characteristics of hidden epidemics to design the most efficient HIV testing strategies.
AIDS (London, England) 2014, 28, 1831-1833.

Visseaux B, Charpentier C, Rouard C, Fagard C, Glohi D, Tubiana R, Damond F, Brun-Vézinet F, Matheron S, Descamps D, FH2ACC
HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients.
AIDS (London, England) 2014, 28, 2160–2162.

Nguyen LBL, Harent S, Peytavin G, Visseaux B, Bastard JP, Dubourg O, Lariven S, Yeni P, Yazdanpanah Y, Lescure FX
Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report.
Aids 2014, 28, 1995–1997.

Nguyen LBL, Harent S, Peytavin G, Visseaux B, Bastard JP, Dubourg O, Lariven S, Yeni P, Yazdanpanah Y, Lescure FX
Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report.
Aids 2014, 28, 1995-1997.

Carrieri MP, Protopopescu C, Raffi F, March L, Reboud P, Spire B, Leport C, ACACSG
Low alcohol consumption as a predictor of higher CD4+ cell count in HIV-treated patients: a french paradox or a proxy of healthy behaviors? The ANRS APROCO-COPILOTE CO-08 cohort.
Journal of Acquired Immune Deficiency Syndromes (1999) 2014, 65, e148-150.

Ouattara EN, Ross EL, Yazdanpanah Y, Wong AY, Robine M, Losina E, Moh R, Walensky RP, Danel C, Paltiel AD, Eholié SP, Freedberg KA, Anglaret X
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.
Journal of Acquired Immune Deficiency Syndromes (1999) 2014, 66, 294-302.

Darmon M, Pichon M, Schwebel C, Ruckly S, Adrie C, Haouache H, Azoulay E, Bouadma L, Clec'h C, Garrouste-Orgeas M, Souweine B, Goldgran-Toledano D, Khallel H, Argaud L, Dumenil AS, Jamali S, Allaouchiche B, Zeni F, Timsit JF
Influence of early dysnatremia correction on survival of critically ill patients.
Shock (Augusta, Ga.) 2014, 41, 394-399.

Jlili NEH, Réjiba S, Smaoui H, Guillard T, Chau F, Kechrid A, Cambau E
Trend of plasmid-mediated quinolone resistance genes at the Children's Hospital in Tunisia.
Journal of Medical Microbiology 2014, 63, 195-202.

Barbut F, Surgers L, Eckert C, Visseaux B, Cuingnet M, Mesquita C, Pradier N, Thiriez A, Ait-Ammar N, Aifaoui A, Grandsire E, Lalande V
Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, 136–144.

Caseris M, Houhou N, Longuet P, Rioux C, Lepeule R, Choquet C, Yazdanpanah Y, Yeni P, Joly V
French 2010-2011 measles outbreak in adults: report from a Parisian teaching hospital.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O242–244.

Caseris M, Houhou N, Longuet P, Rioux C, Lepeule R, Choquet C, Yazdanpanah Y, Yeni P, Joly V
French 2010-2011 measles outbreak in adults: report from a Parisian teaching hospital.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O242-244.

Vironneau P, Kania R, Morizot G, Elie C, Garcia-Hermoso D, Herman P, Lortholary O, Lanternier F, FMSG
Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O336–339.

Cambau E, Drancourt M
Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 1882.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, 196-201.

Valour F, Tasse J, Trouillet-Assant S, Rasigade JP, Lamy B, Chanard E, Verhoeven P, Decousser JW, Marchandin H, Bès M, Chidiac C, Vandenesch F, Ferry T, Laurent F, LBaJIsg
Methicillin-susceptible Staphylococcus aureus clonal complex 398: high prevalence and geographical heterogeneity in bone and joint infection and nasal carriage.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O772-775.

Birgand G, Armand-Lefevre L, Lepainteur M, Lolom I, Neulier C, Reibel F, Yazdanpanah Y, Andremont A, Lucet JC
Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases [RESEARCH NOTE] 2014, 20, O887-890.

Basmaci R, Bonacorsi S, Bidet P, Balashova NV, Lau J, Muñoz-Almagro C, Gene A, Yagupsky P
Genotyping, local prevalence and international dissemination of β-lactamase-producing Kingella kingae strains.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014

Grohs P, Podglajen I, Guerot E, Bellenfant F, Caumont-Prim A, Kac G, Tillecovidin B, Carbonnelle E, Chatellier G, Meyer G, Fagon JY, Gutmann L
Assessment of five screening strategies for optimal detection of carriers of third-generation cephalosporin-resistant Enterobacteriaceae in intensive care units using daily sampling.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O879-886.

Gagneux-Brunon A, Timsit JF, Lepape A, Berthelot P
Vascular catheter-related infection claims to health insurance company: often preventable.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O1084-1087.

Saussereau E, Vachier I, Chiron R, Godbert B, Sermet I, Dufour N, Pirnay JP, De Vos D, Carrié F, Molinari N, Debarbieux L
Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014

Surgers L, Bleibtreu A, Burdet C, Clermont O, Laouénan C, Lefort A, Mentré F, Carbonne B, Bingen E, Meynard JL, Denamur E, CG
Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O1035-1041.

Couffignal C, Pajot O, Laouénan C, Burdet C, Foucrier A, Wolff M, Armand-Lefevre L, Mentré F, Massias L
Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimens.
British Journal of Clinical Pharmacology 2014, 78, 1022-1034.

Almudimeegh A, Rioux C, Ferrand H, Crickx B, Yazdanpanah Y, Descamps V
Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV?.
The British Journal of Dermatology [CASE REPORT] 2014, 171, 895-898.

van Essen GA, Beran J, Devaster JM, Durand C, Duval X, Esen M, Falsey AR, Feldman G, Gervais P, Innis BL, Kovac M, Launay O, Leroux-Roels G, McElhaney JE, McNeil S, Oujaa M, Richardus JH, Ruiz-Palacios G, Osborne RH, Oostvogels L
Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines.
Influenza and Other Respiratory Viruses 2014, 8, 452-462.

Zhang Q, Lapalus M, Asselah T, Laouénan C, Moucari R, Martinot-Peignoux M, Bieche I, Estrabaud E, De Muynck S, Boyer N, Bedossa P, Vidaud M, Marcellin P, Lada O
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients.
Journal of Viral Hepatitis 2014, 21, 525-532.

Borel JC, Pepin JL, Pison C, Vesin A, Gonzalez-Bermejo J, Court-Fortune I, Timsit JF
Long-term adherence with non-invasive ventilation improves prognosis in obese COPD patients.
Respirology (Carlton, Vic.) 2014, 19, 857-865.

Plucain J, Hindré T, Le Gac M, Tenaillon O, Cruveiller S, Médigue C, Leiby N, Harcombe WR, Marx CJ, Lenski RE, Schneider D
Epistasis and allele specificity in the emergence of a stable polymorphism in Escherichia coli.
Science (New York, N.Y.) 2014, 343, 1366-1369.

Sherman KE, Guedj J, Shata MT, Blackard JT, Rouster SD, Castro M, Feinberg J, Sterling RK, Goodman Z, Aronow BJ, Perelson AS
Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients.
Science Translational Medicine 2014, 6, 246ra98.

Périchon B, Goussard S, Walewski V, Krizova L, Cerqueira G, Murphy C, Feldgarden M, Wortman J, Clermont D, Nemec A, Courvalin P
Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp.
Antimicrobial Agents and Chemotherapy 2014, 58, 936-949.

Bourgeois-Nicolaos N, Nguyen TT, Defrance G, Massias L, Alavoine L, Lefort A, Noel V, Senneville E, Doucet-Populaire F, Mentré F, Andremont A, Duval X
The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristics.
Antimicrobial Agents and Chemotherapy 2014, 58, 2681-2687.

Cottrell G, Musset L, Hubert V, Le Bras J, Clain J, APTFSG
Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports.
Antimicrobial Agents and Chemotherapy 2014, 58, 4504–4514.

Laouénan C, Marcellin P, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Peytavin G, Mentré F, Guedj J
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
Antimicrobial Agents and Chemotherapy 2014, 58, 5332-5341.

Réminiac F, Sonneville R, Massias L, Chochillon C, Wolff M
Very-high-dose caspofungin combined with voriconazole to treat central nervous system aspergillosis: substantial penetration of caspofungin into cerebrospinal fluid.
Antimicrobial Agents and Chemotherapy 2014, 58, 3568-3569.

Billard-Pomares T, Fouteau S, Jacquet ME, Roche D, Barbe V, Castellanos M, Bouet JY, Cruveiller S, Médigue C, Blanco J, Clermont O, Denamur E, Branger C
Characterization of a P1-like bacteriophage encoding an SHV-2 extended-spectrum β-lactamase from an Escherichia coli strain.
Antimicrobial Agents and Chemotherapy 2014

Mandelbrot L, Duro D, Belissa E, Peytavin G
Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.
Antimicrobial Agents and Chemotherapy 2014, 58, 5617–5620.

Ammenouche N, Dupont H, Mammeri H
Characterization of a Novel AmpC β-Lactamase Produced by a Carbapenem-Resistant Cedecea davisae Clinical Isolate.
Antimicrobial Agents and Chemotherapy 2014

Jure MA, Duprilot M, Musa HE, López C, de Castillo MC, Weill FX, Arlet G, Decré D
Emergence of KPC-2-Producing Salmonella enterica Serotype Schwarzengrund in Argentina.
Antimicrobial Agents and Chemotherapy 2014, 58, 6335-6336.

Grégoire N, Mimoz O, Mégarbane B, Comets E, Chatelier D, Lasocki S, Gauzit R, Balayn D, Gobin P, Marchand S, Couet W
New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale.
Antimicrobial Agents and Chemotherapy 2014, 58, 7324-7330.

Basmaci R, Bidet P, Berçot B, Jost C, Kwon T, Gaumetou E, Bonacorsi S
First Identification of a Chromosomally Located Penicillinase Gene in Kingella kingae Species Isolated in Continental Europe.
Antimicrobial Agents and Chemotherapy 2014, 58, 6258-6259.

Durviaux S, Treanor J, Beran J, Duval X, Esen M, Feldman G, Frey SE, Launay O, Leroux-Roels G, McElhaney JE, Nowakowski A, Ruiz-Palacios GM, van Essen GA, Oostvogels L, Devaster JM, Walravens K
Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial.
Clinical and vaccine immunology: CVI 2014, 21, 271-279.

Lemaître C, Bidet P, Benoist JF, Schlemmer D, Sobral E, d'Humières C, Bonacorsi S
The ssbL gene harbored by the ColV plasmid of an Escherichia coli neonatal meningitis strain is an auxiliary virulence factor boosting the production of siderophores through the shikimate pathway.
Journal of Bacteriology 2014, 196, 1343-1349.

Bleibtreu A, Clermont O, Darlu P, Glodt J, Branger C, Picard B, Denamur E
The rpoS gene is predominantly inactivated during laboratory storage and undergoes source-sink evolution in the Escherichia coli species.
Journal of Bacteriology 2014

Avettand-Fenoel V, Damond F, Gueudin M, Matheron S, Mélard A, Collin G, Descamps D, Chaix ML, Rouzioux C, Plantier JC, ACH2atAAQWG
New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load.
Journal of Clinical Microbiology 2014, 52, 3017–3022.

Fangous MS, Mougari F, Gouriou S, Calvez E, Raskine L, Cambau E, Payan C, Héry-Arnaud G
Classification Algorithm for Subspecies Identification within the Mycobacterium abscessus Species, Based on Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
Journal of Clinical Microbiology 2014, 52, 3362-3369.

Rouet F, Kania D, Tuaillon E, Maiga A, Nouhin J, Rouzioux C, Descamps D, Plantier JC
Use of reverse transcription-PCR-based assays for quantification of HIV-1 in dried blood spots requires specific HIV-1 RNA isolation for monitoring of antiretroviral treatment efficiency.
Journal of Clinical Microbiology 2014, 52, 2740–2741.

Amara M, Bonacorsi S, Bedel J, Mira JP, Laurent V, Socha K, Bruneel F, Pangon B, Bédos JP, Grimaldi D
Group A Escherichia coli-related purpura fulminans: an unusual manifestation due to an unusual strain?.
Journal of Clinical Microbiology 2014

Basmaci R, Bidet P, Yagupsky P, Muñoz-Almagro C, Balashova NV, Doit C, Bonacorsi S
Major Intercontinentally Distributed Sequence Types of Kingella kingae and Development of a Rapid Molecular Typing Tool.
Journal of Clinical Microbiology 2014

Jost C, Bercot B, Jacquier H, Raskine L, Barranger E, Mouchnino G, Cambau E
Xpert GBS assay for rapid detection of group B streptococcus in gastric fluid samples from newborns.
Journal of Clinical Microbiology 2014, 52, 657-659.

Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Touré-Kane C, Truong LXT, Chaix ML, Delaporte E, Ayouba A, Peeters M, A1SG
Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.
Journal of Clinical Microbiology 2014, 52, 578–586.

Johnson JR, Clermont O, Johnston B, Clabots C, Tchesnokova V, Sokurenko E, Junka AF, Maczynska B, Denamur E
Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131.
Journal of Clinical Microbiology 2014, 52, 1358-1365.

Mougari F, Raskine L, Ferroni A, Marcon E, Sermet-Gaudelus I, Veziris N, Heym B, Gaillard JL, Nassif X, Cambau E
Clonal relationship and differentiation among Mycobacterium abscessus isolates as determined using the semiautomated repetitive extragenic palindromic sequence PCR-based DiversiLab system.
Journal of Clinical Microbiology 2014, 52, 1969-1977.

Lu X, Skurnik D, Pozzi C, Roux D, Cywes-Bentley C, Ritchie JM, Munera D, Gening ML, Tsvetkov YE, Nifantiev NE, Waldor MK, Pier GB
A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.
mBio 2014, 5, e00974-00914.

Raeside C, Gaffé J, Deatherage DE, Tenaillon O, Briska AM, Ptashkin RN, Cruveiller S, Médigue C, Lenski RE, Barrick JE, Schneider D
Large chromosomal rearrangements during a long-term evolution experiment with Escherichia coli.
mBio 2014, 5, e01377-01314.

Juge PA, van Steenbergen HW, Constantin A, Tobon GJ, Schaeverbeke T, Gazal S, Combe B, Devauchelle-Pensec V, Nigon D, van der Helm-van Mil AHM, Dieude P
SPP1 rs9138 variant contributes to the severity of radiological damage in anti-citrullinated protein autoantibody-negative rheumatoid arthritis.
Annals of the Rheumatic Diseases 2014, 73, 1840-1843.

Moulignier A, Lescure FX, Savatovsky J, Campa P
CD8 transverse myelitis in a patient with HIV-1 infection.
BMJ case reports 2014, 2014,

Bremond-Gignac D, Nezzar H, Bianchi PE, Messaoud R, Lazreg S, Voinea L, Speeg-Schatz C, Hartani D, Kaercher T, Kocyla-Karczmarewicz B, Murta J, Delval L, Renault D, Chiambaretta F, ASG
Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis.
The British Journal of Ophthalmology 2014, 98, 739-745.

Birgand G, Azevedo C, Toupet G, Pissard-Gibollet R, Grandbastien B, Fleury E, Lucet JC
Attitudes, risk of infection and behaviours in the operating room (the ARIBO Project): a prospective, cross-sectional study.
BMJ open 2014, 4, e004274.

Rotman Y, Noureddin M, Feld JJ, Guedj J, Witthaus M, Han H, Park YJ, Park SH, Heller T, Ghany MG, Doo E, Koh C, Abdalla A, Gara N, Sarkar S, Thomas E, Ahlenstiel G, Edlich B, Titerence R, Hogdal L, Rehermann B, Dahari H, Perelson AS, Hoofnagle JH, Liang TJ
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C.
Gut 2014, 63, 161-169.

Curlier E, Hoen B, Alla F, Selton-Suty C, Schubel L, Doco-Lecompte T, Minary L, Erpelding ML, Duval X, Chirouze C, APlelPdlI(PF
Relationships between sex, early valve surgery and mortality in patients with left-sided infective endocarditis analysed in a population-based cohort study.
Heart (British Cardiac Society) 2014, 100, 1173-1178.

Iung B, Laouénan C, Himbert D, Eltchaninoff H, Chevreul K, Donzeau-Gouge P, Fajadet J, Leprince P, Leguerrier A, Lièvre M, Prat A, Teiger E, Laskar M, Vahanian A, Gilard M, F2I
Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score.
Heart (British Cardiac Society) 2014, 100, 1016-1023.

Battistella M, Cribier B, Feugeas JP, Roux J, Le Pelletier F, Pinquier L, Plantier F, CHSotFSoD
Vascular invasion and other invasive features in granular cell tumours of the skin: a multicentre study of 119 cases.
Journal of Clinical Pathology 2014, 67, 19-25.

Strullu M, Caye A, Lachenaud J, Cassinat B, Gazal S, Fenneteau O, Pouvreau N, Pereira S, Baumann C, Contet A, Sirvent N, Méchinaud F, Guellec I, Adjaoud D, Paillard C, Alberti C, Zenker M, Chomienne C, Bertrand Y, Baruchel A, Verloes A, Cavé H
Juvenile myelomonocytic leukaemia and Noonan syndrome.
Journal of Medical Genetics 2014, 51, 689-697.

Pépin JL, Timsit JF, Tamisier R, Lévy P
Is CPAP effective in reducing blood pressure in minimally symptomatic obstructive sleep apnoea?.
Thorax [Editorial] 2014, 69, 1068-1070.

Borel JC, Pison C, Timsit JF, Pepin JL
Domiciliary long-term non-invasive ventilation in COPD: should we select subgroups with a better likelihood to respond to NIV in subsequent randomised controlled trials?.
Thorax 2014, 69, 1143.

Hu HH, Benfodda M, Dumaz N, Gazal S, Descamps V, Bourillon A, Basset-Seguin N, Riffault A, Ezzedine K, Bagot M, Bensussan A, Saiag P, Grandchamp B, Soufir N
A large French case-control study emphasizes the role of rare Mc1R variants in melanoma risk.
BioMed Research International 2014, 2014, 925716.

Gazal S, Sahbatou M, Perdry H, Letort S, Génin E, Leutenegger AL
Inbreeding coefficient estimation with dense SNP data: comparison of strategies and application to HapMap III.
Human Heredity 2014, 77, 49-62.

Fassa AA, Mazighi M, Himbert D, Deschamps L, Ducrocq G, Cheong AP, Depoix JP, Dilly MP, Alkhoder S, Mourvillier B, Vahanian A
Successful endovascular stroke rescue with retrieval of an embolized calcium fragment after transcatheter aortic valve replacement.
Circulation. Cardiovascular Interventions 2014, 7, 125-126.

Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD, INSIGHT SMART ESG, SSC
Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Journal of the American Heart Association 2014

Amarenco P, Davis S, Jones EF, Cohen AA, Heiss WD, Kaste M, Laouénan C, Young D, Macleod M, Donnan GA, AARCHTI
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.
Stroke; a Journal of Cerebral Circulation 2014, 45, 1248-1257.

Puntillo KA, Max A, Timsit JF, Vignoud L, Chanques G, Robleda G, Roche-Campo F, Mancebo J, Divatia JV, Soares M, Ionescu DC, Grintescu I, Vasiliu IL, Maggiore SM, Rusinova K, Owczuk R, Egerod I, Papathanassoglou EDE, Kyranou M, Joynt GM, Burghi G, Freebairn RC, Ho KM, Kaarlola A, Gerritsen RT, Kesecioglu J, Sulaj MMS, Norrenberg M, Benoit DD, Seha MSG, Hennein A, Periera FJ, Benbenishty JS, Abroug F, Aquilina A, Monte JRC, An Y, Azoulay E
Determinants of Procedural Pain Intensity in the Intensive Care Unit The Europain (R) Study.
American Journal of Respiratory and Critical Care Medicine 2014, 189, 39-47.

Bonduelle O, Carrat F, Luyt CE, Leport C, Mosnier A, Benhabiles N, Krivine A, Rozenberg F, Yahia N, Samri A, Rousset D, van der Werf S, Autran B, Combadiere B
Characterization of pandemic influenza immune memory signature after vaccination or infection.
The Journal of Clinical Investigation 2014, 124, 3129-3136.

Koskas P, Henry-Feugeas MC, Feugeas JP, Poissonnet A, Pons-Peyneau C, Wolmark Y, Drunat O
The Lawton Instrumental Activities Daily Living/Activities Daily Living Scales A Sensitive Test to Alzheimer Disease in Community-Dwelling Elderly People?.
Journal of Geriatric Psychiatry and Neurology 2014, 27, 85-93.

Abgrall S, Fugon L, Lélé N, Carde E, Bentata M, Patey O, Khuong MA, Spire B, Bouchaud O, Carrieri P, AVsg
Risk factors for adherence failure in HIV-infected sub-Saharan migrants living in France and travelling back to their native country.
Int J STD AIDS 2014, 25, 389–390.

Abgrall S, Fugon L, Lélé N, Carde E, Bentata M, Patey O, Khuong MA, Spire B, Bouchaud O, Carrieri P, AVsg
Risk factors for adherence failure in HIV-infected sub-Saharan migrants living in France and travelling back to their native country.
International journal of STD & AIDS 2014, 25, 389-390.

Weiss E, Timsit JF
Management of invasive candidiasis in nonneutropenic ICU patients.
Therapeutic Advances in Infectious Disease 2014, 2, 105-115.

Cousien A, Obach D, Deuffic-Burban S, Mostafa A, Esmat G, Canva V, El Kassas M, El-Sayed M, Anwar WA, Fontanet A, Mohamed MK, Yazdanpanah Y
Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt.
BMC medical research methodology 2014, 14, 39.

Mizrahi A, Cohen R, Varon E, Bonacorsi S, Bechet S, Poyart C, Levy C, Raymond J
Non typable-Haemophilus influenzae biofilm formation and acute otitis media.
BMC infectious diseases 2014, 14, 400.

Timsit JF, Soubirou JF, Voiriot G, Chemam S, Neuville M, Mourvillier B, Sonneville R, Mariotte E, Bouadma L, Wolff M
Treatment of bloodstream infections in ICUs.
BMC infectious diseases 2014, 14, 489.

Toffart AC, Moro-Sibilot D, Couraud S, Merle P, Perol M, Girard N, Souquet PJ, Mastroianni B, Ferretti GR, Romand P, Chatellain P, Vesin A, Brambilla E, Brambilla C, Timsit JF
Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study.
Bmc Cancer 2014, 14, 989.

Schmidt M, Freund Y, Alves M, Monsel A, Labbe V, Darnal E, Messika J, Bokobza J, Similowski T, Duguet A
Video-based feedback of oral clinical presentations reduces the anxiety of ICU medical students: a multicentre, prospective, randomized study.
BMC medical education 2014, 14, 103.

Fernandez I, Brito RM, Bidet P, Rallu F, Laferrière C, Ovetchkine P, Le Deist F
Invasive group A Streptococcus disease in French-Canadian children is not associated with a defect in MyD88/IRAK4-pathway.
Allergy, Asthma, and Clinical Immunology: Official Journal of the Canadian Society of Allergy and Clinical Immunology 2014, 10, 9.

Vigan M, Stirnemann J, Caillaud C, Froissart R, Boutten A, Fantin B, Belmatoug N, Mentré F
Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological model.
Orphanet Journal of Rare Diseases 2014, 9, 95.

Chenoune M, De Rochefort L, Bruneval P, Lidouren F, Kohlhauer M, Seemann A, Ghaleh B, Korn M, Dubuisson RM, Ben Yahmed A, Maître X, Isabey D, Ricard JD, Kerber RE, Darrasse L, Berdeaux A, Tissier R
Evaluation of lung recovery after static administration of three different perfluorocarbons in pigs.
BMC pharmacology & toxicology 2014, 15, 53.

Daubin C, Haddad L, Folscheid D, Boyer A, Chalumeau-Lemoine L, Guisset O, Hubert P, Pillot J, Robert R, Dreyfuss D
Ethical reflections on end-of-life signs and symptoms in the intensive care setting: a place for neuromuscular blockers?.
Annals of Intensive Care 2014, 4, 23.

Robert R, Salomon L, Haddad L, Graftieaux JP, Eon B, Dreyfuss D, ecotFSoCC(
End of life in the intensive care unit: should French law be adapted?.
Annals of Intensive Care 2014, 4, 6.

Bousquet G, Feugeas JP, Ferreira I, Vercellino L, Jourdan N, Bertheau P, de Bazelaire C, Barranger E, Janin A
Individual xenograft as a personalized therapeutic resort for women with metastatic triple-negative breast carcinoma.
Breast cancer research: BCR 2014, 16, 401.

N'Diaye DS, Schwarzinger M, Obach D, Poissy J, Matheron S, Casalino E, Yazdanpanah Y
Effectiveness and cost of quick diagnostic tests to determine tetanus immunity in patients with a wound in French emergency departments.
BMC infectious diseases 2014, 14, 603.

Desbois A, Rautou P, Biard L, Belmatoug N, Wechsler B, Resche-Rigon M, Zarrouk V, Fantin B, Pineton de Chambrun M, Cacoub P, Valla D, Saadoun D, Plessier A
Behcet¿s disease in Budd-Chiari syndrome.
Orphanet Journal of Rare Diseases 2014, 9, 104.

Vigan M, Stirnemann J, Mentré F
Evaluation of estimation methods and power of tests of discrete covariates in repeated time-to-event parametric models: application to Gaucher patients treated by imiglucerase.
The AAPS journal 2014, 16, 415-423.

Nguyen TT, Guedj J, Chachaty E, de Gunzburg J, Andremont A, Mentré F
Mathematical modeling of bacterial kinetics to predict the impact of antibiotic colonic exposure and treatment duration on the amount of resistant enterobacteria excreted.
PLoS computational biology 2014, 10, e1003840.

Mora A, Dahbi G, López C, Mamani R, Marzoa J, Dion S, Picard B, Blanco M, Alonso MP, Denamur E, Blanco J
Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes.
PloS One 2014, 9, e87025.

Guillard T, Grillon A, de Champs C, Cartier C, Madoux J, Berçot B, Lebreil AL, Lozniewski A, Riahi J, Vernet-Garnier V, Cambau E
Mobile insertion cassette elements found in small non-transmissible plasmids in Proteeae may explain qnrD mobilization.
PloS One 2014, 9, e87801.

Ferraretto X, Estellat C, Damond F, Longuet P, Epelboin S, Demailly P, Yazbeck C, Llabador MA, Pasquet B, Yazdanpanah Y, Matheron S, Patrat C
Timing of intermittent seminal HIV-1 RNA shedding in patients with undetectable plasma viral load under combination antiretroviral therapy.
PloS One 2014, 9, e88922.

N'Diaye DS, Yazdanpanah Y, Krivine A, Andrieu T, Rozenberg F, Picone O, Tsatsaris V, Goffinet F, Launay O
Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France.
PloS One 2014, 9, e89857.

Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD, ISSG, ESG, SSC
Factors associated with D-dimer levels in HIV-infected individuals.
PloS One 2014, 9, e90978.

Casalino E, Choquet C, Leleu A, Hellmann R, Wargon M, Juillien G, Yazdanpanah Y, Bouvet E
Trends in Condom Use and Risk Behaviours after Sexual Exposure to HIV: A Seven-Year Observational Study.
PloS One 2014, 9, e104350.

Lescat M, Reibel F, Pintard C, Dion S, Glodt J, Gateau C, Launay A, Ledda A, Cruvellier S, Tourret J, Tenaillon O
The Conserved nhaAR Operon Is Drastically Divergent between B2 and Non-B2 Escherichia coli and Is Involved in Extra-Intestinal Virulence.
PloS One 2014, 9, e108738.

Garrouste-Orgeas M, Périer A, Mouricou P, Grégoire C, Bruel C, Brochon S, Philippart F, Max A, Misset B
Writing in and reading ICU diaries: qualitative study of families' experience in the ICU.
PloS One 2014, 9, e110146.

Tolsma V, Schwebel C, Azoulay E, Darmon M, Souweine B, Vesin A, Goldgran-Toledano D, Lugosi M, Jamali S, Cheval C, Adrie C, Kallel H, Descorps-Declere A, Garrouste-Orgeas M, Bouadma L, Timsit JF
Sepsis severe or septic shock: outcome according to immune status and immunodeficiency profile.
Chest 2014, 146, 1205-1213.

Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE, P1(93ST
Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
Pediatrics 2014, 134, e1104–1116.

Quéro L, Duval X, Abramowitz L
[Anal cancer in HIV patients].
Bulletin Du Cancer 2014, 101, 1034-1039.

Konofal E, Zhao W, Laouénan C, Lecendreux M, Kaguelidou F, Benadjaoud L, Mentré F, Jacqz-Aigrain E
Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder.
Drug Design, Development and Therapy 2014, 8, 2321-2332.

Rafat C, Schortgen F, Gaudry S, Bertrand F, Miguel-Montanes R, Labbé V, Ricard JD, Hajage D, Dreyfuss D
Use of desmopressin acetate in severe hyponatremia in the intensive care unit.
Clinical journal of the American Society of Nephrology: CJASN 2014, 9, 229-237.

Darmon M, Clec'h C, Adrie C, Argaud L, Allaouchiche B, Azoulay E, Bouadma L, Garrouste-Orgeas M, Haouache H, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Souweine B, Zeni F, Cohen Y, Timsit JF
Acute respiratory distress syndrome and risk of AKI among critically ill patients.
Clinical journal of the American Society of Nephrology: CJASN 2014, 9, 1347-1353.

Rouzet F, Chequer R, Benali K, Lepage L, Ghodbane W, Duval X, Iung B, Vahanian A, Le Guludec D, Hyafil F
Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis.
Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 2014, 55, 1980-1985.

Soubirou JF, Gault N, Alfaiate T, Lolom I, Tubach F, Andremont A, Lucet JC, Wolff M, Barbier F
Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii.
Scandinavian Journal of Infectious Diseases 2014, 46, 215-220.

Abramowitz L, Benabderrahmane M, Pospait D, Philip J, Laouénan C
The prevalence of proctological symptoms amongst patients who see general practitioners in France.
The European Journal of General Practice 2014, 20, 301-306.

Compain F, Decré D, Frazier I, Ramahefasolo A, Lavollay M, Carbonnelle E, Rostane H, Tackin A, Berger-Carbonne A, Podglajen I
Carbapenemase-producing bacteria in patients hospitalized abroad, France.
Emerging Infectious Diseases 2014, 20, 1246-1248.

Landman R, Koulla-Shiro S, Sow PS, Ngolle M, Diallo MB, Guèye NFN, Le Moing V, Eymard-Duvernay S, Benalycherif A, Charpentier C, Peytavin G, Delaporte E, Girard PM, DSG
Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial.
Antiviral Therapy 2014, 19, 51–59.

Reliquet V, Chirouze C, Allavena C, Muret P, Peytavin G, André-Garnier E, Bettinger D, Ferré V, Hoen B, Raffi F
Nevirapine-raltegravir combination, an NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patients.
Antiviral Therapy 2014, 19, 117–123.

Wohl DA, Orkin C, Doroana M, Pilotto JH, Sungkanuparph S, Yeni P, Vanveggel S, Deckx H, Boven K
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).
Antiviral Therapy 2014, 19, 191–200.

Rong L, Guedj J, Dahari H, Perelson AS
Treatment of hepatitis C with an interferon-based lead-in phase: a perspective from mathematical modelling.
Antiviral Therapy 2014, 19, 469-477.

Guedj J, Pang PS, Denning J, Rodriguez-Torres M, Lawitz E, Symonds W, Perelson AS
Analysis of hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS-7977) and GS-0938.
Antiviral Therapy 2014, 19, 211-220.

Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Yeni P, Strohmaier KM, Rodgers A, Barnard RJ, Nguyen BYT, Teppler H, tBST
Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection.
Antiviral Therapy 2014

Borel AL, Schwebel C, Planquette B, Vésin A, Garrouste-Orgeas M, Adrie C, Clec'h C, Azoulay E, Souweine B, Allaouchiche B, Goldgran-Toledano D, Jamali S, Darmon M, Timsit JF
Initiation of nutritional support is delayed in critically ill obese patients: a multicenter cohort study.
The American Journal of Clinical Nutrition 2014, 100, 859-866.

Payros D, Secher T, Boury M, Brehin C, Ménard S, Salvador-Cartier C, Cuevas-Ramos G, Watrin C, Marcq I, Nougayrède JP, Dubois D, Bedu A, Garnier F, Clermont O, Denamur E, Plaisancié P, Theodorou V, Fioramonti J, Olier M, Oswald E
Maternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis.
Gut Microbes 2014, 5, 313-325.

Genuini M, Prot-Labarthe S, Bourdon O, Doit C, Aujard Y, Naudin J, Lorrot M
Fluoroquinolones in pediatrics: review of hospital prescription use over 2 years.
International Journal of Clinical Pharmacology and Therapeutics 2014

Margetis D, Maury E, Boelle PY, Alves M, Galbois A, Baudel JL, Offenstadt G, Guidet B, Ait-Oufella H
Peripheral microcirculatory exploration during mechanical ventilation weaning.
Minerva Anestesiologica 2014

Ruppe E, Armand-Lefevre L, Estellat C, El-Mniai A, Boussadia Y, Consigny P, Girard P, Vittecoq D, Bouchaud O, Pialoux G, Esposito-Farese M, Coignard B, Lucet J, Andremont A, Matheron S
Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013.
Euro surveillance: bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2014, 19,

Leport C, Zylberman P, Guégan JF, Bricaire F, Cavallo JD, Che D, Eliaszewicz M, Moatti JP
Proceedings of the 2nd seminar on emerging infectious diseases, December 7, 2012 – Current trends and proposals.
Revue D'epidemiologie Et De Sante Publique 2014, 62, 153-158.

Dubée V, Zeller V, Fantin B
[Infections associated with orthopaedic devices].
La Revue Du Praticien 2014, 64, 643-650.

Poletto C, Pelat C, Levy-Bruhl D, Yazdanpanah Y, Boelle P, Colizza V
Assessment of the Middle East respiratory syndrome coronavirus (MERS-CoV) epidemic in the Middle East and risk of international spread using a novel maximum likelihood analysis approach.
Euro Surveillance: Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2014, 19,

La Ruche G, Goubard A, Bercot B, Cambau E, Semaille C, Sednaoui P
Gonococcal infections and emergence of gonococcal decreased susceptibility to cephalosporins in France, 2001 to 2012.
Euro Surveillance: Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2014, 19,

Sellier P, Schnepf N, Amarsy R, Maylin S, Coutellier M, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Ricbourg A, Dolores-Moreno AM, Simoneau G, Evans J, Souak S, Matheron S, Mouly S, Benifla JL, Simon F, Bergmann JF
Hepatitis B virus (HBV) status of children born to HIV/HBV co-infected women in a French hospital: a cross-sectional study.
Journal of the International AIDS Society 2014, 17, 19632.

Bercot B, Belkacem A, Goubard A, Mougari F, Sednaoui P, La Ruche G, Cambau E
High-level azithromycin-resistant Neisseria gonorrhoeae clinical isolate in France, March 2014.
Euro Surveillance: Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2014, 19,

Marcelin AG, Charpentier C, Wirden M, Descamps D, Calvez V
Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment.
Journal of the International AIDS Society 2014, 17, 19744.

Yeni P
[HIV infection. Screening, broadcast treatment and prevention of infection are now linked ].
La Revue Du Praticien 2014, 64, 1057-1059.

Matheron S, Girard T
[Which future for HIV-infected children at adolescence and adulthood? ].
La Revue Du Praticien 2014, 64, 1091-1093.

Celse M, Geffroy L, Yeni P
[HIV infection and social condition: a disease which remains singular].
La Revue Du Praticien 2014, 64, 1099-1102.

 2013                                                                            

Mourvillier B, Tubach F, van de Beek D, Garot D, Pichon N, Georges H, Lefevre LM, Bollaert PE, Boulain T, Luis D, Cariou A, Girardie P, Chelha R, Megarbane B, Delahaye A, Chalumeau-Lemoine L, Legriel S, Beuret P, Brivet F, Bruel C, Camou F, Chatellier D, Chillet P, Clair B, Constantin JM, Duguet A, Galliot R, Bayle F, Hyvernat H, Ouchenir K, Plantefeve G, Quenot JP, Richecoeur J, Schwebel C, Sirodot M, Esposito-Farèse M, Le Tulzo Y, Wolff M
Induced hypothermia in severe bacterial meningitis: a randomized clinical trial.
JAMA 2013, 310, 2174-2183.

Steff M, Joly V, Di Lucca J, Feldman J, Burg S, Sarda-Mantel L, Peytavin G, Marinho E, Crickx B, Raymond E, Lariven S, Maubec E
Clinical activity of lenalidomide in visceral human immunodeficiency virus-related Kaposi sarcoma.
JAMA dermatology 2013, 149, 1319-1322.

DRCRN
Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
JAMA ophthalmology 2013, 131, 283-293.

Demaret J, Walencik A, Jacob MC, Timsit JF, Venet F, Lepape A, Monneret G
Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples.
Cytometry. Part B, Clinical Cytometry 2013, 84, 59-62.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Evidence-Based Child Health: A Cochrane Review Journal 2013, 8, 1297-1371.

Dumay A, Feugeas JP, Wittmer E, Lehmann-Che J, Bertheau P, Espié M, Plassa LF, Cottu P, Marty M, André F, Sotiriou C, Pusztai L, de Thé H
Distinct tumor protein p53 mutants in breast cancer subgroups.
International Journal of Cancer. Journal International Du Cancer 2013, 132, 1227-1231.

Ghosn J, Slama L, Chermak A, Houssaini A, Lambert-Niclot S, Schneider L, Fourn E, Duvivier C, Simon A, Courbon E, Murphy R, Flandre P, Peytavin G, Katlama C, RSG
Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1.
Journal of Medical Virology 2013, 85, 8-15.

Thai HT, Mentré F, Holford NHG, Veyrat-Follet C, Comets E
A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed-effects models.
Pharmaceutical Statistics 2013, 12, 129-140.

Azoulay E, Kouatchet A, Jaber S, Lambert J, Meziani F, Schmidt M, Schnell D, Mortaza S, Conseil M, Tchenio X, Herbecq P, Andrivet P, Guerot E, Lafabrie A, Perbet S, Camous L, Janssen-Langenstein R, Collet F, Messika J, Legriel S, Fabre X, Guisset O, Touati S, Kilani S, Alves M, Mercat A, Similowski T, Papazian L, Meert AP, Chevret S, Schlemmer B, Brochard L, Demoule A
Noninvasive mechanical ventilation in patients having declined tracheal intubation.
Intensive Care Medicine 2013, 39, 292-301.

Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2012: I. Neurology and neurointensive care, epidemiology and nephrology, biomarkers and inflammation, nutrition, experimentals.
Intensive Care Medicine 2013, 39, 232-246.

Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2012. II: Pneumonia and infection, sepsis, coagulation, hemodynamics, cardiovascular and microcirculation, critical care organization, imaging, ethics and legal issues.
Intensive Care Medicine 2013, 39, 345-364.

Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2012: III. Noninvasive ventilation, monitoring and patient-ventilator interactions, acute respiratory distress syndrome, sedation, paediatrics and miscellanea.
Intensive Care Medicine 2013, 39, 543-557.

Potton L, Bonadona A, Minet C, Timsit JF
Pink urine.
Intensive Care Medicine 2013, 39, 389-390.

Vesin A, Azoulay E, Ruckly S, Vignoud L, Rusinovà K, Benoit D, Soares M, Azeivedo-Maia P, Abroug F, Benbenishty J, Timsit JF
Reporting and handling missing values in clinical studies in intensive care units.
Intensive Care Medicine 2013, 39, 1396-1404.

Thiolliere F, Serre-Sapin AF, Reignier J, Benedit M, Constantin JM, Lebert C, Guélon D, Timsit JF, Souweine B
Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study.
Intensive Care Medicine 2013, 39, 1460-1468.

Philippart F, Vesin A, Bruel C, Kpodji A, Durand-Gasselin B, Garçon P, Levy-Soussan M, Jagot JL, Calvo-Verjat N, Timsit JF, Misset B, Garrouste-Orgeas M
The ETHICA study (part I): elderly's thoughts about intensive care unit admission for life-sustaining treatments.
Intensive Care Medicine 2013, 39, 1565-1573.

Garrouste-Orgeas M, Tabah A, Vesin A, Philippart F, Kpodji A, Bruel C, Grégoire C, Max A, Timsit JF, Misset B
The ETHICA study (part II): simulation study of determinants and variability of ICU physician decisions in patients aged 80 or over.
Intensive Care Medicine 2013, 39, 1574-1583.

Garrouste-Orgeas M, Valentin A
What's new for patient safety in the ICU?.
Intensive Care Medicine 2013, 39, 1829-1831.

Zahar JR, Garrouste-Orgeas M, Vesin A, Schwebel C, Bonadona A, Philippart F, Ara-Somohano C, Misset B, Timsit JF
Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.
Intensive Care Medicine 2013, 39, 2153-2160.

Roux D, Surugue G, Gaudry S, Wolff M
An intragastric chest tube insertion.
Intensive Care Medicine 2013, 39, 2207-2208.

Fagedet D, Thony F, Timsit JF, Rodiere M, Monnin-Bares V, Ferretti GR, Vesin A, Moro-Sibilot D
Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.
Cardiovascular and Interventional Radiology 2013, 36, 140-149.

Thai HT, Veyrat-Follet C, Mentré F, Comets E
Population pharmacokinetic analysis of free and bound aflibercept in patients with advanced solid tumors.
Cancer Chemotherapy and Pharmacology 2013, 72, 167-180.

Angebault C, Andremont A
Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2013, 32, 581-595.

Cohen JF, Chalumeau M, Levy C, Bidet P, Benani M, Koskas M, Bingen E, Cohen R
Effect of clinical spectrum, inoculum size and physician characteristics on sensitivity of a rapid antigen detection test for group A streptococcal pharyngitis.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2013, 32, 787-793.

Chirouze C, Patry I, Duval X, Baty V, Tattevin P, Aparicio T, Pagenault M, Carbonnel F, Couetdic G, Hoen B
Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2013, 32, 1171-1176.

Harrison L, Ananworanich J, Hamadache D, Compagnucci A, Penazzato M, Bunupuradah T, Mazza A, Ramos JT, Flynn J, Rampon O, Mellado Pena MJ, Floret D, Marczynska M, Puga A, Forcat S, Riault Y, Lallemant M, Castro H, Gibb DM, Giaquinto C, PENfToA(1TT
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children.
AIDS and behavior 2013, 17, 193-202.

Combes FP, Retout S, Frey N, Mentré F
Prediction of shrinkage of individual parameters using the bayesian information matrix in non-linear mixed effect models with evaluation in pharmacokinetics.
Pharmaceutical Research 2013, 30, 2355-2367.

Montravers P, Guglielminotti J, Zappella N, Desmard M, Muller C, Fournier P, Marmuse JP, Dufour G, Augustin P
Clinical features and outcome of postoperative peritonitis following bariatric surgery.
Obesity Surgery 2013, 23, 1536-1544.

Aubin-Auger I, Mercier A, Le Bel J, Bombeke K, Baruch D, Youssefian A, Lebeau JP, Le Trung T, Peremans L, Van Royen P
From qualitative data to GP training on CRC screening.
Journal of Cancer Education: The Official Journal of the American Association for Cancer Education 2013, 28, 439-443.

Moulignier A, Savatovsky J, Polivka M, Boutboul D, Depaz R, Lescure FX
CD8 T lymphocytes encephalitis mimicking brain tumor in HIV-1 infection.
Journal of Neurovirology 2013, 19, 606-609.

Dumont C, Mentré F, Gaynor C, Brendel K, Gesson C, Chenel M
Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.
Clinical Pharmacokinetics 2013, 52, 43-57.

Goulenok T, Fantin B
Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.
Clinical Pharmacokinetics 2013, 52, 869-883.

Duval X
Simplification of the prophylaxis of endocarditis: we were right!.
Archives of Cardiovascular Diseases 2013, 106, 69-71.

Prinapori R, Guinaud J, Khalil A, Lecuyer H, Gendrel D, Lortholary O, Nassif X, Viscoli C, Zahar JR
Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae.
American Journal of Infection Control 2013, 41, 259-260.

Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC
Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.
American Journal of Infection Control 2013, 41, 443-447.

Rivard-Yazigi L, Zahar JR, Le Guillou S, Chalouhi C, Lecuyer H, Bureau C, Nassif X, Gendrel D, Abadie V
Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae carriage at admission in an infant cohort at a tertiary teaching hospital in France.
American Journal of Infection Control 2013, 41, 844-845.

Decousser JW, Ramarao N, Duport C, Dorval M, Bourgeois-Nicolaos N, Guinebretière MH, Razafimahefa H, Doucet-Populaire F
Bacillus cereus and severe intestinal infections in preterm neonates: Putative role of pooled breast milk.
American Journal of Infection Control 2013, 41, 918-921.

Paul M, Iung B, Montravers P, Longrois D, Guglielminotti J
[Anaesthetic management of patients with bicuspid aortic valve for delivery. About two consecutive cases].
Annales Françaises D'anesthèsie Et De Rèanimation 2013, 32, 607-610.

Prague M, Commenges D, Guedj J, Drylewicz J, Thiébaut R
NIMROD: a program for inference via a normal approximation of the posterior in models with random effects based on ordinary differential equations.
Computer Methods and Programs in Biomedicine 2013, 111, 447-458.

Biendo M, Mammeri H, Pluquet E, Guillon H, Rousseau F, Canarelli B, Belmekki M, Eb F
Value of Xpert MRSA/SA blood culture assay on the Gene Xpert® Dx System for rapid detection of Staphylococcus aureus and coagulase-negative staphylococci in patients with staphylococcal bacteremia.
Diagnostic Microbiology and Infectious Disease 2013, 75, 139-143.

Dallaudière B, Meyer P, Hummel V, Perozziello A, Peuchant A, Moreau-Durieux MH, Silvestre A, Pelé E, Wakim N, Loriaut P, Boyer P, Schouman-Claeys E, Serfaty JM, Pesquer L
Efficacy of second intra-tendinous platelet-rich-plasma injection in case of incomplete response of the first injection: three-year follow up experience.
Diagnostic and Interventional Imaging 2013, 94, 871-877.

Dallaudière B, Lempicki M, Pesquer L, Louedec L, Preux PM, Meyer P, Hess A, Durieux MHM, Hummel V, Larbi A, Deschamps L, Benayoun Y, Journe C, Perozziello A, Schouman-Claeys E, Michel JB, Serfaty JM
Acceleration of tendon healing using US guided intratendinous injection of bevacizumab: first pre-clinical study on a murine model.
European Journal of Radiology 2013, 82, e823-828.

Potron A, Rondinaud E, Poirel L, Belmonte O, Boyer S, Camiade S, Nordmann P
Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae.
International Journal of Antimicrobial Agents 2013, 41, 325-329.

Marcelin AG, Delaugerre C, Beaudoux C, Descamps D, Morand-Joubert L, Amiel C, Schneider V, Ferre V, Izopet J, Si-Mohamed A, Maillard A, Henquell C, Desbois D, Lazrek M, Signori-Schmuck A, Rogez S, Yerly S, Trabaud MA, Plantier JC, Fourati S, Houssaini A, Masquelier B, Calvez V, Flandre P, AARG
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.
International Journal of Antimicrobial Agents 2013, 42, 42-47.

Omnes S, Jondeau G, Detaint D, Dumont A, Yazbeck C, Guglielminotti J, Luton D, Azria E
Pregnancy outcomes among women with Marfan syndrome.
International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 2013, 122, 219-223.

Clermont O, Glodt J, Burdet C, Pognard D, Lefort A, Branger C, Denamur E, CGM
Complexity of Escherichia coli bacteremia pathophysiology evidenced by comparison of isolates from blood and portal of entry within single patients.
International journal of medical microbiology: IJMM 2013, 303, 529-532.

Chousterman BG, Bouadma L, Moutereau S, Loric S, Alvarez-Gonzalez A, Mekontso-Dessap A, Laissy JP, Rahmouni A, Katsahian S, Brochard L, Schortgen F
Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
Journal of Critical Care 2013, 28, 701-709.

Ploin D, Chidiac C, Carrat F, Cohen B, Javouhey E, Mayaud C, Desenclos JC, Lina B, Leport C, Fsg
Complications and factors associated with severity of influenza in hospitalized children and adults during the pandemic wave of A(H1N1)pdm2009 infections--the Fluco French cohort.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2013, 58, 114-119.

Visseaux B, Larrouy L, Calin R, Katlama C, Poynard T, Ratziu V, Thibault V
Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2013, 58, 385-390.

Delarue S, Didier E, Damond F, Ponscarme D, Brengle-Pesce K, Resche-Rigon M, Vray M, Gueudin M, Simon F
Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infection.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2013, 58, 461-467.

Martinot-Peignoux M, Lapalus M, Laouénan C, Lada O, Netto-Cardoso ACF, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2013, 58, 401-407.

Deuffic-Burban S, Yazdanpanah Y
Mathematical modeling: a tool for selecting agents with complementary modes of action?.
Journal of Hepatology 2013, 59, 1346-1348.

Lepelletier D, Lucet JC
Controlling meticillin-susceptible Staphylococcus aureus: not simply meticillin-resistant S. aureus revisited.
The Journal of Hospital Infection 2013, 84, 13-21.

Goulenok T, Ferroni A, Bille E, Lécuyer H, Join-Lambert O, Descamps P, Nassif X, Zahar JR
Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?.
The Journal of Hospital Infection 2013, 84, 294-299.

Rivière S, Lortholary O, Michon J, Bougnoux ME, Mainardi JL, Sendid B, Bretagne S, Lefort A
Aspergillus endocarditis in the era of new antifungals: major role for antigen detection.
The Journal of Infection 2013, 67, 85-88.

Denneman L, Vial-Dupuy A, Gault N, Wolff M, van de Beek D, Mourvillier B
Repeated lumbar puncture in adults with pneumococcal meningitis: an observational study.
The Journal of Infection 2013, 67, 350-353.

Aidara-Kane A, Andremont A, Collignon P
Antimicrobial resistance in the food chain and the AGISAR initiative.
Journal of Infection and Public Health 2013, 6, 162-165.

Cohen JF, Cohen R, Bidet P, Levy C, Deberdt P, d'Humières C, Liguori S, Corrard F, Thollot F, Mariani-Kurkdjian P, Chalumeau M, Bingen E
Rapid-antigen detection tests for group a streptococcal pharyngitis: revisiting false-positive results using polymerase chain reaction testing.
The Journal of Pediatrics 2013, 162, 1282-1284, 1284.e1.

Lefort A
[Why should antibiotic therapy be avoided in case of acute infectious diarrhea?].
Presse Médicale (Paris, France: 1983) 2013, 42, 82-83.

Picard B
[When should request a stool culture?].
Presse Médicale (Paris, France: 1983) 2013, 42, 66-67.

Jolly D, Lorette G, Ambrosi P, Dreyfuss D, Chaffanjon P, Le Jeunne C, Obert L, Rogez JM
[Results of the 2012 national ranking in France].
Presse Médicale (Paris, France: 1983) 2013, 42, 1138-1140.

Gavazzi G, Delerce E, Cambau E, François P, Corroyer B, de Wazières B, Fougère B, Paccalin M, Gaillat J
Diagnostic criteria for urinary tract infection in hospitalized elderly patients over 75 years of age: a multicenter cross-sectional study.
Médecine Et Maladies Infectieuses 2013, 43, 189-194.

Chakvetadze C, Bani-Sadr F, Lescure FX, Fontaine C, Le Pendeven C, Bonnard P, Mariot P, Soussan P, Pialoux G
Liver stiffness values in HIV-infected patients with isolated anti-hepatitis B core antibodies.
Medecine Et Maladies Infectieuses 2013, 43, 222-225.

FSfHH(, Lucet JC, Parneix P, Grandbastien B, Berthelot P
Should public reporting be made for performance indicators on healthcare-associated infections?.
Medecine Et Maladies Infectieuses 2013, 43, 108-113.

Mattioni S, Develoux M, Brun S, Martin A, Jaureguy F, Naggara N, Bouchaud O
Management of mycetomas in France.
Médecine Et Maladies Infectieuses 2013, 43, 286-294.

Stahl JP, Salmon D, Bruneel F, Caumes E, Freymuth F, Bru JP, Morand P, Roblot F, Schmit JL, Strady C, Timsit JF, Rabaud C, I
Adult patients hospitalized for measles in France, in the 21st century.
Medecine Et Maladies Infectieuses 2013, 43, 410-416.

Novy E, Sonneville R, Mazighi M, Klein IF, Mariotte E, Mourvillier B, Bouadma L, Wolff M
Neurological complications of infective endocarditis: new breakthroughs in diagnosis and management.
Medecine Et Maladies Infectieuses 2013, 43, 443-450.

Defrance G, Birgand G, Ruppé E, Billard M, Ruimy R, Bonnal C, Andremont A, Armand-Lefèvre L
Time-to-positivity-based discrimination between Enterobacteriaceae, Pseudomonas aeruginosa and strictly anaerobic Gram-negative bacilli in aerobic and anaerobic blood culture vials.
Journal of Microbiological Methods 2013, 93, 77-79.

Nebbad-Lechani B, Emirian A, Maillebuau F, Mahjoub N, Fihman V, Legrand P, Decousser JW
New procedure to reduce the time and cost of broncho-pulmonary specimen management using the Previ Isola® automated inoculation system.
Journal of Microbiological Methods 2013, 95, 384-388.

Vaznaisiene D, Beltrand E, Laiskonis AP, Yazdanpanah Y, Migaud H, Senneville E
Major amputation of lower extremity: prognostic value of positive bone biopsy cultures.
Orthopaedics & traumatology, surgery & research: OTSR 2013, 99, 88-93.

Gelly J, Mentre F, Nougairede M, Duval X
Preventive services recommendations for adults in primary care settings: agreement between Canada, France and the USA--a systematic review.
Preventive Medicine 2013, 57, 3-11.

Frank T, Gody JC, Nguyen LBL, Berthet N, Le Fleche-Mateos A, Bata P, Rafaï C, Kazanji M, Breurec S
First case of Elizabethkingia anophelis meningitis in the Central African Republic.
Lancet (London, England) 2013, 381, 1876.

Lorrot M, Haas H, Hentgen V, Van Den Abbeele T, Bonacorsi S, Doit C, Cohen R, Grimprel E
[Antibiotherapy of severe ENT infections in children: peripharyngeal abscesses].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2013, 20 Suppl 3, e1-4.

McElhaney JE, Beran J, Devaster JM, Esen M, Launay O, Leroux-Roels G, Ruiz-Palacios GM, van Essen GA, Caplanusi A, Claeys C, Durand C, Duval X, El Idrissi M, Falsey AR, Feldman G, Frey SE, Galtier F, Hwang SJ, Innis BL, Kovac M, Kremsner P, McNeil S, Nowakowski A, Richardus JH, Trofa A, Oostvogels L, Isg
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.
The Lancet Infectious Diseases 2013, 13, 485-496.

Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJO, Nguyen BYT, Teppler H, BST
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
The Lancet. Infectious Diseases 2013, 13, 587-596.

Andremont A, Lucet JC
Extensively resistant VIM-2-positive Pseudomonas aeruginosa.
The Lancet. Infectious Diseases 2013, 13, 828-829.

Kluytmans J, Price L, Grayson L, Gottlieb T, Mehtar S, Andremont A, Wegener HC, Johnson J
Enterobacteria: Ban resistant strains from food chain.
Nature 2013, 501, 316.

Séroussi B, Laouénan C, Gligorov J, Uzan S, Mentré F, Bouaud J
Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?.
British Journal of Cancer 2013, 109, 1147-1156.

Burkovics P, Sebesta M, Sisakova A, Plault N, Szukacsov V, Robert T, Pinter L, Marini V, Kolesar P, Haracska L, Gangloff S, Krejci L
Srs2 mediates PCNA-SUMO-dependent inhibition of DNA repair synthesis.
The EMBO journal 2013, 32, 742-755.

Vlasakakis G, Comets E, Keunecke A, Gueorguieva I, Magni P, Terranova N, Della Pasqua O, de Lange EC, Kloft C
White paper: landscape on technical and conceptual requirements and competence framework in drug/disease modeling and simulation.
CPT: pharmacometrics & systems pharmacology 2013, 2, e40.

Mentré F, Chenel M, Comets E, Grevel J, Hooker A, Karlsson MO, Lavielle M, Gueorguieva I
Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members.
CPT: pharmacometrics & systems pharmacology 2013, 2, e46.

Nguyen THT, Guedj J, Yu J, Levi M, Mentré F
Influence of a priori Information, Designs, and Undetectable Data on Individual Parameters Estimation and Prediction of Hepatitis C Treatment Outcome.
CPT: pharmacometrics & systems pharmacology 2013, 2, e56.

Karlsson MO, Mentré F
Best practices in population modeling should always be evolving.
CPT: pharmacometrics & systems pharmacology 2013, 2, e52.

Lau DTY, Negash A, Chen J, Crochet N, Sinha M, Zhang Y, JG, Holder S, Saito T, Lemon SM, Luxon BA, Perelson AS, Gale M
Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection.
Gastroenterology 2013, 144, 402-413.e12.

Hoen B, Duval X
Infective endocarditis.
The New England Journal of Medicine 2013, 369, 785.

Hoen B, Duval X
Clinical practice. Infective endocarditis.
The New England Journal of Medicine 2013, 368, 1425-1433.

Guedj J, Dahari H, Rong L, Sansone ND, Nettles RE, Cotler SJ, Layden TJ, Uprichard SL, Perelson AS
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life.
Proceedings of the National Academy of Sciences of the United States of America 2013, 110, 3991-3996.

Jacquier H, Birgy A, Le Nagard H, Mechulam Y, Schmitt E, Glodt J, Bercot B, Petit E, Poulain J, Barnaud G, Gros PA, Tenaillon O
Capturing the mutational landscape of the beta-lactamase TEM-1.
Proceedings of the National Academy of Sciences of the United States of America 2013, 110, 13067-13072.

Wielgoss S, Barrick JE, Tenaillon O, Wiser MJ, Dittmar WJ, Cruveiller S, Chane-Woon-Ming B, Médigue C, Lenski RE, Schneider D
Mutation rate dynamics in a bacterial population reflect tension between adaptation and genetic load.
Proceedings of the National Academy of Sciences of the United States of America 2013, 110, 222-227.

Skurnik D, Roux D, Cattoir V, Danilchanka O, Lu X, Yoder-Himes DR, Han K, Guillard T, Jiang D, Gaultier C, Guerin F, Aschard H, Leclercq R, Mekalanos JJ, Lory S, Pier GB
Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing.
Proceedings of the National Academy of Sciences of the United States of America 2013, 110, 20747-20752.

Cywes-Bentley C, Skurnik D, Zaidi T, Roux D, Deoliveira RB, Garrett WS, Lu X, O'Malley J, Kinzel K, Zaidi T, Rey A, Perrin C, Fichorova RN, Kayatani AKK, Maira-Litràn T, Gening ML, Tsvetkov YE, Nifantiev NE, Bakaletz LO, Pelton SI, Golenbock DT, Pier GB
Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens.
Proceedings of the National Academy of Sciences of the United States of America 2013, 110, E2209-2218.

Kebe K, Thiam M, Diagne Gueye NR, Diop H, Dia A, Signate Sy H, Charpentier C, Belec L, Mboup S, Toure Kane C
High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
AIDS research and human retroviruses 2013, 29, 242-249.

Bobin-Dubigeon C, Biron C, Volteau C, Piroth L, Biron A, Perré P, Leport C, Prazuck T, Sébille-Rivain V, Raffi F, Bard JM
Short communication: Paraoxonase 1 (PON1) in French HIV-infected patients under antiretroviral therapy: relationship with the metabolic syndrome and inflammation.
AIDS research and human retroviruses 2013, 29, 1571-1574.

Lafeuille E, Decré D, Mahjoub-Messai F, Bidet P, Arlet G, Bingen E
OXA-48 carbapenemase-producing Klebsiella pneumoniae isolated from Libyan patients.
Microbial Drug Resistance (Larchmont, N.Y.) 2013, 19, 491-497.

Jin J, Limburg S, Joshi SK, Landman R, Park M, Zhang Q, Kim HT, Kuo AC
Peripheral nerve repair in rats using composite hydrogel-filled aligned nanofiber conduits with incorporated nerve growth factor.
Tissue Engineering. Part A 2013, 19, 2138-2146.

Chaix ML, Seng R, Frange P, Tran L, Avettand-Fenoël V, Ghosn J, Reynes J, Yazdanpanah Y, Raffi F, Goujard C, Rouzioux C, Meyer L, APCSG
Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 56, 880-887.

Charpentier C, Camacho R, Ruelle J, Kaiser R, Eberle J, Gürtler L, Pironti A, Stürmer M, Brun-Vézinet F, Descamps D, Obermeier M
HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 56, 1654-1658.

Lescure FX, Moulignier A, Savatovsky J, Amiel C, Carcelain G, Molina JM, Gallien S, Pacanovski J, Pialoux G, Adle-Biassette H, Gray F
CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 101-108.

Briand N, Warszawski J, Mandelbrot L, Dollfus C, Pannier E, Cravello L, Nguyen R, Matheron I, Winer N, Tubiana R, Rouzioux C, Faye A, Blanche S, AECCSG
Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 903-914.

Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J, A1P(IMESG
Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 891-902.

Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, d'Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, Jansen K, Meyer L, Muñoz P, Obel N, Soler-Palacin P, Papadopoulos A, Raffi F, Ramos JT, Rockstroh JK, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Lundgren JD, OIWGobotCoOHERE(siE
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 1038-1047.

Hyafil F, Rouzet F, Lepage L, Benali K, Raffoul R, Duval X, Hvass U, Iung B, Nataf P, Lebtahi R, Vahanian A, Le Guludec D
Role of radiolabelled leucocyte scintigraphy in patients with a suspicion of prosthetic valve endocarditis and inconclusive echocardiography.
European Heart Journal Cardiovascular Imaging 2013, 14, 586-594.

Hekimian G, Boutten A, Flamant M, Duval X, Dehoux M, Benessiano J, Huart V, Dupré T, Berjeb N, Tubach F, Iung B, Vahanian A, Messika-Zeitoun D
Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients--the COFRASA study.
European Heart Journal 2013, 34, 1915-1922.

Birgand G, Radu C, Alkhoder S, Al Attar N, Raffoul R, Dilly MP, Nataf P, Lucet JC
Does a gentamicin-impregnated collagen sponge reduce sternal wound infections in high-risk cardiac surgery patients?.
Interactive Cardiovascular and Thoracic Surgery 2013, 16, 134-141.

PLTOI(IPTotCoOHERE(, Costagliola D, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touloumi G, Mussini C, Castagna A, Stephan C, García F, Zangerle R, Duval X, Perez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chêne G, Grarup J, Phillips A, Lodwick R, Torti C, Dorrucci M, Günthard HF, Michalik C, Chrysos G, Castagna A
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes.
The Journal of Infectious Diseases 2013, 207, 759-767.

Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TFR, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
The Journal of Infectious Diseases 2013, 207 Suppl 2, S70-77.

Angebault C, Djossou F, Abélanet S, Permal E, Ben Soltana M, Diancourt L, Bouchier C, Woerther PL, Catzeflis F, Andremont A, d'Enfert C, Bougnoux ME
Candida albicans is not always the preferential yeast colonizing humans: a study in Wayampi Amerindians.
The Journal of Infectious Diseases 2013, 208, 1705-1716.

Potron A, Nordmann P, Rondinaud E, Jaureguy F, Poirel L
A mosaic transposon encoding OXA-48 and CTX-M-15: towards pan-resistance.
The Journal of Antimicrobial Chemotherapy 2013, 68, 476-477.

Lê MP, Stitou H, Soulie C, Katlama C, Peytavin G
Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy.
The Journal of Antimicrobial Chemotherapy 2013, 68, 727-729.

Charpentier C, Joly V, Larrouy L, Fagard C, Visseaux B, de Verdière NC, Raffi F, Yeni P, Descamps D, A1ATSG
Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.
The Journal of Antimicrobial Chemotherapy 2013, 68, 690-696.

Pautas C, Sbidian E, Hicheri Y, Bastuji-Garin S, Bretagne S, Corbel C, Gregoire L, Maury S, Merabet L, Cordonnier C, Cambau E
A new workflow for the microbiological diagnosis of febrile neutropenia in patients with a central venous catheter.
The Journal of Antimicrobial Chemotherapy 2013, 68, 943-946.

Reigadas S, Marcelin AG, Houssaïni A, Yerly S, Descamps D, Plantier JC, Ruffault A, Amiel C, Trabaud MA, Flandre P, Fleury H, Masquelier B, AARSG
HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes.
The Journal of Antimicrobial Chemotherapy 2013, 68, 969-972.

Lê MP, Gervais A, Le Beller C, Long K, Larrouy L, Papy E, Mal H, Descamps D, Peytavin G
Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1208-1209.

Lambert-Niclot S, Charpentier C, Storto A, Fofana DB, Soulié C, Fourati S, Visseaux B, Wirden M, Morand-Joubert L, Masquelier B, Flandre P, Calvez V, Descamps D, Marcelin AG
Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1237-1242.

Assoumou L, Descamps D, Yerly S, Dos Santos G, Marcelin AG, Delaugerre C, Morand-Joubert L, Ruffault A, Izopet J, Plantier JC, Pakianather S, Montes B, Chaix ML, Wirden M, Costagliola D, Masquelier B, AARG
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1400-1405.

Desroches M, Potier J, Laurent F, Bourrel AS, Doucet-Populaire F, Decousser JW, MSG
Prevalence of mupirocin resistance among invasive coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus (MRSA) in France: emergence of a mupirocin-resistant MRSA clone harbouring mupA.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1714-1717.

Huttner B, Haustein T, Uçkay I, Renzi G, Stewardson A, Schaerrer D, Agostinho A, Andremont A, Schrenzel J, Pittet D, Harbarth S
Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2375-2382.

Charpentier C, Lambert-Niclot S, Visseaux B, Morand-Joubert L, Storto A, Larrouy L, Landman R, Calvez V, Marcelin AG, Descamps D
Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2197-2198.

Fourati S, Visseaux B, Armenia D, Morand-Joubert L, Artese A, Charpentier C, Van Den Eede P, Costa G, Alcaro S, Wirden M, Perno CF, Ceccherini Silberstein F, Descamps D, Calvez V, Marcelin AG
Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2199-2204.

Descamps D, Assoumou L, Chaix ML, Chaillon A, Pakianather S, de Rougemont A, Storto A, Dos Santos G, Krivine A, Delaugerre C, Montes B, Izopet J, Charpentier C, Wirden M, Maillard A, Morand-Joubert L, Pallier C, Plantier JC, Guinard J, Tamalet C, Cottalorda J, Marcelin AG, Desbois D, Henquell C, Calvez V, Brun-Vézinet F, Masquelier B, Costagliola D, AARSG
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2626-2631.

Gravey F, Galopin S, Grall N, Auzou M, Andremont A, Leclercq R, Cattoir V
Lincosamide resistance mediated by lnu(C) (L phenotype) in a Streptococcus anginosus clinical isolate.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2464-2467.

Todesco E, Sayon S, Fourati S, Tubiana R, Simon A, Ktorza N, Schneider L, Peytavin G, Malet I, Van den Eede P, Katlama C, Calvez V, Marcelin AG, Wirden M
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2882-2889.

Jacquier H, Marcadé G, Raffoux E, Dombret H, Woerther PL, Donay JL, Arlet G, Cambau E
In vivo selection of a complex mutant TEM (CMT) from an inhibitor-resistant TEM (IRT) during ceftazidime therapy.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2792-2796.

Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Peytavin G, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC
Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft.
AIDS (London, England) 2013, 27, 2655-2657.

Guglielminotti J, Mentré F, Bedairia E, Montravers P, Longrois D
Development and evaluation of a score to predict difficult epidural placement during labor.
Regional Anesthesia and Pain Medicine 2013, 38, 233-238.

Timsit JF, Laupland KB
Is the burden of severe sepsis and septic shock changing?.
Critical Care Medicine 2013, 41, 1361-1363.

Schwebel C, Clec'h C, Magne S, Minet C, Garrouste-Orgeas M, Bonadona A, Dumenil AS, Jamali S, Kallel H, Goldgran-Toledano D, Marcotte G, Azoulay E, Darmon M, Ruckly S, Souweine B, Timsit JF
Safety of Intrahospital Transport in Ventilated Critically Ill Patients: A Multicenter Cohort Study.
Critical Care Medicine 2013, 41, 1919-1928.

Ricard JD, Salomon L, Boyer A, Thiery G, Meybeck A, Roy C, Pasquet B, Le Mière E, Dreyfuss D
Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial.
Critical Care Medicine 2013, 41, 2108-2115.

Darbera L, Chenoune M, Lidouren F, Kohlhauer M, Adam C, Bruneval P, Ghaleh B, Dubois-Randé JL, Carli P, Vivien B, Ricard JD, Berdeaux A, Tissier R
Hypothermic liquid ventilation prevents early hemodynamic dysfunction and cardiovascular mortality after coronary artery occlusion complicated by cardiac arrest in rabbits.
Critical Care Medicine 2013, 41, e457-465.

Bertrand J, Balding DJ
Multiple single nucleotide polymorphism analysis using penalized regression in nonlinear mixed-effect pharmacokinetic models.
Pharmacogenetics and Genomics 2013, 23, 167-174.

Bidet P, Collin E, Basmaci R, Courroux C, Prisse V, Dufour V, Bingen E, Grimprel E, Bonacorsi S
Investigation of an outbreak of osteoarticular infections caused by Kingella kingae in a childcare center using molecular techniques.
The Pediatric Infectious Disease Journal 2013, 32, 558-560.

Versporten A, Sharland M, Bielicki J, Drapier N, Vankerckhoven V, Goossens H, APGM
The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide.
The Pediatric Infectious Disease Journal 2013, 32, e242-253.

Lepainteur M, Desroches M, Bourrel AS, Aberrane S, Fihman V, L'Hériteau F, Razafimahefa H, Derouin V, Doucet-Populaire F, Decousser JW
Role of the central venous catheter in bloodstream infections caused by coagulase-negative staphylococci in very preterm neonates.
The Pediatric Infectious Disease Journal 2013, 32, 622-628.

Levy C, Bidet P, Bonacorsi S, Cohen R, BMSG
Group A streptococcal meningitis in children: French surveillance network from 2001 to 2012.
The Pediatric Infectious Disease Journal 2013, 32, 1041-1042.

Lemaître C, Angoulvant F, Gabor F, Makhoul J, Bonacorsi S, Naudin J, Alison M, Faye A, Bingen E, Lorrot M
Necrotizing pneumonia in children: report of 41 cases between 2006 and 2011 in a French tertiary care center.
The Pediatric Infectious Disease Journal 2013, 32, 1146-1149.

Barbier F, Andremont A, Wolff M, Bouadma L
Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
Current Opinion in Pulmonary Medicine 2013, 19, 216-228.

Rafat C, Klouche K, Ricard JD, Messika J, Roch A, Machado S, Sonneville R, Guisset O, Pujol W, Guérin C, Teboul JL, Mrozek N, Darmon M, Chemouni F, Schmidt M, Mercier E, Dreyfuss D, Gaudry S
Severe Measles Infection: The Spectrum of Disease in 36 Critically Ill Adult Patients.
Medicine 2013

Charpentier C, Bertine M, Visseaux B, Leleu J, Larrouy L, Peytavin G, Mourez T, Collin G, Brun-Vézinet F, Plantier JC, Descamps D
In-vitro phenotypic susceptibility of HIV-1 'non-B' integrase inhibitors naive clinical isolates to dolutegravir and raltegravir.
AIDS (London, England) 2013, 27, 2959-2961.

Zetterberg E, Neuhaus J, Baker JV, Somboonwit C, Llibre JM, Palfreeman A, Chini M, Lundgren JD, ISSG
Platelet count kinetics following interruption of antiretroviral treatment.
AIDS (London, England) 2013, 27, 59-68.

Larrouy L, Vivot A, Charpentier C, Bénard A, Visseaux B, Damond F, Matheron S, Chene G, Brun-Vezinet F, Descamps D, ACH2C
Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients.
AIDS (London, England) 2013, 27, 69-80.

Visseaux B, Charpentier C, Taieb A, Damond F, Bénard A, Larrouy L, Chêne G, Brun-Vézinet F, Matheron S, Descamps D, ACH2C
Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
AIDS (London, England) 2013, 27, 292-295.

Bunupuradah T, Duong T, Compagnucci A, McMaster P, Bernardi S, Kanjanavanit S, Rampon O, Faye A, Saïdi Y, Riault Y, De Rossi A, Klein N, Ananworanich J, Gibb D, P1ESG
Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions.
AIDS (London, England) 2013, 27, 579-589.

Lacombe JM, Boue F, Grabar S, Viget N, Gazaignes S, Lascaux-Cametz AS, Pacanowski J, Partisani M, Launay O, Matheron S, Rosenthal E, Rouveix E, Tattevin P, de Truchis P, Costagliola D, Goedert JJ
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy.
AIDS (London, England) 2013, 27, 635-643.

Stellbrink HJ, Reynes J, Lazzarin A, Voronin E, Pulido F, Felizarta F, Almond S, St Clair M, Flack N, Min S, S1T
Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.
AIDS (London, England) 2013, 27, 1771-1778.

Charpentier C, Visseaux B, Bénard A, Peytavin G, Damond F, Roy C, Taieb A, Chêne G, Matheron S, Brun-Vézinet F, Descamps D, ACH2C
Transmitted drug resistance in French HIV-2-infected patients.
AIDS 2013, 27, 1671–1674.

Charpentier C, Visseaux B, Bénard A, Peytavin G, Damond F, Roy C, Taieb A, Chêne G, Matheron S, Brun-Vézinet F, Descamps D, ACH2C
Transmitted drug resistance in French HIV-2-infected patients.
AIDS (London, England) 2013, 27, 1671-1674.

Leoz M, Feyertag F, Charpentier C, Delaugerre C, Wirden M, Lemee V, Plantier JC
Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France.
AIDS (London, England) 2013, 27, 2309-2312.

Cuzin L, Allavena C, Pugliese P, Rey D, Hoen B, Poizot-Martin I, Cabie A, Yazdanpanah Y, DSG
Can the "seek, test, treat, and retain" strategy be effective in France?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 62, e119-121.

Descours B, Lambert-Niclot S, Mory B, Samri A, Charlotte F, Peytavin G, Tubiana R, Papagno L, Bacchus C, Lecardonnel F, Katlama C, Autran B, Marcelin AG, Valantin MA, Carcelain G, DaOSG
Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patients.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 62, 255-259.

Rockstroh JK, DeJesus E, Lennox JL, Yazdanpanah Y, Saag MS, Wan H, Rodgers AJ, Walker ML, Miller M, DiNubile MJ, Nguyen BY, Teppler H, Leavitt R, Sklar P, SI
Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK.
Journal of acquired immune deficiency syndromes (1999) 2013, 63, 77-85.

Semaille C, Barin F, Bouyssou A, Peytavin G, Guinard J, Le Vu S, Pillonel J, Spire B, Velter A
High viral loads among HIV-positive MSM attending gay venues: implications for HIV transmission.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 63, e122-124.

Cotte L, Dellamonica P, Raffi F, Yazdanpanah Y, Molina JM, Boué F, Urata Y, Chan HP, Zhu L, Chang I, Bertz R, Hanna GJ, Grasela DM, Hwang C
Randomized placebo-controlled study of the safety, tolerability, antiviral activity, and pharmacokinetics of 10-day monotherapy with BMS-986001, a novel HIV NRTI, in treatment-experienced HIV-1-infected subjects.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 63, 346-354.

de Montmollin E, Tandjaoui-Lambiotte Y, Legrand M, Lambert J, Mokart D, Kouatchet A, Lemiale V, Pène F, Bruneel F, Vincent F, Mayaux J, Chevret S, Azoulay E
Outcomes in critically ill cancer patients with septic shock of pulmonary origin.
Shock (Augusta, Ga.) 2013, 39, 250-254.

Decroix V, Goudjil S, Kongolo G, Mammeri H
'Leptotrichia amnionii', a newly reported cause of early onset neonatal meningitis.
Journal of Medical Microbiology 2013, 62, 785-788.

Mougari F, Jacquier H, Berçot B, Hannouche D, Nizard R, Cambau E, Zadegan F
Prosthetic knee arthritis due to Granulicatella adiacens after dental treatment.
Journal of Medical Microbiology 2013, 62, 1624-1627.

Dahyot S, Broutin I, de Champs C, Guillon H, Mammeri H
Contribution of asparagine 346 residue to the carbapenemase activity of CMY-2 β-lactamase.
FEMS microbiology letters 2013, 345, 147-153.

Clermont O, Christenson JK, Denamur E, Gordon DM
The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups.
Environmental Microbiology Reports 2013, 5, 58-65.

Wyplosz B, Burdet C, François H, Durrbach A, Duclos-Vallée JC, Mamzer-Bruneel MF, Poujol P, Launay O, Samuel D, Vittecoq D, Consigny PH, G
Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation.
American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2013, 13, 2458-2461.

Cohen J, Guedj J, Fries N
Umbilical artery Doppler assessment: a clear disparity in ultrasound practice in a national survey.
Acta Obstetricia Et Gynecologica Scandinavica 2013, 92, 1115-1116.

Gray F, Lescure FX, Adle-Biassette H, Polivka M, Gallien S, Pialoux G, Moulignier A
Encephalitis with infiltration by CD8+ lymphocytes in HIV patients receiving combination antiretroviral treatment.
Brain Pathology (Zurich, Switzerland) 2013, 23, 525-533.

Murat JB, Lebeau B, Chumpitazi B, Cornet M, Maubon D, Faure O, Quesada JL, Thiebaut-Bertrand A, Timsit JF, Pelloux H
Minimum inhibitory concentrations of amphotericin B against Candida krusei isolates from a French teaching hospital laboratory: a retrospective study over 8 years.
Mycoses 2013, 56, 56-60.

Nguyen HL, Charpentier C, Nguyen N, de Truchis P, Molina JM, Ruxrungtham K, Delaugerre C
Longitudinal analysis of integrase N155H variants in heavily treated patients failing raltegravir-based regimens.
HIV medicine 2013, 14, 85-91.

Landraud L, Jauréguy F, Frapy E, Guigon G, Gouriou S, Carbonnelle E, Clermont O, Denamur E, Picard B, Lemichez E, Brisse S, Nassif X
Severity of Escherichia coli bacteraemia is independent of the intrinsic virulence of the strains assessed in a mouse model.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2013, 19, 85-90.

Blanchon T, Mentré F, Charlois-Ou C, Dornic Q, Mosnier A, Bouscambert M, Carrat F, Duval X, Enouf V, Leport C, BSG
Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2013, 19, 196-203.

Lescat M, Clermont O, Woerther PL, Glodt J, Dion S, Skurnik D, Djossou F, Dupont C, Perroz G, Picard B, Catzeflis F, Andremont A, Denamur E
Commensal Escherichia coli strains in Guiana reveal a high genetic diversity with host-dependant population structure.
Environmental Microbiology Reports 2013, 5, 49-57.

Baroux N, Rouchon B, Huon B, Germain A, Meunier JM, D'Ortenzio E
High prevalence of rheumatic heart disease in schoolchildren detected by echocardiography screening in New Caledonia.
Journal of Paediatrics and Child Health 2013, 49, 109-114.

Hatzakis A, Van Damme P, Alcorn K, Gore C, Benazzouz M, Berkane S, Buti M, Carballo M, Cortes Martins H, Deuffic-Burban S, Dominguez A, Donoghoe M, Elzouki AN, Ben-Alaya Bouafif N, Esmat G, Esteban R, Fabri M, Fenton K, Goldberg D, Goulis I, Hadjichristodoulou C, Hadjichristodoulou T, Hatzigeorgiou T, Hamouda O, Hasurdjiev S, Hughes S, Kautz A, Malik M, Manolakopoulos S, Matičič M, Papatheodoridis G, Peck R, Peterle A, Potamitis G, Prati D, Roudot-Thoraval F, Reic T, Sharara A, Shennak M, Shiha G, Shouval D, Sočan M, Thomas H, Thursz M, Tosti M, Trépo C, Vince A, Vounou E, Wiessing L, Manns M
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.
Journal of Viral Hepatitis 2013, 20 Suppl 2, 1-20.

Bertrand D, Pallet N, Sartorius A, Zahar JR, Soussan RS, Lortholary O, Legendre C, Mamzer MF
Clinical and microbial impact of screening kidney allograft preservative solution for bacterial contamination with high-sensitivity methods.
Transplant International: Official Journal of the European Society for Organ Transplantation 2013, 26, 795-799.

Rousseaux S, Debernardi A, Jacquiau B, Vitte AL, Vesin A, Nagy-Mignotte H, Moro-Sibilot D, Brichon PY, Lantuejoul S, Hainaut P, Laffaire J, de Reyniès A, Beer DG, Timsit JF, Brambilla C, Brambilla E, Khochbin S
Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers.
Science Translational Medicine 2013, 5, 186ra66.

Grall N, Massias L, Nguyen TT, Sayah-Jeanne S, Ducrot N, Chachaty E, de Gunzburg J, Andremont A
Oral DAV131, a charcoal-based adsorbent, inhibits intestinal colonization by β-lactam-resistant Klebsiella pneumoniae in cefotaxime-treated mice.
Antimicrobial Agents and Chemotherapy 2013, 57, 5423-5425.

Ruppé E, Lixandru B, Cojocaru R, Büke C, Paramythiotou E, Angebault C, Visseaux C, Djuikoue I, Erdem E, Burduniuc O, El Mniai A, Marcel C, Perrier M, Kesteman T, Clermont O, Denamur E, Armand-Lefèvre L, Andremont A
Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women.
Antimicrobial Agents and Chemotherapy 2013, 57, 4512-4517.

Barau C, Furlan V, Yazdanpanah Y, Fagard C, Molina JM, Taburet AM, Barrail-Tran A
Characterization of binding of raltegravir to plasma proteins.
Antimicrobial Agents and Chemotherapy 2013, 57, 5147-5150.

Kardas-Sloma L, Boëlle PY, Opatowski L, Guillemot D, Temime L
Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant Staphylococcus aureus.
Antimicrobial Agents and Chemotherapy 2013, 57, 4410-4416.

Clavel-Osorio C, Cazassus F, Stegmann S, Huc-Anaïs P, Lecam D, Peytavin G
One-month transplacental pharmacokinetics of raltegravir in a premature newborn after short-course treatment of the HIV-1-infected mother.
Antimicrobial Agents and Chemotherapy 2013, 57, 6393-6394.

Guillard T, Cambau E, Chau F, Massias L, de Champs C, Fantin B
Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.
Antimicrobial Agents and Chemotherapy 2013, 57, 5830-5835.

Joly V, Fagard C, Grondin C, Descamps D, Yazdanpanah Y, Charpentier C, Colin de Verdiere N, Tabuteau S, Raffi F, Cabie A, Chene G, Yeni P, S1ATG
Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).
Antimicrobial Agents and Chemotherapy 2013, 57, 758-765.

Vinot C, Gavard L, Tréluyer JM, Manceau S, Courbon E, Scherrmann JM, Declèves X, Duro D, Peytavin G, Mandelbrot L, Giraud C
Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression.
Antimicrobial Agents and Chemotherapy 2013, 57, 1415-1420.

Armand-Lefevre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppe E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plesiat P, Andremont A
Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients.
Antimicrobial Agents and Chemotherapy 2013, 57, 1488-1495.

Recordon-Pinson P, Raymond S, Bellecave P, Marcelin AG, Soulie C, Descamps D, Calvez V, Harrigan PR, Fleury H, Izopet J, Masquelier B, SARSG
HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replication.
Antimicrobial Agents and Chemotherapy 2013, 57, 930-935.

Woodrow CJ, Dahlström S, Cooksey R, Flegg JA, Le Nagard H, Mentré F, Murillo C, Ménard D, Nosten F, Sriprawat K, Musset L, Quashie NB, Lim P, Fairhurst RM, Nsobya SL, Sinou V, Noedl H, Pradines B, Johnson JD, Guerin PJ, Sibley CH, Le Bras J
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.
Antimicrobial Agents and Chemotherapy 2013, 57, 3121-3130.

Parienti JJ, Barrail-Tran A, Duval X, Nembot G, Descamps D, Vigan M, Vrijens B, Panhard X, Taburet AM, Mentré F, Goujard C
Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.
Antimicrobial Agents and Chemotherapy 2013, 57, 2265-2271.

Berthe T, Ratajczak M, Clermont O, Denamur E, Petit F
Evidence for coexistence of distinct Escherichia coli populations in various aquatic environments and their survival in estuary water.
Applied and Environmental Microbiology 2013, 79, 4684-4693.

Smati M, Clermont O, Le Gal F, Schichmanoff O, Jauréguy F, Eddi A, Denamur E, Picard B, CG
Real-time PCR for quantitative analysis of human commensal Escherichia coli populations reveals a high frequency of subdominant phylogroups.
Applied and Environmental Microbiology 2013, 79, 5005-5012.

Woerther PL, Burdet C, Chachaty E, Andremont A
Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.
Clinical Microbiology Reviews 2013, 26, 744-758.

Augustin P, Alsalih G, Launey Y, Delbosc S, Louedec L, Ollivier V, Chau F, Montravers P, Duval X, Michel JB, Meilhac O
Predominant role of host proteases in myocardial damage associated with infectious endocarditis induced by Enterococcus faecalis in a rat model.
Infection and Immunity 2013, 81, 1721-1729.

Bleibtreu A, Gros PA, Laouénan C, Clermont O, Le Nagard H, Picard B, Tenaillon O, Denamur E
Fitness, stress resistance, and extraintestinal virulence in Escherichia coli.
Infection and Immunity 2013, 81, 2733-2742.

Belmekki M, Mammeri H, Hamdad F, Rousseau F, Canarelli B, Biendo M
Comparison of Xpert MRSA/SA Nasal and MRSA/SA ELITe MGB assays for detection of the mecA gene with susceptibility testing methods for determination of methicillin resistance in Staphylococcus aureus isolates.
Journal of Clinical Microbiology 2013, 51, 3183-3191.

Basmaci R, Ilharreborde B, Doit C, Presedo A, Lorrot M, Alison M, Mazda K, Bidet P, Bonacorsi S
Two atypical cases of Kingella kingae invasive infection with concomitant human rhinovirus infection.
Journal of Clinical Microbiology 2013, 51, 3137-3139.

Birgy A, Mariani-Kurkdjian P, Bidet P, Doit C, Genel N, Courroux C, Arlet G, Bingen E
Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131.
Journal of Clinical Microbiology 2013, 51, 1727-1732.

Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, Andersen LP, Goossens H, Glupczynski Y, SGp
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption.
Gut 2013, 62, 34-42.

Cimadevilla C, Cueff C, Hekimian G, Dehoux M, Lepage L, Iung B, Duval X, Huart V, Tubach F, Vahanian A, Messika-Zeitoun D
Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study.
Heart (British Cardiac Society) 2013, 99, 461-467.

Champenois K, Cousien A, Ndiaye B, Soukouna Y, Baclet V, Alcaraz I, Choisy P, Chaud P, Velter A, Gallay A, Yazdanpanah Y
Risk factors for syphilis infection in men who have sex with men: results of a case-control study in Lille, France.
Sexually Transmitted Infections 2013, 89, 128-132.

Lorente N, Champenois K, Blanche J, Préau M, Suzan-Monti M, Mora M, Fugon L, Carrieri MP, Sagaon-Teyssier L, Le Gall JM, Spire B, Yazdanpanah Y
Investigating Recent Testing among MSM: Results from Community-Based HIV Rapid Testing Attendees in France.
Journal of Sexually Transmitted Diseases 2013, 2013, 648791.

Goulenok T, Klein I, Mazighi M, Messika-Zeitoun D, Alexandra JF, Mourvillier B, Laissy JP, Leport C, Iung B, Duval X, Isg
Infective endocarditis with symptomatic cerebral complications: contribution of cerebral magnetic resonance imaging.
Cerebrovascular Diseases (Basel, Switzerland) 2013, 35, 327-336.

Escoubet B, Couffignal C, Laisy JP, Mangin L, Chillon S, Laouénan C, Serfaty JM, Jeunemaitre X, Mentré F, Zennaro MC
Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations.
Circulation. Cardiovascular Genetics 2013, 6, 381-390.

Duval X, Alla F, Hoen B
Letter by Duval et al regarding article, "Incidence of Infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines".
Circulation 2013, 127, e520.

Iung B, Tubiana S, Klein I, Messika-Zeitoun D, Brochet E, Lepage L, Al-Attar N, Ruimy R, Leport C, Wolff M, Duval X, EISG
Determinants of cerebral lesions in endocarditis on systematic cerebral magnetic resonance imaging: a prospective study.
Stroke 2013, 44, 3056-3062.

Dreyfuss D, Ricard JD, Gaudry S
Amphotericin B deoxycholate for candidiasis in intensive care unit patients revisited: medical, ethical, and financial implications.
American Journal of Respiratory and Critical Care Medicine 2013, 187, 661-663.

Pham T, Combes A, Rozé H, Chevret S, Mercat A, Roch A, Mourvillier B, Ara-Somohano C, Bastien O, Zogheib E, Clavel M, Constan A, Marie Richard JC, Brun-Buisson C, Brochard L, RRN
Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis.
American Journal of Respiratory and Critical Care Medicine 2013, 187, 276-285.

Planquette B, Timsit JF, Misset BY, Schwebel C, Azoulay E, Adrie C, Vesin A, Jamali S, Zahar JR, Allaouchiche B, Souweine B, Darmon M, Dumenil AS, Goldgran-Toledano D, Mourvillier BH, Bédos JP, OSG
Pseudomonas aeruginosa ventilator-associated pneumonia. predictive factors of treatment failure.
American Journal of Respiratory and Critical Care Medicine 2013, 188, 69-76.

Annane D, Timsit JF, Megarbane B, Martin C, Misset B, Mourvillier B, Siami S, Chagnon JL, Constantin JM, Petitpas F, Souweine B, Amathieu R, Forceville X, Charpentier C, Tesnière A, Chastre J, Bohe J, Colin G, Cariou A, Renault A, Brun-Buisson C, Bellissant E, ATI
Recombinant human activated protein C for adults with septic shock: a randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2013, 187, 1091-1097.

Timsit JF, Bouadma L, Mimoz O, Parienti JJ, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Herrault MC, Schwebel C, Ruckly S, Souweine B, Lucet JC
Jugular versus femoral short-term catheterization and risk of infection in intensive care unit patients. Causal analysis of two randomized trials.
American Journal of Respiratory and Critical Care Medicine 2013, 188, 1232-1239.

Díaz-Muñoz SL, Tenaillon O, Goldhill D, Brao K, Turner PE, Chao L
Electrophoretic mobility confirms reassortment bias among geographic isolates of segmented RNA phages.
BMC evolutionary biology 2013, 13, 206.

Rodríguez-Verdugo A, Gaut BS, Tenaillon O
Evolution of Escherichia coli rifampicin resistance in an antibiotic-free environment during thermal stress.
BMC evolutionary biology 2013, 13, 50.

Maharjan RP, Gaffé J, Plucain J, Schliep M, Wang L, Feng L, Tenaillon O, Ferenci T, Schneider D
A case of adaptation through a mutation in a tandem duplication during experimental evolution in Escherichia coli.
BMC genomics 2013, 14, 441.

Radomski N, Roguet A, Lucas FS, Veyrier FJ, Cambau E, Accrombessi H, Moilleron R, Behr MA, Moulin L
atpE gene as a new useful specific molecular target to quantify Mycobacterium in environmental samples.
BMC microbiology 2013, 13, 277.

Laouénan C, Guedj J, Mentré F
Clinical trial simulation to evaluate power to compare the antiviral effectiveness of two hepatitis C protease inhibitors using nonlinear mixed effect models: a viral kinetic approach.
BMC medical research methodology 2013, 13, 60.

Domenech de Cellès M, Zahar JR, Abadie V, Guillemot D
Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward.
BMC infectious diseases 2013, 13, 187.

Champenois K, Cousien A, Cuzin L, Le Vu S, Deuffic-Burban S, Lanoy E, Lacombe K, Patey O, Béchu P, Calvez M, Semaille C, Yazdanpanah Y
Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study.
BMC infectious diseases 2013, 13, 200.

Yang ZT, Zahar JR, Méchaï F, Postaire M, Blanot S, Balfagon-Viel S, Nassif X, Lortholary O
Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris.
BMC infectious diseases 2013, 13, 245.

Launay O, Duval X, Fitoussi S, Jilg W, Kerdpanich A, Montellano M, Schwarz TF, Watanveerade V, Wenzel JJ, Zalcman G, Bambure V, Li P, Caplanusi A, Madan A, Gillard P, Vaughn DW
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.
BMC infectious diseases 2013, 13, 435.

Gasse B, Baroux N, Rouchon B, Meunier JM, Frémicourt ID, D'Ortenzio E
Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study.
BMC public health 2013, 13, 131.

Gharbi M, Flegg JA, Hubert V, Kendjo E, Metcalf JE, Bertaux L, Guérin PJ, Le Bras J, MotFNRCfIMS, Aboubaca A, Agnamey P, Angoulvant A, Barbut P, Basset D, Belkadi G, Bellanger AP, Bemba D, Benoit-Vica F, Berry A, Bigel ML, Bonhomme J, Botterel F, Bouchaud O, Bougnoux ME, Bourée P, Bourgeois N, Branger C, Bret L, Buret B, Casalino E, Chevrier S, Conquere de Monbrison F, Cuisenier B, Danis M, Darde ML, De Gentile L, Delarbre JM, Delaunay P, Delaval A, Desoubeaux G, Develoux M, Dunand J, Durand R, Eloy O, Fauchet N, Faugere B, Faye A, Fenneteau O, Flori P, Fontrouge M, Garabedian C, Gayandrieu F, Godineau N, Houzé P, Houzé S, Hurst JP, Ichou H, Lachaud L, Lebuisson A, Lefevre M, LeGuern AS, Le Moal G, Lusina D, Machouart MC, Malvy D, Matheron S, Maubon D, Mechali D, Megarbane B, Menard G, Millon L, Aiach MM, Minodier P, Morelle C, Nevez G, Parola P, Parzy D, Patey O, Patoz P, Penn P, Perignon A, Picot S, Pilo JE, Poilane I, Pons D, Poupart M, Pradines B, Raffenot D, Rapp C, Receveur MC, Sarfati C, Senghor Y, Simon F, Siriez JY, Taudon N, Thellier M, Thouvenin M, Toubas D
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011.
Malar. J. 2013, 12, 35.

Gharbi M, Flegg JA, Hubert V, Kendjo E, Metcalf JE, Bertaux L, Guérin PJ, Le Bras J, MotFNRCfIMS, Aboubaca A, Agnamey P, Angoulvant A, Barbut P, Basset D, Belkadi G, Bellanger AP, Bemba D, Benoit-Vica F, Berry A, Bigel ML, Bonhomme J, Botterel F, Bouchaud O, Bougnoux ME, Bourée P, Bourgeois N, Branger C, Bret L, Buret B, Casalino E, Chevrier S, Conquere de Monbrison F, Cuisenier B, Danis M, Darde ML, De Gentile L, Delarbre JM, Delaunay P, Delaval A, Desoubeaux G, Develoux M, Dunand J, Durand R, Eloy O, Fauchet N, Faugere B, Faye A, Fenneteau O, Flori P, Fontrouge M, Garabedian C, Gayandrieu F, Godineau N, Houzé P, Houzé S, Hurst JP, Ichou H, Lachaud L, Lebuisson A, Lefevre M, LeGuern AS, Le Moal G, Lusina D, Machouart MC, Malvy D, Matheron S, Maubon D, Mechali D, Megarbane B, Menard G, Millon L, Aiach MM, Minodier P, Morelle C, Nevez G, Parola P, Parzy D, Patey O, Patoz P, Penn P, Perignon A, Picot S, Pilo JE, Poilane I, Pons D, Poupart M, Pradines B, Raffenot D, Rapp C, Receveur MC, Sarfati C, Senghor Y, Simon F, Siriez JY, Taudon N, Thellier M, Thouvenin M, Toubas D
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011.
Malaria Journal 2013, 12, 35.

Cordel H, Cailhol J, Matheron S, Bloch M, Godineau N, Consigny PH, Gros H, Campa P, Bourée P, Fain O, Ralaimazava P, Bouchaud O
Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases.
Malaria Journal 2013, 12,

Gaillard T, Briolant S, Houzé S, Baragatti M, Wurtz N, Hubert V, Lavina M, Pascual A, Travaillé C, Le Bras J, Pradines B, FNRCfIMSG
PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria.
Malar. J. 2013, 12, 414.

Gaillard T, Briolant S, Houzé S, Baragatti M, Wurtz N, Hubert V, Lavina M, Pascual A, Travaillé C, Le Bras J, Pradines B, FNRCfIMSG
PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria.
Malaria Journal 2013, 12, 414.

Goudet V, Timsit JF, Lucet JC, Lepape A, Balayn D, Seguin S, Mimoz O
Comparison of four skin preparation strategies to prevent catheter-related infection in intensive care unit (CLEAN trial): a study protocol for a randomized controlled trial.
Trials 2013, 14, 114.

Timsit JF, Azoulay E, Cornet M, Gangneux JP, Jullien V, Vésin A, Schir E, Wolff M
EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial.
Trials 2013, 14, 399.

Birgand G, Ruimy R, Schwarzinger M, Lolom I, Bendjelloul G, Houhou N, Armand-Lefevre L, Andremont A, Yazdanpanah Y, Lucet JC
Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs.
Antimicrobial Resistance and Infection Control 2013, 2, 30.

Ait-Oufella H, Bourcier S, Alves M, Galbois A, Baudel JL, Margetis D, Bige N, Offenstadt G, Maury E, Guidet B
Alteration of skin perfusion in mottling area during septic shock.
Annals of Intensive Care 2013, 3, 31.

Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec'h C, Garrouste-Orgeas M, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Zeni F, Timsit JF
Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change.
Critical Care (London, England) 2013, 17, R12.

Perier A, Revah-Levy A, Bruel C, Cousin N, Angeli S, Brochon S, Philippart F, Max A, Gregoire C, Misset B, Garrouste-Orgeas M
Phenomenologic analysis of healthcare worker perceptions of intensive care unit diaries.
Critical Care (London, England) 2013, 17, R13.

Claessens YE, Aegerter P, Boubaker H, Guidet B, Cariou A, CRN
Are clinical trials dealing with severe infection fitting routine practices? Insights from a large registry.
Critical Care (London, England) 2013, 17, R89.

Toffart AC, Timsit JF
Is prolonged mechanical ventilation of cancer patients futile?.
Critical Care (London, England) 2013, 17, 189.

Adrie C, Schwebel C, Garrouste-Orgeas M, Vignoud L, Planquette B, Azoulay E, Kallel H, Darmon M, Souweine B, Dinh-Xuan AT, Jamali S, Zahar JR, Timsit JF, AWWobotOSG
Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance.
Critical Care (London, England) 2013, 17, R265.

Niven DJ, Laupland KB, Tabah A, Vesin A, Rello J, Koulenti D, Dimopoulos G, de Waele J, Timsit JF, EI
Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey.
Critical Care (London, England) 2013, 17, R289.

Cornely OA, Miller MA, Fantin B, Mullane K, Kean Y, Gorbach S
Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin.
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2013, 31, 2493-2499.

Rekic D, Röshammar D, Bergstrand M, Tarning J, Calcagno A, D'Avolio A, Ormaasen V, Vigan M, Barrail-Tran A, Ashton M, Gisslén M, Äbelö A
External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients.
The AAPS journal 2013, 15, 308-315.

Allyn J, Guglielminotti J, Omnes S, Guezouli L, Egan M, Jondeau G, Longrois D, Montravers P
Marfan's syndrome during pregnancy: anesthetic management of delivery in 16 consecutive patients.
Anesthesia and Analgesia 2013, 116, 392-398.

Guglielminotti J, Mentré F, Gaillard J, Ghalayini M, Montravers P, Longrois D
Assessment of pain during labor with pupillometry: a prospective observational study.
Anesthesia and Analgesia 2013, 116, 1057-1062.

Abgrall S, Le Bel J, Lele N, Laouénan C, Eychenne N, Mentré F, Peytavin G, Bouchaud O, VSG
Lack of effect of doxycycline on trough concentrations of protease inhibitors or non-nucleoside reverse transcriptase inhibitors in HIV-infected patients.
HIV clinical trials 2013, 14, 313-318.

Lloret-Linares C, Mouly S, Hoang-Nguyen DT, Evans J, Raskine L, Lopes A, Cambau E, Bergmann JF, Sellier P
Inadequate therapeutic response to a recommended antituberculosis fixed-dose combination regimen in an overweight patient with Mycobacterium bovis infection.
The Annals of Pharmacotherapy 2013, 47, e4.

Rong L, Guedj J, Dahari H, Coffield DJ, Levi M, Smith P, Perelson AS
Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model.
PLoS computational biology 2013, 9, e1002959.

Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, Bouscaillou J, Peytavin G, Mahiane SG, Sitta R, Puren A, Lewis D
Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys.
PLoS medicine 2013, 10, e1001509.

Mocroft A, Lundgren JD, Sabin ML, Monforte Ad, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O, CoOHERE(siE
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
PLoS medicine 2013, 10, e1001510.

Tubiana S, Mikulski M, Becam J, Lacassin F, Lefèvre P, Gourinat AC, Goarant C, D'Ortenzio E
Risk factors and predictors of severe leptospirosis in New Caledonia.
PLoS neglected tropical diseases 2013, 7, e1991.

Goarant C, Bourhy P, D'Ortenzio E, Dartevelle S, Mauron C, Soupé-Gilbert ME, Bruyère-Ostells L, Gourinat AC, Picardeau M, Nato F, Chanteau S
Sensitivity and Specificity of a New Vertical Flow Rapid Diagnostic Test for the Serodiagnosis of Human Leptospirosis.
PLoS neglected tropical diseases 2013, 7, e2289.

Cordel H, Prendki V, Madec Y, Houze S, Paris L, Bourée P, Caumes E, Matheron S, Bouchaud O, ASG
Imported amoebic liver abscess in France.
PLoS neglected tropical diseases 2013

Guerrier G, Hie P, Gourinat AC, Huguon E, Polfrit Y, Goarant C, D'Ortenzio E, Missotte I
Association between age and severity to leptospirosis in children.
PLoS neglected tropical diseases 2013, 7, e2436.

Charpentier C, Fagard C, Colin C, Katlama C, Molina JM, Jacomet C, Visseaux B, Taburet AM, Brun-Vézinet F, Chêne G, Yazdanpanah Y, Descamps D, ATTsg
Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).
PloS One 2013, 8, e53621.

Charpentier C, Lambert-Niclot S, Alteri C, Storto A, Flandre P, Svicher V, Perno CF, Brun-Vézinet F, Calvez V, Marcelin AG, Ceccherini-Silberstein F, Descamps D
Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes.
PloS One 2013

Bjerk SM, Baker JV, Emery S, Neuhaus J, Angus B, Gordin FM, Pett SL, Stephan C, Kunisaki KM, ISSG
Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.
PloS One 2013

Charpentier C, Champenois K, Gervais A, Landman R, Joly V, Le Gac S, Larrouy L, Damond F, Brun-Vézinet F, Descamps D, Yazdanpanah Y
Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients.
PloS One 2013, 8, e59205.

Guerrier G, D'Ortenzio E
The Jarisch-Herxheimer reaction in leptospirosis: a systematic review.
PloS One 2013, 8, e59266.

Rondy M, Puig-Barbera J, Launay O, Duval X, Castilla J, Guevara M, Costanzo S, de Gaetano Donati K, Moren A
2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study.
PloS One 2013, 8, e59681.

Lécuroux C, Girault I, Chéret A, Versmisse P, Nembot G, Meyer L, Rouzioux C, Pancino G, Venet A, Sáez-Cirión A, A1Oct
CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection.
PloS One 2013

Lapidus N, de Lamballerie X, Salez N, Setbon M, Delabre RM, Ferrari P, Moyen N, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F
Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population.
PloS One 2013, 8, e60127.

Bacchus C, Cheret A, Avettand-Fenoël V, Nembot G, Mélard A, Blanc C, Lascoux-Combe C, Slama L, Allegre T, Allavena C, Yazdanpanah Y, Duvivier C, Katlama C, Goujard C, Seksik BCP, Leplatois A, Molina JM, Meyer L, Autran B, Rouzioux C, OA1sg
A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection.
PloS One 2013, 8, e64219.

Schwarzinger M, Sagaon-Teyssier L, Cabaret O, Bretagne S, Cordonnier C, PI
Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.
PloS One 2013, 8, e65776.

Birgand G, Lepelletier D, Baron G, Barrett S, Breier AC, Buke C, Markovic-Denic L, Gastmeier P, Kluytmans J, Lyytikainen O, Sheridan E, Szilagyi E, Tacconelli E, Troillet N, Ravaud P, Lucet JC
Agreement among healthcare professionals in ten European countries in diagnosing case-vignettes of surgical-site infections.
PloS One 2013, 8, e68618.

Frange P, Meyer L, Jung M, Goujard C, Zucman D, Abel S, Hochedez P, Gousset M, Gascuel O, Rouzioux C, Chaix ML, APCSG
Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner.
PloS One 2013

Borie R, Crestani B, Dieude P, Nunes H, Allanore Y, Kannengiesser C, Airo P, Matucci-Cerinic M, Wallaert B, Israel-Biet D, Cadranel J, Cottin V, Gazal S, Peljto AL, Varga J, Schwartz DA, Valeyre D, Grandchamp B
The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population.
PloS One 2013, 8, e70621.

Krastinova E, Seng R, Yeni P, Viard JP, Vittecoq D, Lascoux-Combe C, Fourn E, Pahlavan G, Delfraissy JF, Meyer L, APaCC
Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.
PLoS ONE 2013, 8, e71473.

Nicolas-Chanoine MH, Robert J, Vigan M, Laouénan C, Brisse S, Mentré F, Jarlier V, CBsg
Different factors associated with CTX-M-producing ST131 and non-ST131 Escherichia coli clinical isolates.
PloS One 2013, 8, e72191.

Lemaître C, Mahjoub-Messai F, Dupont D, Caro V, Diancourt L, Bingen E, Bidet P, Bonacorsi S
A conserved virulence plasmidic region contributes to the virulence of the multiresistant Escherichia coli meningitis strain S286 belonging to phylogenetic group C.
PloS One 2013, 8, e74423.

Legeai C, Vigouroux C, Souberbielle JC, Bouchaud O, Boufassa F, Bastard JP, Carlier R, Capeau J, Goujard C, Meyer L, Viard JP, ACCSG
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
PLoS ONE 2013, 8, e74868.

Houzé S, Boutron I, Marmorat A, Dalichampt M, Choquet C, Poilane I, Godineau N, Le Guern AS, Thellier M, Broutier H, Fenneteau O, Millet P, Dulucq S, Hubert V, Houzé P, Tubach F, Le Bras J, Matheron S
Performance of rapid diagnostic tests for imported malaria in clinical practice: results of a national multicenter study.
PloS One 2013

Klein N, Sefe D, Mosconi I, Zanchetta M, Castro H, Jacobsen M, Jones H, Bernardi S, Pillay D, Giaquinto C, Walker AS, Gibb DM, De Rossi A, PENfToA1TT
The immunological and virological consequences of planned treatment interruptions in children with HIV infection.
PloS One 2013

Yazdanpanah Y, Perelman J, DiLorenzo MA, Alves J, Barros H, Mateus C, Pereira J, Mansinho K, Robine M, Park JE, Ross EL, Losina E, Walensky RP, Noubary F, Freedberg KA, Paltiel AD
Routine HIV screening in Portugal: clinical impact and cost-effectiveness.
PloS One 2013, 8, e84173.

Skurnik D, Roux D, Aschard H, Cattoir V, Yoder-Himes D, Lory S, Pier GB
A comprehensive analysis of in vitro and in vivo genetic fitness of Pseudomonas aeruginosa using high-throughput sequencing of transposon libraries.
PLoS pathogens 2013, 9, e1003582.

Rafat C, Fihman V, Ricard JD
A 51-year-old man presenting with shock and lower-lobe consolidation with interlobar bulging fissure.
Chest 2013, 143, 1167-1169.

Guedj J, Dahari H, Uprichard SL, Perelson AS
The hepatitis C virus NS5A inhibitor daclatasvir has a dual mode of action and leads to a new virus half-life estimate.
Expert Review of Gastroenterology & Hepatology 2013, 7, 397-399.

Tourret J, Deray G, Isnard-Bagnis C
Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?.
Journal of the American Society of Nephrology: JASN 2013, 24, 1519-1527.

Chougrani I, Luton D, Matheron S, Mandelbrot L, Azria E
Safety of protease inhibitors in HIV-infected pregnant women.
HIV/AIDS (Auckland, N.Z.) 2013, 5, 253-262.

Zaidan M, Lescure FX, Brochériou I, Dettwiler S, Guiard-Schmid JB, Pacanowski J, Rondeau E, Pialoux G, Girard PM, Ronco P, Plaisier E
Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.
Clinical journal of the American Society of Nephrology: CJASN 2013, 8, 930-938.

Dervaux B, Baseilhac E, Fagon JY, portNoGWX(, Ameye V, Angot P, Audry A, Becquemont L, Borel T, Cazeneuve B, Courtois J, Detournay B, Favre P, Granger M, Josseran A, Lassale C, Louvet O, Pinson J, de Pouvourville G, Rochaix L, Rumeau-Pichon C, de Saab R, Schwarzinger M, Sun A
Medico-economic evaluation of health products in the context of the Social Security Financing Act for 2012.
Therapie 2013, 68, 253-263.

Zucman D, De Truchis P, Peytavin G, Descamps D, Duvivier C, Tegna L, Weiss L, Delassus JL, Benalycherif A, Landman R
Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patients.
Scandinavian Journal of Infectious Diseases 2013, 45, 407-410.

Schnell D, Lécuyer H, Geeraerts T, Dumenil AS, Bille E, Mercier FJ, Benhamou D, Zahar JR
Preliminary evaluation of a new clinical algorithm to interpret blood cultures growing coagulase-negative staphylococci.
Scandinavian Journal of Infectious Diseases 2013, 45, 562-566.

Hess A, Klein I, Iung B, Lavallée P, Ilic-Habensus E, Dornic Q, Arnoult F, Mimoun L, Wolff M, Duval X, Laissy JP
Brain MRI findings in neurologically asymptomatic patients with infective endocarditis.
AJNR. American journal of neuroradiology 2013, 34, 1579-1584.

Nguyen LBL, Epelboin L, Gabarre J, Lecso M, Guillot S, Bricaire F, Caumes E, Guiso N
Recurrent Bordetella holmesii bacteremia and nasal carriage in a patient receiving rituximab.
Emerging Infectious Diseases 2013, 19, 1703-1705.

Ruppé E, Andremont A
Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria.
Frontiers in Microbiology 2013, 4, 129.

Ricard JD
The authors respond to: High-flow nasal cannula oxygen therapy in the emergency department: welcome, but selection should be the first step.
Respiratory Care 2013, 58, e67-68.

Bernard C, Brossier F, Sougakoff W, Veziris N, Frechet-Jachym M, Metivier N, Renvoisé A, Robert J, Jarlier V, MTMgotN
A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union.
Euro Surveillance: Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2013, 18, 20555.

Tourdjman M, Le Hello S, Gossner C, Delmas G, Tubiana S, Fabre L, Kerléguer A, Tarantola A, Fruth A, Friesema I, Thorstensen Brandal L, Lawrence J, Fisher I, Dufour M, Weill FX, de Valk H
Unusual increase in reported cases of paratyphoid A fever among travellers returning from Cambodia, January to September 2013.
Euro Surveillance: Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2013, 18,

Zahar JR, Timsit JF
Clostridium difficile outcomes difficult to generalize. Authors' response.
Critical Care (London, England) 2013, 17, 415.

 2012                                                                            

Bouaud J, Messai N, Laouénan C, Mentré F, Séroussi B
Elicitating patient patterns of physician non-compliance with breast cancer guidelines using formal concept analysis.
Studies in Health Technology and Informatics 2012, 180, 477-481.

Yazdanpanah Y, Walensky RP, Rozenbaum W, Yeni P, Paltiel AD
What is a modest public health impact?.
Archives of Internal Medicine 2012, 172, 521-522; author reply 522-523.

Coeurjolly JF, Nguile-Makao M, Timsit JF, Liquet B
Attributable risk estimation for adjusted disability multistate models: application to nosocomial infections.
Biometrical Journal. Biometrische Zeitschrift 2012, 54, 600-616.

Karch H, Denamur E, Dobrindt U, Finlay BB, Hengge R, Johannes L, Ron EZ, Tønjum T, Sansonetti PJ, Vicente M
The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak.
EMBO molecular medicine 2012, 4, 841-848.

Guedj J, Dahari H, Shudo E, Smith P, Perelson AS
Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128).
Hepatology (Baltimore, Md.) 2012, 55, 1030-1037.

Pariente B, Pineton de Chambrun G, Krzysiek R, Desroches M, Louis G, De Cassan C, Baudry C, Gornet JM, Desreumaux P, Emilie D, Colombel JF, Allez M
Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease.
Inflammatory Bowel Diseases 2012, 18, 1199-1206.

Soulié C, Charpentier C, Flandre P, Nino C, Carcelain G, Simon A, Katlama C, Landman R, Brun-Vézinet F, Descamps D, Calvez V, Marcelin AG
Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism.
Journal of Medical Virology 2012, 84, 1853-1856.

Nguyen TT, Bazzoli C, Mentré F
Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models.
Statistics in Medicine 2012, 31, 1043-1058.

Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.
Intensive Care Medicine 2012, 38, 192-209.

Rhodes A, Moreno RP, Azoulay E, Capuzzo M, Chiche JD, Eddleston J, Endacott R, Ferdinande P, Flaatten H, Guidet B, Kuhlen R, León-Gil C, Martin Delgado MC, Metnitz PG, Soares M, Sprung CL, Timsit JF, Valentin A, TFoSaQoESoICM(
Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM).
Intensive Care Medicine 2012, 38, 598-605.

Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation.
Intensive Care Medicine 2012, 38, 345-358.

Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2011: III. ARDS and ECMO, weaning, mechanical ventilation, noninvasive ventilation, pediatrics and miscellanea.
Intensive Care Medicine 2012, 38, 542-556.

Azoulay E, Garrouste M, Goldgran-Toledano D, Adrie C, Max A, Vesin A, Francais A, Zahar JR, Cohen Y, Allaouchiche B, Schlemmer B, Timsit JF
Increased nonbeneficial care in patients spending their birthday in the ICU.
Intensive Care Medicine 2012, 38, 1169-1176.

Ait-Oufella H, Joffre J, Boelle PY, Galbois A, Bourcier S, Baudel JL, Margetis D, Alves M, Offenstadt G, Guidet B, Maury E
Knee area tissue oxygen saturation is predictive of 14-day mortality in septic shock.
Intensive Care Medicine 2012, 38, 976-983.

Dufour N, Delville M, Teboul JL, Camous L, Favier du Noyer A, Richard C, Monnet X
Transpulmonary thermodilution measurements are not affected by continuous veno-venous hemofiltration at high blood pump flow.
Intensive Care Medicine 2012, 38, 1162-1168.

Ricard JD, Roux D
Candida colonization in ventilated ICU patients: no longer a bystander!.
Intensive Care Medicine 2012, 38, 1243-1245.

Timsit JF, L'Hériteau F, Lepape A, Francais A, Ruckly S, Venier AG, Jarno P, Boussat S, Coignard B, Savey A
A multicentre analysis of catheter-related infection based on a hierarchical model.
Intensive Care Medicine 2012, 38, 1662-1672.

Lakhal K, Serveaux-Delous M, Lefrant JY, Capdevila X, Jaber S, AnftRsg
Chest radiographs in 104 French ICUs: current prescription strategies and clinical value (the RadioDay study).
Intensive Care Medicine 2012, 38, 1787-1799.

Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi de Carvalho F, Paiva JA, Cakar N, Ma X, Eggimann P, Antonelli M, Bonten MJM, Csomos A, Krueger WA, Mikstacki A, Lipman J, Depuydt P, Vesin A, Garrouste-Orgeas M, Zahar JR, Blot S, Carlet J, Brun-Buisson C, Martin C, Rello J, Dimopoulos G, Timsit JF
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.
Intensive Care Medicine 2012, 38, 1930-1945.

Messika J, Magdoud F, Clermont O, Margetis D, Gaudry S, Roux D, Branger C, Dreyfuss D, Denamur E, Ricard JD
Pathophysiology of Escherichia coli ventilator-associated pneumonia: implication of highly virulent extraintestinal pathogenic strains.
Intensive Care Medicine 2012, 38, 2007-2016.

Bargui F, D'Agostino I, Mariani-Kurkdjian P, Alberti C, Doit C, Bellier N, Morin L, Galli Gibertini G, Smail A, Zanin A, Lorrot M, Dauger S, Neve M, Faye A, Armoogum P, Bourrillon A, Bingen E, Mercier JC, Bonacorsi S, Nigrovic LE, Titomanlio L
Factors influencing neurological outcome of children with bacterial meningitis at the emergency department.
European Journal of Pediatrics 2012, 171, 1365-1371.

Charpentier C, Piketty C, Laureillard D, Tisserand P, Si-Mohamed A, Weiss L, Bélec L
Dynamics of HIV-1 DNA level in highly antiretroviral-experienced patients receiving raltegravir-based therapy.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 129-133.

Ruppe E, Pitsch A, Tubach F, de Lastours V, Chau F, Pasquet B, Lucet JC, Andremont A, Fantin B
Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.
European Journal of Clinical Microbiology & Infectious Diseases 2012, 31, 319-325.

Angoulvant F, Skurnik D, Bellanger H, Abdoul H, Bellettre X, Morin L, Aptecar M, Galli-Gibertini G, Bourdon O, Doit C, Faye A, Mercier JC, Cohen R, Alberti C
Impact of implementing French antibiotic guidelines for acute respiratory-tract infections in a paediatric emergency department, 2005-2009.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 1295-1303.

Diamantis S, Rioux C, Bonnal C, Farfour É, Papy E, Andremont A, Yeni P, Bouvet É, Lucet JC
Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it.
Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31, 1667–1671.

Diamantis S, Rioux C, Bonnal C, Farfour É, Papy E, Andremont A, Yeni P, Bouvet É, Lucet JC
Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 1667-1671.

Chirouze C, Hoen B, Duval X
Infective endocarditis prophylaxis: moving from dental prophylaxis to global prevention?.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 2089-2095.

Lemaître C, Ferroni A, Doit C, Vu-Thien H, Glorion C, Raymond J, Mary P, Wicart P, Bingen E, Ilharreborde B, Lorrot M
Pediatric osteoarticular infections caused by Streptococcus pneumoniae before and after the introduction of the heptavalent pneumococcal conjugate vaccine.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 2773-2781.

Bidet P, Liguori S, Plainvert C, Bonacorsi S, Courroux C, d'Humières C, Poyart C, Efstratiou A, Bingen E
Identification of group A streptococcal emm types commonly associated with invasive infections and antimicrobial resistance by the use of multiplex PCR and high-resolution melting analysis.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 2817-2826.

Guyot K, Biran V, Doit C, Moissenet D, Guillard T, Brasme L, Courroux C, Maquelin K, van Leeuwen W, Vuthien H, Aujard Y, De Champs C, Bingen E
Raman spectroscopic analysis of the clonal and horizontal spread of CTX-M-15-producing Klebsiella pneumoniae in a neonatal intensive care unit.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 2827-2834.

Mellon G, Clec'h C, Picard B, Cohen Y, Jauréguy F
Postsurgical meningitis due to multiresistant Acinetobacter baumannii successfully treated with high doses of ampicillin/sulbactam combined with rifampicin and fosfomycin.
Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy 2012, 18, 958-960.

Nguyen THT, Comets E, Mentré F
Extension of NPDE for evaluation of nonlinear mixed effect models in presence of data below the quantification limit with applications to HIV dynamic model.
Journal of Pharmacokinetics and Pharmacodynamics 2012, 39, 499-518.

Pallier K, Cazes A, El Khattabi L, Lecchi C, Desroches M, Danel C, Riquet M, Fabre-Guillevin E, Laurent-Puig P, Blons H
DeltaN TP63 reactivation, epithelial phenotype maintenance, and survival in lung squamous cell carcinoma.
Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 2012, 33, 41-51.

de Montmollin E, Corcos O, Noussair L, Leflon-Guibout V, Belmatoug N, Joly F, Lefort A
Retroperitoneal abscesses due to Nocardia farcinica: report of two cases in patients with malnutrition.
Infection 2012, 40, 93-96.

Vuillaumier-Barrot S, Bouchet-Séraphin C, Chelbi M, Devisme L, Quentin S, Gazal S, Laquerrière A, Fallet-Bianco C, Loget P, Odent S, Carles D, Bazin A, Aziza J, Clemenson A, Guimiot F, Bonnière M, Monnot S, Bole-Feysot C, Bernard JP, Loeuillet L, Gonzales M, Socha K, Grandchamp B, Attié-Bitach T, Encha-Razavi F, Seta N
Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly.
American Journal of Human Genetics 2012, 91, 1135-1143.

Guillet M, Zahar JR, Timsit MO, Grandin L, Carbonnelle E, Join-Lambert O, Quesne G, Nassif X, Mejean A, Carbonne A
Horizontal transmission of Streptococcus pneumoniae in the surgical ward: a rare source of nosocomial wound infection.
American Journal of Infection Control 2012, 40, 71-72.

Guet-Revillet H, Le Monnier A, Breton N, Descamps P, Lecuyer H, Alaabouche I, Bureau C, Nassif X, Zahar JR
Environmental contamination with extended-spectrum β-lactamases: is there any difference between Escherichia coli and Klebsiella spp?.
American Journal of Infection Control 2012, 40, 845-848.

Carlet J, Rambaud C, Pulcini C, lcddbm(
[Alliance against MDRO: safeguarding antibiotics].
Ann Fr Anesth Reanim 2012, 31, 704–708.

Fourati S, Malet I, Guenzel CA, Soulie C, Maidou-Peindara P, Morand-Joubert L, Wirden M, Sayon S, Peytavin G, Simon A, Katlama C, Benichou S, Calvez V, Marcelin AG
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations.
Antiviral Research 2012, 93, 167-174.

Escuret V, Cornu C, Boutitie F, Enouf V, Mosnier A, Bouscambert-Duchamp M, Gaillard S, Duval X, Blanchon T, Leport C, Gueyffier F, Van Der Werf S, Lina B
Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
Antiviral Research 2012, 96, 130-137.

Mekinian A, Stirnemann J, Belmatoug N, Heraoui D, Fantin B, Fain O, Charpentier A, Rose C
Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment.
Blood Cells, Molecules & Diseases 2012, 49, 53-57.

Meinzer U, Barreau F, Esmiol-Welterlin S, Jung C, Villard C, Léger T, Ben-Mkaddem S, Berrebi D, Dussaillant M, Alnabhani Z, Roy M, Bonacorsi S, Wolf-Watz H, Perroy J, Ollendorff V, Hugot JP
Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction.
Cell Host & Microbe 2012, 11, 337-351.

Bourcier V, Winnock M, Ait Ahmed M, Sogni P, Pambrun E, Poizot-Martin I, Chaffaut C, Chevret S, Trinchet JC, Salmon D, ACHsg, ACCsg
Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir).
Clinics and Research in Hepatology and Gastroenterology 2012, 36, 214-221.

Ajzenberg N, Ducrocq G, Farnoud R, Huisse MG, Alavoine L, Duval X, Mentré F, Steg PG
Recurrent acute coronary syndromes are associated with increased shear induced platelet aggregation. A case-control study.
International Journal of Cardiology 2012, 155, 313-314.

d'Humières C, Cohen R, Levy C, Bidet P, Thollot F, Wollner A, Bingen E
Decline in macrolide-resistant Streptococcus pyogenes isolates from French children.
International journal of medical microbiology: IJMM 2012, 302, 300-303.

Guglielminotti J, Dehoux M, Mentré F, Bedairia E, Montravers P, Desmonts JM, Longrois D
Assessment of salivary amylase as a stress biomarker in pregnant patients.
International Journal of Obstetric Anesthesia 2012, 21, 35-39.

Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen B, ASG
Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys.
Journal of the American College of Cardiology 2012, 59, 1968-1976.

Sztrymf B, Messika J, Mayot T, Lenglet H, Dreyfuss D, Ricard JD
Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: a prospective observational study.
Journal of Critical Care 2012, 27, 324.e9-13.

Ouanes I, Schwebel C, Français A, Bruel C, Philippart F, Vesin A, Soufir L, Adrie C, Garrouste-Orgeas M, Timsit JF, Misset B, OSG
A model to predict short-term death or readmission after intensive care unit discharge.
Journal of Critical Care 2012, 27, 422.e1-9.

Maylin S, Laouénan C, Martinot-Peignoux M, Panhard X, Lapalus M, Nicolas-Chanoine MH, Bedossa P, Asselah T, Marcellin P
Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2012, 53, 43-47.

Guedj J, Dahari H, Pohl RT, Ferenci P, Perelson AS
Understanding silibinin's modes of action against HCV using viral kinetic modeling.
Journal of Hepatology 2012, 56, 1019-1024.

Deuffic-Burban S, Castel H, Wiegand J, Manns MP, Wedemeyer H, Mathurin P, Yazdanpanah Y
Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysis.
Journal of Hepatology 2012, 57, 260-266.

Zahar JR, Masse V, Watier L, Lanternier F, Degand N, Postaire M, Descamps P, Nassif X, Lortholary O
Is hand-rub consumption correlated with hand hygiene and rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE)-acquired infections?.
The Journal of Hospital Infection 2012, 80, 348-350.

Gibert P, Brudieu E, Timsit JF, Foroni L, Thiébaut-Bertrand A, Allenet B, Pelloux H, Brenier Pinchart MP
Invasive aspergillosis: drug-dispensing systems as a source of filamentous fungal contamination in high-risk units?.
The Journal of Hospital Infection 2012, 82, 293-296.

Pang KAP, Godet C, Fekkar A, Scholler J, Nivoix Y, Letscher-Bru V, Massias L, Kauffmann-Lacroix C, Elsendoorn A, Uzunov M, Datry A, Herbrecht R
Breakthrough invasive mould infections in patients treated with caspofungin.
The Journal of Infection 2012, 64, 424-429.

Fihman V, Le Monnier A, Corvec S, Jaureguy F, Tankovic J, Jacquier H, Carbonnelle E, Bille E, Illiaquer M, Cattoir V, Zahar JR
Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study.
The Journal of Infection 2012, 64, 391-398.

Ricard JD, Conti G, Boucherie M, Hormann C, Poelaert J, Quintel M, Rubertsson S, Torres A
A European survey of nosocomial infection control and hospital-acquired pneumonia prevention practices.
The Journal of Infection 2012, 65, 285-291.

Jolly D, Lorette G, Ambrosi P, Dreyfuss D, Chaffanjon P, Kohler C, Duhaut P, Rogez JM
[Results of the 2011 national ranking in France].
Presse Médicale (Paris, France: 1983) 2012, 41, 323-325.

Nagy-Mignotte H, Guillem P, Vignoud L, Coudurier M, Vesin A, Bonneterre V, Toffart AC, Sakhri L, Brambilla C, Brambilla E, Timsit JF, Moro-Sibilot D, MTOG
Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: a retrospective study of 300 patients.
Lung Cancer (Amsterdam, Netherlands) 2012, 78, 112-120.

Lebeaux D, Zarrouk V, Petrover D, Nicolas-Chanoine MH, Fantin B
Salmonella Colindale osteomyelitis in an immunocompetent female patient.
Medecine Et Maladies Infectieuses 2012, 42, 36-37.

Renault P, Balleydier E, D'Ortenzio E, Bâville M, Filleul L
Epidemiology of Chikungunya infection on Reunion Island, Mayotte, and neighboring countries.
Medecine Et Maladies Infectieuses 2012, 42, 93-101.

Ciotti C, Pellissier G, Rabaud C, Lucet JC, Abiteboul D, Bouvet E, G
Effectiveness of respirator masks for healthcare workers, in France.
Medecine Et Maladies Infectieuses 2012, 42, 264-269.

Gros C, Yazdanpanah Y, Vachet A, Roussel-Delvallez M, Senneville E, Lemaire X
Skin and soft tissue infections due to Panton-Valentine leukocidin producing Staphylococcus aureus.
Medecine Et Maladies Infectieuses 2012, 42, 488-494.

Leport C, Guégan JF, Zylberman P, Bitar D, Bricaire F, Cavallo JD, Eliaszewicz M, Moatti JP
Proceedings of the seminar on Emerging Infectious Diseases, November 9, 2011: current trends and proposals.
Médecine Et Maladies Infectieuses 2012, 42, 569-573.

Viala C, Le Monnier A, Maataoui N, Rousseau C, Collignon A, Poilane I
Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
Journal of Microbiological Methods 2012, 90, 83-85.

Galvan L, Lepejová N, Gaillard MC, Malgorn C, Guillermier M, Houitte D, Bonvento G, Petit F, Dufour N, Héry P, Gérard M, Elalouf JM, Déglon N, Brouillet E, de Chaldée M
Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo.
Neurobiology of Aging 2012, 33, 1845.e5-6.

Minet C, Vivodtzev I, Tamisier R, Arbib F, Wuyam B, Timsit JF, Monneret D, Borel JC, Baguet JP, Lévy P, Pépin JL
Reduced six-minute walking distance, high fat-free-mass index and hypercapnia are associated with endothelial dysfunction in COPD.
Respiratory Physiology & Neurobiology 2012, 183, 128-134.

Froissart A, Gazaignes S, Gellen-Dautremer J, Leflon-Guibout V, Iakovlev G, Zarrouk V, Lefort A, Fantin B
[Intermittent prolonged fever triggered by efforts].
La Revue De Médecine Interne / Fondée ... Par La Société Nationale Francaise De Médecine Interne 2012, 33, 519-521.

Zeidan S, El Ghoneimi A, Peuchmaur M, Bingen E, Bonacorsi S
Effect of partial ureteral obstruction and bacterial virulence on the occurrence of renal scarring in a mouse model.
Urology 2012, 80, 486.e1-7.

Boissier F, Khalil A, Chalumeau-Lemoine L, Lescure FX, Parrot A
Rash diagnosis of blood expectoration.
Lancet (London, England) 2012, 379, 1170.

DeJesus E, Rockstroh JK, Henry K, Molina JM, Gathe J, Ramanathan S, Wei X, Yale K, Szwarcberg J, White K, Cheng AK, Kearney BP, G20ST
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.
Lancet 2012, 379, 2429-2438.

Bidet P, Bonarcorsi S, Bingen E
[Virulence factors and pathophysiology of extraintestinal pathogenic Escherichia coli].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2012, 19 Suppl 3, S80-92.

Mariani-Kurkdjian P, Doit C, Bingen E
[Extended-spectrum beta-lactamase producing-enterobacteriaceae].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2012, 19 Suppl 3, S93-96.

PLTOI(Ipt, OHERE(G, Costagliola D, Lodwick R, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touoloumi G, Mussini C, Castagna A, Stephan C, García F, Zangerle R, Duval X, Pérez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Phillips A
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study.
The Lancet. Infectious Diseases 2012, 12, 119-127.

Dubois A, Gsteiger S, Balser S, Pigeolet E, Steimer JL, Pillai G, Mentré F
Pharmacokinetic similarity of biologics: analysis using nonlinear mixed-effects modeling.
Clinical Pharmacology and Therapeutics 2012, 91, 234-242.

Comets E, Diquet B, Legrain S, Huisse MG, Godon A, Bruhat C, Chauveheid MP, Delpierre S, Duval X, Berrut G, Verstuyft C, Aumont MC, Mentré F
Pharmacokinetic and pharmacodynamic variability of fluindione in octogenarians.
Clinical Pharmacology and Therapeutics 2012, 91, 777-786.

Savic RM, Barrail-Tran A, Duval X, Nembot G, Panhard X, Descamps D, Verstuyft C, Vrijens B, Taburet AM, Goujard C, Mentré F, A13SG
Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients.
Clinical Pharmacology and Therapeutics 2012, 92, 575-583.

Labie D, Denamur E
[Genetic adaptation of bacteria].
Médecine Sciences: M/S 2012, 28, 588-590.

Galbois A, Stenard F, Margetis D
A ghost pancreas.
Gastroenterology 2012, 142, 211, 412.

Deuffic-Burban S, Deltenre P, Buti M, Stroffolini T, Parkes J, Mühlberger N, Siebert U, Moreno C, Hatzakis A, Rosenberg W, Zeuzem S, Mathurin P
Predicted effects of treatment for HCV infection vary among European countries.
Gastroenterology 2012, 143, 974-985.e14.

Préau M, Protopopescu C, Raffi F, Rey D, Chêne G, Marcellin F, Perronne C, Ragnaud JM, Leport C, Spire B, ACACSG
Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability.
AIDS care 2012, 24, 434-443.

Zhou Y, Callendret B, Xu D, Brasky KM, Feng Z, Hensley LL, Guedj J, Perelson AS, Lemon SM, Lanford RE, Walker CM
Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection.
The Journal of Experimental Medicine 2012, 209, 1481-1492.

Nazih H, Raffi F, Taïeb A, Reynes J, Choutet P, Cassuto JP, Ferry T, Chêne G, Leport C, Bard JM, ACAC0SG
Peroxisome proliferator activating receptor alpha and gamma polymorphisms and metabolic abnormalities in HIV-infected patients receiving highly active antiretroviral therapy: the ANRS CO8 APROCO-COPILOTE study.
AIDS research and human retroviruses 2012, 28, 393-399.

Wilkin A, Pozniak AL, Morales-Ramirez J, Lupo SH, Santoscoy M, Grinsztejn B, Ruxrungtham K, Rimsky LT, Vanveggel S, Boven K, TCSG
Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial.
AIDS research and human retroviruses 2012, 28, 437-446.

Péré H, Charpentier C, Mbelesso P, Dandy M, Matta M, Moussa S, De Dieu Longo J, Grésenguet G, Abraham B, Bélec L
Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic.
AIDS research and human retroviruses 2012, 28, 315-323.

Rozenberg S, Lanoy E, Bentata M, Viard JP, Valantin MA, Missy P, Darasteanu I, Roux C, Kolta S, Costagliola D, A1FSG
Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).
AIDS research and human retroviruses 2012, 28, 972-980.

Monleau M, Aghokeng AF, Nkano BA, Chaix ML, Peeters M, AAWG
Drug resistance mutations of HIV type 1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-saharan countries and discordant interpretations.
AIDS research and human retroviruses 2012, 28, 1157-1160.

Biron A, Bobin-Dubigeon C, Volteau C, Piroth L, Perré P, Leport C, Prazuck T, Jovelin T, Billard M, Sébille V, Bard JM, Raffi F, Biron C
Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.
AIDS research and human retroviruses 2012, 28, 1672-1678.

Desmard M, Foresti R, Morin D, Dagouassat M, Dagoussat M, Berdeaux A, Denamur E, Crook SH, Mann BE, Scapens D, Montravers P, Boczkowski J, Motterlini R
Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules.
Antioxidants & Redox Signaling 2012, 16, 153-163.

Jacquier H, Le Monnier A, Carbonnelle E, Corvec S, Illiaquer M, Bille E, Zahar JR, Jauréguy F, Fihman V, Tankovic J, Cattoir V, GSG
In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates.
Microbial Drug Resistance (Larchmont, N.Y.) 2012, 18, 396-401.

Dupont-Rouzeyrol M, Caro V, Guillaumot L, Vazeille M, D'Ortenzio E, Thiberge JM, Baroux N, Gourinat AC, Grandadam M, Failloux AB
Chikungunya virus and the mosquito vector Aedes aegypti in New Caledonia (South Pacific Region).
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.) 2012, 12, 1036-1041.

Laupland KB, Zahar JR, Adrie C, Minet C, Vésin A, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Schwebel C, Jamali S, Darmon M, Dumenil AS, Kallel H, Souweine B, Timsit JF
Severe hypothermia increases the risk for intensive care unit-acquired infection.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1064-1070.

Mermond S, Zurawski V, D'Ortenzio E, Driscoll AJ, DeLuca AN, Deloria-Knoll M, Moïsi JC, Murdoch DR, Missotte I, Besson-Leaud L, Chevalier C, Debarnot V, Feray F, Noireterre S, Duparc B, Fresnais F, O'Connor O, Dupont-Rouzeyrol M, Levine OS
Lower respiratory infections among hospitalized children in New Caledonia: a pilot study for the Pneumonia Etiology Research for Child Health project.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54 Suppl 2, S180-189.

Rammaert B, Lanternier F, Zahar JR, Dannaoui E, Bougnoux ME, Lecuit M, Lortholary O
Healthcare-associated mucormycosis.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54 Suppl 1, S44-54.

Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O, FMSG
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54 Suppl 1, S35-43.

Deuffic-Burban S, Yazdanpanah Y
It is time to change the paradigm for hepatitis C virus testing.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1272-1274.

Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen B, ASG
Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1230-1239.

HCC
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1364-1372.

Wolff M, Mourvillier B
Linezolid for the treatment of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 160-161.

Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Mueller B
Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 651-662.

Amit U, Porat N, Basmaci R, Bidet P, Bonacorsi S, Dagan R, Yagupsky P
Genotyping of invasive Kingella kingae isolates reveals predominant clones and association with specific clinical syndromes.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 1074-1079.

Skurnik D, Kropec A, Roux D, Theilacker C, Huebner J, Pier GB
Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 1188-1197.

Thiébaut R, Charpentier C, Damond F, Taieb A, Antoine R, Capeau J, Chêne G, Collin G, Matheron S, Descamps D, Brun-Vézinet F, FAH2CC
Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 1417-1425.

Dubée V, Lenoir T, Leflon-Guibout V, Briere-Bellier C, Guigui P, Fantin B
Three-month antibiotic therapy for early-onset postoperative spinal implant infections.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 1481-1487.

Iung B, Klein I, Mourvillier B, Olivot JM, Détaint D, Longuet P, Ruimy R, Fourchy D, Laurichesse JJ, Laissy JP, Escoubet B, Duval X, SG
Respective effects of early cerebral and abdominal magnetic resonance imaging on clinical decisions in infective endocarditis.
European Heart Journal Cardiovascular Imaging 2012, 13, 703-710.

Lepage L, Krapf L, Hekimian G, Duval X, Nataf P, Hvass U, Vahanian A, Messika-Zeitoun D
Unusual presentation of cryolife O'Brien(R) stentless aortic valve bioprosthesis dysfunction mimicking infective endocarditis.
European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 2012, 41, 800-805.

Genin A, Desir J, Lambert N, Biervliet M, Van Der Aa N, Pierquin G, Killian A, Tosi M, Urbina M, Lefort A, Libert F, Pirson I, Abramowicz M
Kinetochore KMN network gene CASC5 mutated in primary microcephaly.
Human Molecular Genetics 2012, 21, 5306-5317.

CoOHERE(iE, Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, van Sighem A, Kirk O, Obel N, Panos G, Ghosn J, Dabis F, Mary-Krause M, Leport C, Perez-Hoyos S, Sobrino-Vegas P, Stephan C, Castagna A, Antinori A, d'Arminio Monforte A, Torti C, Mussini C, Isern V, Calmy A, Teira R, Egger M, Grarup J, Chêne G
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.
International Journal of Epidemiology 2012, 41, 433-445.

May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, Thiébaut R, Gill MJ, Kirk O, van Sighem A, Saag MS, Navarro G, Sobrino-Vegas P, Lampe F, Ingle S, Guest JL, Crane HM, D'Arminio Monforte A, Vehreschild JJ, Sterne JAC, ATCC(C
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.
International Journal of Epidemiology 2012, 41, 1807-1820.

Visseaux B, Hurtado-Nedelec M, Charpentier C, Collin G, Storto A, Matheron S, Larrouy L, Damond F, Brun-Vézinet F, Descamps D, AC0H2C
Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool.
The Journal of Infectious Diseases 2012, 205, 111-120.

Skurnik D, Davis MR, Benedetti D, Moravec KL, Cywes-Bentley C, Roux D, Traficante DC, Walsh RL, Maira-Litràn T, Cassidy SK, Hermos CR, Martin TR, Thakkallapalli EL, Vargas SO, McAdam AJ, Lieberman TD, Kishony R, Lipuma JJ, Pier GB, Goldberg JB, Priebe GP
Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection.
The Journal of Infectious Diseases 2012, 205, 1709-1718.

Courbon E, Laylavoix F, Soulié C, Le Beller C, Calvez V, Katlama C, Peytavin G
Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patient.
The Journal of Antimicrobial Chemotherapy 2012, 67, 250-251.

Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C, Cambau E, Aubry A
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
The Journal of Antimicrobial Chemotherapy 2012, 67, 819-831.

Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B
Mycobacterium abscessus: a new antibiotic nightmare.
The Journal of Antimicrobial Chemotherapy 2012, 67, 810-818.

Dominguez S, Ghosn J, Cassard B, Melica G, Poizot-Martin I, Solas C, Lascaux AS, Bouvier-Alias M, Katlama C, Lévy Y, Peytavin G
Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1449-1452.

Marcelin AG, Charpentier C, Wirden M, Landman R, Valantin MA, Simon A, Katlama C, Yeni P, Descamps D, Aubron-Olivier C, Calvez V
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1475-1478.

Lambert-Niclot S, Flandre P, Valantin MA, Peytavin G, Sayon S, Morand-Joubert L, Delaugerre C, Algarte-Genin M, Katlama C, Calvez V, Marcelin AG
Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1470-1474.

Charpentier C, Larrouy L, Visseaux B, Landman R, Levittas M, Storto A, Damond F, Yazdanpanah Y, Yeni P, Brun-Vézinet F, Descamps D
Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1459-1461.

Thiébaut ACM, Arlet G, Andremont A, Papy E, Sollet JP, Bernède-Bauduin C, Guillemot D, Schlemmer B, CSG
Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1525-1536.

Nelson M, Amaya G, Clumeck N, Arns da Cunha C, Jayaweera D, Junod P, Li T, Tebas P, Stevens M, Buelens A, Vanveggel S, Boven K, EaTSG
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2020-2028.

Charpentier C, Landman R, Laouénan C, Joly V, Hamet G, Damond F, Brun-Vézinet F, Mentré F, Descamps D, Yeni P
Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2231-2235.

Lambert-Niclot S, Masquelier B, Cohen Codar I, Soulie C, Delaugerre C, Morand-Joubert L, Charpentier C, Ferre V, Plantier JC, Montes B, Carret S, Perrot V, Peytavin G, Costagliola D, Calvez V, Marcelin AG, ESG
Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2487-2493.

Lê MP, Solas C, Garraffo R, Gagnieu MC, Muret P, Yeni P, Dhiver C, Katlama C, Poizot-Martin I, Durant J, Peytavin G
Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2779-2781.

Guillard T, de Champs C, Moret H, Bertrand X, Scheftel JM, Cambau E
High-resolution melting analysis for rapid characterization of qnr alleles in clinical isolates and detection of two novel alleles, qnrB25 and qnrB42.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2635-2639.

Roux D, Pier GB, Skurnik D
Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2785-2787.

Lescure FX, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard PM, Ronco P, Pialoux G, Plaisier E
HIV-associated kidney glomerular diseases: changes with time and HAART.
Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2012, 27, 2349-2355.

Quesnel C, Piednoir P, Gelly J, Nardelli L, Garnier M, Leçon V, Lasocki S, Bouadma L, Philip I, Elbim C, Mentré F, Soler P, Crestani B, Dehoux M
Alveolar fibrocyte percentage is an independent predictor of poor outcome in patients with acute lung injury.
Critical Care Medicine 2012, 40, 21-28.

Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P, FTMRC
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
Critical Care Medicine 2012, 40, 104-111.

Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, Timsit JF
Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study.
Critical Care Medicine 2012, 40, 11-17.

Laupland KB, Zahar JR, Adrie C, Schwebel C, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Jamali S, Souweine B, Darmon M, Timsit JF
Determinants of temperature abnormalities and influence on outcome of critical illness.
Critical Care Medicine 2012, 40, 145-151.

Garrouste-Orgeas M, Soufir L, Tabah A, Schwebel C, Vesin A, Adrie C, Thuong M, Timsit JF, OSG
A multifaceted program for improving quality of care in intensive care units: IATROREF study.
Critical Care Medicine 2012, 40, 468-476.

Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP, Francais A, Martin C, Guidet B, Timsit JF
Systemic antifungal therapy in critically ill patients without invasive fungal infection*.
Critical Care Medicine 2012, 40, 813-822.

Parienti JJ, du Cheyron D, Timsit JF, Traoré O, Kalfon P, Mimoz O, Mermel LA
Meta-analysis of subclavian insertion and nontunneled central venous catheter-associated infection risk reduction in critically ill adults.
Critical Care Medicine 2012, 40, 1627-1634.

Timsit JF, Bouadma L, Ruckly S, Schwebel C, Garrouste-Orgeas M, Bronchard R, Calvino-Gunther S, Laupland K, Adrie C, Thuong M, Herault MC, Pease S, Arrault X, Lucet JC
Dressing disruption is a major risk factor for catheter-related infections.
Crit Care Med 2012, 40, 1707-14.

Garrouste-Orgeas M, Coquet I, Périer A, Timsit JF, Pochard F, Lancrin F, Philippart F, Vesin A, Bruel C, Blel Y, Angeli S, Cousin N, Carlet J, Misset B
Impact of an intensive care unit diary on psychological distress in patients and relatives*.
Critical Care Medicine 2012, 40, 2033-2040.

Piednoir P, Quesnel C, Nardelli L, Leçon V, Bouadma L, Lasocki S, Philip I, Mailleux A, Soler P, Crestani B, Dehoux M
Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: role of platelet-derived growth factor pathway*.
Critical Care Medicine 2012, 40, 2041-2049.

Heming N, Lettéron P, Driss F, Millot S, El Benna J, Tourret J, Denamur E, Montravers P, Beaumont C, Lasocki S
Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*.
Critical Care Medicine 2012, 40, 2141-2148.

François B, Luyt CE, Dugard A, Wolff M, Diehl JL, Jaber S, Forel JM, Garot D, Kipnis E, Mebazaa A, Misset B, Andremont A, Ploy MC, Jacobs A, Yarranton G, Pearce T, Fagon JY, Chastre J
Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial.
Critical Care Medicine 2012, 40, 2320-2326.

Minet C, Lugosi M, Savoye PY, Menez C, Ruckly S, Bonadona A, Schwebel C, Hamidfar-Roy R, Dumanoir P, Ara-Somohano C, Ferretti GR, Timsit JF
Pulmonary embolism in mechanically ventilated patients requiring computed tomography: Prevalence, risk factors, and outcome.
Critical Care Medicine 2012, 40, 3202-3208.

Bertrand J, Chou M, Richardson DM, Verstuyft C, Leger PD, Mentré F, Taburet AM, Haas DW, A1SG
Multiple genetic variants predict steady-state nevirapine clearance in HIV-infected Cambodians.
Pharmacogenetics and Genomics 2012, 22, 868-876.

Couloigner V, Levy C, François M, Bidet P, Hausdorff WP, Pascal T, Boucherat M, Bingen E, Mariani P, Pierrot S, Bille E, Carbonnelle E, Varon E, Cohen R
Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels.
The Pediatric Infectious Disease Journal 2012, 31, 154-158.

Chauny JV, Lorrot M, Prot-Labarthe S, De Lauzanne A, Doit C, Géréral T, Bourdon O
Treatment of tuberculosis with levofloxacin or moxifloxacin: report of 6 pediatric cases.
The Pediatric Infectious Disease Journal 2012, 31, 1309-1311.

Timsit JF, Laupland KB
Update on bloodstream infections in ICUs.
Current Opinion in Critical Care 2012, 18, 479-486.

Ricard JD
New therapies for pneumonia.
Current Opinion in Pulmonary Medicine 2012, 18, 181-186.

Lebeaux D, Larroque B, Gellen-Dautremer J, Leflon-Guibout V, Dreyer C, Bialek S, Froissart A, Hentic O, Tessier C, Ruimy R, Pelletier AL, Crestani B, Fournier M, Papo T, Barry B, Zarrouk V, Fantin B
Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature.
Medicine 2012, 91, 309-318.

Lamiraud K, Moatti JP, Raffi F, Carrieri MP, Protopopescu C, Michelet C, Schneider L, Collin F, Leport C, Spire B
Adherence to and effectiveness of highly active antiretroviral treatment for HIV infection: assessing the bidirectional relationship.
Medical Care 2012, 50, 410-418.

Sloan CE, Champenois K, Choisy P, Losina E, Walensky RP, Schackman BR, Ajana F, Melliez H, Paltiel AD, Freedberg KA, Yazdanpanah Y, CEoPAC(i
Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.
AIDS (London, England) 2012, 26, 45-56.

Dray-Spira R, Legeai C, Le Den M, Boué F, Lascoux-Combe C, Simon A, May T, Goujard C, Meyer L, ACCSG
Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use.
AIDS 2012, 26, 207–215.

Dray-Spira R, Legeai C, Le Den M, Boué F, Lascoux-Combe C, Simon A, May T, Goujard C, Meyer L, ACCSG
Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use.
AIDS (London, England) 2012, 26, 207-215.

Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Ceron D, Protopopescu C, Leport C, Raffi F, Chêne G, ACACCSG
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
AIDS (London, England) 2012, 26, 303-314.

Lévy Y, Thiébaut R, Gougeon ML, Molina JM, Weiss L, Girard PM, Venet A, Morlat P, Poirier B, Lascaux AS, Boucherie C, Sereni D, Rouzioux C, Viard JP, Lane C, Delfraissy JF, Sereti I, Chêne G, ISG
Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV.
AIDS (London, England) 2012, 26, 711-720.

HCC
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
AIDS (London, England) 2012, 26, 1691-1705.

Pasquet A, Ajana F, Melliez H, Giurca C, Poissy J, Yazdanpanah Y
Central nervous system HIV replication and HIV-related pachymeningitis in a patient on protease inhibitor monotherapy despite an undetectable plasma viral load.
AIDS (London, England) 2012, 26, 1726-1728.

Solas C, Pambrun E, Winnock M, Salmon D, Poizot-Martin I, Dominguez S, Bani-Sadr F, Izopet J, Garraffo R, Peytavin G, AC1HSG
Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?.
AIDS (London, England) 2012, 26, 2193-2199.

PLTOI(Ipt, CoOHERE(G, Nakagawa F, Lodwick R, Costagliola D, van Sighem A, Torti C, Podzamczer D, Mocroft A, Ledergerber B, Dorrucci M, Cozzi-Lepri A, Jansen K, Masquelier B, García F, De Wit S, Stephan C, Obel N, Fätkenhaeuer G, Castagna A, Sambatakou H, Mussini C, Ghosn J, Zangerle R, Duval X, Meyer L, Perez-Hoyos S, Fabre Colin C, Kjaer J, Chene G, Grarup J, Phillips A
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 59, 294-299.

Fagard C, Colin C, Charpentier C, Rami A, Jacomet C, Yeni P, Vittecoq D, Katlama C, Molina JM, Descamps D, Chêne G, Yazdanpanah Y, A1TTG
Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 59, 489-493.

Henard S, Jeanmaire E, Nguyen Y, Yazdanpanah Y, Cheret A, Hoen B, Rey D, Borel A, Chavanet P, May T, Rabaud C, IG
Is total community viral load a robust predictive marker of the efficacy of the TasP strategy?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 61, 400-402.

Cuzin L, Trabelsi S, Delobel P, Barbuat C, Reynes J, Allavena C, Peytavin G, Ghosn J, Lascoux-Combe C, Psomas C, Corbeau P, Flandre P, A1MSg
Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 study.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 61, 557-564.

Bouadma L, Wolff M, Lucet JC
Ventilator-associated pneumonia and its prevention.
Current Opinion in Infectious Diseases 2012, 25, 395-404.

d'Humières C, Birgy A, Doit C, Bidet P, Arlet G, Bingen E
Use of a new screening medium to detect carbapenem-non-susceptible members of the Enterobacteriaceae.
Journal of Medical Microbiology 2012, 61, 878-880.

Touchon M, Charpentier S, Pognard D, Picard B, Arlet G, Rocha EPC, Denamur E, Branger C
Antibiotic resistance plasmids spread among natural isolates of Escherichia coli in spite of CRISPR elements.
Microbiology (Reading, England) 2012, 158, 2997-3004.

Zhao W, Cella M, Della Pasqua O, Burger D, Jacqz-Aigrain E, PENfToA(1sg
Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers.
British Journal of Clinical Pharmacology 2012, 73, 641-650.

Guedj H, Guedj J, Negro F, Lagging M, Westin J, Bochud PY, Bibert S, Neumann AU, DHsg
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin.
Journal of Viral Hepatitis 2012, 19, 488-496.

Galbois A, Zorzi L, Meurisse S, Kernéis S, Margetis D, Alves M, Ait-Oufella H, Baudel JL, Offenstadt G, Maury E, Guidet B
Outcome of spontaneous and iatrogenic pneumothoraces managed with small-bore chest tubes.
Acta Anaesthesiologica Scandinavica 2012, 56, 507-512.

Senneville E, Gaworowska D, Topolinski H, Devemy F, Nguyen S, Singer B, Beltrand E, Legout L, Caillaux M, Descamps D, Canonne JP, Yazdanpanah Y
Outcome of patients with diabetes with negative percutaneous bone biopsy performed for suspicion of osteomyelitis of the foot.
Diabet Med 2012, 29, 56-61.

Pichenot M, Deuffic-Burban S, Cuzin L, Yazdanpanah Y
Efficacy of new antiretroviral drugs in treatment-experienced HIV-infected patients: a systematic review and meta-analysis of recent randomized controlled trials.
HIV Med 2012, 13, 148-55.

Legout L, Sarraz-Bournet B, D'Elia PV, Devos P, Pasquet A, Caillaux M, Wallet F, Yazdanpanah Y, Senneville E, Haulon S, Leroy O
Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18, 352-358.

Bille E, Dauphin B, Leto J, Bougnoux ME, Beretti JL, Lotz A, Suarez S, Meyer J, Join-Lambert O, Descamps P, Grall N, Mory F, Dubreuil L, Berche P, Nassif X, Ferroni A
MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18, 1117-1125.

Lefort A, Chartier L, Sendid B, Wolff M, Mainardi JL, Podglajen I, Desnos-Ollivier M, Fontanet A, Bretagne S, Lortholary O, FMSG
Diagnosis, management and outcome of Candida endocarditis.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18, E99-E109.

Basmaci R, Ilharreborde B, Bidet P, Doit C, Lorrot M, Mazda K, Bingen E, Bonacorsi S
Isolation of Kingella kingae in the oropharynx during K. kingae arthritis in children.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18, E134-136.

Lada O, Gervais A, Branger M, Peytavin G, Roquebert B, Collin G, Fraqueiro G, Moucari R, Hamet G, Martinot-Peignoux M, Matheron S, Marcellin P
Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G.
Liver International: Official Journal of the International Association for the Study of the Liver 2012, 32, 93-101.

Bertrand J, Comets E, Chenel M, Mentré F
Some alternatives to asymptotic tests for the analysis of pharmacogenetic data using nonlinear mixed effects models.
Biometrics 2012, 68, 146-155.

Fournier S, Lepainteur M, Kassis-Chikhani N, Huang M, Brun-Buisson C, Jarlier V, AHOCG
Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.
Journal of Travel Medicine 2012, 19, 320-323.

Guillard T, Cambau E, Neuwirth C, Nenninger T, Mbadi A, Brasme L, Vernet-Garnier V, Bajolet O, de Champs C
Description of a 2,683-base-pair plasmid containing qnrD in two Providencia rettgeri isolates.
Antimicrobial Agents and Chemotherapy 2012, 56, 565-568.

Lebeaux D, Barbier F, Angebault C, Benmahdi L, Ruppé E, Felix B, Gaillard K, Djossou F, Epelboin L, Dupont C, Renard M, Peroz G, Vandenesch F, Wolff M, Andremont A, Ruimy R
Evolution of nasal carriage of methicillin-resistant coagulase-negative staphylococci in a remote population.
Antimicrobial Agents and Chemotherapy 2012, 56, 315-323.

Saleh-Mghir A, Dumitrescu O, Dinh A, Boutrad Y, Massias L, Martin E, Vandenesch F, Etienne J, Lina G, Crémieux AC
Ceftobiprole efficacy in vitro against Panton-Valentine leukocidin production and in vivo against community-associated methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.
Antimicrobial Agents and Chemotherapy 2012, 56, 6291-6297.

Grégoire C, Brumpt C, Loirat D, Lau N, Bruel C, Philippart F, Couzigou C, Garrouste-Orgeas M, Misset B
A case of daptomycin-induced immune thrombocytopenia.
Antimicrobial Agents and Chemotherapy 2012, 56, 6430-6431.

Visseaux B, Charpentier C, Hurtado-Nedelec M, Storto A, Antoine R, Peytavin G, Damond F, Matheron S, Brun-Vézinet F, Descamps D, FAH2C(C0V2
In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors.
Antimicrobial Agents and Chemotherapy 2012, 56, 137-139.

Dahyot S, Mammeri H
Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.
Antimicrobial Agents and Chemotherapy 2012, 56, 1151-1156.

Lepeule R, Ruppé E, Le P, Massias L, Chau F, Nucci A, Lefort A, Fantin B
Cefoxitin as an Alternative to Carbapenems in a Murine Model of Urinary Tract Infection Due to Escherichia coli Harboring CTX-M-15-Type Extended-Spectrum β-Lactamase.
Antimicrobial Agents and Chemotherapy 2012, 56, 1376-1381.

Pouillot F, Chomton M, Blois H, Courroux C, Noelig J, Bidet P, Bingen E, Bonacorsi S
Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15.
Antimicrobial Agents and Chemotherapy 2012, 56, 3568-3575.

Bercot B, Nordmann P, Drancourt M, Poirel L
Chromosome-encoded extended-spectrum class A β-lactamase MIN-1 from Minibacterium massiliensis.
Antimicrobial Agents and Chemotherapy 2012, 56, 4009-4012.

Nguyen TT, Chachaty E, Huy C, Cambier C, de Gunzburg J, Mentré F, Andremont A
Correlation between fecal concentrations of ciprofloxacin and fecal counts of resistant Enterobacteriaceae in piglets treated with ciprofloxacin: toward new means to control the spread of resistance?.
Antimicrobial Agents and Chemotherapy 2012, 56, 4973-4975.

Clavel C, Peytavin G, Tubiana R, Soulié C, Courbon E, Crenn-Hebert C, Ichou H, Blanc C, Schneider L, Katlama C, Marcelin AG, Mandelbrot L
Etravirine concentrations in the cervicovaginal compartment in HIV-1-infected women receiving etravirine-containing antiretroviral therapy: DIVA 02 study.
Antimicrobial Agents and Chemotherapy 2012, 56, 4018-4020.

Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E
Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype.
Infection and Immunity 2012, 80, 1554-1562.

Bingen E, Bidet P, Birgy A, Sobral E, Mariani P, Cohen R
In vitro interaction between cefixime and amoxicillin-clavulanate against extended-spectrum-beta-lactamase-producing Escherichia coli causing urinary tract infection.
Journal of Clinical Microbiology 2012, 50, 2540-2541.

Brisse S, Diancourt L, Laouénan C, Vigan M, Caro V, Arlet G, Drieux L, Leflon-Guibout V, Mentré F, Jarlier V, Nicolas-Chanoine MH, CBSG
Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.
Journal of Clinical Microbiology 2012, 50, 2974-2981.

Broutin V, Bañuls AL, Aubry A, Keck N, Choisy M, Bernardet JF, Michel C, Raymond JC, Libert C, Barnaud A, Stragier P, Portaels F, Terru D, Belon C, Dereure O, Gutierrez C, Boschiroli ML, Van De Perre P, Cambau E, Godreuil S
Genetic diversity and population structure of Mycobacterium marinum: new insights into host and environmental specificities.
Journal of Clinical Microbiology 2012, 50, 3627-3634.

Birgy A, Bidet P, Genel N, Doit C, Decré D, Arlet G, Bingen E
Phenotypic screening of carbapenemases and associated β-lactamases in carbapenem-resistant Enterobacteriaceae.
Journal of Clinical Microbiology 2012, 50, 1295-1302.

Lazareth H, Peytavin G, Polivka L, Dupin N
The hairy-print for levamisole-induced vasculitis.
BMJ case reports 2012, 2012,

Champenois K, Le Gall JM, Jacquemin C, Jean S, Martin C, Rios L, Benoit O, Vermoesen S, Lert F, Spire B, Yazdanpanah Y
ANRS-COM'TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with men.
BMJ open 2012, 2, e000693.

Carrieri MP, Protopopescu C, Le Moing V, Reboud P, Raffi F, Mahy S, Roux P, Cuzin L, Spire B, Leport C, SCACSG
Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapy.
BMJ open 2012

Deuffic-Burban S, Mathurin P, Pol S, Larsen C, Roudot-Thoraval F, Desenclos JC, Dhumeaux D, Yazdanpanah Y
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis.
Gut 2012, 61, 290-296.

Fallot G, Halgand B, Garnier E, Branger M, Gervais A, Roque-Afonso AM, Thiers V, Billaud E, Matheron S, Samuel D, Féray C
Recombination of hepatitis B virus DNA in patients with HIV.
Gut 2012, 61, 1197-1208.

Génin E, Sahbatou M, Gazal S, Babron MC, Perdry H, Leutenegger AL
Could inbred cases identified in GWAS data succeed in detecting rare recessive variants where affected sib-pairs have failed?.
Human Heredity 2012, 74, 142-152.

Bouleti C, Iung B, Laouénan C, Himbert D, Brochet E, Messika-Zeitoun D, Détaint D, Garbarz E, Cormier B, Michel PL, Mentré F, Vahanian A
Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients.
Circulation 2012, 125, 2119-2127.

Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, Dellamonica J, Bouadma L, Cook F, Beji O, Brun-Buisson C, Lemaire F, Brochard L
Fever control using external cooling in septic shock: a randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2012, 185, 1088-1095.

Foucrier A, Woerther PL, Le Dorze M, Ruimy R, Laissy JP, Castier Y, Mourvillier B
Pulmonary sequestration syndrome diagnosed from a Nocardia infection.
American Journal of Respiratory and Critical Care Medicine 2012, 186, 288.

Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Lepape A, Vesin A, Arrault X, Schwebel C, Adrie C, Zahar JR, Ruckly S, Tournegros C, Lucet JC
Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults.
American Journal of Respiratory and Critical Care Medicine 2012, 186, 1272-1278.

Shi JG, Chen X, Emm T, Scherle PA, McGee RF, Lo Y, Landman RR, McKeever EG, Punwani NG, Williams WV, Yeleswaram S
The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in healthy volunteers.
Journal of Clinical Pharmacology 2012, 52, 809-818.

Comets E, Brendel K, Mentré F
Why should prediction discrepancies be renamed standardized visual predictive check?.
Journal of Clinical Pharmacology 2012, 52, 1284-1285; author reply 1286-1287.

Scoccianti C, Vesin A, Martel G, Olivier M, Brambilla E, Timsit JF, Tavecchio L, Brambilla C, Field JK, Hainaut P, EELCC
Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort.
The European Respiratory Journal 2012, 40, 177-184.

Crestani B, Chapron J, Wallaert B, Bergot E, Delaval P, Israel-Biet D, Lacronique J, Monnet I, Reynaud-Gaubert M, Tazi A, Lebtahi R, Debray MP, Brauner M, Dehoux M, Dornic Q, Aubier M, Mentré F, Duval X
Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study.
The European Respiratory Journal 2012, 39, 772-775.

Lemaître C, Bidet P, Bingen E, Bonacorsi S
Transcriptional analysis of the Escherichia coli ColV-Ia plasmid pS88 during growth in human serum and urine.
BMC microbiology 2012, 12, 115.

Aubron C, Glodt J, Matar C, Huet O, Borderie D, Dobrindt U, Duranteau J, Denamur E, Conti M, Bouvet O
Variation in endogenous oxidative stress in Escherichia coli natural isolates during growth in urine.
BMC microbiology 2012, 12, 120.

Liquet B, Timsit JF, Rondeau V
Investigating hospital heterogeneity with a multi-state frailty model: application to nosocomial pneumonia disease in intensive care units.
BMC medical research methodology 2012, 12, 79.

Duval X, Caplanusi A, Laurichesse H, Deplanque D, Loulergue P, Vaman T, Launay O, Gillard P
Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial.
BMC infectious diseases 2012, 12, 162.

Birgy A, Cohen R, Levy C, Bidet P, Courroux C, Benani M, Thollot F, Bingen E
Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in French children.
BMC infectious diseases 2012, 12, 315.

Aubron C, Huet O, Ricome S, Borderie D, Pussard E, Leblanc PE, Bouvet O, Vicaut E, Denamur E, Duranteau J
Changes in urine composition after trauma facilitate bacterial growth.
BMC infectious diseases 2012, 12, 330.

Poissy J, Champenois K, Dewilde A, Melliez H, Georges H, Senneville E, Yazdanpanah Y
Impact of Herpes simplex virus load and red blood cells in cerebrospinal fluid upon herpes simplex meningo-encephalitis outcome.
BMC infectious diseases 2012, 12, 356.

Lapidus N, de Lamballerie X, Salez N, Setbon M, Ferrari P, Delabre RM, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F
Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort.
BMC public health 2012, 12, 417.

Salmon-Ceron D, Cohen J, Winnock M, Roux P, Sadr FB, Rosenthal E, Martin IP, Loko MA, Mora M, Sogni P, Spire B, Dabis F, Carrieri MP, Hg
Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).
BMC health services research 2012, 12,

Meybeck A, Lecomte L, Valette M, Van Grunderbeeck N, Boussekey N, Chiche A, Georges H, Yazdanpanah Y, Leroy O
Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study.
AIDS research and therapy 2012, 9, 27.

Stirnemann J, Vigan M, Hamroun D, Heraoui D, Rossi-Semerano L, Berger MG, Rose C, Camou F, de Roux-Serratrice C, Grosbois B, Kaminsky P, Robert A, Caillaud C, Froissart R, Levade T, Masseau A, Mignot C, Sedel F, Dobbelaere D, Vanier MT, Valayanopoulos V, Fain O, Fantin B, de Villemeur TB, Mentré F, Belmatoug N
The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients.
Orphanet Journal of Rare Diseases 2012, 7, 77.

Hayden JA, Cartwright JL, Riley RD, Vantulder MW, CLBPIMAG
Exercise therapy for chronic low back pain: protocol for an individual participant data meta-analysis.
Systematic Reviews 2012, 1, 64.

Garrouste-Orgeas M, Philippart F, Bruel C, Max A, Lau N, Misset B
Overview of medical errors and adverse events.
Annals of Intensive Care 2012, 2, 2.

Ait-Oufella H, Boelle PY, Galbois A, Baudel JL, Margetis D, Alves M, Offenstadt G, Maury E, Guidet B
Comparison of superior vena cava and femoroiliac vein pressure according to intra-abdominal pressure.
Annals of Intensive Care 2012, 2, 21.

Graftieaux JP, Bollaert PE, Haddad L, Kentish-Barnes N, Nitenberg G, Robert R, Villers D, Dreyfuss D
Contribution of the ethics committee of the French Intensive Care Society to describing a scenario for implementing organ donation after Maastricht type III cardiocirculatory death in France.
Annals of Intensive Care 2012, 2, 23.

Mrozek N, Lautrette A, Timsit JF, Souweine B
How to deal with dialysis catheters in the ICU setting.
Annals of Intensive Care 2012, 2, 48.

Lucet JC
Methicillin-resistant Staphylococcus aureus carriage at ICU admission: to screen (rapidly) or not to screen?.
Critical Care (London, England) 2012, 16, 120.

Richard JCM, Pham T, Brun-Buisson C, Reignier J, Mercat A, Beduneau G, Régnier B, Mourvillier B, Guitton C, Castanier M, Combes A, Le Tulzo Y, Brochard L, Rsg
Interest of a simple on-line screening registry for measuring ICU burden related to an influenza pandemic.
Critical Care (London, England) 2012, 16, R118.

Zahar JR, Schwebel C, Adrie C, Garrouste-Orgeas M, Français A, Vesin A, Nguile-Makao M, Tabah A, Laupland K, Le-Monnier A, Timsit JF, Osg
Outcome of ICU patients with Clostridium difficile infection.
Critical Care (London, England) 2012, 16, R215.

Clec'h C, Darmon M, Lautrette A, Chemouni F, Azoulay E, Schwebel C, Dumenil AS, Garrouste-Orgeas M, Goldgran-Toledano D, Cohen Y, Timsit JF
Efficacy of renal replacement therapy in critically ill patients: a propensity analysis.
Critical Care (London, England) 2012, 16, R236.

Pajares MJ, Agorreta J, Larrayoz M, Vesin A, Ezponda T, Zudaire I, Torre W, Lozano MD, Brambilla E, Brambilla C, Wistuba II, Behrens C, Timsit JF, Pio R, Field JK, Montuenga LM
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2012, 30, 1129-1136.

Plan EL, Maloney A, Mentré F, Karlsson MO, Bertrand J
Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response models.
The AAPS journal 2012, 14, 420-432.

Sonneville R, Schmidt M, Messika J, Ait Hssain A, da Silva D, Klein IF, Bouadma L, Wolff M, Mourvillier B
Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis.
Neurology 2012, 79, 1762-1766.

Colombie V, Pugliese-Wehrlen S, Deuffic-Burban S, Cuzin L, Pugliese P, Katlama C, Poizot-Martin I, Raffi F, Cabie A, Dellamonica P, Yazdanpanah Y, D
Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription.
International journal of STD & AIDS 2012, 23, 865-869.

Schneider L, Ktorza N, Fourati S, Assoumou L, Courbon E, Caby F, Blanc C, Tindel M, Agher R, Marcelin AG, Calvez V, Peytavin G, Katlama C
Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study.
HIV clinical trials 2012, 13, 284-288.

OIPTotCoOHERiE(iE, Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutierrez F, Obel N, Kirk O, Miro JM, Furrer H, Castagna A, De Wit S, Muñoz J, Kjaer J, Grarup J, Chêne G, Bucher H
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.
PLoS medicine 2012, 9, e1001194.

Cambau E, Chauffour-Nevejans A, Tejmar-Kolar L, Matsuoka M, Jarlier V
Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.
PLoS neglected tropical diseases 2012, 6, e1739.

Groh M, Faussart A, Villena I, Ajzenberg D, Carme B, Demar M, Joly V, Houze S, Simon S, Aubert D, Charlois-Ou C, Yeni P
Acute lung, heart, liver, and pancreatic involvements with hyponatremia and retinochoroiditis in a 33-year-old French Guianan patient.
PLoS neglected tropical diseases 2012

Nicolas-Chanoine MH, Jarlier V, Robert J, Arlet G, Drieux L, Leflon-Guibout V, Laouénan C, Larroque B, Caro V, Mentré F, GCB
Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study.
PloS One 2012, 7, e30498.

Boumendil A, Angus DC, Guitonneau AL, Menn AM, Ginsburg C, Takun K, Davido A, Masmoudi R, Doumenc B, Pateron D, Garrouste-Orgeas M, Somme D, Simon T, Aegerter P, Guidet B, ICsg
Variability of intensive care admission decisions for the very elderly.
PloS One 2012, 7, e34387.

Lepelletier D, Ravaud P, Baron G, Lucet JC
Agreement among health care professionals in diagnosing case Vignette-based surgical site infections.
PloS One 2012, 7, e35131.

Lucet JC, Laouenan C, Chelius G, Veziris N, Lepelletier D, Friggeri A, Abiteboul D, Bouvet E, Mentre F, Fleury E
Electronic sensors for assessing interactions between healthcare workers and patients under airborne precautions.
PloS One 2012, 7, e37893.

Basmaci R, Yagupsky P, Ilharreborde B, Guyot K, Porat N, Chomton M, Thiberge JM, Mazda K, Bingen E, Bonacorsi S, Bidet P
Multilocus sequence typing and rtxA toxin gene sequencing analysis of Kingella kingae isolates demonstrates genetic diversity and international clones.
PloS One 2012, 7, e38078.

Bouadma L, Barbier F, Biard L, Esposito-Farèse M, Le Corre B, Macrez A, Salomon L, Bonnal C, Zanker C, Najem C, Mourvillier B, Lucet JC, Régnier B, Wolff M, Tubach F, IASG
Personal decision-making criteria related to seasonal and pandemic A(H1N1) influenza-vaccination acceptance among French healthcare workers.
PloS One 2012, 7, e38646.

Cohen JF, Chalumeau M, Levy C, Bidet P, Thollot F, Wollner A, Bingen E, Cohen R
Spectrum and inoculum size effect of a rapid antigen detection test for group A streptococcus in children with pharyngitis.
PloS One 2012, 7, e39085.

Le Vu S, Velter A, Meyer L, Peytavin G, Guinard J, Pillonel J, Barin F, Semaille C
Biomarker-based HIV incidence in a community sample of men who have sex with men in Paris, France.
PloS One 2012

Verger P, Flicoteaux R, Schwarzinger M, Sagaon-Teyssier L, Peretti-Watel P, Launay O, Sebbah R, Moatti JP
Pandemic influenza (A/H1N1) vaccine uptake among French private general practitioners: a cross sectional study in 2010.
PloS One 2012, 7, e41837.

Pellissier G, Yazdanpanah Y, Adehossi E, Tosini W, Madougou B, Ibrahima K, Lolom I, Legac S, Rouveix E, Champenois K, Rabaud C, Bouvet E
Is universal HBV vaccination of healthcare workers a relevant strategy in developing endemic countries? The case of a university hospital in Niger.
PloS one 2012, 7, e44442.

Legriel S, Schraub O, Azoulay E, Hantson P, Magalhaes E, Coquet I, Bretonniere C, Gilhodes O, Anguel N, Megarbane B, Benayoun L, Schnell D, Plantefeve G, Charpentier J, Argaud L, Mourvillier B, Galbois A, Chalumeau-Lemoine L, Rivoal M, Durand F, Geffroy A, Simon M, Stoclin A, Pallot JL, Arbelot C, Nyunga M, Lesieur O, Troché G, Bruneel F, Cordoliani YS, Bedos JP, Pico F, CIPRESSG(
Determinants of recovery from severe posterior reversible encephalopathy syndrome.
PloS One 2012, 7, e44534.

Al-Salih G, Al-Attar N, Delbosc S, Louedec L, Corvazier E, Loyau S, Michel JB, Pidard D, Duval X, Meilhac O
Role of vegetation-associated protease activity in valve destruction in human infective endocarditis.
PloS One 2012, 7, e45695.

Casalino E, Bernot B, Bouchaud O, Alloui C, Choquet C, Bouvet E, Damond F, Firmin S, Delobelle A, Nkoumazok BE, Der Sahakian G, Viard JP, Zbar OZD, Aslangul E, Krivine A, Zundel J, Ghosn J, Nordmann P, Claessens YE, Tahi T, Riou B, Gautheret-Dejean A, Katlama C, Hausfater P, Brun-Vézinet F, Costagliola D
Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study.
PLoS ONE 2012, 7, e46437.

Vimont S, Boyd A, Bleibtreu A, Bens M, Goujon JM, Garry L, Clermont O, Denamur E, Arlet G, Vandewalle A
The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities.
PloS One 2012, 7, e46547.

Hocqueloux L, Choisy P, Le Moal G, Borsa-Lebas F, Plainchamp D, Legac E, Prazuck T, de la Tribonnière X, Yazdanpanah Y, Parienti JJ
Pharmacologic boosting of atazanavir in maintenance HIV-1 therapy: the COREYA propensity-score adjusted study.
PloS One 2012, 7, e49289.

Ribeiro RM, Li H, Wang S, Stoddard MB, Learn GH, Korber BT, Bhattacharya T, Guedj J, Parrish EH, Hahn BH, Shaw GM, Perelson AS
Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate.
PLoS pathogens 2012, 8, e1002881.

Fougère B, Gaillat J, François P, Cambau E, Corroyer B, de Wazières B, Gavazzi G, Paccalin M, LdSdPIdLFFdGeG
[Adequacy to the recommendations in urinary tract infections: a multicenter transversal survey in hospitalized patients aged over 75 years].
Gériatrie Et Psychologie Neuropsychiatrie Du Vieillissement 2012, 10, 9-15.

Roux D, Huy C, Lolom I, Andremont A, Arlet G, Armand-Lefevre L, Lucet JC
Diversity of extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission.
Scandinavian Journal of Infectious Diseases 2012, 44, 231-236.

Zaidan M, Berçot B, Petit A, Bardin T, Richette P
Whipple disease mimicking adult-onset Still's disease and treated by anakinra: diagnosis using PCR.
Scandinavian Journal of Rheumatology 2012, 41, 321-323.

Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F, Lortholary O, FMSG
Candida spp. with acquired echinocandin resistance, France, 2004-2010.
Emerging Infectious Diseases 2012, 18, 86-90.

Lupo J, Bernard S, Wintenberger C, Baccard M, Vabret A, Antona D, Timsit JF, Morand P
Fatal measles without rash in immunocompetent adult, France.
Emerging Infectious Diseases 2012, 18, 521-523.

Poirel L, Berçot B, Millemann Y, Bonnin RA, Pannaux G, Nordmann P
Carbapenemase-producing Acinetobacter spp. in Cattle, France.
Emerging Infectious Diseases 2012, 18, 523-525.

Cojean S, Houzé S, Haouchine D, Huteau F, Lariven S, Hubert V, Michard F, Bories C, Pratlong F, Le Bras J, Loiseau PM, Matheron S
Leishmania resistance to miltefosine associated with genetic marker.
Emerging Infectious Diseases 2012, 18, 704-706.

Marcelin AG, Descamps D, Tamalet C, Cottalorda J, Izopet J, Delaugerre C, Morand-Joubert L, Trabaud MA, Bettinger D, Rogez S, Ruffault A, Henquell C, Signori-Schmuck A, Bouvier-Alias M, Vallet S, Masquelier B, Flandre P, Calvez V, AARSg
Emerging mutations and associated factors in patients displaying treatment failure on an etravirine-containing regimen.
Antiviral Therapy 2012, 17, 119-123.

Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P, Bouchaud O, Capeau J, Meyer L, Vigouroux C, ACCSG
Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort.
Antivir. Ther. (Lond.) 2012, 17, 91–100.

Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P, Bouchaud O, Capeau J, Meyer L, Vigouroux C, ACCSG
Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort.
Antiviral Therapy 2012, 17, 91-100.

Lada O, Gervais A, Branger M, Peytavin G, Roquebert B, Collin G, Fraqueiro G, Moucari R, Leclerc L, Martinot-Peignoux M, Matheron S, Marcellin P
Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovir.
Antiviral Therapy 2012, 17, 61-70.

Protopopescu C, Raffi F, Brunet-François C, Salmon D, Verdon R, Reboud P, Carrieri MP, Leport C, Spire B, Michel L, AC(CSG
Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.
Antiviral Therapy 2012, 17, 1079-1083.

Carrat F, Duval X, Tubach F, Mosnier A, Van der Werf S, Tibi A, Blanchon T, Leport C, Flahault A, Mentré F, Bsg
Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.
Antiviral Therapy 2012, 17, 1085-1090.

Calin R, Paris L, Simon A, Peytavin G, Wirden M, Schneider L, Valantin MA, Tubiana R, Agher R, Katlama C
Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy.
Antiviral Therapy 2012, 17, 1601-1604.

Chatterjee A, Guedj J, Perelson AS
Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents?.
Antiviral Therapy 2012, 17, 1171-1182.

Laurichesse H, Zimmermann U, Galtier F, Launay O, Duval X, Richard P, Sadorge C, Soubeyrand B
Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults: new considerations for the management of patients with tetanus-prone injuries.
Human Vaccines & Immunotherapeutics 2012, 8, 1875-1881.

Lenglet H, Sztrymf B, Leroy C, Brun P, Dreyfuss D, Ricard JD
Humidified high flow nasal oxygen during respiratory failure in the emergency department: feasibility and efficacy.
Respiratory Care 2012, 57, 1873-1878.

Guiyedi V, Mounoury O, Boucherit S, Longuet P, Brunet-François C, Kendjo E, Ecobichon JL, Okome-Nkoumou M, Leport C, Raffi F
Optimized Antiretroviral Therapy with Darunavir/Ritonavir, Etravirine and/or Raltegarvir: A Salvage Therapy Option in HIV-1 Infected Patients with Long-Term Therapeutic Failures, about 23 Cases.
World Journal of AIDS 2012, 02, 300-305.

Breton G, Bourgarit A, Pavy S, Bonnet D, Martinez V, Duval X, Longuet P, Abgrall S, Simon A, Leport C, PTSG
Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease 2012, 16, 1365-1370.

Hong E, Barraud O, Bidet P, Bingen E, Blondiaux N, Bonacorsi S, Burucoa C, Carrer A, Fortineau N, Couetdic G, Courcol R, Garnier F, Hery-Arnaud G, Lanotte P, Le Bars H, Legrand-Quillien MC, Lemée L, Mereghetti L, Millardet C, Minet J, Plouzeau-Jayle C, Pons JL, Schneider J, Taha MK
Proficiency of PCR in hospital settings for nonculture diagnosis of invasive meningococcal infections.
Clinical Laboratory 2012, 58, 343-346.

Hoen B, Duval X
[Epidemiology of infective endocarditis].
La Revue Du Praticien 2012, 62, 511-514.

Leport C
[Is infective endocarditis prophylaxis always recommended?].
La Revue Du Praticien 2012, 62, 515-517.

De Prost N, Dreyfuss D
How to prevent ventilator-induced lung injury?.
Minerva Anestesiologica 2012, 78, 1054-1066.

Cambau E, Guillard T
Antimicrobials that affect the synthesis and conformation of nucleic acids.
Revue Scientifique Et Technique (International Office of Epizootics) 2012, 31, 77-87, 65-76.

Fournier S, Brossier F, Fortineau N, Gillaizeau F, Akpabie A, Aubry A, Barbut F, Chedhomme FX, Kassis-Chikhani N, Lucet JC, Robert J, Seytre D, Simon I, Vanjak D, Zahar JR, Brun-Buisson C, Jarlier V
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2012, 17,

Woerther PL, Andremont A
[How to explain antibiotic resistance?].
La Revue Du Praticien 2012, 62, 967-971.

Jeanmougin P, Aubert JP, Le Bel J, Nougairède M
[Antibioclic: a tool for rational antibiotic therapy in primary care].
La Revue Du Praticien 2012, 62, 978.

Gaudry S, Ricard JD, Dreyfuss D
[Acute respiratory distress syndrome].
La Revue Du Praticien 2012, 62, 1197-1203.

Séroussi B, Soulet A, Messai N, Laouénan C, Mentré F, Bouaud J
Patient clinical profiles associated with physician non-compliance despite the use of a guideline-based decision support system: a case study with OncoDoc2 using data mining techniques.
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium 2012, 2012, 828-837.

Guedj J, Perelson AS
Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: implications for treatment duration.
Hepatology (Baltimore, Md.) 2011, 53, 1801-1808.

Guedj J, Bazzoli C, Neumann AU, Mentré F
Design evaluation and optimization for models of hepatitis C viral dynamics.
Statistics in Medicine 2011, 30, 1045-1056.

Dubois A, Lavielle M, Gsteiger S, Pigeolet E, Mentré F
Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.
Statistics in Medicine 2011, 30, 2582-2600.

Dahari H, Guedj J, Perelson AS, Layden TJ
Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.
Current Hepatitis Reports 2011, 10, 214-227.

Miskinyte S, Butler MG, Hervé D, Sarret C, Nicolino M, Petralia JD, Bergametti F, Arnould M, Pham VN, Gore AV, Spengos K, Gazal S, Woimant F, Steinberg GK, Weinstein BM, Tournier-Lasserve E
Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.
American Journal of Human Genetics 2011, 88, 718-728.

Stirnemann J, Boutten A, Vincent C, Mekinian A, Heraoui D, Fantin B, Fain O, Mentré F, Belmatoug N
Impact of imiglucerase on the serum glycosylated-ferritin level in Gaucher disease.
Blood Cells, Molecules & Diseases 2011, 46, 34-38.

Le Nagard H, Vincent C, Mentré F, Le Bras J
Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression.
Computer Methods and Programs in Biomedicine 2011, 104, 10-18.

Friggeri A, Chelius G, Fleury E, Fraboulet A, Mentré F, Lucet J
Reconstructing social interactions using an unreliable wireless sensor network.
Computer Communications 2011, 34, 609-618.

Pelletier AL, Stefanescu C, Vincent C, Etienney I, Mentré F, Soulé JC
Is the length of postoperative recurrence on the neo ileum terminal ileum predictable in Crohn's disease?.
Journal of Crohn's & Colitis 2011, 5, 24-27.

Berçot B, Poirel L, Nordmann P
Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: high prevalence among NDM-1 producers.
Diagnostic Microbiology and Infectious Disease 2011, 71, 442-445.

Clermont O, Olier M, Hoede C, Diancourt L, Brisse S, Keroudean M, Glodt J, Picard B, Oswald E, Denamur E
Animal and human pathogenic Escherichia coli strains share common genetic backgrounds.
Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2011, 11, 654-662.

P1(93ST, Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibb DM, Harper L, Harrison L, Hughes M, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
The Lancet. Infectious Diseases 2011, 11, 273-283.

Leutenegger AL, Sahbatou M, Gazal S, Cann H, Génin E
Consanguinity around the world: what do the genomic data of the HGDP-CEPH diversity panel tell us?.
European journal of human genetics: EJHG 2011, 19, 583-587.

Lieberman TD, Michel JB, Aingaran M, Potter-Bynoe G, Roux D, Davis MR, Skurnik D, Leiby N, LiPuma JJ, Goldberg JB, McAdam AJ, Priebe GP, Kishony R
Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes.
Nature Genetics 2011, 43, 1275-1280.

Guedj J, Dahari H, Perelson AS
Understanding the nature of early HCV RNA blips and the use of mathematical modeling of viral kinetics during IFN-based therapy.
Proceedings of the National Academy of Sciences of the United States of America 2011, 108, E302; author reply E303.

Gazal S, Daudin JJ, Robin S
Accuracy of variational estimates for random graph mixture models.
Journal of Statistical Computation and Simulation 2011, 82, 849-862.

Benard A, van Sighem A, Taieb A, Valadas E, Ruelle J, Soriano V, Calmy A, Balotta C, Damond F, Brun-Vezinet F, Chene G, Matheron S, ACSG
Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2011, 52, 1257-1266.

Woerther PL, Angebault C, Jacquier H, Hugede HC, Janssens AC, Sayadi S, El Mniai A, Armand-Lefèvre L, Ruppé E, Barbier F, Raskine L, Page AL, de Rekeneire N, Andremont A
Massive increase, spread, and exchange of extended spectrum β-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2011, 53, 677-685.

Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla F, ASG
The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results?.
European Heart Journal 2011, 32, 2003-2015.

Launay O, Desaint C, Durier C, Loulergue P, Duval X, Jacomet C, Pialoux G, Ghosn J, Raffi F, Rey D, Ajana F, Colin de Verdière N, Reynes J, Foubert V, Roman F, Devaster JM, Delfraissy JF, Aboulker JP, A1HSGatFCVN(NdCeVR
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial.
The Journal of Infectious Diseases 2011, 204, 124-134.

Berçot B, Poirel L, Dortet L, Nordmann P
In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae.
The Journal of Antimicrobial Chemotherapy 2011, 66, 2295-2297.

Gutierrez A, Elez M, Clermont O, Denamur E, Matic I
Escherichia coli YafP protein modulates DNA damaging property of the nitroaromatic compounds.
Nucleic Acids Research 2011, 39, 4192-4201.

Larrouy L, Charpentier C, Landman R, Capitant C, Chazallon C, Yeni P, Peytavin G, Damond F, Brun-Vezinet F, Descamps D, A1sg
Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen.
AIDS (London, England) 2011, 25, 2143-2148.

Depatureaux A, Charpentier C, Leoz M, Unal G, Damond F, Kfutwah A, Vessière A, Simon F, Plantier JC
Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M.
Journal of Acquired Immune Deficiency Syndromes (1999) 2011, 56, 139-145.

Tourret J, Aloulou M, Garry L, Tenaillon O, Dion S, Ryffel B, Monteiro RC, Denamur E
The interaction between a non-pathogenic and a pathogenic strain synergistically enhances extra-intestinal virulence in Escherichia coli.
Microbiology (Reading, England) 2011, 157, 774-785.

Thai HT, Veyrat-Follet C, Vivier N, Dubruc C, Sanderink G, Mentré F, Comets E
A mechanism-based model for the population pharmacokinetics of free and bound aflibercept in healthy subjects.
British Journal of Clinical Pharmacology 2011, 72, 402-414.

Sabarly V, Bouvet O, Glodt J, Clermont O, Skurnik D, Diancourt L, de Vienne D, Denamur E, Dillmann C
The decoupling between genetic structure and metabolic phenotypes in Escherichia coli leads to continuous phenotypic diversity.
Journal of Evolutionary Biology 2011, 24, 1559-1571.

Clermont O, Gordon DM, Brisse S, Walk ST, Denamur E
Characterization of the cryptic Escherichia lineages: rapid identification and prevalence.
Environmental Microbiology 2011, 13, 2468-2477.

Courpon-Claudinon A, Lefort A, Panhard X, Clermont O, Dornic Q, Fantin B, Mentré F, Wolff M, Denamur E, Branger C, CG
Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2011, 17, 557-565.

Denamur E
The 2011 Shiga toxin-producing Escherichia coli O104:H4 German outbreak: a lesson in genomic plasticity.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2011, 17, 1124-1125.

Bonnet-Zamponi D, Aumont MC, Comets E, Bruhat C, Chauveheid MP, Duval X, Huisse MG, Diquet B, Berrut G, Mentre F, Delpierre S, Legrain S
Heparin bridging therapy and bleeding events in octogenarian inpatients with atrial fibrillation starting anticoagulation: results of an ancillary study.
Journal of the American Geriatrics Society 2011, 59, 2174-2178.

Guedj J, Thiébaut R, Commenges D
Joint modeling of the clinical progression and of the biomarkers' dynamics using a mechanistic model.
Biometrics 2011, 67, 59-66.

Lavielle M, Samson A, Karina Fermin A, Mentré F
Maximum likelihood estimation of long-term HIV dynamic models and antiviral response.
Biometrics 2011, 67, 250-259.

Lepelletier D, Andremont A, Grandbastien B, NWG
Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries: about the French recommendations to limit their spread.
Journal of Travel Medicine 2011, 18, 344-351.

Charpentier C, Roquebert B, Delelis O, Larrouy L, Matheron S, Tubiana R, Karmochkine M, Duval X, Chêne G, Storto A, Collin G, Bénard A, Damond F, Mouscadet JF, Brun-Vézinet F, Descamps D, FAH2C(C0V2
Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir.
Antimicrobial Agents and Chemotherapy 2011, 55, 1293-1295.

Billard-Pomares T, Tenaillon O, Le Nagard H, Rouy Z, Cruveiller S, Médigue C, Arlet G, Denamur E, Branger C
Complete nucleotide sequence of plasmid pTN48, encoding the CTX-M-14 extended-spectrum β-lactamase from an Escherichia coli O102-ST405 strain.
Antimicrobial Agents and Chemotherapy 2011, 55, 1270-1273.

Bazzoli C, Bénech H, Rey E, Retout S, Salmon D, Duval X, Tréluyer JM, Mentré F, CA1SG
Joint population pharmacokinetic analysis of zidovudine, lamivudine, and their active intracellular metabolites in HIV patients.
Antimicrobial Agents and Chemotherapy 2011, 55, 3423-3431.

Guillon H, Tande D, Mammeri H
Emergence of Ertapenem Resistance in an Escherichia coli Clinical Isolate Producing Extended-Spectrum ?-Lactamase AmpC▿.
Antimicrobial Agents and Chemotherapy 2011, 55, 4443-4446.

Ingle DJ, Clermont O, Skurnik D, Denamur E, Walk ST, Gordon DM
Biofilm formation by and thermal niche and virulence characteristics of Escherichia spp.
Applied and Environmental Microbiology 2011, 77, 2695-2700.

Vieira G, Sabarly V, Bourguignon PY, Durot M, Le Fèvre F, Mornico D, Vallenet D, Bouvet O, Denamur E, Schachter V, Médigue C
Core and panmetabolism in Escherichia coli.
Journal of Bacteriology 2011, 193, 1461-1472.

Lefort A, Panhard X, Clermont O, Woerther PL, Branger C, Mentré F, Fantin B, Wolff M, Denamur E, CG
Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia.
Journal of Clinical Microbiology 2011, 49, 777-783.

Damond F, Benard A, Balotta C, Böni J, Cotten M, Duque V, Ferns B, Garson J, Gomes P, Gonçalves F, Gottlieb G, Kupfer B, Ruelle J, Rodes B, Soriano V, Wainberg M, Taieb A, Matheron S, Chene G, Brun-Vezinet F, ASG
An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study.
Journal of Clinical Microbiology 2011, 49, 3491-3497.

Rendueles O, Travier L, Latour-Lambert P, Fontaine T, Magnus J, Denamur E, Ghigo JM
Screening of Escherichia coli species biodiversity reveals new biofilm-associated antiadhesion polysaccharides.
mBio 2011, 2, e00043-00011.

Cueff C, Serfaty JM, Cimadevilla C, Laissy JP, Himbert D, Tubach F, Duval X, Iung B, Enriquez-Sarano M, Vahanian A, Messika-Zeitoun D
Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction.
Heart (British Cardiac Society) 2011, 97, 721-726.

Ni XJ, Delelis O, Charpentier C, Storto A, Collin G, Damond F, Descamps D, Mouscadet JF
G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to raltegravir whereas Y143C does not.
Retrovirology 2011, 8, 68.

Maubec E, Petrow P, Scheer-Senyarich I, Duvillard P, Lacroix L, Gelly J, Certain A, Duval X, Crickx B, Buffard V, Basset-Seguin N, Saez P, Duval-Modeste AB, Adamski H, Mansard S, Grange F, Dompmartin A, Faivre S, Mentré F, Avril MF
Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin.
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2011, 29, 3419-3426.

Savic RM, Mentré F, Lavielle M
Implementation and evaluation of the SAEM algorithm for longitudinal ordered categorical data with an illustration in pharmacokinetics-pharmacodynamics.
The AAPS journal 2011, 13, 44-53.

Bertrand J, Laffont CM, Mentré F, Chenel M, Comets E
Development of a complex parent-metabolite joint population pharmacokinetic model.
The AAPS journal 2011, 13, 390-404.

Larsen C, Chaix ML, Le Strat Y, Velter A, Gervais A, Aupérin I, Alric L, Duval X, Miailhes P, Pioche C, Pol S, Piroth L, Delarocque-Astagneau E, scotHs
Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG Study.
PloS One 2011, 6, e29322.

Franrenet S, Moutel G, Raffi F, Dabis F, Bruyand M, Hervé C, Leport C, Duchange N
Information that should be given to HIV cohort participants during ongoing research: the viewpoints of patient representatives and research professionals.
Journal of empirical research on human research ethics: JERHRE 2011, 6, 76-83.

Charpentier C, Larrouy L, Matheron S, Damond F, Delelis O, Mouscadet JF, Campa P, Chêne G, Brun-Vézinet F, Descamps D, FAH2C(C0
Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawal.
Antiviral Therapy 2011, 16, 937-940.

Loulergue P, Duval X, Galtier F, Lenzi N, Laurichesse H, Launay O
Questions for biotechs: REIVAC.
Human Vaccines 2011, 7, 142-143.

PLTOI(IPTftCoOHERE(, Lodwick R, Costagliola D, Reiss P, Torti C, Teira R, Dorrucci M, Ledergerber B, Mocroft A, Podzamczer D, Cozzi-Lepri A, Obel N, Masquelier B, Staszewski S, García F, De Wit S, Castagna A, Antinori A, Judd A, Ghosn J, Touloumi G, Mussini C, Duval X, Ramos J, Meyer L, Warsawski J, Thorne C, Masip J, Pérez-Hoyos S, Pillay D, van Sighem A, Lo Caputo S, Günthard H, Paredes R, De Luca A, Paraskevis D, Fabre-Colin C, Kjaer J, Chêne G, Lundgren JD, Phillips AN
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years.
Archives of Internal Medicine 2010, 170, 410-419.

Piroth L, Larsen C, Binquet C, Alric L, Auperin I, Chaix ML, Dominguez S, Duval X, Gervais A, Ghosn J, Delarocque-Astagneau E, Pol S, SCotHS
Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study.
Hepatology (Baltimore, Md.) 2010, 52, 1915-1921.

Frainais C, Vialard F, Rougier N, Aegerther P, Damond F, Ayel JP, Yazbeck C, Hazout A, Selva J
Impact of freezing/thawing technique on sperm DNA integrity in HIV-1 patients.
Journal of Assisted Reproduction and Genetics 2010, 27, 415-421.

Brendel K, Comets E, Laffont C, Mentré F
Evaluation of different tests based on observations for external model evaluation of population analyses.
Journal of Pharmacokinetics and Pharmacodynamics 2010, 37, 49-65.

Dubois A, Gsteiger S, Pigeolet E, Mentré F
Bioequivalence tests based on individual estimates using non-compartmental or model-based analyses: evaluation of estimates of sample means and type I error for different designs.
Pharmaceutical Research 2010, 27, 92-104.

Selton-Suty C, Doco-Lecompte T, Bernard Y, Duval X, Letranchant L, Delahaye F, Célard M, Alla F, Carteaux JP, Hoen B, ASG
Clinical and microbiologic features of multivalvular endocarditis.
Current Infectious Disease Reports 2010, 12, 237-243.

Bazzoli C, Retout S, Mentré F
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0.
Computer Methods and Programs in Biomedicine 2010, 98, 55-65.

Nguyen DT, Delahaye F, Obadia JF, Duval X, Selton-Suty C, Carteaux JP, Hoen B, Alla F, Asg
Aortic valve replacement for active infective endocarditis: 5-year survival comparison of bioprostheses, homografts and mechanical prostheses.
European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 2010, 37, 1025-1032.

Dhanji H, Doumith M, Clermont O, Denamur E, Hope R, Livermore DM, Woodford N
Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum beta-lactamases.
International Journal of Antimicrobial Agents 2010, 36, 355-358.

Schubert S, Nörenberg D, Clermont O, Magistro G, Wieser A, Romann E, Hoffmann C, Weinert K, Denamur E
Prevalence and phylogenetic history of the TcpC virulence determinant in Escherichia coli.
International journal of medical microbiology: IJMM 2010, 300, 429-434.

Tourret J, Diard M, Garry L, Matic I, Denamur E
Effects of single and multiple pathogenicity island deletions on uropathogenic Escherichia coli strain 536 intrinsic extra-intestinal virulence.
International journal of medical microbiology: IJMM 2010, 300, 435-439.

Stegmann S, Manea ME, Charpentier C, Damond F, Karmochkine M, Laureillard D, Si-Mohamed A, Weiss L, Piketty C
Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2010, 47, 79-81.

Guedj J, Neumann AU
Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
Journal of Theoretical Biology 2010, 267, 330-340.

Depatureaux A, Leoz M, De Oliveira F, Gueudin M, Damond F, Descamps D, Brun-Vézinet F, Lemée V, Simon F, Barin F, Plantier JC
[Specific diagnosis and follow-up of HIV-1 group O infection: RES-O data].
Medecine Et Maladies Infectieuses 2010, 40, 669-676.

Gestermann N, Mekinian A, Comets E, Loiseau P, Puechal X, Hachulla E, Gottenberg JE, Mariette X, Miceli-Richard C
STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling.
Genes and Immunity 2010, 11, 432-438.

Denamur E, Delezoide AL, Alberti C, Bourillon A, Gubler MC, Bouvier R, Pascaud O, Elion J, Grandchamp B, Michel-Calemard L, Missy P, Zaccaria I, Le Nagard H, Gerard B, Loirat C, SFdF, Barbet J, Beaufrère AM, Berchel C, Bessières B, Boudjemaa S, Buenerd A, Carles D, Clemenson A, Dechelotte P, Devisme L, Dijoud F, Espérandieu O, Fallet C, Gonzalès M, Hillion Y, Jacob B, Joubert M, Kermanach P, Lallemand A, Laquerrière A, Laurent N, Liprandi A, Loeuillet L, Loget P, Martinovic J, Ménez F, Narcy F, Roux JJ, Rouleau-Dubois C, Sinico M, Tantau J, Wann AR
Genotype-phenotype correlations in fetuses and neonates with autosomal recessive polycystic kidney disease.
Kidney International 2010, 77, 350-358.

Woerther PL, Angebault C, Lescat M, Ruppé E, Skurnik D, Mniai AE, Clermont O, Jacquier H, Costa AD, Renard M, Bettinger RM, Epelboin L, Dupont C, Guillemot D, Rousset F, Arlet G, Denamur E, Djossou F, Andremont A
Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population.
The Journal of Infectious Diseases 2010, 202, 515-523.

Burgard M, Jasseron C, Matheron S, Damond F, Hamrene K, Blanche S, Faye A, Rouzioux C, Warszawski J, Mandelbro L, AFPCEC
Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2010, 51, 833-843.

Berçot B, Poirel L, Ozdamar M, Hakko E, Türkoglu S, Nordmann P
Low prevalence of 16S methylases among extended-spectrum-beta-lactamase-producing Enterobacteriaceae from a Turkish hospital.
The Journal of Antimicrobial Chemotherapy 2010, 65, 797-798.

Mihaila L, Wyplosz B, Clermont O, Garry L, Hipeaux MC, Vittecoq D, Dussaix E, Denamur E, Branger C
Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone.
The Journal of Antimicrobial Chemotherapy 2010, 65, 1537-1539.

Mnif B, Vimont S, Boyd A, Bourit E, Picard B, Branger C, Denamur E, Arlet G
Molecular characterization of addiction systems of plasmids encoding extended-spectrum beta-lactamases in Escherichia coli.
The Journal of Antimicrobial Chemotherapy 2010, 65, 1599-1603.

PENfToA
Response to planned treatment interruptions in HIV infection varies across childhood.
AIDS (London, England) 2010, 24, 231-241.

Charpentier C, Larrouy L, Collin G, Damond F, Matheron S, Chêne G, Nie T, Schinazi R, Brun-Vézinet F, Descamps D, FAH2C(C0V2
In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572.
AIDS (London, England) 2010, 24, 2753-2755.

Jacquier H, Allard A, Richette P, Ea HK, Sanson-Le Pors MJ, Berçot B
Postoperative spondylodiscitis due to Kytococcus schroeteri in a diabetic woman.
Journal of Medical Microbiology 2010, 59, 127-129.

Potron A, Mainardi JL, Podglajen I, Meunier F, Sanson-le Pors MJ, Berçot B
Recurrent infective endocarditis due to Aggregatibacter actinomycetemcomitans: reinfection or relapse?.
Journal of Medical Microbiology 2010, 59, 1524-1526.

Guedj J, Rong L, Dahari H, Perelson AS
A perspective on modelling hepatitis C virus infection.
Journal of Viral Hepatitis 2010, 17, 825-833.

Berçot B, Poirel L, Silva-Sanchez J, Nordmann P
Association of the extended-spectrum beta-lactamase gene blaTLA-1 with a novel ISCR element, ISCR20.
Antimicrobial Agents and Chemotherapy 2010, 54, 4026-4028.

Depatureaux A, Charpentier C, Collin G, Leoz M, Descamps D, Vessière A, Damond F, Rousset D, Brun-Vézinet F, Plantier JC
Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide.
Antimicrobial Agents and Chemotherapy 2010, 54, 4016-4019.

Chou M, Bertrand J, Segeral O, Verstuyft C, Borand L, Comets E, Le Tiec C, Becquemont L, Ouk V, Mentre F, Taburet AM
Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patients.
Antimicrobial Agents and Chemotherapy 2010, 54, 4432-4439.

Barrail-Tran A, Mentré F, Cosson C, Piketty C, Chazallon C, Gérard L, Girard PM, Taburet AM
Influence of alpha-1 glycoprotein acid concentrations and variants on atazanavir pharmacokinetics in HIV-infected patients included in the ANRS 107 trial.
Antimicrobial Agents and Chemotherapy 2010, 54, 614-619.

Grégoire N, Raherison S, Grignon C, Comets E, Marliat M, Ploy MC, Couet W
Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy 2010, 54, 2379-2384.

Mammeri H, Guillon H, Eb F, Nordmann P
Phenotypic and Biochemical Comparison of the Carbapenem-Hydrolyzing Activities of Five Plasmid-Borne AmpC ?-Lactamases.
Antimicrobial Agents and Chemotherapy 2010, 54, 4556-4560.

Michel A, Clermont O, Denamur E, Tenaillon O
Bacteriophage PhiX174's ecological niche and the flexibility of its Escherichia coli lipopolysaccharide receptor.
Applied and Environmental Microbiology 2010, 76, 7310-7313.

Diard M, Garry L, Selva M, Mosser T, Denamur E, Matic I
Pathogenicity-associated islands in extraintestinal pathogenic Escherichia coli are fitness elements involved in intestinal colonization.
Journal of Bacteriology 2010, 192, 4885-4893.

Moissenet D, Salauze B, Clermont O, Bingen E, Arlet G, Denamur E, Mérens A, Mitanchez D, Vu-Thien H
Meningitis caused by Escherichia coli producing TEM-52 extended-spectrum beta-lactamase within an extensive outbreak in a neonatal ward: epidemiological investigation and characterization of the strain.
Journal of Clinical Microbiology 2010, 48, 2459-2463.

Damond F, Avettand-Fenoel V, Collin G, Roquebert B, Plantier JC, Ganon A, Sizmann D, Babiel R, Glaubitz J, Chaix ML, Brun-Vezinet F, Descamps D, Rouzioux C
Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification.
Journal of Clinical Microbiology 2010, 48, 1413-1416.

Hekimian G, Kim M, Passefort S, Duval X, Wolff M, Leport C, Leplat C, Steg G, Iung B, Vahanian A, Messika-Zeitoun D
Preoperative use and safety of coronary angiography for acute aortic valve infective endocarditis.
Heart (British Cardiac Society) 2010, 96, 696-700.

Ratajczak M, Laroche E, Berthe T, Clermont O, Pawlak B, Denamur E, Petit F
Influence of hydrological conditions on the Escherichia coli population structure in the water of a creek on a rural watershed.
BMC microbiology 2010, 10, 222.

Stirnemann J, Belmatoug N, Vincent C, Fain O, Fantin B, Mentré F
Bone events and evolution of biologic markers in Gaucher disease before and during treatment.
Arthritis Research & Therapy 2010, 12, R156.

Touzain F, Denamur E, Médigue C, Barbe V, El Karoui M, Petit MA
Small variable segments constitute a major type of diversity of bacterial genomes at the species level.
Genome Biology 2010, 11, R45.

Duval X, van der Werf S, Blanchon T, Mosnier A, Bouscambert-Duchamp M, Tibi A, Enouf V, Charlois-Ou C, Vincent C, Andreoletti L, Tubach F, Lina B, Mentré F, Leport C, BSG
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial.
PLoS medicine 2010, 7, e1000362.

Adiba S, Nizak C, van Baalen M, Denamur E, Depaulis F
From grazing resistance to pathogenesis: the coincidental evolution of virulence factors.
PloS One 2010, 5, e11882.

Duval X, Iung B, Klein I, Brochet E, Thabut G, Arnoult F, Lepage L, Laissy JP, Wolff M, Leport C, I(MIatAPoESG
Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study.
Annals of Internal Medicine 2010, 152, 497-504, W175.

Comets E, Brendel K, Mentré F
Model evaluation in nonlinear mixed effect models, with applications to pharmacokinetics.
Journal de la Société Française de Statistique 2010, 151, 106-128.

Duval X
[Meningitis and meningoencephalitis in children].
La Revue Du Praticien 2010, 60, 839-848.

Bazzoli C, Jullien V, Le Tiec C, Rey E, Mentre F, Taburet AM
Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action.
Clinical Pharmacokinetics 2010, 49, 17-45.

Lucet JC, Paoletti X, Demontpion C, Degrave M, Vanjak D, Vincent C, Andremont A, Jarlier V, Mentré F, Nicolas-Chanoine MH, SaRalMeHAD(HSG
Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members.
Archives of Internal Medicine 2009, 169, 1372-1378.

Miceli-Richard C, Gestermann N, Ittah M, Comets E, Loiseau P, Puechal X, Hachulla E, Gottenberg JE, Lebon P, Becquemont L, Mariette X
The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome.
Arthritis and Rheumatism 2009, 60, 1991-1997.

Auber F, Jeanpierre C, Denamur E, Jaubert F, Schleiermacher G, Patte C, Cabrol S, Leverger G, Nihoul-Fékété C, Sarnacki S
Management of Wilms tumors in Drash and Frasier syndromes.
Pediatric Blood & Cancer 2009, 52, 55-59.

Bazzoli C, Retout S, Mentré F
Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
Statistics in Medicine 2009, 28, 1940-1956.

Abramowitz L, Benabderrahmane D, Baron G, Walker F, Yeni P, Duval X
Systematic evaluation and description of anal pathology in HIV-infected patients during the HAART era.
Diseases of the Colon and Rectum 2009, 52, 1130-1136.

Bertrand J, Treluyer JM, Panhard X, Tran A, Auleley S, Rey E, Salmon-Céron D, Duval X, Mentré F, CA1SG
Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART.
European Journal of Clinical Pharmacology 2009, 65, 667-678.

Bertrand J, Comets E, Laffont CM, Chenel M, Mentré F
Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm.
Journal of Pharmacokinetics and Pharmacodynamics 2009, 36, 317-339.

Aparicio T, Navazesh A, Boutron I, Bouarioua N, Chosidow D, Mion M, Choudat L, Sobhani I, Mentré F, Soulé JC
Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment.
Critical Reviews in Oncology/Hematology 2009, 71, 249-257.

Walker F, Abramowitz L, Benabderrahmane D, Duval X, Descatoire V, Hénin D, Lehy T, Aparicio T
Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
Human Pathology 2009, 40, 1517-1527.

Roquebert B, Damond F, Brun-Vézinet F, Descamps D
[HIV genetic diversity and its consequences].
Pathologie-Biologie 2009, 57, 142-148.

Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, Lemée V, Damond F, Robertson DL, Simon F
A new human immunodeficiency virus derived from gorillas.
Nature Medicine 2009, 15, 871-872.

Retout S, Comets E, Bazzoli C, Mentré F
Design Optimization in Nonlinear Mixed Effects Models Using Cost Functions: Application to a Joint Model of Infliximab and Methotrexate Pharmacokinetics.
Communications in Statistics - Theory and Methods 2009, 38, 3351-3368.

Fantin B, Duval X, Massias L, Alavoine L, Chau F, Retout S, Andremont A, Mentré F
Ciprofloxacin dosage and emergence of resistance in human commensal bacteria.
The Journal of Infectious Diseases 2009, 200, 390-398.

Yazdanpanah Y, Fagard C, Descamps D, Taburet AM, Colin C, Roquebert B, Katlama C, Pialoux G, Jacomet C, Piketty C, Bollens D, Molina JM, Chêne G, A1TTG
High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2009, 49, 1441-1449.

Skurnik D, Lacheeb S, Bernede C, le Menac'h A, Elbaz S, Mohler J, Denamur E, Andremont A, Ruimy R
Integrons and antibiotic resistance in phylogenetic group B2 Escherichia coli.
Microbial Drug Resistance (Larchmont, N.Y.) 2009, 15, 173-178.

Marcadé G, Deschamps C, Boyd A, Gautier V, Picard B, Branger C, Denamur E, Arlet G
Replicon typing of plasmids in Escherichia coli producing extended-spectrum beta-lactamases.
The Journal of Antimicrobial Chemotherapy 2009, 63, 67-71.

Turnier SL, Nordmann P, Eb F, Mammeri H
Potential evolution of hydrolysis spectrum for AmpC β-lactamase of Escherichia coli.
Journal of Antimicrobial Chemotherapy 2009, 63, 216-218.

Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppé E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains.
The Journal of Antimicrobial Chemotherapy 2009, 64, 274-277.

Desmard M, Davidge KS, Bouvet O, Morin D, Roux D, Foresti R, Ricard JD, Denamur E, Poole RK, Montravers P, Motterlini R, Boczkowski J
A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia.
FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2009, 23, 1023-1031.

Roux D, Gaudry S, Dreyfuss D, El-Benna J, de Prost N, Denamur E, Saumon G, Ricard JD
Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat.
Critical Care Medicine 2009, 37, 1062-1067.

Landman R, Damond F, Gerbe J, Brun-Vezinet F, Yeni P, Matheron S
Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients.
AIDS (London, England) 2009, 23, 426-428.

Collin F, Duval X, Le Moing V, Piroth L, Al Kaied F, Massip P, Villes V, Chêne G, Raffi F, ACACsg
Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.
AIDS (London, England) 2009, 23, 1021-1024.

Bénard A, Damond F, Campa P, Peytavin G, Descamps D, Lascoux-Combes C, Taieb A, Simon F, Autran B, Brun-Vézinet F, Chêne G, Matheron S, ACH2CSG
Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients.
AIDS (London, England) 2009, 23, 1171-1173.

Mouala C, Guiguet M, Houzé S, Damond F, Pialoux G, Viget N, Costagliola D, Le Bras J, Matheron S, FACCEG
Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl.
AIDS (London, England) 2009, 23, 1997-2004.

Deschamps C, Clermont O, Hipeaux MC, Arlet G, Denamur E, Branger C
Multiple acquisitions of CTX-M plasmids in the rare D2 genotype of Escherichia coli provide evidence for convergent evolution.
Microbiology (Reading, England) 2009, 155, 1656-1668.

Duval X, Mentré F, Rey E, Auleley S, Peytavin G, Biour M, Métro A, Goujard C, Taburet AM, Lascoux C, Panhard X, Tréluyer JM, Salmon-Céron D, C2SG
Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen--ANRS 111 trial.
Fundamental & Clinical Pharmacology 2009, 23, 491-500.

Abbara C, Rousseau JM, Turcant A, Lallement G, Comets E, Bardot I, Clair P, Diquet B
Bioavailability of diazepam after intramuscular injection of its water-soluble prodrug alone or with atropine-pralidoxime in healthy volunteers.
British Journal of Pharmacology 2009, 157, 1390-1397.

Lescat M, Calteau A, Hoede C, Barbe V, Touchon M, Rocha E, Tenaillon O, Médigue C, Johnson JR, Denamur E
A module located at a chromosomal integration hot spot is responsible for the multidrug resistance of a reference strain from Escherichia coli clonal group A.
Antimicrobial Agents and Chemotherapy 2009, 53, 2283-2288.

Mammeri H, Galleni M, Nordmann P
Role of the Ser-287-Asn Replacement in the Hydrolysis Spectrum Extension of AmpC β-Lactamases in Escherichia coli.
Antimicrobial Agents and Chemotherapy 2009, 53, 323-326.

Allou N, Cambau E, Massias L, Chau F, Fantin B
Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.
Antimicrobial Agents and Chemotherapy 2009, 53, 4292-4297.

Bercot B, Kannengiesser C, Oudin C, Grandchamp B, Sanson-le Pors MJ, Mouly S, Elbim C
First description of NOD2 variant associated with defective neutrophil responses in a woman with granulomatous mastitis related to corynebacteria.
Journal of Clinical Microbiology 2009, 47, 3034-3037.

Bergamaschi A, Ayinde D, David A, Le Rouzic E, Morel M, Collin G, Descamps D, Damond F, Brun-Vezinet F, Nisole S, Margottin-Goguet F, Pancino G, Transy C
The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection.
Journal of Virology 2009, 83, 4854-4860.

Klein I, Iung B, Labreuche J, Hess A, Wolff M, Messika-Zeitoun D, Lavallée P, Laissy JP, Leport C, Duval X, ISG
Cerebral microbleeds are frequent in infective endocarditis: a case-control study.
Stroke 2009, 40, 3461-3465.

Lescat M, Hoede C, Clermont O, Garry L, Darlu P, Tuffery P, Denamur E, Picard B
aes, the gene encoding the esterase B in Escherichia coli, is a powerful phylogenetic marker of the species.
BMC microbiology 2009, 9, 273.

Schubert S, Darlu P, Clermont O, Wieser A, Magistro G, Hoffmann C, Weinert K, Tenaillon O, Matic I, Denamur E
Role of intraspecies recombination in the spread of pathogenicity islands within the Escherichia coli species.
PLoS pathogens 2009, 5, e1000257.

Dam E, Quercia R, Glass B, Descamps D, Launay O, Duval X, Kräusslich HG, Hance AJ, Clavel F, A1SG
Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss.
PLoS pathogens 2009, 5, e1000345.

Gros PA, Tenaillon O
Selection for Chaperone-Like Mediated Genetic Robustness at Low Mutation Rate: Impact of Drift, Epistasis and Complexity.
Genetics 2009, 182, 555-564.

Comets E, Zohar S
A survey of the way pharmacokinetics are reported in published phase I clinical trials, with an emphasis on oncology.
Clinical Pharmacokinetics 2009, 48, 387-395.

Peretti-Watel P, Garelik D, Baron G, Spire B, Ravaud P, Duval X, ESG
Smoking motivations and quitting motivations among HIV-infected smokers.
Antiviral Therapy 2009, 14, 781-787.

Guiguet M, Kendjo E, Carcelain G, Abgrall S, Mary-Krause M, Tattevin P, Yazdanpanah Y, Costagliola D, Duval X, FACEG
CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3.
Antiviral Therapy 2009, 14, 451-457.

Peretti-Watel P, Villes V, Duval X, Collin F, Reynes J, Sobel A, Protopopescu C, Chêne G, Spire B, Raffi F, ACACsg
How do HIV-infected smokers react to cigarette price increases? Evidence from the APROCO-COPILOTE-ANRS CO8 Cohort.
Current HIV research 2009, 7, 462-467.

Chenel M, Bouzom F, Cazade F, Ogungbenro K, Aarons L, Mentré F
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial results.
Journal of Pharmacokinetics and Pharmacodynamics 2008, 35, 661-681.

Duval X
[Prophylaxis of infective endocarditis: trends and new recommendations].
Annales De Cardiologie Et D'angeiologie 2008, 57, 102-108.

Comets E, Brendel K, Mentré F
Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.
Computer Methods and Programs in Biomedicine 2008, 90, 154-166.

Guedeney A, Foucault C, Bougen E, Larroque B, Mentré F
Screening for risk factors of relational withdrawal behaviour in infants aged 14-18 months.
European Psychiatry: The Journal of the Association of European Psychiatrists 2008, 23, 150-155.

Rümke HC, Bayas JM, de Juanes JR, Caso C, Richardus JH, Campins M, Rombo L, Duval X, Romanenko V, Schwarz TF, Fassakhov R, Abad-Santos F, von Sonnenburg F, Dramé M, Sänger R, Ballou WR
Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial.
Vaccine 2008, 26, 2378-2388.

Duval X, Gallien S, Leport C
[What is the state of infective endocarditis prophylaxis guidelines according to the latest American recommendations?].
Medecine Et Maladies Infectieuses 2008, 38 Suppl 2, S52-54.

Duval X, Leport C
Prophylaxis of infective endocarditis: current tendencies, continuing controversies.
The Lancet. Infectious Diseases 2008, 8, 225-232.

Bertrand J, Comets E, Mentre F
Comparison of model-based tests and selection strategies to detect genetic polymorphisms influencing pharmacokinetic parameters.
Journal of Biopharmaceutical Statistics 2008, 18, 1084-1102.

Cressey TR, Green H, Khoo S, Treluyer JM, Compagnucci A, Saidi Y, Lallemant M, Gibb DM, Burger DM, PENfToAISG
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2008, 46, 1601-1608.

Mammeri H, Eb F, Berkani A, Nordmann P
Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital.
The Journal of Antimicrobial Chemotherapy 2008, 61, 498-503.

Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C, Denamur E, Arlet G
The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup.
The Journal of Antimicrobial Chemotherapy 2008, 61, 1024-1028.

Roquebert B, Damond F, Collin G, Matheron S, Peytavin G, Bénard A, Campa P, Chêne G, Brun-Vézinet F, Descamps D, FAH2C(C0V2
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro.
The Journal of Antimicrobial Chemotherapy 2008, 62, 914-920.

Essig M, Escoubet B, de Zuttere D, Blanchet F, Arnoult F, Dupuis E, Michel C, Mignon F, Mentre F, Clerici C, Vrtovsnik F
Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease.
Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2008, 23, 239-248.

Gueudin M, Damond F, Braun J, Taïeb A, Lemée V, Plantier JC, Chêne G, Matheron S, Brun-Vézinet F, Simon F
Differences in proviral DNA load between HIV-1- and HIV-2-infected patients.
AIDS (London, England) 2008, 22, 211-215.

Drylewicz J, Matheron S, Lazaro E, Damond F, Bonnet F, Simon F, Dabis F, Brun-Vezinet F, Chêne G, Thiébaut R
Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.
AIDS (London, England) 2008, 22, 457-468.

Damond F, Lariven S, Roquebert B, Males S, Peytavin G, Morau G, Toledano D, Descamps D, Brun-Vezinet F, Matheron S
Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients.
AIDS (London, England) 2008, 22, 665-666.

Leoz M, Depatureaux A, Vessière A, Roquebert B, Damond F, Rousset D, Roques P, Simon F, Plantier JC, ROg
Integrase polymorphism and HIV-1 group O diversity.
AIDS (London, England) 2008, 22, 1239-1243.

Roquebert B, Blum L, Collin G, Damond F, Peytavin G, Leleu J, Matheron S, Chêne G, Brun-Vézinet F, Descamps D, AH2CC
Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen.
AIDS (London, England) 2008, 22, 2045-2046.

Costagliola D, Damond F, Palmer P, Rouzioux C, Brun-Vezinet F
One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection?.
AIDS (London, England) 2008, 22, 2042-2044.

Benhammou V, Warszawski J, Bellec S, Doz F, André N, Lacour B, Levine M, Bavoux F, Tubiana R, Mandelbrot L, Clavel J, Blanche S, AEPF
Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.
AIDS (London, England) 2008, 22, 2165-2177.

Hirt D, Mentré F, Tran A, Rey E, Auleley S, Salmon D, Duval X, Tréluyer JM, CASG
Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
British Journal of Clinical Pharmacology 2008, 65, 548-557.

Bellier C, Bert F, Durand F, Retout S, Belghiti J, Mentré F, Fantin B
Risk factors for Enterobacteriaceae bacteremia after liver transplantation.
Transplant International: Official Journal of the European Society for Organ Transplantation 2008, 21, 755-763.

Clermont O, Lescat M, O'Brien CL, Gordon DM, Tenaillon O, Denamur E
Evidence for a human-specific Escherichia coli clone.
Environmental Microbiology 2008, 10, 1000-1006.

Skurnik D, Bonnet D, Bernède-Bauduin C, Michel R, Guette C, Becker JM, Balaire C, Chau F, Mohler J, Jarlier V, Boutin JP, Moreau B, Guillemot D, Denamur E, Andremont A, Ruimy R
Characteristics of human intestinal Escherichia coli with changing environments.
Environmental Microbiology 2008, 10, 2132-2137.

Gordon DM, Clermont O, Tolley H, Denamur E
Assigning Escherichia coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR triplex method.
Environmental Microbiology 2008, 10, 2484-2496.

Desbois D, Roquebert B, Peytavin G, Damond F, Collin G, Bénard A, Campa P, Matheron S, Chêne G, Brun-Vézinet F, Descamps D, FAH2C(C0V2
In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors.
Antimicrobial Agents and Chemotherapy 2008, 52, 1545-1548.

Damond F, Benard A, Ruelle J, Alabi A, Kupfer B, Gomes P, Rodes B, Albert J, Böni J, Garson J, Ferns B, Matheron S, Chene G, Brun-Vezinet F, ACoH2ISG
Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006.
Journal of Clinical Microbiology 2008, 46, 2088-2091.

Miceli-Richard C, Comets E, Verstuyft C, Tamouza R, Loiseau P, Ravaud P, Kupper H, Becquemont L, Charron D, Mariette X
A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.
Annals of the Rheumatic Diseases 2008, 67, 478-484.

Duval X, Leport C, Danchin N
The new American Heart Association guidelines on the prevention of infective endocarditis: culmination of a long process of thought.
Heart (British Cardiac Society) 2008, 94, 715-716.

Durand-Zaleski IS, Alberti C, Durieux P, Duval X, Gottot S, Ravaud P, Gainotti S, Vincent-Genod C, Moreau D, Amiel P
Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception.
Journal of Medical Ethics 2008, 34, e16.

Rouzet F, Dominguez Hernandez M, Hervatin F, Sarda-Mantel L, Lefort A, Duval X, Louedec L, Fantin B, Le Guludec D, Michel JB
Technetium 99m-labeled annexin V scintigraphy of platelet activation in vegetations of experimental endocarditis.
Circulation 2008, 117, 781-789.

Jaureguy F, Landraud L, Passet V, Diancourt L, Frapy E, Guigon G, Carbonnelle E, Lortholary O, Clermont O, Denamur E, Picard B, Nassif X, Brisse S
Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains.
BMC genomics 2008, 9, 560.

Duval X, Baron G, Garelik D, Villes V, Dupré T, Leport C, Lert F, Peretti-Watel P, Ravaud P, Spire B, ESG
Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study.
Antiviral Therapy 2008, 13, 389-397.

Miceli-Richard C, Comets E, Loiseau P, Puechal X, Hachulla E, Mariette X
Association of an IRF5 gene functional polymorphism with Sjögren's syndrome.
Arthritis and Rheumatism 2007, 56, 3989-3994.

Panhard X, Taburet AM, Piketti C, Mentré F
Impact of modelling intra-subject variability on tests based on non-linear mixed-effects models in cross-over pharmacokinetic trials with application to the interaction of tenofovir on atazanavir in HIV patients.
Statistics in Medicine 2007, 26, 1268-1284.

Retout S, Comets E, Samson A, Mentré F
Design in nonlinear mixed effects models: optimization using the Fedorov-Wynn algorithm and power of the Wald test for binary covariates.
Statistics in Medicine 2007, 26, 5162-5179.

Samson A, Lavielle M, Mentré F
The SAEM algorithm for group comparison tests in longitudinal data analysis based on non-linear mixed-effects model.
Statistics in Medicine 2007, 26, 4860-4875.

Comets E, Verstuyft C, Lavielle M, Jaillon P, Becquemont L, Mentré F
Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters.
European Journal of Clinical Pharmacology 2007, 63, 437-449.

Panhard X, Legrand M, Taburet AM, Diquet B, Goujard C, Mentré F, C1A1SG
Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.
European Journal of Clinical Pharmacology 2007, 63, 1019-1029.

Lavielle M, Mentré F
Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software.
Journal of Pharmacokinetics and Pharmacodynamics 2007, 34, 229-249.

Guedj J, Thiébaut R, Commenges D
Practical identifiability of HIV dynamics models.
Bulletin of Mathematical Biology 2007, 69, 2493-2513.

Clermont O, Johnson JR, Menard M, Denamur E
Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia.
Diagnostic Microbiology and Infectious Disease 2007, 57, 129-136.

Duval X
[Analyzing clinical trials: subgroup, stratified, and intermediate analyses, and composite outcome criteria].
Presse Medicale (Paris, France: 1983) 2007, 36, 519-523.

Diard M, Baeriswyl S, Clermont O, Gouriou S, Picard B, Taddei F, Denamur E, Matic I
Caenorhabditis elegans as a simple model to study phenotypic and genetic virulence determinants of extraintestinal pathogenic Escherichia coli.
Microbes and Infection / Institut Pasteur 2007, 9, 214-223.

Roussel R, Mentré F, Bouchemal N, Hadjadj S, Lièvre M, Chatellier G, Menard J, Panhard X, Le Hénanff A, Marre M, Le Moyec L, DSG
NMR-based prediction of cardiovascular risk in diabetes.
Nature Medicine 2007, 13, 399-400.

Duval X, Alla F, Doco-Lecompte T, Le Moing V, Delahaye F, Mainardi JL, Plesiat P, Célard M, Hoen B, Leport C, AplelPdlI(
Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality.
European Heart Journal 2007, 28, 59-64.

Mammeri H, Poirel L, Nordmann P
Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
The Journal of Antimicrobial Chemotherapy 2007, 60, 490-494.

Le Gall T, Clermont O, Gouriou S, Picard B, Nassif X, Denamur E, Tenaillon O
Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains.
Molecular Biology and Evolution 2007, 24, 2373-2384.

Collin F, Chêne G, Retout S, Peytavin G, Salmon D, Bouvet E, Raffi F, Garraffo R, Mentré F, Duval X, ACACSG
Indinavir trough concentration as a determinant of early nephrolithiasis in HIV-1-infected adults.
Therapeutic Drug Monitoring 2007, 29, 164-170.

Duval X, Peytavin G, Breton G, Ecobichon JL, Descamps D, Thabut G, Leport C
Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination.
AIDS (London, England) 2007, 21, 106-108.

Abramowitz L, Benabderrahmane D, Ravaud P, Walker F, Rioux C, Jestin C, Bouvet E, Soulé JC, Leport C, Duval X
Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors.
AIDS (London, England) 2007, 21, 1457-1465.

Bouvresse S, Sophie B, Marcelin AG, Anne-Geneviève M, Franck N, Nathalie F, Regnier S, Stéphanie R, Damond F, Florence D, Tulliez M, Micheline T, Dupin N, Nicolas D
The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient.
AIDS (London, England) 2007, 21, 1492-1494.

Barin F, Cazein F, Lot F, Pillonel J, Brunet S, Thierry D, Damond F, Brun-Vézinet F, Desenclos JC, Semaille C
Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003-2006.
AIDS (London, England) 2007, 21, 2351-2353.

Gueudin M, Plantier JC, Lemée V, Schmitt MP, Chartier L, Bourlet T, Ruffault A, Damond F, Vray M, Simon F
Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes.
Journal of Acquired Immune Deficiency Syndromes (1999) 2007, 44, 500-505.

Rouet F, Chaix ML, Nerrienet E, Ngo-Giang-Huong N, Plantier JC, Burgard M, Peeters M, Damond F, Ekouevi DK, Msellati P, Ferradini L, Rukobo S, Maréchal V, Schvachsa N, Wakrim L, Rafalimanana C, Rakotoambinina B, Viard JP, Seigneurin JM, Rouzioux C
Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test.
Journal of Acquired Immune Deficiency Syndromes (1999) 2007, 45, 380-388.

Essig M, Duval X, Kaied FA, Iordache L, Gervais A, Longuet P, Blanchet F, Peytavin G, Leport C
Is phosphatemia the best tool to monitor renal tenofovir toxicity?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2007, 46, 256-258.

Dartois C, Brendel K, Comets E, Laffont CM, Laveille C, Tranchand B, Mentre F, Lemenuel-Diot A, Girard P
Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature survey.
British Journal of Clinical Pharmacology 2007, 64, 603-612.

Guedj J, Thiébaut R, Commenges D
Maximum likelihood estimation in dynamical models of HIV.
Biometrics 2007, 63, 1198-1206.

Metkar S, Awasthi S, Denamur E, Kim KS, Gangloff SC, Teichberg S, Haziot A, Silver J, Goyert SM
Role of CD14 in responses to clinical isolates of Escherichia coli: effects of K1 capsule expression.
Infection and Immunity 2007, 75, 5415-5424.

Plainvert C, Bidet P, Peigne C, Barbe V, Médigue C, Denamur E, Bingen E, Bonacorsi S
A new O-antigen gene cluster has a key role in the virulence of the Escherichia coli meningitis clone O45:K1:H7.
Journal of Bacteriology 2007, 189, 8528-8536.

Damond F, Roquebert B, Bénard A, Collin G, Miceli M, Yéni P, Brun-Vezinet F, Descamps D
Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays.
Journal of Clinical Microbiology 2007, 45, 3436-3438.

Karoubi Nordon E, Hayem G, Mentre F, Palazzo E, Legrain S, Meyer O, Raveau P
Late onset systemic lupus erythematosus: a new approach.
Lupus 2007, 16, 1011-1014.

Klein I, Iung B, Wolff M, Brochet E, Longuet P, Laissy JP, Duval X
Silent T2* cerebral microbleeds: a potential new imaging clue in infective endocarditis.
Neurology 2007, 68, 2043.

Silander OK, Tenaillon O, Chao L
Understanding the Evolutionary Fate of Finite Populations: The Dynamics of Mutational Effects.
PLoS Biol 2007, 5, e94.

Tenaillon O, Silander OK, Uzan JP, Chao L
Quantifying Organismal Complexity using a Population Genetic Approach.
PLoS ONE 2007, 2, e217.

Brendel K, Dartois C, Comets E, Lemenuel-Diot A, Laveille C, Tranchand B, Girard P, Laffont CM, Mentré F
Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.
Clinical Pharmacokinetics 2007, 46, 221-234.

Bouaud J, Séroussi B, Brizon A, Culty T, Mentré F, Ravery V
How updating textual clinical practice guidelines impacts clinical decision support systems: a case study with bladder cancer management.
Studies in Health Technology and Informatics 2007, 129, 829-833.

Pasquier C, Anderson D, Andreutti-Zaugg C, Baume-Berkenbosch R, Damond F, Devaux A, Englert Y, Galimand J, Gilling-Smith C, Guist'hau O, Hollander L, Leruez-Ville M, Lesage B, Maillard A, Marcelin Ag, Schmitt MP, Semprini A, Vourliotis M, Xu C, Bujan L, CN
Multicenter quality control of the detection of HIV-1 genome in semen before medically assisted procreation.
Journal of Medical Virology 2006, 78, 877-882.

Mentré F, Escolano S
Prediction discrepancies for the evaluation of nonlinear mixed-effects models.
Journal of Pharmacokinetics and Pharmacodynamics 2006, 33, 345-367.

Brendel K, Comets E, Laffont C, Laveille C, Mentré F
Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide.
Pharmaceutical Research 2006, 23, 2036-2049.

Samson A, Lavielle M, Mentre F
Extension of the SAEM algorithm to left-censored data in nonlinear mixed-effects model: Application to HIV dynamics model.
Computational Statistics & Data Analysis 2006, 51, 1562-1574.

Fonquernie L, Eholié SP, Damond F, Lacombe K, Girard PM
Failure of HIV-2 viral load assay in a severely immunodeficient patient: clinical and therapeutic management issues.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2006, 100, 282-284.

Duval X, Alla F, Hoen B, Danielou F, Larrieu S, Delahaye F, Leport C, Briançon S
Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2006, 42, e102-107.

Johnson JR, Clermont O, Menard M, Kuskowski MA, Picard B, Denamur E
Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source.
The Journal of Infectious Diseases 2006, 194, 1141-1150.

Skurnik D, Ruimy R, Andremont A, Amorin C, Rouquet P, Picard B, Denamur E
Effect of human vicinity on antimicrobial resistance and integrons in animal faecal Escherichia coli.
The Journal of Antimicrobial Chemotherapy 2006, 57, 1215-1219.

Cattoir V, Lesprit P, Lascols C, Denamur E, Legrand P, Soussy CJ, Cambau E
In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
The Journal of Antimicrobial Chemotherapy 2006, 58, 1054-1057.

Matheron S, Damond F, Benard A, Taieb A, Campa P, Peytavin G, Pueyo S, Brun-Vezinet F, Chene G, ACHCSG
CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort.
AIDS (London, England) 2006, 20, 459-462.

Izzedine H, Damond F, Brocheriou I, Ghosn J, Lassal H, Deray G
HIV-2 infection and HIV-associated nephropathy.
AIDS (London, England) 2006, 20, 949-950.

Descamps D, Damond F, Bénard A, Matheron S, Campa P, Taieb A, Yahyaoui R, Chêne G, Brun-Vézinet F
No association between GB virus C infection and disease progression in HIV-2-infected patients from the French ANRS HIV-2 cohort.
AIDS (London, England) 2006, 20, 1076-1079.

Denamur E, Matic I
Evolution of mutation rates in bacteria.
Molecular Microbiology 2006, 60, 820-827.

Escobar-Páramo P, Le Menac'h A, Le Gall T, Amorin C, Gouriou S, Picard B, Skurnik D, Denamur E
Identification of forces shaping the commensal Escherichia coli genetic structure by comparing animal and human isolates.
Environmental Microbiology 2006, 8, 1975-1984.

Le Moing V, Rabaud C, Journot V, Duval X, Cuzin L, Cassuto JP, Al Kaied F, Dellamonica P, Chêne G, Raffi F, ASG
Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimen.
HIV medicine 2006, 7, 261-267.

Kaddouri H, Nakache S, Houzé S, Mentré F, Le Bras J
Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
Antimicrobial Agents and Chemotherapy 2006, 50, 3343-3349.

Mammeri H, Poirel L, Fortineau N, Nordmann P
Naturally Occurring Extended-Spectrum Cephalosporinases in Escherichia coli.
Antimicrobial Agents and Chemotherapy 2006, 50, 2573-2576.

Marchand S, Forsell A, Chenel M, Comets E, Lamarche I, Couet W
Norfloxacin blood-brain barrier transport in rats is not affected by probenecid coadministration.
Antimicrobial Agents and Chemotherapy 2006, 50, 371-373.

Maniar JK, Damond F, Kamath RR, Mandalia S, Surjushe A
Antiretroviral drug-resistant HIV-2 infection--a new therapeutic dilemma.
International journal of STD & AIDS 2006, 17, 781-782.

Hoede C, Denamur E, Tenaillon O
Selection acts on DNA secondary structures to decrease transcriptional mutagenesis.
PLoS genetics 2006, 2, e176.

Alatrakchi N, Damond F, Matheron S, Beretta-Tempelhoff S, Campa P, Carcelain G, Brun-Vezinet F, Autran B, FH2sg
Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection.
AIDS (London, England) 2006, 20, 29-34.

Berki-Benhaddad Z, Ecobichon JL, Mentré F, Capillon A, Certain A, Secondi C, Gervais A, Longuet P, Vildé JL, Leport C
[Adherence intervention for HIV-infected patients receiving antiretroviral treatment. Implementation and initial assessment].
Presse Médicale (Paris, France: 1983) 2006, 35, 1241-1248.

Launay O, Duval X, Dalban C, Descamps D, Peytavin G, Certain A, Mouajjah S, Ralaimazava P, Verdon R, Costagliola D, Clavel F, A1VSG
Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109).
Antiviral Therapy 2006, 11, 889-899.

Descamps D, Ait-Khaled M, Craig C, Delarue S, Damond F, Collin G, Brun-Vézinet F
Rare selection of the K65R mutation in antiretroviral-naive patients failing a first-line abacavir/ lamivudine-containing HAART regimen.
Antiviral Therapy 2006, 11, 701-705.

Bert F, Bellier C, Lassel L, Lefranc V, Durand F, Belghiti J, Mentré F, Fantin B
Risk factors for Staphylococcus aureus infection in liver transplant recipients.
Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005, 11, 1093-1099.

Panhard X, Mentré F
Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.
Statistics in Medicine 2005, 24, 1509-1524.

Jamois C, Comets E, Mentré F, Marion S, Farinotti R, Bonhomme-Faivre L
Pharmacokinetics and neutrophil toxicity of paclitaxel orally administered in mice with recombinant interleukin-2.
Cancer Chemotherapy and Pharmacology 2005, 55, 61-71.

Pillai GC, Mentré F, Steimer JL
Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science.
Journal of Pharmacokinetics and Pharmacodynamics 2005, 32, 161-183.

Labat F, Pradillon O, Garry L, Peuchmaur M, Fantin B, Denamur E
Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis.
FEMS immunology and medical microbiology 2005, 44, 317-321.

Pèlerin H, Compain S, Duval X, Gimenez F, Bénech H, Mabondzo A
Development of an assay method for the detection and quantification of protease and non-nucleoside reverse transcriptase inhibitors in plasma and in peripherical blood mononuclear cells by liquid chromatography coupled with ultraviolet or tandem mass spectrometry detection.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2005, 819, 47-57.

Abramowitz L, Benabderrahmane D, Bouvet E, Duval X
[Anal condyloma prevalence among HIV infected patients].
Medecine Et Maladies Infectieuses 2005, 35, 299-301.

Benveniste O, Flahault A, Rollot F, Elbim C, Estaquier J, Pédron B, Duval X, Dereuddre-Bosquet N, Clayette P, Sterkers G, Simon A, Ameisen JC, Leport C
Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
The Journal of Infectious Diseases 2005, 191, 1670-1679.

Guglielminotti J, Rackelboom T, Tesniere A, Panhard X, Mentre F, Bonay M, Mantz J, Desmonts JM
Assessment of the cough reflex after propofol anaesthesia for colonoscopy.
British Journal of Anaesthesia 2005, 95, 406-409.

Le Gall T, Mavris M, Martino MC, Bernardini ML, Denamur E, Parsot C
Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri.
Microbiology (Reading, England) 2005, 151, 951-962.

Le Gall T, Darlu P, Escobar-Páramo P, Picard B, Denamur E
Selection-driven transcriptome polymorphism in Escherichia coli/Shigella species.
Genome Research 2005, 15, 260-268.

Bourgoin H, Paintaud G, Büchler M, Lebranchu Y, Autret-Leca E, Mentré F, Le Guellec C
Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients.
British Journal of Clinical Pharmacology 2005, 59, 18-27.

Panhard X, Goujard C, Legrand M, Taburet AM, Diquet B, Mentre F
Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV-infected patients on HAART.
British Journal of Clinical Pharmacology 2005, 60, 390-403.

Brendel K, Legrand M, Taburet AM, Baron G, Goujard C, Mentré F, C1A1TG
Population pharmacokinetic analysis of indinavir in HIV-infected patient treated with a stable antiretroviral therapy.
Fundamental & Clinical Pharmacology 2005, 19, 373-383.

Suchland RJ, Bourillon A, Denamur E, Stamm WE, Rothstein DM
Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil.
Antimicrobial Agents and Chemotherapy 2005, 49, 1120-1126.

Skurnik D, Le Menac'h A, Zurakowski D, Mazel D, Courvalin P, Denamur E, Andremont A, Ruimy R
Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure.
Antimicrobial Agents and Chemotherapy 2005, 49, 3062-3065.

Hommais F, Pereira S, Acquaviva C, Escobar-Páramo P, Denamur E
Single-nucleotide polymorphism phylotyping of Escherichia coli.
Applied and Environmental Microbiology 2005, 71, 4784-4792.

Damond F, Brun-Vezinet F, Matheron S, Peytavin G, Campa P, Pueyo S, Mammano F, Lastere S, Farfara I, Simon F, Chene G, Descamps D
Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors.
Journal of Clinical Microbiology 2005, 43, 484-487.

Damond F, Collin G, Descamps D, Matheron S, Pueyo S, Taieb A, Campa P, Benard A, Chêne G, Brun-Vezinet F
Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay.
Journal of Clinical Microbiology 2005, 43, 4234-4236.

Delaunay C, Brun-Vézinet F, Landman R, Collin G, Peytavin G, Trylesinski A, Flandre P, Miller M, Descamps D
Comparative selection of the K65R and M184V/I mutations in human immunodeficiency virus type 1-infected patients enrolled in a trial of first-line triple-nucleoside analog therapy (Tonus IMEA 021).
Journal of Virology 2005, 79, 9572-9578.

Danchin N, Duval X, Leport C
Prophylaxis of infective endocarditis: French recommendations 2002.
Heart (British Cardiac Society) 2005, 91, 715-718.

Driss F, Vrtovsnik F, Katsahian S, Michel C, Baron G, Kolta A, Sedrati N, Mentré F, Mignon F, Cabantchik I, Grandchamp B
Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients.
Nephron. Clinical Practice 2005, 99, c63-67.

Steg PG, Joubin L, McCord J, Abraham WT, Hollander JE, Omland T, Mentré F, McCullough PA, Maisel AS
B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea.
Chest 2005, 128, 21-29.

Gueudin M, Damond F, Simon F
Quantification of proviral DNA load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR.
Methods in Molecular Biology (Clifton, N.J.) 2005, 304, 215-220.

Denamur E, Tenaillon O, Deschamps C, Skurnik D, Ronco E, Gaillard JL, Picard B, Branger C, Matic I
Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli.
Genetics 2005, 171, 825-827.

Branger C, Zamfir O, Geoffroy S, Laurans G, Arlet G, Thien HV, Gouriou S, Picard B, Denamur E
Genetic background of Escherichia coli and extended-spectrum beta-lactamase type.
Emerging Infectious Diseases 2005, 11, 54-61.

Descamps D, Chaix ML, André P, Brodard V, Cottalorda J, Deveau C, Harzic M, Ingrand D, Izopet J, Kohli E, Masquelier B, Mouajjah S, Palmer P, Pellegrin I, Plantier JC, Poggi C, Rogez S, Ruffault A, Schneider V, Signori-Schmück A, Tamalet C, Wirden M, Rouzioux C, Brun-Vezinet F, Meyer L, Costagliola D
French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.
Journal of Acquired Immune Deficiency Syndromes (1999) 2005, 38, 545-552.

Duval X, Mentré F, Lamotte C, Chêne G, Spire B, Dellamonica P, Panhard X, Salmon D, Raffi F, Peytavin G, Leport C, ASG
Indinavir plasma concentration and adherence score are codeterminant of early virologic response in HIV-infected patients of the APROCO cohort.
Therapeutic Drug Monitoring 2005, 27, 63-70.

Duval X, Descamps D, Breton G, Darmon S, Ecobichon JL, Delarue S, Peytavin G, Leport C, Vildé JL, Brun-Vézinet F
Evolution of protease and reverse transcriptase inhibitor resistance-associated mutations in HIV-1-infected protease inhibitor-treated patients with persistent low viraemia.
Antiviral Therapy 2005, 10, 197-199.

Costagliola D, Potard V, Duvivier C, Pradier C, Dupont C, Salmon D, Duval X, FHDoH
Impact of newly available drugs on clinical progression in patients with virological failure after exposure to three classes of antiretrovirals.
Antiviral Therapy 2005, 10, 563-573.

Gambotti L, Batisse D, Colin-de-Verdiere N, Delaroque-Astagneau E, Desenclos JC, Dominguez S, Dupont C, Duval X, Gervais A, Ghosn J, Larsen C, Pol S, Serpaggi J, Simon A, Valantin MA, Velter A, AhCcg
Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2005, 10, 115-117.

Verstuyft C, Marcellin F, Morand-Joubert L, Launay O, Brendel K, Mentré F, Peytavin G, Gérard L, Becquemont L, Aboulker JP, ASG
Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapy.
AIDS (London, England) 2005, 19, 2127-2131.

Damond F, Collin G, Matheron S, Peytavin G, Campa P, Delarue S, Taieb A, Bénard A, Chêne G, Brun-Vézinet F, Descamps D, FAH2C(C5V2
Letter. In vitro phenotypic susceptibility to nucleoside reverse transcriptase inhibitors of HIV-2 isolates with the Q151M mutation in the reverse transcriptase gene.
Antiviral Therapy 2005, 10, 861-865.

Goujard C, Legrand M, Panhard X, Diquet B, Duval X, Peytavin G, Vincent I, Katlama C, Leport C, Bonnet B, Salmon-Céron D, Mentré F, Taburet AM, CA1SG
High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy.
Clinical Pharmacokinetics 2005, 44, 1267-1278.

Tenaillon O, Denamur E, Matic I
Evolutionary significance of stress-induced mutagenesis in bacteria.
Trends in Microbiology 2004, 12, 264-270.

Barraud de Lagerie S, Comets E, Gautrand C, Fernandez C, Auchere D, Singlas E, Mentre F, Gimenez F
Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice.
British Journal of Pharmacology 2004, 141, 1214-1222.

Breton G, Alexandre M, Duval X, Prie D, Peytavin G, Leport C, Vildei JL
Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.
Scandinavian Journal of Infectious Diseases 2004, 36, 527-528.

Lefort A, Arthur M, Depardieu F, Chau F, Pouzet C, Courvalin P, Fantin B
Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
The Journal of Infectious Diseases 2004, 189, 90-97.

Duval X, Selton-Suty C, Alla F, Salvador-Mazenq M, Bernard Y, Weber M, Lacassin F, Nazeyrolas P, Chidiac C, Hoen B, Leport C, AplelPdlI
Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2004, 39, 68-74.

Duval X, Journot V, Leport C, Chêne G, Dupon M, Cuzin L, May T, Morlat P, Waldner A, Salamon R, Raffi F, AC(SG
Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2004, 39, 248-255.

Breton G, Duval X, Estellat C, Poaletti X, Bonnet D, Mvondo Mvondo D, Longuet P, Leport C, Vildé JL
Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2004, 39, 1709-1712.

Breton G, Bouldouyre MA, Gervais A, Duval X, Longuet P, Leport C, Vildé JL
Failure of valacyclovir for herpes zoster in a moderately immunocompromised HIV-infected patient.
AIDS patient care and STDs 2004, 18, 255-257.

Duval X, Peytavin G, Albert I, Bénoliel S, Ecobichon JL, Brun-Vézinet F, Mentré F, Leport C, Vildé JL
Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients.
HIV medicine 2004, 5, 307-313.

Escobar-Páramo P, Grenet K, Le Menac'h A, Rode L, Salgado E, Amorin C, Gouriou S, Picard B, Rahimy MC, Andremont A, Denamur E, Ruimy R
Large-scale population structure of human commensal Escherichia coli isolates.
Applied and Environmental Microbiology 2004, 70, 5698-5700.

Joly V, Descamps D, Peytavin G, Touati F, Mentre F, Duval X, Delarue S, Yeni P, Brun-Vezinet F
Evolution of human immunodeficiency virus type 1 (HIV-1) resistance mutations in nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1-infected patients switched to antiretroviral therapy without NNRTIs.
Antimicrobial Agents and Chemotherapy 2004, 48, 172-175.

Trout H, Mentré F, Panhard X, Kodjo A, Escaut L, Pernet P, Gobert JG, Vittecoq D, Knellwolf AL, Caulin C, Bergmann JF
Enhanced saquinavir exposure in human immunodeficiency virus type 1-infected patients with diarrhea and/or wasting syndrome.
Antimicrobial Agents and Chemotherapy 2004, 48, 538-545.

Escobar-Páramo P, Sabbagh A, Darlu P, Pradillon O, Vaury C, Denamur E, Lecointre G
Decreasing the effects of horizontal gene transfer on bacterial phylogeny: the Escherichia coli case study.
Molecular Phylogenetics and Evolution 2004, 30, 243-250.

Lastere S, Dalban C, Collin G, Descamps D, Girard PM, Clavel F, Costagliola D, Brun-Vezinet F, NTG(0
Impact of insertions in the HIV-1 p6 PTAPP region on the virological response to amprenavir.
Antiviral Therapy 2004, 9, 221-227.

Lamotte C, Landman R, Peytavin G, Mentre F, Gerbe J, Brun-Vezinet F, Boue F, Spiridon G, Valantin MA, Michelet C, Farinotti R, Yeni P
Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study).
Antiviral Therapy 2004, 9, 247-256.

Selton-Suty C, Duval X, Brochet E, Doco-Lecompte T, Hoen B, Delahaye E, Leport C, Danchin N
[New French recommendations for the prophylaxis of infectious endocarditis].
Archives Des Maladies Du Coeur Et Des Vaisseaux 2004, 97, 626-631.

Duval X, Pajot O, Le Moing V, Longuet P, Ecobichon JL, Mentre F, Leport C, Vilde JL
Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy.
AIDS (London, England) 2004, 18, 1342-1344.

Rombout F, Aarons L, Karlsson M, Man A, Mentré F, Nygren P, Racine A, Schaefer H, Steimer JL, Troconiz I, van Peer A, CBE
Modelling and simulation in the development and use of anti-cancer agents: an underused tool?.
Journal of Pharmacokinetics and Pharmacodynamics 2004, 31, 419-440.

Simon-Bouy B, Satre V, Ferec C, Malinge MC, Girodon E, Denamur E, Leporrier N, Lewin P, Forestier F, Muller F, FCG
Hyperechogenic fetal bowel: a large French collaborative study of 682 cases.
American Journal of Medical Genetics. Part A 2003, 121A, 209-213.

Panhard X, Dominique S, Gaub MP, Ravery V, Grandchamp B, Mentré F
Construction of a global score quantifying allelic imbalance among biallelic SIDP markers in bladder cancer.
Statistics in Medicine 2003, 22, 3771-3779.

Camus M, Hennere G, Baron G, Peytavin G, Massias L, Mentre F, Farinotti R
Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity.
European Journal of Clinical Pharmacology 2003, 59, 583-587.

Escobar-Páramo P, Giudicelli C, Parsot C, Denamur E
The evolutionary history of Shigella and enteroinvasive Escherichia coli revised.
Journal of Molecular Evolution 2003, 57, 140-148.

Comets E, Mentré F, Grass P, Kawai R, Marbach P, Vonderscher J
Population pharmacodynamic analysis of octreotide in acromegalic patients.
Clinical Pharmacology and Therapeutics 2003, 73, 95-106.

Retout S, Mentré F
Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics.
Journal of Biopharmaceutical Statistics 2003, 13, 209-227.

Abgrall S, Duval X, Joly V, Descamps D, Matheron S, Costagliola D, CEGftFHDoH
Clinical and immunologic outcome in patients with human immunodeficiency virus infection, according to virologic efficacy in the year after virus undetectability, during antiretroviral therapy.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2003, 37, 1517-1526.

Bjedov I, Tenaillon O, Gérard B, Souza V, Denamur E, Radman M, Taddei F, Matic I
Stress-induced mutagenesis in bacteria.
Science (New York, N.Y.) 2003, 300, 1404-1409.

Jacqz-Aigrain E DT
Population Pharmacokinetics of Nalbuphine in Neonates.
Paediatric and Perinatal Drug Therapy 2003, 5, 190-198.

Legrand M, Comets E, Aymard G, Tubiana R, Katlama C, Diquet B
An in vivo pharmacokinetic/pharmacodynamic model for antiretroviral combination.
HIV clinical trials 2003, 4, 170-183.

Kesrouani AK, Guibourdenche J, Muller F, Denamur E, Vuillard E, Garel C, Delezoide AL, Eydoux P, Tachdjian G, Lebon P, de Lagausie P, Sibony O, Bauman C, Oury JF, Luton D
Etiology and outcome of fetal echogenic bowel. Ten years of experience.
Fetal Diagnosis and Therapy 2003, 18, 240-246.

Imbert F, Jardin M, Fernandez C, Gantier JC, Dromer F, Baron G, Mentre F, Van Beijsterveldt L, Singlas E, Gimenez F
Effect of efflux inhibition on brain uptake of itraconazole in mice infected with Cryptococcus neoformans.
Drug Metabolism and Disposition: The Biological Fate of Chemicals 2003, 31, 319-325.

Bjedov I, Lecointre G, Tenaillon O, Vaury C, Radman M, Taddei F, Denamur E, Matic I
Polymorphism of genes encoding SOS polymerases in natural populations of Escherichia coli.
DNA repair 2003, 2, 417-426.

Loirat C, André JL, Champigneulle J, Acquaviva C, Chantereau D, Bourquard R, Elion J, Denamur E
WT1 splice site mutation in a 46,XX female with minimal-change nephrotic syndrome and Wilms' tumour.
Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2003, 18, 823-825.

Crémieux AC, Muller-Serieys C, Panhard X, Delatour F, Tchimichkian M, Mentre F, Andremont A
Emergence of resistance in normal human aerobic commensal flora during telithromycin and amoxicillin-clavulanic acid treatments.
Antimicrobial Agents and Chemotherapy 2003, 47, 2030-2035.

Hommais F, Gouriou S, Amorin C, Bui H, Rahimy MC, Picard B, Denamur E
The FimH A27V mutation is pathoadaptive for urovirulence in Escherichia coli B2 phylogenetic group isolates.
Infection and Immunity 2003, 71, 3619-3622.

Breton G, Duval X, Gervais A, Longuet P, Leport C, Vildé JL
Retroviral rebound syndrome with meningoencephalitis after cessation of antiretroviral therapy.
The American Journal of Medicine 2003, 114, 769-770.

Servin FS, Bougeois B, Gomeni R, Mentré F, Farinotti R, Desmonts JM
Pharmacokinetics of propofol administered by target-controlled infusion to alcoholic patients.
Anesthesiology 2003, 99, 576-585.

Kousignian I, Abgrall S, Duval X, Descamps D, Matheron S, Costagliola D, CEGotFHDoH
Modeling the time course of CD4 T-lymphocyte counts according to the level of virologic rebound in HIV-1-infected patients on highly active antiretroviral therapy.
Journal of Acquired Immune Deficiency Syndromes (1999) 2003, 34, 50-57.

Comets E, Ikeda K, Hoff P, Fumoleau P, Wanders J, Tanigawara Y
Comparison of the pharmacokinetics of S-1, an oral anticancer agent, in Western and Japanese patients.
Journal of Pharmacokinetics and Pharmacodynamics 2003, 30, 257-283.

Retout S, Mentré F
Optimization of individual and population designs using Splus.
Journal of Pharmacokinetics and Pharmacodynamics 2003, 30, 417-443.

Retout S, Mentré F, Bruno R
Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics.
Statistics in Medicine 2002, 21, 2623-2639.

Lucet JC, Rigaud MP, Mentre F, Kassis N, Deblangy C, Andremont A, Bouvet E
Hand contamination before and after different hand hygiene techniques: a randomized clinical trial.
Journal of Hospital Infection 2002, 50, 276-280.

Denamur E, Bonacorsi S, Giraud A, Duriez P, Hilali F, Amorin C, Bingen E, Andremont A, Picard B, Taddei F, Matic I
High frequency of mutator strains among human uropathogenic Escherichia coli isolates.
Journal of Bacteriology 2002, 184, 605-609.

Duval X, Lamotte C, Race E, Descamps D, Damond F, Clavel F, Leport C, Peytavin G, Vilde JL
Amprenavir inhibitory quotient and virological response in human immunodeficiency virus-infected patients on an amprenavir-containing salvage regimen without or with ritonavir.
Antimicrobial Agents and Chemotherapy 2002, 46, 570-574.

Vrtovsnik F, Porcher R, Michel C, Hufnagel G, Queffeulou G, Mentré F, Mignon F
Survival of elderly patients on peritoneal dialysis: retrospective study of 292 patients, from 1982 to 1999.
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 2002, 22, 73-81.

Duffull SB, Retout S, Mentré F
The use of simulated annealing for finding optimal population designs.
Computer Methods and Programs in Biomedicine 2002, 69, 25-35.

Schubert S, Picard B, Gouriou S, Heesemann J, Denamur E
Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections.
Infection and Immunity 2002, 70, 5335-5337.

Rocha EPC, Pradillon O, Bui H, Sayada C, Denamur E
A new family of highly variable proteins in the Chlamydophila pneumoniae genome.
Nucleic Acids Research 2002, 30, 4351-4360.

Sasomsin P, Mentré F, Diquet B, Simon F, Brun-Vezinet F
Relationship between exposure to zidovudine and decrease of P24 antigenemia in HIV-infected patients in monotherapy.
Fundamental & Clinical Pharmacology 2002, 16, 347-352.

Duval X, Larger E, Longuet P, Leport C, Vilde JL
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.
Lancet (London, England) 2001, 357, 475.

Retout S, Duffull S, Mentre F
Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs.
Computer Methods and Programs in Biomedicine 2001, 65, 141-151.

Aarons L, Karlsson MO, Mentre F, Rombout F, Steimer JL, van Peer A
Role of modelling and simulation in Phase I drug development.
European Journal of Pharmaceutical Sciences 2001, 13, 115-122.

Duffull SB, Mentre F, Aarons L
Optimal design of a population pharmacodynamic experiment for ivabradine.
Pharmaceutical Research 2001, 18, 83-89.

Mentre F, Dubruc C, Thenot JP
Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children.
Journal of Pharmacokinetics and Pharmacodynamics 2001, 28, 299-319.

Comets E, Mentre F
Evaluation of tests based on individual versus population modeling to compare dissolution curves..
Journal of biopharmaceutical statistics 2001, 11, 107-23.

Fidouh-Houhou N, Duval X, Bissuel F, Bourbonneux V, Flandre P, Ecobichon JL, Jordan MC, Vildé JL, Brun-Vézinet F, Leport C
Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2001, 33, 1406-1411.

Picard B, Duriez P, Gouriou S, Matic I, Denamur E, Taddei F
Mutator natural Escherichia coli isolates have an unusual virulence phenotype.
Infection and Immunity 2001, 69, 9-14.

Deloménie C, Fouix S, Longuemaux S, Brahimi N, Bizet C, Picard B, Denamur E, Dupret JM
Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid.
Journal of Bacteriology 2001, 183, 3417-3427.

Lechat P, Lardoux H, Mallet A, Sanchez P, Derumeaux G, Lecompte T, Maillard L, Mas JL, Mentre F, Pousset F, Lacomblez I, Pisica G, Solbes-Latourette S, Raynaud P, Chaumet-Riffaud P
Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation - A randomized trial (fluindione, fibrillation auriculaire, aspirin et contraste spontane; FFAACS).
Cerebrovascular Diseases 2001, 12, 245-252.

Descamps D, Calvez V, Izopet J, Buffet-Janvresse C, Schmuck A, Colson P, Ruffault A, Maillard A, Masquelier B, Cottalorda J, Harzic M, Brun-Vézinet F, Costagliola D, AARSG
Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study.
AIDS (London, England) 2001, 15, 1777-1782.

Le Moing V, Eid Z, Ecobichon JL, Duval X, Longuet P, Elbim C, Brun-Vezinet F, Leport C, Vilde JL
[Long-term immunologic response in HIV-infected patients with CD4 cell counts Annales De Medecine Interne 2001, 152, 11-14.

Descamps V, Duval X, Grossin M, Crickx B, Leport C
Topical cidofovir for bowenoid papulosis in an HIV-infected patient.
The British Journal of Dermatology 2001, 144, 642-643.

Duval X, Papastamopoulos V, Longuet P, Benoit C, Perronne C, Leport C, Vildé JL
Definite streptococcus bovis endocarditis: characteristics in 20 patients.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2001, 7, 3-10.

Duval X, Djendli S, Le Moing V, Longuet P, Barry B, Leport C, Vildé JL
Recurrent Staphylococcus aureus extracerebral infections complicating hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease).
The American Journal of Medicine 2001, 110, 671-672.

Duriez P, Clermont O, Bonacorsi S, Bingen E, Chaventré A, Elion J, Picard B, Denamur E
Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations.
Microbiology (Reading, England) 2001, 147, 1671-1676.

Chen JM, Cutler C, Jacques C, Boeuf G, Denamur E, Lecointre G, Mercier B, Cramb G, Férec C
A combined analysis of the cystic fibrosis transmembrane conductance regulator: implications for structure and disease models.
Molecular Biology and Evolution 2001, 18, 1771-1788.

Swiatecka-Urban A, Mokrzycki MH, Kaskel F, Da Silva F, Denamur E
Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome.
Pediatric Nephrology (Berlin, Germany) 2001, 16, 627-630.

Maccari F, Descamps V, Duval X, Grossin M, Vildé JL, Crickx B
[Skin manifestations of immune restoration syndrome in treated tuberculosis].
Annales De Dermatologie Et De Venereologie 2001, 128, 1028-1030.

Duval X, Trad S, Le Moing V, Longuet P, Leport C, Vildé JL
[Paradoxical aggravation of tuberculosis after antiretroviral therapy in HIV-infected patients].
Presse Medicale (Paris, France: 1983) 2001, 30, 213-216.

Comets E, Mentre F, Kawai R, Nimmerfall F, Marbach P, Vonderscher J
Modeling the kinetics of release of octreotide from long-acting formulations injected intramuscularly in rabbits.
Journal of Pharmaceutical Sciences 2000, 89, 1123-1133.

Denamur E, Bocquet N, Baudouin V, Da Silva F, Veitia R, Peuchmaur M, Elion J, Gubler MC, Fellous M, Niaudet P, Loirat C
WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis.
Kidney International 2000, 57, 1868-1872.

Deschamps C, Dubruc C, Mentre F, Rosenzweig P
Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
Clinical Pharmacology & Therapeutics 2000, 68, 647-657.

Bert F, Galdbart JO, Zarrouk V, Le Mee J, Durand F, Mentre F, Belghiti J, Lambert-Zechovsky N, Fantin B
Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipients.
Clinical Infectious Diseases 2000, 31, 1295-1299.

Comets E, Pousset F, Mentre F, Diquet B, Ankri A, Mallet A, Lechat P
Prediction of fluindione maintenance dosage hampered by large intraindividual variability.
Therapeutic Drug Monitoring 2000, 22, 668-675.

Descamps D, Flandre P, Calvez V, Peytavin G, Meiffredy V, Collin G, Delaugerre C, Robert-Delmas S, Bazin B, Aboulker JP, Pialoux G, Raffi F, Brun-Vézinet F
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).
JAMA 2000, 283, 205-211.

Cavé H, Polak M, Drunat S, Denamur E, Czernichow P
Refinement of the 6q chromosomal region implicated in transient neonatal diabetes.
Diabetes 2000, 49, 108-113.

Duval X
[The 39th ICAAC (San Francisco) and the 7th European Conference on Clinical Aspects and Treatment of HIV-infection (Lisbon). HIV infection: antiretroviral agents in the development and trial stage].
Presse Medicale (Paris, France: 1983) 2000, 29, 253-256.

Aguilar-Martinez P, Schved JF, Badens C, Thuret I, Michel G, Neonato MG, Peltier JY, Girot R, Pissard S, Galacteros F, Bachir D, Rose C, Picot MC, Denamur E, Elion J
Iron overload in thalassaemias and genetic haemochromatosis.
European Journal of Haematology 2000, 64, 279-280.

Denamur E, André JL, Niaudet P, Loirat C
Absence of correlation between genotype and the severity of diffuse mesangial sclerosis in Denys-Drash syndrome.
Pediatric Nephrology (Berlin, Germany) 2000, 14, 439-440.

Tredano M, Cneude F, Denamur E, Truffert P, Capron F, Manouvrier S, Feldmann D, Couderc R, Elion J, Lacaze-Masmonteil T
[Constitutional deficiency of pulmonary surfactant protein B: clinical presentation, histologic and molecular diagnosis].
Archives De Pédiatrie: Organe Officiel De La Sociéte Française De Pédiatrie 2000, 7, 641-644.

Dunn DT, Simonds RJ, Bulterys M, Kalish LA, Moye J, de Maria A, Kind C, Rudin C, Denamur E, Krivine A, Loveday C, Newell ML
Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples.
AIDS (London, England) 2000, 14, 1421-1428.

Bönte A, Schröder W, Denamur E, Querfeld U
Absent pubertal development in a child with chronic renal failure: the case of Frasier syndrome.
Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2000, 15, 1688-1690.

Duval X, Le Moing V, Longuet C, Leport C, Vildé JL, Lamotte C, Peytavin G, Farinotti R
Efavirenz-induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir.
Antimicrobial Agents and Chemotherapy 2000, 44, 2593.

Denamur E, Lecointre G, Darlu P, Tenaillon O, Acquaviva C, Sayada C, Sunjevaric I, Rothstein R, Elion J, Taddei F, Radman M, Matic I
Evolutionary implications of the frequent horizontal transfer of mismatch repair genes.
Cell 2000, 103, 711-721.

Lechat P, Lardoux H, Mallet A, Sanchez P, Derumeaux G, Lecompte T, Maillard L, Mas JL, Mentre F, Pousset F, Lacomblez L, Pisica G, Solbes-Latourette S, Raynaud P, Chaumet-Riffaud P
Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (FFAACS).
Therapie 2000, 55, 681-689.

Comets E, Mentre F, Nimmerfall F, Kawai R, Mueller I, Marbach P, Vonderscher J
Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR.
Journal of Controlled Release 1999, 59, 197-205.

Merle Y, Mentre F
Optimal sampling times for Bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring.
Journal of Pharmacokinetics and Biopharmaceutics 1999, 27, 85-101.

Mentre F, Kovarik J, Gerbeau C
Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis: An application to basiliximab in renal transplantation.
Journal of Pharmacokinetics and Biopharmaceutics 1999, 27, 213-230.

Le Moing V, Lacassin F, Delahousse M, Duval X, Longuet P, Leport C, Vildé JL
Use of corticosteroids in glomerulonephritis related to infective endocarditis: three cases and review.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 1999, 28, 1057-1061.

Benveniste O, Longuet P, Duval X, Le Moing V, Leport C, Vildé JL
Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 1999, 28, 1180-1181.

Topaloglu R, Denamur E, Akyüz C, Kale G, Bakkaloglu A
Wilms' tumour-associated late nephrotic syndrome responsive to treatment.
Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 1999, 14, 954-956.

François B, Duval X, Le Moing V, Bruneel F, Leport C, Vilde JL
[Bupivacaine-induced meningitis].
La Revue De Medecine Interne 1999, 20, 719-720.

Descamps V, Duval X, Crickx B, Bouscarat F, Coffin B, Belaich S
Global improvement of systemic scleroderma under long-term administration of octreotide.
European journal of dermatology: EJD 1999, 9, 446-448.

Denamur E, Bocquet N, Mougenot B, Da Silva F, Martinat L, Loirat C, Elion J, Bensman A, Ronco PM
Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases.
Journal of the American Society of Nephrology: JASN 1999, 10, 2219-2223.

Duval X, Peytavin G, Fouqueray B, Leport C, Vildé JL
Renin-angiotensin system inhibition in a patient having an overdose of HIV protease inhibitor.
AIDS (London, England) 1999, 13, 1983-1984.

Longuet P, Duval X, Le Moing V, Scanvic-Hameg A, Leport C, Vildé JL
[Antibiotic prophylaxis in patients at high risk of nosocomial outbreak of legionellosis].
Presse Medicale (Paris, France: 1983) 1999, 28, 1755-1756.

Leport C, Duval X
[Cerebral toxoplasmosis in an HIV-infected patient. Diagnosis, development, treatment and prevention].
La Revue Du Praticien 1999, 49, 2271-2274.

Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bingen E, Elion J, Denamur E
The link between phylogeny and virulence in Escherichia coli extraintestinal infection.
Infection and Immunity 1999, 67, 546-553.

Tenaillon O, Toupance B, Le Nagard H, Taddei F, Godelle B
Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria.
Genetics 1999, 152, 485-493.

Mentre F, Pousset F, Comets E, Plaud B, Diquet B, Montalescot G, Ankri A, Mallet A, Lechat P
Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients.
Clinical Pharmacology & Therapeutics 1998, 63, 64-78.

Mentre F, Golmard JL, Launay JM, Aubin-Brunet V, Bouhassira M, Jouvent R
Relationships between low red blood cell count and clinical response to fluoxetine in depressed elderly patients.
Psychiatry Research 1998, 81, 403-405.

Aymard G, Legrand M, Comets E, Mentre F, Diquet B
Rapid and simple micromethod for the quantification of fluindione in human plasma using high-performance liquid chromatography.
Journal of Chromatography B 1998, 707, 169-173.

Patron-Bizet F, Mentre F, Genton M, Thomas-Haimez C, Maccario J
Assessment of the global two-stage method to EC50 determination.
Journal of Pharmacological and Toxicological Methods 1998, 39, 103-108.

Mesnil F, Mentre F, Dubruc C, Thenot JP, Mallet A
Population pharmacokinetic analysis of mizolastine and validation from sparse data on patients using the nonparametric maximum likelihood method.
Journal of Pharmacokinetics and Biopharmaceutics 1998, 26, 133-161.

Tod M, Mentre F, Merle Y, Mallet A
Robust optimal design for the estimation of hyperparameters in population pharmacokinetics.
Journal of Pharmacokinetics and Biopharmaceutics 1998, 26, 689-716.

Jeanpierre C, Denamur E, Henry I, Cabanis MO, Luce S, Cécille A, Elion J, Peuchmaur M, Loirat C, Niaudet P, Gubler MC, Junien C
Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
American Journal of Human Genetics 1998, 62, 824-833.

Comets E, Mentre F, Pousset F, Diquet B, Montalescot G, Ankri A, Mallet A, Lechat P
Modeling INR data to predict maintenance fluindione dosage.
Therapeutic Drug Monitoring 1998, 20, 631-639.

Derkinderen P, Duval X, Bruneel F, Laissy JP, Regnier B
Intramedullary spinal cord abscess associated with cervical spondylodiskitis and epidural abscess.
Scandinavian Journal of Infectious Diseases 1998, 30, 618-619.

Bingen E, Picard B, Brahimi N, Mathy S, Desjardins P, Elion J, Denamur E
Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains.
The Journal of Infectious Diseases 1998, 177, 642-650.

Verlingue C, Vuillaumier S, Mercier B, Le Gac M, Elion J, Férec C, Denamur E
Absence of mutations in the interspecies conserved regions of the CFTR promoter region in cystic fibrosis (CF) and CF related patients.
Journal of Medical Genetics 1998, 35, 137-140.

Muller F, Dommergues M, Simon-Bouy B, Ferec C, Oury JF, Aubry MC, Bessis R, Vuillard E, Denamur E, Bienvenu T, Serre JL
Cystic fibrosis screening: a fetus with hyperechogenic bowel may be the index case.
Journal of Medical Genetics 1998, 35, 657-660.

Dixméras I, Lapouméroulie C, Tallec LP, Bens M, Elion J, Vandewalle A, Denamur E
CFTR regions containing duodenum specific DNase I hypersensitive sites drive expression in intestinal crypt cells but not in fibroblasts.
Biochemical and Biophysical Research Communications 1998, 250, 328-334.

Duval X, Chosidow O, Tissot-Dupont H, Raoult D, Frances C
[Cutaneous signs of Rickettsia and related microorganisms].
La Revue De Medecine Interne 1998, 19, 548-557.

Rolland K, Lambert-Zechovsky N, Picard B, Denamur E
Shigella and enteroinvasive Escherichia coli strains are derived from distinct ancestral strains of E. coli.
Microbiology (Reading, England) 1998, 144 ( Pt 9), 2667-2672.

Lecointre G, Rachdi L, Darlu P, Denamur E
Escherichia coli molecular phylogeny using the incongruence length difference test.
Molecular Biology and Evolution 1998, 15, 1685-1695.

Gouya L, Pascaud O, Munck A, Elion J, Denamur E
Novel mutation (A141D) in exon 4 of the CFTR gene identified in an Algerian patient.
Human Mutation 1997, 10, 86-87.

Merle Y, Mentre F
Stochastic optimization algorithms of a Bayesian design criterion for Bayesian parameter estimation of nonlinear regression models: Application in pharmacokinetics.
Mathematical Biosciences 1997, 144, 45-70.

Mesnil F, Dubruc C, Mentre F, Huet S, Mallet A, Thenot JP
Pharmacokinetic analysis of mizolastine in healthy young volunteers after single oral and intravenous doses: Noncompartmental approach and compartmental modeling.
Journal of Pharmacokinetics and Biopharmaceutics 1997, 25, 125-147.

Jerling M, Merle Y, Mentre F, Mallet A
Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method.
British Journal of Clinical Pharmacology 1997, 44, 447-453.

Mentre F, Mallet A, Baccar D
Optimal design in random-effects regression models.
Biometrika 1997, 84, 429-442.

Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, Simon F, Saragosti S, Brun-Vézinet F
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.
Journal of Virology 1997, 71, 8893-8898.

Vuillaumier S, Kaltenboeck B, Lecointre G, Lehn P, Denamur E
Phylogenetic analysis of cystic fibrosis transmembrane conductance regulator gene in mammalian species argues for the development of a rabbit model for cystic fibrosis.
Molecular Biology and Evolution 1997, 14, 372-380.

Duval X, Clayette P, Dereuddre-Bosquet N, Fretier P, Martin M, Salmon-Ceron D, Gras G, Vilde JL, Dormont D
Dapsone and HIV-1 replication in primary cultures of lymphocytes and monocyte-derived macrophages.
AIDS (London, England) 1997, 11, 943-944.

Matic I, Radman M, Taddei F, Picard B, Doit C, Bingen E, Denamur E, Elion J
Highly variable mutation rates in commensal and pathogenic Escherichia coli.
Science (New York, N.Y.) 1997, 277, 1833-1834.

Bingen E, Bonacorsi S, Brahimi N, Denamur E, Elion J
Virulence patterns of Escherichia coli K1 strains associated with neonatal meningitis.
Journal of Clinical Microbiology 1997, 35, 2981-2982.

Vuillaumier S, Dixmeras I, Messaï H, Lapouméroulie C, Lallemand D, Gekas J, Chehab FF, Perret C, Elion J, Denamur E
Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation.
The Biochemical Journal 1997, 327 ( Pt 3), 651-662.

Lechat P, Canet E, Bellissant E, Billaud E, Brouard R, Bruguerolle B, Bruno R, Cudennec C, Degos L, Diquet B, Dubruc C, Garaffo R, Humbert H, Jochensen R, Laurent S, Laurin S, Laveille C, Mentre F, Paintaud G, Rosenzweig P, Simon P, Thibault N, Thuillez C, Warot D
Determination of time-dependent effect profile of drugs.
Therapie 1997, 52, 291-298.

Aarons L, Balant LP, Mentre F, Rowland M, Steimer JL, Vozeh S
Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies.
European Journal of Clinical Pharmacology 1996, 49, 251-254.

Gérard B, Peponnet C, Brunie G, Cavé H, Denamur E, d'Auriol L, Monplaisir N, Simon F, Elion J, Grandchamp B
Fluorometric detection of HIV-1 genome through use of an internal control, inosine-substituted primers, and microtiter plate format.
Clinical Chemistry 1996, 42, 696-703.

Doit C, Denamur E, Picard B, Geslin P, Elion J, Bingen E
Mechanisms of the spread of penicillin resistance in Streptococcus pneumoniae strains causing meningitis in children in France.
The Journal of Infectious Diseases 1996, 174, 520-528.

Messaoud T, Verlingue C, Denamur E, Pascaud O, Quéré I, Fattoum S, Elion J, Férec C
Distribution of CFTR mutations in cystic fibrosis patients of Tunisian origin: identification of two novel mutations.
European journal of human genetics: EJHG 1996, 4, 20-24.

Bingen E, Denamur E, Brahimi N, Elion J
Genotyping may provide rapid identification of Escherichia coli K1 organisms that cause neonatal meningitis.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 1996, 22, 152-156.

Vozeh S, Steimer JL, Rowland M, Morselli P, Mentre F, Balant LP, Aarons L
The use of population pharmacokinetics in drug development.
Clinical Pharmacokinetics 1996, 30, 81-93.

Burtin P, Mentre F, vanBree J, Steimer JL
Sparse sampling for assessment of drug exposure in toxicological studies.
European Journal of Drug Metabolism and Pharmacokinetics 1996, 21, 105-111.

Merle Y, Mentre F
Bayesian Design Criteria - Computation, Comparison, and Application to a Pharmacokinetic and a Pharmacodynamic Model.
Journal of Pharmacokinetics and Biopharmaceutics 1995, 23, 101-125.

Mentre F, Gomeni R
A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics..
Journal of biopharmaceutical statistics 1995, 5, 141-58.

Mentré F, Burtin P, Merlé Y, Bree Jv, Mallet A, Steimer JL
Sparse-Sampling Optimal Designs in Pharmacokinetics and Toxicokinetics*.
Drug Information Journal 1995, 29, 997-1019.

Denamur E, Chehab FF
Methylation status of CpG sites in the mouse and human CFTR promoters.
DNA and cell biology 1995, 14, 811-815.

Desjardins P, Picard B, Kaltenböck B, Elion J, Denamur E
Sex in Escherichia coli does not disrupt the clonal structure of the population: evidence from random amplified polymorphic DNA and restriction-fragment-length polymorphism.
Journal of Molecular Evolution 1995, 41, 440-448.

Descamps D, Collin G, Loussert-Ajaka I, Saragosti S, Simon F, Brun-Vézinet F
HIV-1 group O sensitivity to antiretroviral drugs.
AIDS (London, England) 1995, 9, 977-978.

Sayada C, Denamur E, Grandchamp B, Orfila J, Elion J
Denaturing gradient gel electrophoresis analysis for the detection of point mutations in the Chlamydia trachomatis major outer-membrane protein gene.
Journal of Medical Microbiology 1995, 43, 14-25.

Sayada C, Andersen AA, Storey C, Milon A, Eb F, Hashimoto N, Hirai K, Elion J, Denamur E
Usefulness of omp1 restriction mapping for avian Chlamydia psittaci isolate differentiation.
Research in Microbiology 1995, 146, 155-165.

Duval X, Chosidow O, Semah F, Lipsker D, Francès C, Herson S
Lamotrigine versus carbamazepine in epilepsy.
Lancet (London, England) 1995, 345, 1301-1302.

Duval X, Paty MC, Longuet P, Lacassin F, Perronne C, Leport C, Vildé JL
[Pneumopathies caused by Streptococcus pneumoniae in 27 HIV infected patients].
Presse Medicale (Paris, France: 1983) 1995, 24, 715-718.

Sayada C, Vretou E, Orfila J, Elion J, Denamur E
Heterogeneity within the first constant segment of the major outer membrane protein gene in Chlamydia trachomatis serovar D/Da distinguishes 2 lineages.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1995, 318, 943-949.

Dunn DT, Brandt CD, Krivine A, Cassol SA, Roques P, Borkowsky W, De Rossi A, Denamur E, Ehrnst A, Loveday C
The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission.
AIDS (London, England) 1995, 9, F7-11.

Merle Y, Mentre F, Mallet A, Aurengo A
Designing an Optimal Experiment for Bayesian-Estimation - Application to the Kinetics of Iodine Thyroid Uptake.
Statistics in Medicine 1994, 13, 185-196.

Mentre F, Mallet A
Handling Covariates in Population Pharmacokinetics.
International Journal of Bio-Medical Computing 1994, 36, 25-33.

Taright N, Mentre F, Mallet A, Jouvent R
Nonparametric-Estimation of Population Characteristics of the Kinetics.
Therapeutic Drug Monitoring 1994, 16, 258-269.

Denamur E, Chehab FF
Analysis of the mouse and rat CFTR promoter regions.
Human Molecular Genetics 1994, 3, 1089-1094.

Vilmer E, Quelvennec E, Plouvier E, Denamur E, Rohrlich P, Elion J, Sterkers G
HLA-mismatched cord blood transplantation: immunological studies.
Blood Cells 1994, 20, 235-241.

Dufourcq R, Vuillaumier S, Pascaud O, Guidal C, Oury JF, Elion J, Denamur E
Compound heterozygosity for delta F508 and F508C: a cautionary note on the molecular diagnosis of cystic fibrosis.
Prenatal Diagnosis 1994, 14, 1176-1177.

Picard B, Denamur E, Barakat A, Elion J, Goullet P
Genetic heterogeneity of Pseudomonas aeruginosa clinical isolates revealed by esterase electrophoretic polymorphism and restriction fragment length polymorphism of the ribosomal RNA gene region.
Journal of Medical Microbiology 1994, 40, 313-322.

Bingen EH, Denamur E, Elion J
Use of ribotyping in epidemiological surveillance of nosocomial outbreaks.
Clinical Microbiology Reviews 1994, 7, 311-327.

Pescatore P, Marteau P, Lemière E, Xerri B, Denamur E, Elion J, Matuchansky C, Rambaud JC
[Mucoviscidosis discovered after the age of 25 years. Review and follow-up of cases of the literature].
Gastroentérologie Clinique Et Biologique 1994, 18, 195-199.

Cavé H, Mariani P, Grandchamp B, Elion J, Denamur E
Reliability of PCR directly from stool samples: usefulness of an internal standard.
BioTechniques 1994, 16, 809-810.

Cavé H, Bingen E, Elion J, Denamur E
Differentiation of Escherichia coli strains using randomly amplified polymorphic DNA analysis.
Research in Microbiology 1994, 145, 141-150.

Sayada C, Andersen A, Rodriguez P, Eb F, Milon A, Elion J, Denamur E
Homogeneity of the major outer membrane protein gene of feline Chlamydia psittaci.
Research in Veterinary Science 1994, 56, 116-118.

Mariani-Kurkdjian P, Denamur E, Milon A, Picard B, Cave H, Lambert-Zechovsky N, Loirat C, Goullet P, Sansonetti PJ, Elion J
Identification of a clone of Escherichia coli O103:H2 as potential agent of hemolytic-uremic syndrome in France.
Journal of Clinical Microbiology 1994, 32, 860.

Aarons L, Balant L, Mentre F, Morselli P, Rowland M, Steimer J, Vozeh S
Population Approaches in Drug Development - Report on an Expert Meeting.
European Journal of Clinical Pharmacology 1994, 46, 389-391.

Jerling M, Merle Y, Mentre F, Mallet A
Population Pharmacokinetics of Nortriptyline During Monotherapy and During Concomitant Treatment with Drugs That Inhibit Cyp2d6 - an Evaluation with the Nonparametric Maximum-Likelihood Method.
British Journal of Clinical Pharmacology 1994, 38, 453-462.

Gomeni R, Pineau G, Mentre F
Population-Kinetics and Conditional Assessment of the Optimal Dosage Regimen Using the P-Pharm Software Package.
Anticancer Research 1994, 14, 2321-2326.

Balant L, Rowland M, Aarons L, Mentre F, Morselli P, Steimer J, Vozeh S
New Strategies in Drug Development and Clinical-Evaluation - the Population Approach - Commentary on an Action for Cooperative Research.
European Journal of Clinical Pharmacology 1993, 45, 93-94.

Mentre F, Escolano S, Diquet B, Golmard J, Mallet A
Clinical Pharmacokinetics of Zidovudine - Inter and Intraindividual Variability and Relationship to Long-Term Efficacy and Toxicity.
European Journal of Clinical Pharmacology 1993, 45, 397-407.

Merle Y, Mentre F, Mallet A, Aurengo A
Computer-Assisted Individual Estimation of Radioiodine Thyroid Uptake in Graves-Disease.
Computer Methods and Programs in Biomedicine 1993, 40, 33-41.

Mignon F, Michel C, Mentre F, Viron B
Worldwide demographics and future trends of the management of renal failure in the elderly..
Kidney international. Supplement 1993, 41, S18-26.

Duval X, Debord T, Fournier B, Darie H, Lemoing V, Roue R
Q fever with cutaneous and encephalitic involvement.
Lancet (London, England) 1993, 341, 1094-1095.

Denamur E, Picard B, Decoux G, Denis JB, Elion J
The absence of correlation between allozyme and rrn RFLP analysis indicates a high gene flow rate within human clinical Pseudomonas aeruginosa isolates.
FEMS microbiology letters 1993, 110, 275-280.

Denamur E, Levine M, Simon F, Rohrlich P, Cave H, Rahimy C, de Crepy A, Boissinot C, Larchee R, Lescoeur B
Conversion of HIV-1 viral markers during the first few months of life in HIV-infected children born to seropositive mothers.
AIDS (London, England) 1993, 7, 897-899.

Bingen EH, Desjardins P, Arlet G, Bourgeois F, Mariani-Kurkdjian P, Lambert-Zechovsky NY, Denamur E, Philippon A, Elion J
Molecular epidemiology of plasmid spread among extended broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital.
Journal of Clinical Microbiology 1993, 31, 179-184.

Mariani-Kurkdjian P, Denamur E, Milon A, Picard B, Cave H, Lambert-Zechovsky N, Loirat C, Goullet P, Sansonetti PJ, Elion J
Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in France.
Journal of Clinical Microbiology 1993, 31, 296-301.

Simon F, Rahimy C, Krivine A, Levine M, Pepin JM, Lapierre D, Denamur E, Vernoux L, De Crepy A, Blot P
Antibody avidity measurement and immune complex dissociation for serological diagnosis of vertically acquired HIV-1 infection.
Journal of Acquired Immune Deficiency Syndromes 1993, 6, 201-207.

Bingen E, Cavé H, Aujard Y, Lambert-Zechovsky N, Desjardins P, Elion J, Denamur E
Molecular analysis of multiply recurrent meningitis due to Escherichia coli K1 in an infant.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 1993, 16, 82-85.

Bingen E, Boissinot C, Desjardins P, Cave H, Brahimi N, Lambert-Zechovsky N, Denamur E, Blot P, Elion J
Arbitrarily primed polymerase chain reaction provides rapid differentiation of Proteus mirabilis isolates from a pediatric hospital.
Journal of Clinical Microbiology 1993, 31, 1055-1059.

Bindi P, Mougenot B, Mentre F, Noel L, Peraldi M, Vanhille P, Lesavre P, Mignon F, Ronco P
Necrotizing Crescentic Glomerulonephritis Without Significant Immune Deposits - a Clinical and Serological Study.
Quarterly Journal of Medicine 1993, 86, 55-68.

Mignon F, Michel C, Viron B, Mentre F, Jaar B
End-stage renal diseases in patients 75 and over: a new medical, socio-economical and ethical challenge..
The European journal of medicine 1992, 1, 302-7.

Bingen E, Denamur E, Lambert-Zechovsky N, Elion J
[Contribution of molecular typing in the surveillance of nosocomial infections. Experience in pediatric hospitals].
Presse Médicale (Paris, France: 1983) 1992, 21, 1504-1506.

Bingen E, Denamur E, Lambert-Zechovsky N, Boissinot C, Brahimi N, Aujard Y, Blot P, Elion J
Mother-to-infant vertical transmission and cross-colonization of Streptococcus pyogenes confirmed by DNA restriction fragment length polymorphism analysis.
The Journal of Infectious Diseases 1992, 165, 147-150.

Bingen E, Denamur E, Lambert-Zechovsky N, Aujard Y, Brahimi N, Geslin P, Elion J
Analysis of DNA restriction fragment length polymorphism extends the evidence for breast milk transmission in Streptococcus agalactiae late-onset neonatal infection.
The Journal of Infectious Diseases 1992, 165, 569-573.

Lambert-Zechovsky N, Bingen E, Denamur E, Brahimi N, Brun P, Mathieu H, Elion J
Molecular analysis provides evidence for the endogenous origin of bacteremia and meningitis due to Enterobacter cloacae in an infant.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 1992, 15, 30-32.

Bingen E, Denamur E, Lambert-Zechovsky N, Brahimi N, el Lakany M, Elion J
Rapid genotyping shows the absence of cross-contamination in Enterobacter cloacae nosocomial infections.
The Journal of Hospital Infection 1992, 21, 95-101.

Bingen EH, Mariani-Kurkdjian P, Lambert-Zechovsky NY, Desjardins P, Denamur E, Aujard Y, Vilmer E, Elion J
Ribotyping provides efficient differentiation of nosocomial Serratia marcescens isolates in a pediatric hospital.
Journal of Clinical Microbiology 1992, 30, 2088-2091.

Bingen E, Denamur E, Lambert-Zechovsky N, Braimi N, el Lakany M, Elion J
DNA restriction fragment length polymorphism differentiates recurrence from relapse in treatment failures of Streptococcus pyogenes pharyngitis.
Journal of Medical Microbiology 1992, 37, 162-164.

Bingen E, Denamur E, Picard B, Goullet P, Lambert-Zechovsky N, Foucaud P, Navarro J, Elion J
Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 1992, 11, 432-437.

Sayada C, Denamur E, Elion J
Complete sequence of the major outer membrane protein-encoding gene of Chlamydia trachomatis serovar Da.
Gene 1992, 120, 129-130.

Picard B, Denamur E, Souriau A, Orfila J, Rodolakis A, Goullet P
Enzyme electrophoretic polymorphism differentiates invasive from non-invasive Chlamydia psittaci ruminant isolates.
Research in Microbiology 1992, 143, 525-531.

Sayada C, Denamur E, Xerri B, Orfila J, Catalan F, Elion J
[Epidemiology of Chlamydia trachomatis using analysis of gene encoding of the major outer membrane protein].
Pathologie-Biologie 1992, 40, 583-589.

Vilmer E, Sterkers G, Rahimy C, Denamur E, Elion J, Broyart A, Lescoeur B, Tiercy JM, Gerota J, Blot P
HLA-mismatched cord-blood transplantation in a patient with advanced leukemia.
Transplantation 1992, 53, 1155-1157.

Bingen EH, Denamur E, Picard B, Goullet P, Lambert-Zechovsky NY, Brahimi N, Mercier JC, Beaufils F, Elion J
Molecular epidemiology unravels the complexity of neonatal Escherichia coli acquisition in twins.
Journal of Clinical Microbiology 1992, 30, 1896-1898.

Escolano S, Mentre F, Golmard J, Diquet B, Mallet A
Plasma-Concentrations of Zidovudine.
New England Journal of Medicine 1992, 326, 1571-1571.

Coustere C, Mentre F, Sommadossi J, Diasio R, Steimer J
A Mathematical-Model of the Kinetics of 5-Fluorouracil and Its Metabolites in Cancer-Patients.
Cancer Chemotherapy and Pharmacology 1991, 28, 123-129.

Denamur E, Picard B, Goullet P, Bingen E, Lambert N, Elion J
Complexity of Pseudomonas aeruginosa infection in cystic fibrosis: combined results from esterase electrophoresis and rDNA restriction fragment length polymorphism analysis.
Epidemiology and Infection 1991, 106, 531-539.

Bingen EH, Denamur E, Lambert-Zechovsky NY, Bourdois A, Mariani-Kurkdjian P, Cezard JP, Navarro J, Elion J
DNA restriction fragment length polymorphism differentiates crossed from independent infections in nosocomial Xanthomonas maltophilia bacteremia.
Journal of Clinical Microbiology 1991, 29, 1348-1350.

Bingen EH, Denamur E, Lambert-Zechovsky NY, Elion J
Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital.
Journal of Clinical Microbiology 1991, 29, 1888-1892.

Denamur E, Sayada C, Souriau A, Orfila J, Rodolakis A, Elion J
Restriction pattern of the major outer-membrane protein gene provides evidence for a homogeneous invasive group among ruminant isolates of Chlamydia psittaci.
Journal of General Microbiology 1991, 137, 2525-2530.

Sayada C, Denamur E, Orfila J, Catalan F, Elion J
Rapid genotyping of the Chlamydia trachomatis major outer membrane protein by the polymerase chain reaction.
FEMS microbiology letters 1991, 67, 73-78.

Jarry C, Denamur E, Suermondt G, Tossou H, Capron JP, Orfila J
[Cholangitis caused by Aeromonas hydrophila and Aeromonas caviae].
Presse Médicale (Paris, France: 1983) 1991, 20, 1345.

Denamur E, Picard-Pasquier N, Mura C, Picard B, Orfila J, Krishnamoorthy R
Comparison of molecular epidemiological tools for Branhamella catarrhalis typing.
Research in Microbiology 1991, 142, 585-589.

Escolano S, Mentre F, Golmard J, Diquet B, Mallet A
A Reduced Dose of Zidovudine in Patients with Aids.
New England Journal of Medicine 1991, 324, 995-995.

Bindi P, Mougenot B, Mentre F, Noel L, Peraldi M, Vanhille P, Lesavre P, Mignon F, Ronco P
Necrotizing and Crescentic Glomerulonephritis Without Immunoglobulin Deposits - Renal Location of Systemic Vasculitis with Antineutrophil Cytoplasm Antibodies.
Presse Medicale 1991, 20, 1939-1943.

Leclercq J, Denjoy I, Mentre F, Coumel P
Flecainide Acetate Dose-Concentration Relationship in Cardiac-Arrhythmias - Influence of Heart-Failure and Amiodarone.
Cardiovascular Drugs and Therapy 1990, 4, 1161-1165.

Leggett JE, Fantin B, Ebert S, Totsuka K, Vogelman B, Calame W, Mattie H, Craig WA
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.
The Journal of Infectious Diseases 1989, 159, 281-292.

Suermondt G, Denamur E, Fleuret A, Laurans G, Orfila J
[In vitro activity of miocamycin compared with four other macrolides and with pristinamycin against Branhamella catarrhalis].
Pathologie-Biologie 1989, 37, 386-389.

Denamur E, Suermondt G, Debroca A, Defouilloy C, Laurans G, Muir JF, Orfila J
[Nosocomial pulmonary infections caused by Branhamella catarrhalis in intensive care units].
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquées Aux Effets De L'agression 1989, 30, 251-253.

Picard B, Goullet P, Denamur E, Suermondt G
Esterase electrophoresis: a molecular tool for studying the epidemiology of Branhamella catarrhalis nosocomial infection.
Epidemiology and Infection 1989, 103, 547-554.

Puy H, Canarelli B, Denamur E, Strunsky V, Orfila J
[Otitis caused by Vibrio alginolyticus].
Presse Médicale (Paris, France: 1983) 1989, 18, 985.

Mallet A, Mentre F, Gilles J, Kelman A, Thomson A, Bryson S, Whiting B
Handling covariates in population pharmacokinetics with an application to gentamicin.
Biomedical Measurement Information and Control 1988, 2, 138-146.

Mallet A, Mentre F, Steimer J, Lokiec F
Nonparametric Maximum-Likelihood Estimation for Population Pharmacokinetics, with Application to Cyclosporine.
Journal of Pharmacokinetics and Biopharmaceutics 1988, 16, 311-327.

Mentre F, Mallet A, Steimer J
Hyperparameter Estimation Using Stochastic-Approximation with Application to Population Pharmacokinetics.
Biometrics 1988, 44, 673-683.

Ducroix JP, Guerlin M, Hary L, Smail A, Denamur E, Eb F, Andrejak M, Baillet J
[Clinical and pharmacokinetic study of ceftriaxone in the treatment of 14 episodes of ascitic fluid infection].
Pathologie-Biologie 1988, 36, 1007-1010.

Suermondt G, Denamur E, Laurans G, Orfila J
[In vitro activity of 3 fluoroquinolones on Branhamella catarrhalis].
Pathologie-Biologie 1988, 36, 647-650.

Denamur E, Thomas D, Eb F, Sevenet F, Mancheron H, Fardellone P, Sebert JL
[Listeria monocytogenes septic arthritis of the knee].
Revue Du Rhumatisme Et Des Maladies Ostéo-Articulaires 1988, 55, 963-964.

Leport C, Raffi F, Matheron S, Katlama C, Regnier B, Saimot AG, Marche C, Vedrenne C, Vilde JL
Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.
The American Journal of Medicine 1988, 84, 94-100.

Mentre F, Mallet A, Steimer J, Lokiec F
An Application of Population Pharmacokinetics to the Clinical Use of Cyclosporine in Bone-Marrow Transplant Patients.
Transplantation Proceedings 1988, 20, 466-470.

Denamur E, Pautard JC, Ducroix JP, Masmoudi K, Eb F, Riou JY, Orfila J
Meningococcal disease due to group A Neisseria meningitidis in contacts of Mecca pilgrims.
Lancet 1987, 2, 1211.

Denamur E, Suermondt G, Laurans G, Muir JF, Orfila J
[Increasing role of Branhamella catarrhalis in bronchopulmonary pathology in adults].
Presse Médicale (Paris, France: 1983) 1987, 16, 1202.

Denamur E, Tribouilloy C, Lesbre JP
[Endocarditis in Barlow's disease. Value of two-dimensional echography].
Presse Médicale (Paris, France: 1983) 1985, 14, 430-431.

Mentre F, Steimer J, Sommadossi J, Diasio R, Cano J
A Mathematical-Model of the Kinetics of 5-Fluorouracil and Its Catabolites in Freshly Isolated Rat Hepatocytes.
Biochemical Pharmacology 1984, 33, 2727-2732.

Roué R, Debord T, Denamur E, Ferry M, Dormont D, Barre-Sinoussi F, Rouzioux C
Diagnosis of Toxoplasma encephalitis in absence of neurological signs by early computerised tomographic scanning in patients with AIDS.
Lancet 1984, 2, 1472.

Lallement PY, Kaloustian E, Denamur E, Veyssier P
[Postserum cephalic tetanus. A case after anatoxin therapy and homologous serotherapy].
Presse Médicale (Paris, France: 1983) 1984, 13, 562.

Denamur E, Kaloustian E, Veyssier P, Plouin PF
Polyuria polydipsia syndrome showing a renal infarction.
Clinical Nephrology 1984, 22, 107-108.

Denamur E, Tumerelle E, Lallement PY, Darchis JP, Veyssier P
[Clostridium paraputrificum fulminant septicemia and gas gangrene disclosing acute promyelocytic leukemia].
LARC médical 1984, 4, 236.

Denamur E, Latrive JP, Veyssier P
[Clear cell adenocarcinoma of the left kidney. Successive thyroid, duodenopancreatic and cervical lymph node metastases].
Presse Médicale (Paris, France: 1983) 1983, 12, 3003.